Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LYPD8,Ly6/PLAUR domain-containing protein 8,15724,0.244069808668148,0.0571820408922052,0.131993008519426,0.356146608816871,1.98127817379996e-05
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,COL9A2,Collagen alpha-2(IX) chain,13710,0.20937852719768,0.0530744847671171,0.105352537054131,0.31340451734123,8.01998560589594e-05
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,STX7,Syntaxin-7,13552,0.197901113074163,0.0561201051108861,0.0879057070568261,0.3078965190915,0.000422666946328613
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SERPINA6,Corticosteroid-binding globulin,13992,0.0637622778759942,0.0190965813395878,0.0263329784504022,0.101191577301586,0.000843195088704563
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IGSF9,Protein turtle homolog A,13974,0.312153317564905,0.0937182138502837,0.128465618418349,0.495841016711461,0.00086832384717669
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,STX1B,Syntaxin-1B,13590,0.160307961002016,0.0488137695279249,0.0646329727272829,0.255982949276749,0.00102577528885829
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,13946,0.23706024179468,0.0752987744368614,0.0894746438984312,0.384645839690928,0.00164591213050473
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DPEP1,Dipeptidase 1,15925,-0.168516668129736,0.0552269102606216,-0.276761412240554,-0.0602719240189175,0.00228189639544958
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,VEGFB,Vascular endothelial growth factor B,13552,-0.098376033495988,0.0327296415473937,-0.16252613092888,-0.0342259360630963,0.00265441144164523
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CRTAC1,Cartilage acidic protein 1,16301,-0.100605327396776,0.0338532075282905,-0.166957614152225,-0.0342530406413262,0.00296481666892224
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FLT3LG,Fms-related tyrosine kinase 3 ligand,16272,0.111951265203801,0.037685766454711,0.0380871629525676,0.185815367455035,0.00297603525948566
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,15664,0.18721752257559,0.0643620605508977,0.0610678838958303,0.313367161255349,0.00363308288602975
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,STXBP3,Syntaxin-binding protein 3,15724,0.146096239652035,0.0502975287472035,0.0475130833075165,0.244679395996554,0.00368187662045824
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LY96,Lymphocyte antigen 96,15950,-0.115570085482763,0.0402759502108897,-0.194510947896107,-0.0366292230694194,0.00411718543203948
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MICALL2,MICAL-like protein 2,13590,0.224764074228608,0.0792801808880169,0.0693749196880944,0.380153228769121,0.00458847644620884
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,13894,0.11383201818316,0.0404410803999994,0.0345675005991612,0.193096535767159,0.00488820938706587
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MYO9B,Unconventional myosin-IXb,15826,0.208520391678355,0.0756004400510639,0.0603435291782699,0.35669725417844,0.00581891357568495
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TAP1,Antigen peptide transporter 1,13710,0.181501651873509,0.0663279018896217,0.0514989641698504,0.311504339577168,0.00621898890517563
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PLA2G7,Platelet-activating factor acetylhydrolase,16101,-0.0970439351334448,0.0359971948391543,-0.167598437018187,-0.0264894332487025,0.00702770375792666
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GCG,Pro-glucagon,15724,0.377112924780469,0.141638950710334,0.0995005813882151,0.654725268172723,0.0077642844870003
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",13974,0.0924919018527355,0.0348722032617014,0.0241423834598009,0.16084142024567,0.00800334397391691
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,USP47,Ubiquitin carboxyl-terminal hydrolase 47,13486,0.259569669439338,0.0978749003060073,0.067734864839564,0.451404474039113,0.00800970896775666
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,OCLN,Occludin,13946,0.132980454097184,0.0501471277088188,0.0346920837878992,0.231268824406469,0.00801531746746633
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RARRES1,Retinoic acid receptor responder protein 1,15724,0.101835646397242,0.038451677085207,0.0264703593102362,0.177200933484248,0.00809531991582176
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PALM,Paralemmin-1,13835,0.0916596876746075,0.0348779199670328,0.0232989645392232,0.160020410809992,0.00859797095917253
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PFDN2,Prefoldin subunit 2,15688,0.158970848486284,0.0611955466867269,0.0390275769802989,0.278914119992268,0.00939240049447113
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,13894,0.143662397188314,0.0554308204191749,0.0350179891667312,0.252306805209897,0.0095591301380831
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MAPKAPK2,MAP kinase-activated protein kinase 2,13710,0.221468783124616,0.0856106718668731,0.0536718662655445,0.389265699983687,0.00969374672179191
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FGFR2,Fibroblast growth factor receptor 2,16118,0.064069990686009,0.0247740478117142,0.0155128569750492,0.112627124396969,0.00971349421382532
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,REEP4,Receptor expression-enhancing protein 4,13946,0.182604596616702,0.0706813372130761,0.0440691756790732,0.321140017554332,0.00979069237020269
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PTH,Parathyroid hormone,13590,0.23920339657029,0.0926255757672412,0.057657268066497,0.420749525074082,0.00981976726923062
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RLN2,Prorelaxin H2,13665,-0.331994255788834,0.129599122967457,-0.586008536805051,-0.077979974772618,0.0104267241139511
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",16008,0.100349938035032,0.0392925449987072,0.0233365498375657,0.177363326232498,0.010661021880857
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TRAF2,TNF receptor-associated factor 2,16073,0.202583202634741,0.0797403978327053,0.0462920228826384,0.358874382386843,0.0110776620673374
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,16085,-0.327441916472741,0.129295331543872,-0.580860766298729,-0.0740230666467526,0.0113343009488483
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,OXT,Oxytocin-neurophysin 1,16230,0.399555335157034,0.157783516135871,0.0902996435307262,0.708811026783341,0.011341025812176
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AFP,Alpha-fetoprotein,15900,0.192211971584498,0.0759883638487319,0.0432747784409833,0.341149164728012,0.0114323600926255
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PRAP1,Proline-rich acidic protein 1,13972,0.115227903511908,0.0457270692728167,0.0256028477371877,0.204852959286629,0.0117496916314853
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ATP6V1G1,V-type proton ATPase subunit G 1,13610,0.206762395283474,0.0823655876657706,0.0453258434585636,0.368198947108384,0.0120743544774476
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SPON1,Spondin-1,16107,-0.0917069236377432,0.0369958011982097,-0.164218693986234,-0.0191951532892521,0.0131909584295123
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CDC123,Cell division cycle protein 123 homolog,13480,0.184329496611394,0.0746731804045642,0.037970063018448,0.33068893020434,0.0135810257192845
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SOD2,"Superoxide dismutase [Mn], mitochondrial",16101,0.105973444975359,0.0429986094943227,0.0216961703664861,0.190250719584231,0.0137278271723323
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DBN1,Drebrin,13552,0.142896656314376,0.0580153441577615,0.0291865817651637,0.256606730863589,0.0137871216838451
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",13610,0.125913497201374,0.0512556614580516,0.0254524007435929,0.226374593659155,0.01403916758943
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PLSCR3,Phospholipid scramblase 3,13902,0.166087507749684,0.0676734600672215,0.0334475260179304,0.298727489481438,0.0141301114814065
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FRMD4B,FERM domain-containing protein 4B,13486,0.194102189088692,0.0794382062762908,0.0384033047871622,0.349801073390222,0.0145608860057631
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TXN,Thioredoxin,13744,0.120957876128833,0.0495276195080919,0.0238837418929731,0.218032010364693,0.0146093378240589
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CFB,Complement factor B,13741,0.0911021586417949,0.0373979349194643,0.017802206199645,0.164402111083945,0.0148624496393063
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NFAT5,Nuclear factor of activated T-cells 5,13552,0.235586934499067,0.0967947882299816,0.0458691495683033,0.425304719429831,0.0149507755056798
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MMP12,Macrophage metalloelastase,16104,0.144698391764225,0.0595820781182571,0.0279175186524413,0.261479264876009,0.0151699816166178
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,13946,0.181346319919202,0.0746839625468989,0.03496575332728,0.327726886511124,0.0151872636431722
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CNTN1,Contactin-1,16301,-0.073824937364799,0.0304256275334693,-0.133459167330399,-0.0141907073991992,0.0152599646531438
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IMMT,MICOS complex subunit MIC60,13894,0.122965214776289,0.0506876921269637,0.0236173382074396,0.222313091345137,0.0152815239876837
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KRT6C,"Keratin, type II cytoskeletal 6C",13486,0.106683248476261,0.0440924329426393,0.0202620799086874,0.193104417043834,0.0155534551590779
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BGN,Biglycan,15701,0.324313222425785,0.134573866658639,0.0605484437748532,0.588078001076717,0.0159671394767351
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,COL1A1,Collagen alpha-1(I) chain,16301,-0.0688808428274077,0.0286426608302189,-0.125020458054637,-0.0127412276001786,0.016190902865899
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SIL1,Nucleotide exchange factor SIL1,13610,0.090546163750495,0.0376658268314154,0.0167211431609209,0.164371184340069,0.0162329955698005
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PIGR,Polymeric immunoglobulin receptor,15872,0.0986276149038376,0.0410302670467023,0.0182082914923011,0.179046938315374,0.016238067508546
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TMEM25,Transmembrane protein 25,13946,0.124382462925365,0.0518977107954925,0.0226629497661997,0.22610197608453,0.0165572375165111
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CTHRC1,Collagen triple helix repeat-containing protein 1,13972,0.075538521865684,0.0315409306920485,0.013718297709269,0.137358746022099,0.0166363508599985
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FCRL5,Fc receptor-like protein 5,16101,-0.155138155505079,0.0650683568332919,-0.282672134898331,-0.027604176111827,0.0171262605387953
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SLAMF7,SLAM family member 7,16073,-0.156640730899697,0.0657850177831031,-0.285579365754579,-0.0277020960448152,0.0172725939206005
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TSPAN8,Tetraspanin-8,13913,0.272257023466664,0.114512385841906,0.0478127472165277,0.496701299716801,0.0174423105555662
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PRSS8,Prostasin,16025,0.109493040798034,0.0461211682108702,0.0190955511047287,0.19989053049134,0.0176068403899472
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MAMDC2,MAM domain-containing protein 2,13974,0.092094782064496,0.0388210481647586,0.0160055276615691,0.168184036467423,0.0176916871741811
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GPRC5C,G-protein coupled receptor family C group 5 member C,13894,0.150713650811781,0.0643534880005259,0.0245808143307504,0.276846487292812,0.0191965471056881
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,13684,-0.109015730040454,0.046644147534364,-0.200438259207808,-0.017593200873101,0.0194442280500595
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,13486,0.176097289000265,0.0754222000250176,0.0282697769512305,0.323924801049299,0.0195674166628076
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",13610,0.151666397532349,0.0650604292787371,0.0241479561460238,0.279184838918673,0.0197593608355956
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,13552,0.145441193679685,0.0627498568481431,0.022451474257325,0.268430913102046,0.0204753924746647
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IRAK1,Interleukin-1 receptor-associated kinase 1,15826,0.185188633994189,0.0799744720303526,0.0284386688146976,0.34193859917368,0.0205930226670869
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ADGRV1,Adhesion G-protein coupled receptor V1,13474,-0.184350205011161,0.0797329818888087,-0.340626849513226,-0.0280735605090958,0.0207874809893472
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MMP1,Interstitial collagenase,15535,0.239323175656271,0.104261802474991,0.034970042805289,0.443676308507254,0.0217231347319906
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DYNLT3,Dynein light chain Tctex-type 3,13894,0.11384327533194,0.0496312174671273,0.0165660890963709,0.21112046156751,0.0218177968804452
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,OGFR,Opioid growth factor receptor,16008,0.0854233269982716,0.0372800300237766,0.0123544681516695,0.158492185844874,0.0219534343118533
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DDX53,Probable ATP-dependent RNA helicase DDX53,13590,0.0965919926272645,0.0421611436620231,0.0139561510496993,0.17922783420483,0.021977547380944
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MELTF,Melanotransferrin,13974,0.0759217463988835,0.0332390796290161,0.0107731503260119,0.141070342471755,0.0223799536388388
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FBP1,"Fructose-1,6-bisphosphatase 1",16102,0.19163818909343,0.0839363416877149,0.027122959385509,0.356153418801351,0.022435265250637
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,13328,0.132342151474204,0.0581225506173423,0.0184219522642128,0.246262350684195,0.0228049947977319
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NTF4,Neurotrophin-4,15724,-0.100980285269881,0.0444280737801497,-0.188059309878974,-0.0139012606607875,0.0230460357832925
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TRIM58,E3 ubiquitin-protein ligase TRIM58,13894,0.224512158254419,0.0990687503357902,0.0303374075962705,0.418686908912568,0.0234528895472331
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,COCH,Cochlin,13974,0.117473702372608,0.0520456177066025,0.0154642916676671,0.219483113077549,0.0240153705766197
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DEFB104A_DEFB104B,Beta-defensin 104,13474,-0.140220316583673,0.0622553972370667,-0.262240895168324,-0.0181997379990226,0.024316843383256
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CRELD2,Protein disulfide isomerase CRELD2,16132,0.131003581231101,0.058299446770701,0.0167366655605269,0.245270496901675,0.0246483219714433
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FSTL1,Follistatin-related protein 1,13610,0.0581867562909986,0.0259537104160327,0.00731748387557441,0.109056028706423,0.0249810739613328
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AZI2,5-azacytidine-induced protein 2,13946,0.141275556393833,0.0630535804545718,0.0176905387028721,0.264860574084794,0.025070052576583
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MZB1,Marginal zone B- and B1-cell-specific protein,16135,-0.128615906900151,0.0576121265639334,-0.24153567496546,-0.0156961388348417,0.0255992421250525
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,INHBB,Inhibin beta B chain,13684,0.131826160735587,0.0591029380366631,0.0159844021837268,0.247667919287446,0.0257337345509171
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CASP9,Caspase-9,13552,0.15642580113764,0.0702169513716988,0.0188005764491106,0.29405102582617,0.0259135710166006
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL18,Interleukin-18,16020,0.117647008526154,0.0528343290089074,0.0140917236686957,0.221202293383613,0.0259801667995229
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CBS,Cystathionine beta-synthase,13610,0.12789261658924,0.0577971266726533,0.0146102483108392,0.24117498486764,0.0269290195745051
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SEPTIN8,Septin-8,13893,0.0831928738895522,0.0376990727580871,0.00930269128370144,0.157083056495403,0.0273470153616468
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CDHR2,Cadherin-related family member 2,16008,0.181212798052093,0.0826045263246676,0.0193079264557442,0.343117669648441,0.0282684924924903
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,OTUD7B,OTU domain-containing protein 7B,13946,0.15678248055913,0.0716198569565435,0.0164075609243047,0.297157400193955,0.0286066638520312
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,13552,0.111010679873574,0.0508855130049666,0.0112750743838399,0.210746285363309,0.0291578848462358
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,13974,0.150641369744525,0.069252888617411,0.0149057080543992,0.28637703143465,0.0296291671822016
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PTPRS,Receptor-type tyrosine-protein phosphatase S,16301,-0.0603236734289669,0.0277524676089057,-0.114718509942422,-0.0059288369155118,0.0297470808722199
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EHBP1,EH domain-binding protein 1,13974,0.181180213432058,0.0838080163329121,0.0169165014195506,0.345443925444566,0.030646812515575
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,13573,0.0975365727073178,0.0451174484422669,0.00910637376047474,0.185966771654161,0.0306481754092285
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PVR,Poliovirus receptor,16230,0.0905154432521189,0.0419528614005787,0.00828783490698455,0.172743051597253,0.0309773879093106
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DGKZ,Diacylglycerol kinase zeta,15826,0.0891666485177536,0.0413619460093211,0.00809723433948421,0.170236062696023,0.0311170338798499
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BMP4,Bone morphogenetic protein 4,15924,0.110354911838476,0.0513001899744012,0.00980653948864924,0.210903284188302,0.0314785902679273
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,OPLAH,5-oxoprolinase,13610,0.168945672023594,0.0786435291756687,0.0148043548392833,0.323086989207904,0.0317118046277707
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SAFB2,Scaffold attachment factor B2,13946,0.0660766909075984,0.0307767718132354,0.005754218153657,0.12639916366154,0.0318131743304698
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DCTN6,Dynactin subunit 6,15688,0.170601467178731,0.079675158040483,0.0144381574193843,0.326764776938078,0.0322722573919805
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PLA2G2A,"Phospholipase A2, membrane associated",16079,-0.13661267768026,0.0638679001153065,-0.26179376190626,-0.0114315934542589,0.0324516640121802
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,16164,-0.0837484465255217,0.0392601588800268,-0.160698357930374,-0.00679853512066914,0.0329261198092518
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,13927,0.0983838401439293,0.0461844141264491,0.007862388456089,0.18890529183177,0.0331693797851289
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LAG3,Lymphocyte activation gene 3 protein,16008,-0.0985548372198036,0.0463557840095482,-0.189412173878518,-0.00769750056108912,0.0335141497898106
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ITGA6,Integrin alpha-6,16073,0.124673693042985,0.058868111027756,0.0092921954285836,0.240055190657387,0.0342032906554599
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GBP4,Guanylate-binding protein 4,15688,0.115385127130697,0.054501051722932,0.00856306575375017,0.222207188507643,0.0342655900685576
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,13486,0.113494318374385,0.0536959230271295,0.0082503092412109,0.218738327507558,0.0345636134016611
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MEGF10,Multiple epidermal growth factor-like domains protein 10,16076,-0.0939197105746455,0.0445683515270785,-0.181273679567719,-0.00656574158157164,0.0351054421934942
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SNAPIN,SNARE-associated protein Snapin,13946,0.137764250517354,0.0657016158636326,0.0089890834246345,0.266539417610074,0.03602778043064
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MSLN,Mesothelin,15978,0.132652589681878,0.0634279248076943,0.00833385705879691,0.256971322304959,0.0365087955143251
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SAT2,Thialysine N-epsilon-acetyltransferase,13710,0.166630446704373,0.0797197010502759,0.0103798326458326,0.322881060762914,0.0366178628011185
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,13684,0.139558408425951,0.067075900163503,0.00808964410548477,0.271027172746416,0.0374887129960687
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HSD17B3,Testosterone 17-beta-dehydrogenase 3,13486,0.116955369128995,0.0562255900374259,0.00675321265564051,0.22715752560235,0.0375343712196613
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PDZD2,PDZ domain-containing protein 2,13486,0.142870391980531,0.0687472582620151,0.00812576578698185,0.277615018174081,0.0377100425912573
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RAB33A,Ras-related protein Rab-33A,13486,0.157796831249715,0.0761481660327482,0.00854642582552836,0.307047236673901,0.0382625862793097
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BACH1,Transcription regulator protein BACH1,16073,0.170184636778766,0.0822058734702331,0.00906112477710877,0.331308148780422,0.0384472453176834
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,13684,0.0512181838836432,0.024743173501437,0.00272156382082672,0.0997148039464597,0.0384717821032475
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ORM1,Alpha-1-acid glycoprotein 1,13946,0.0467209657687947,0.0225985394001813,0.00242782854443944,0.09101410299315,0.0387117946740249
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SLC27A4,Long-chain fatty acid transport protein 4,15688,0.153894242173574,0.0747725576022907,0.0073400292730845,0.300448455074064,0.0395908164581177
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SFTPD,Pulmonary surfactant-associated protein D,16102,0.157002306623776,0.0763006884871621,0.0074529571889381,0.306551656058614,0.0396370566778689
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CDNF,Cerebral dopamine neurotrophic factor,16008,0.0751055600009147,0.0368379662785947,0.00290314609486907,0.14730797390696,0.0414855486984633
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NEXN,Nexilin,13982,0.15635130109159,0.0768313535437797,0.0057618481457816,0.306940754037398,0.0418703748117053
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,16174,-0.100583014700522,0.0494641276038262,-0.197532704804021,-0.0036333245970227,0.0420230093368415
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,13508,0.0635641334663703,0.0312937430359735,0.00222839711586231,0.124899869816878,0.0422533545372618
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FAM3D,Protein FAM3D,13913,0.196741812032414,0.0968717790564682,0.00687312508173613,0.386610498983091,0.0422789847177456
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FCN1,Ficolin-1,13954,0.12697184688745,0.0627636219834414,0.0039551477999048,0.249988545974995,0.0430904889935783
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SERPINA4,Kallistatin,13740,0.0539343499025218,0.0266688471249776,0.00166340953756568,0.106205290267478,0.0431572125887783
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NEK7,Serine/threonine-protein kinase Nek7,13710,0.172857809367344,0.0855048909249599,0.00526822315442269,0.340447395580266,0.0432357440506921
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",13610,0.0748159871610002,0.037042928005933,0.00221184826937164,0.147420126052629,0.0434330135707161
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,OSM,Oncostatin-M,16001,-0.162304094172948,0.0803902876216463,-0.319869057911375,-0.00473913043452132,0.0435089170521456
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,INSL4,Early placenta insulin-like peptide,13894,-0.116331586310247,0.0576558630579718,-0.229337077903872,-0.00332609471662218,0.0436428932332149
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SUOX,"Sulfite oxidase, mitochondrial",13946,0.145442516102579,0.0721270962069152,0.0040734075370254,0.286811624668133,0.0437694379768221
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GFRAL,GDNF family receptor alpha-like,13522,0.143151016040576,0.0710451783697133,0.00390246643593811,0.282399565645214,0.0439318253116209
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ATRN,"Attractin, Isoform 2",13992,0.0379866522328371,0.0188688340060854,0.00100373758090973,0.0749695668847644,0.0441131970443741
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LYPD1,Ly6/PLAUR domain-containing protein 1,15688,0.143506377274206,0.0713750604733328,0.00361125874647347,0.283401495801938,0.0443852919373128
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EPPK1,Epiplakin,13610,0.16875816412453,0.0839440531757089,0.00422781990014068,0.33328850834892,0.0444123112063975
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL1A,Interleukin-1 alpha,15826,0.130132063366525,0.0647741967105324,0.00317463781388128,0.257089488919168,0.0445529490544537
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,15826,0.125502818439439,0.0625118817446524,0.00297953021991994,0.248026106658957,0.0446960512691935
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LRG1,Leucine-rich alpha-2-glycoprotein,13992,0.0608528137066559,0.0304065495615726,0.0012559765659736,0.120449650847338,0.0453787065154957
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",13610,0.176206724777764,0.0880759598084505,0.00357784355320107,0.348835606002327,0.0454529615672073
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",13610,0.113562611984707,0.0567838380671449,0.00226628937310326,0.224858934596311,0.0455297522939923
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TAX1BP1,Tax1-binding protein 1,13927,0.144540554006921,0.0722818710663246,0.00286808671692512,0.286213021296918,0.0455543238484156
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CLASP1,CLIP-associating protein 1,13480,0.169123739601872,0.0848803972363746,0.00275816101857726,0.335489318185166,0.0463369613201415
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,YTHDF3,YTH domain-containing family protein 3,15826,0.195592735804723,0.0982026976441556,0.00311544842217812,0.388070023187268,0.0464184466949607
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ECM1,Extracellular matrix protein 1,13603,-0.0820335465856948,0.0411931422299505,-0.162772105356398,-0.00129498781499182,0.0464528522671249
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PECR,Peroxisomal trans-2-enoyl-CoA reductase,13610,0.0642121996612812,0.0322528569703461,0.000996599999402756,0.12742779932316,0.04651190927875
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CES3,Carboxylesterase 3,16008,0.156002352561315,0.0783897605818346,0.00235842182091872,0.30964628330171,0.0465984756085248
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MRPL52,"39S ribosomal protein L52, mitochondrial",13456,-0.0571292947740659,0.0287798550820802,-0.113537810734943,-0.000720778813188654,0.0471598056048182
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SNX15,Sorting nexin-15,13684,0.123173121568018,0.0620991846218993,0.00145871970909574,0.244887523426941,0.0473326793538945
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LMOD2,Leiomodin-2,13474,0.141700363207394,0.0714560426506565,0.0016465196121071,0.281754206802681,0.0473829841200308
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FGF2,Fibroblast growth factor 2,16073,0.150762364450164,0.0762468650371113,0.00131850897742589,0.300206219922902,0.0480256354453099
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PSMD1,26S proteasome non-ATPase regulatory subunit 1,13946,0.111266834694574,0.0562819497552692,0.00095421317424646,0.221579456214902,0.0480664964940669
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL10RB,Interleukin-10 receptor subunit beta,16160,0.0637130549536748,0.0322570673772431,0.000489202894278395,0.126936907013071,0.0482663457604904
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",13894,0.0840278821198757,0.0426290434677776,0.000474956923031511,0.16758080731672,0.048727512774708
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AAMDC,Mth938 domain-containing protein,13610,0.117673074556704,0.0597208868136055,0.000620136402037286,0.234726012711371,0.0488146467521138
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,VMO1,Vitelline membrane outer layer protein 1 homolog,16008,0.151172364545153,0.0767678808781916,0.000707318023897507,0.301637411066409,0.0489457880576482
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,STX6,Syntaxin-6,15724,0.152769210249786,0.0776318190473706,0.000610844916939579,0.304927575582632,0.0491007329991997
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MATN3,Matrilin-3,15924,-0.0715894988621787,0.0364124184483378,-0.142957839020921,-0.000221158703436683,0.0493074569013653
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HMMR,Hyaluronan mediated motility receptor,13456,0.108237346580386,0.0551439831967269,0.000155139514800784,0.21631955364597,0.0496884575020777
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PPP1R9B,Neurabin-2,16272,0.208375896802712,0.106177731595009,0.000267542876495691,0.416484250728929,0.0497190302080785
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RNASE4,Ribonuclease 4,13501,0.0596419509760746,0.0304099079218245,3.85314492985789e-05,0.119245370502851,0.0498684202693194
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MFAP4,Microfibril-associated glycoprotein 4,13684,0.0705457277131711,0.036040344089864,-9.33467029622798e-05,0.141184802129304,0.0503196095242187
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ATP6V1D,V-type proton ATPase subunit D,16008,0.0596654383105942,0.0305225439666144,-0.000158747863970105,0.119489624485159,0.0506241946132504
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",13552,0.0986186595332358,0.0504536761199399,-0.000270545661846491,0.197507864728318,0.0506463961432375
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CCN1,CCN family member 1,15985,0.168696400476377,0.0864092652981647,-0.000665759508025859,0.33805856046078,0.0509206054349189
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,15950,-0.062266690238436,0.0318970419423655,-0.124784892445472,0.000251511968600335,0.0509420546384298
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ICAM3,Intercellular adhesion molecule 3,16301,-0.0579368577651613,0.0297166755536517,-0.116181541850319,0.000307826319995923,0.0512360254385693
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SNX5,Sorting nexin-5,13610,0.0666118072457309,0.0341745839207533,-0.000370377238945424,0.133593991730407,0.0512965928933444
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,REN,Renin,16102,-0.167125437929822,0.0857726881173497,-0.335239906639827,0.000989030780183697,0.0513762130854914
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PLXNB2,Plexin-B2,16225,-0.0522426147112359,0.0268316603944667,-0.104832669084391,0.000347439661918837,0.0515458505541434
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NT5C1A,Cytosolic 5'-nucleotidase 1A,13927,0.0716691075700563,0.0368654930401221,-0.000587258788582942,0.143925473928696,0.05190711365328
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FOXJ3,Forkhead box protein J3,13552,0.100589196777167,0.0517787496789337,-0.000897152593542894,0.202075546147877,0.0520763454771181
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL12RB1,Interleukin-12 receptor subunit beta-1,15826,0.0825545324238207,0.0426107931425294,-0.000962622135536911,0.166071686983178,0.0527131578408852
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",15688,-0.0658456342172671,0.0340938778330554,-0.132669634770056,0.000978366335521452,0.0534635077193339
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TGFB1,Transforming growth factor beta-1 proprotein,16248,0.0841349580808697,0.043594638799959,-0.00131053396704993,0.169580450128789,0.0536318985116187
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LRRC38,Leucine-rich repeat-containing protein 38,13590,0.107665459597052,0.0558334753601333,-0.00176815210880885,0.217099071302914,0.0538347111344038
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PODXL,Podocalyxin,16008,0.0335434447289226,0.0174089258453072,-0.000578049927879604,0.0676649393857248,0.0540227816473643
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MCAM,Cell surface glycoprotein MUC18,16174,0.0722936479400652,0.0375633006461745,-0.00133042132643686,0.145917717206567,0.0542992237510844
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MVK,Mevalonate kinase,15826,0.176145943864795,0.0918811094881014,-0.00394103073188318,0.356232918461474,0.055242304144998
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GCLM,Glutamate--cysteine ligase regulatory subunit,13486,0.100408404758766,0.0524825639255194,-0.00245742053525218,0.203274230052784,0.0557466430044177
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MME,Neprilysin,16008,0.174041874014322,0.0914140836837573,-0.00512973000584199,0.353213478034486,0.056943132782733
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CDC26,Anaphase-promoting complex subunit CDC26,13889,0.152826917521035,0.0803782346876297,-0.00471442246671913,0.310368257508789,0.0572772692123773
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LY9,T-lymphocyte surface antigen Ly-9,15920,-0.0623787394188335,0.0328666459458795,-0.126797365472757,0.00203988663509026,0.0577228054103484
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,OMD,Osteomodulin,16160,-0.0929578319334888,0.0490397201010364,-0.18907568333152,0.00316001946454252,0.0580358219602086
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ELOB,Elongin-B,13486,0.0861477054729998,0.0454474233591185,-0.00292924431087252,0.175224655256872,0.0580414167634864
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MYOM3,Myomesin-3,13684,-0.201051241961973,0.106664466551098,-0.410113596402125,0.00801111247817987,0.059465307093996
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DMD,Dystrophin,13610,0.109905631244315,0.0583294902200608,-0.0044201695870041,0.224231432075634,0.0595564488051512
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,15778,-0.106243437749929,0.0564158252362159,-0.216818455212912,0.00433157971305445,0.0596888883622498
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MCEMP1,Mast cell-expressed membrane protein 1,13552,0.193606410056016,0.102842822480509,-0.00796552200578288,0.395178342117814,0.0597832597622854
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PHLDB1,Pleckstrin homology-like domain family B member 1,13913,0.115704977213452,0.0614741418269708,-0.00478434076741077,0.236194295194315,0.0598333882301738
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LAMP3,Lysosome-associated membrane glycoprotein 3,16248,0.108084515569511,0.0576133597707858,-0.00483766958122958,0.221006700720251,0.0606687928827033
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MAN2B2,Epididymis-specific alpha-mannosidase,13974,0.125442288321269,0.0671208554461214,-0.0061145883531295,0.256999164995667,0.0616574006960725
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD28,T-cell-specific surface glycoprotein CD28,15724,0.0792594505925859,0.0424202079998143,-0.00388415708705023,0.162403058272222,0.0617198985043274
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MYBPC2,"Myosin-binding protein C, fast-type",13610,-0.177971838729312,0.095258126835212,-0.364677767326327,0.00873408986770402,0.0617401776873117
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GIPC2,PDZ domain-containing protein GIPC2,13927,0.0632681254556936,0.0339568920872536,-0.00328738303532335,0.129823633946711,0.0624566617130725
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KIF22,Kinesin-like protein KIF22,13486,0.258429248385184,0.138738199396603,-0.0134976224321582,0.530356119202526,0.0625246072178728
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AMY2A,Pancreatic alpha-amylase,15445,-0.101781711345537,0.0547324609576255,-0.209057334822483,0.00549391213140885,0.062957982239021
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD40,Tumor necrosis factor receptor superfamily member 5,16084,0.104265643034431,0.056112910498804,-0.00571566154322439,0.214246947612087,0.0631674108081199
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MMP9,Matrix metalloproteinase-9,16073,-0.127774882565451,0.0689306996563746,-0.262879053891946,0.00732928876104269,0.063804478225419
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AMY2B,Alpha-amylase 2B,14976,-0.102901274093733,0.0556045159917788,-0.211886125437619,0.00608357725015385,0.0642479654717306
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TCOF1,Treacle protein,13974,0.0665065463890579,0.035949519129935,-0.00395451110561465,0.13696760388373,0.0643349242209922
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BAX,Apoptosis regulator BAX,15663,0.184299005391344,0.0996713547398089,-0.0110568498986812,0.37965486068137,0.0644669966340294
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SMAD3,Mothers against decapentaplegic homolog 3,13894,0.107661980177155,0.0582279232603719,-0.00646474941317415,0.221788709767484,0.0644826584246113
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,INPP1,Inositol polyphosphate 1-phosphatase,16008,0.112980451514671,0.0612295994284739,-0.00702956336513802,0.23299046639448,0.0650278871391543
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ARL13B,ADP-ribosylation factor-like protein 13B,13486,0.144884410219344,0.0786615492735153,-0.00929222635674559,0.299061046795434,0.0655160177290589
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ICAM5,Intercellular adhesion molecule 5,16102,-0.0933818470508878,0.0507369164075636,-0.192826203209712,0.00606250910793672,0.0657116730656582
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PLB1,"Phospholipase B1, membrane-associated",13927,0.123890378371105,0.0675788575316205,-0.00856418239087116,0.256344939133081,0.0667835917889674
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RUVBL1,RuvB-like 1,15724,0.216068335820952,0.117887701866637,-0.0149915598376554,0.44712823147956,0.0668464938379306
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,15778,0.173150333483047,0.0946006504298823,-0.0122669413595219,0.358567608325617,0.0672195968790313
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ARHGEF5,Rho guanine nucleotide exchange factor 5,13474,0.155650128239058,0.0850682573462282,-0.0110836561595489,0.322383912637665,0.0673156199323993
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,COMP,Cartilage oligomeric matrix protein,15951,-0.0695594389908671,0.0380268374507899,-0.144092040394415,0.00497316241268107,0.0673853818086193
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AGR3,Anterior gradient protein 3,15700,0.126182878449525,0.0690487209252111,-0.00915261456388869,0.261518371462939,0.0676515752291314
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,13610,0.158951827949495,0.0870547282829226,-0.0116754394850337,0.329579095384023,0.067889671995588
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL18BP,Interleukin-18-binding protein,16174,0.0634084989536291,0.0347458376280095,-0.00469334279726945,0.131510340704528,0.0680310114847386
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CXCL9,C-X-C motif chemokine 9,16160,0.136750357544359,0.0751648102088076,-0.010572670464904,0.284073385553622,0.0688780625413024
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KRT5,"Keratin, type II cytoskeletal 5",15688,0.100778511713719,0.0555027234932848,-0.00800682633311946,0.209563849760557,0.0694293730033947
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,COL9A1,Collagen alpha-1(IX) chain,16073,-0.0958046849506186,0.0528244971680299,-0.199340699399957,0.00773132949871998,0.0697516385472098
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL33,Interleukin-33,15826,0.0813411602551416,0.0449432695902939,-0.00674764814183454,0.169429968652118,0.070336014849404
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ZNF174,Zinc finger protein 174,13552,0.0758285370196264,0.0419191985035067,-0.00633309204724664,0.157990166086499,0.0704853830479956
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CRTAP,Cartilage-associated protein,13590,0.105059657968943,0.0581141652186786,-0.00884410585966741,0.218963421797553,0.0706574250565914
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,VNN2,Vascular non-inflammatory molecule 2,16008,-0.0953946684012991,0.0528363114730617,-0.1989538388885,0.00816450208590175,0.0710190941333516
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TCP11,T-complex protein 11 homolog,13710,0.121891061995398,0.0675580948919473,-0.0105228039928183,0.254304927983615,0.0712155473334285
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TCTN3,Tectonic-3,13974,0.0604467207490027,0.0335112204286973,-0.00523527129124406,0.126128712789249,0.0712880459758634
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,15724,0.129562946183335,0.0718434619069662,-0.0112502391543191,0.270376131520988,0.0713435925768261
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PTGES2,Prostaglandin E synthase 2,13445,0.111976748423477,0.0621318757908849,-0.00980172812665692,0.233755224973612,0.0715295677022859
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DNAJB2,DnaJ homolog subfamily B member 2,13684,0.111174276927396,0.0617154838954945,-0.00978807150777292,0.232136625362565,0.0716618723114397
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL1B,Interleukin-1 beta,15734,0.117991133088601,0.0655181917231818,-0.0104245226888353,0.246406788866037,0.0717391930341529
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,WFDC1,WAP four-disulfide core domain protein 1,13617,0.112202214568589,0.0623081313454335,-0.00992172286846078,0.234326152005638,0.0717622903021311
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,COL4A1,Collagen alpha-1(IV) chain,16102,0.0808235525018305,0.0449214483256198,-0.00722248621638438,0.168869591220045,0.0720026749082899
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,WIF1,Wnt inhibitory factor 1,16209,-0.0696544258023547,0.0387153896653908,-0.145536589546521,0.00622773794181121,0.0720150667221652
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PBLD,Phenazine biosynthesis-like domain-containing protein,15688,0.103217130738014,0.0573982431189998,-0.00928342577522594,0.215717687251253,0.0721545915821276
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GAMT,Guanidinoacetate N-methyltransferase,13486,-0.0744047239121968,0.0414352592018658,-0.155617831947854,0.00680838412346016,0.0725668358526078
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CFD,Complement factor D,13992,0.0397209516152854,0.0221417318408596,-0.00367684279279937,0.0831187460233702,0.072844255564909
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SMTN,Smoothelin,13907,0.194054235359148,0.108176049332496,-0.0179708213325442,0.40607929205084,0.072854970834355
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,STX4,Syntaxin-4,16008,0.122849914291396,0.0687206757701373,-0.0118426102180731,0.257542438800865,0.0738481351420532
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ZNRD2,Protein ZNRD2,13913,0.142729589260758,0.0799105135182605,-0.0138950172350322,0.299354195756549,0.0741019814538413
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,13913,0.0610671957060149,0.0342177736882643,-0.00599964072298316,0.128134032135013,0.074337794736069
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DGKA,Diacylglycerol kinase alpha,13552,0.109554607179872,0.061409465322525,-0.0108079448522771,0.229917159212021,0.0744457356618597
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ACP6,Lysophosphatidic acid phosphatase type 6,16186,0.133140370559542,0.0746456754476138,-0.0131651533177813,0.279445894436865,0.0745023263964883
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,VCAN,Versican core protein,16230,0.0603891941988911,0.0338883208511635,-0.00603191466938931,0.126810303067172,0.0747669451224034
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SV2A,Synaptic vesicle glycoprotein 2A,13590,0.127401321627882,0.0714950553461604,-0.012728986850592,0.267531630106357,0.0747781162661589
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RPA2,Replication protein A 32 kDa subunit,13552,0.0623228578608736,0.0349964509899837,-0.00627018607949448,0.130915901801242,0.0749620459047223
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PAXX,Protein PAXX,13684,0.0929172391433886,0.0522076940851499,-0.00940984126350512,0.195244319550282,0.0751372249825511
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ESPL1,Separin,13480,-0.111399148782582,0.0626356932008163,-0.234165107456182,0.0113668098910182,0.0753402187638337
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ANXA2,Annexin A2,13381,0.142790408249138,0.0804223233129404,-0.0148373454442251,0.300418161942501,0.0758369371415777
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CRYBB1,Beta-crystallin B1,13974,0.130503463559735,0.0735788597068861,-0.0137111014657618,0.274718028585232,0.0761421395174066
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CCL26,C-C motif chemokine 26,16073,-0.182083006194484,0.102797631200967,-0.38356636334838,0.0194003509594117,0.0765337317864378
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FABP9,Fatty acid-binding protein 9,16073,-0.111334680563149,0.0631242504137727,-0.235058211374144,0.0123888502478453,0.0777950016297068
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",16301,-0.0580204035916622,0.0329222444518579,-0.122548002717304,0.0065071955339794,0.0780295196866339
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FZD8,Frizzled-8,13474,-0.0851748456414905,0.0483453662281413,-0.179931763448647,0.00958207216566637,0.0781258644097272
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ZCCHC8,Zinc finger CCHC domain-containing protein 8,13486,0.123156407200476,0.0699994497050368,-0.0140425142213962,0.260355328622348,0.078533802196253
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ASRGL1,Isoaspartyl peptidase/L-asparaginase,13610,0.202875798894623,0.115433000329726,-0.0233728817516394,0.429124479540885,0.0788517301100051
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CHAD,Chondroadherin,13684,-0.103771929812938,0.0591315186214954,-0.219669706311069,0.012125846685193,0.0792929473048032
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CSF1,Macrophage colony-stimulating factor 1,16160,0.0532365745521524,0.0303586791606972,-0.00626643660281408,0.112739585707119,0.0795203328034
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BTNL10,Butyrophilin-like protein 10,13480,0.0816275014366269,0.0465566323198444,-0.00962349791026813,0.172878500783522,0.0795741684554484
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TPK1,Thiamin pyrophosphokinase 1,13974,0.0537722066572297,0.0306835098281357,-0.00636747260591639,0.113911885920376,0.0797134293349873
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,13552,0.0715247894594887,0.0409766584020428,-0.00878946100851519,0.151839039927493,0.0809204216420515
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RRP15,RRP15-like protein,13474,-0.180920430116196,0.103725779494162,-0.384222957924754,0.0223820976923625,0.0811438119752729
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,YAP1,Transcriptional coactivator YAP1,13927,0.0543469778016543,0.0311888840085932,-0.00678323485518843,0.115477190458497,0.0814411388079735
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ITGBL1,Integrin beta-like protein 1,13972,0.0718818032916749,0.0412918506337714,-0.00905022395051699,0.152813830533867,0.0817366439222518
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IGFBPL1,Insulin-like growth factor-binding protein-like 1,16102,0.0662006179102865,0.0380362084731707,-0.00835035069712797,0.140751586517701,0.0817968508057037
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NAPRT,Nicotinate phosphoribosyltransferase,13927,0.0652817480397498,0.0375308560880008,-0.00827872989273186,0.138842225972231,0.0819838415852569
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",13610,0.180812973635354,0.104031980194926,-0.0230897075467018,0.384715654817409,0.0822243217637004
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GBP2,Guanylate-binding protein 2,15826,0.119693135849022,0.0689087160459041,-0.0153679476009501,0.254754219298994,0.0824099845182217
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SCRN1,Secernin-1,16073,0.109120251416833,0.0628241152666139,-0.0140150145057304,0.232255517339396,0.0824210596569755
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,VNN1,Pantetheinase,13982,0.142072023138936,0.0818380773445131,-0.0183306084563097,0.302474654734181,0.0825834635874839
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TMED4,Transmembrane emp24 domain-containing protein 4,13486,-0.10934378097629,0.0630592881866332,-0.232939985822091,0.0142524238695107,0.0829438427192482
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,S100P,Protein S100-P,15778,-0.107069478866142,0.0618656102708026,-0.228326074996915,0.0141871172646311,0.0835286986149346
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MYH9,Myosin-9,13972,0.220286783882709,0.127412796164335,-0.0294422965993876,0.470015864364806,0.0838451713497675
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AKR1C4,Aldo-keto reductase family 1 member C4,15778,-0.103629137102337,0.0599575743600204,-0.221145982847977,0.0138877086433028,0.08394070225685
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CXCL6,C-X-C motif chemokine 6,16272,0.150258368271808,0.087073055464188,-0.020404820438001,0.320921556981616,0.0844278486807518
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GHR,Growth hormone receptor,13684,0.056289838533109,0.0326202456618874,-0.00764584296419037,0.120225520030408,0.0844401071920862
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CDH2,Cadherin-2,16102,0.0693664551469356,0.0402255526088832,-0.00947562796647555,0.148208538260347,0.0846480842238626
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ERC2,ERC protein 2,13590,0.150840041880005,0.0874936359979211,-0.02064748467592,0.322327568435931,0.0847285174405834
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TGFA,Protransforming growth factor alpha,16073,-0.0904746922769204,0.0525601429644863,-0.193492572487314,0.0125431879334727,0.0852055896043021
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CIT,Citron Rho-interacting kinase,13590,0.0939847032341334,0.0546043091393052,-0.0130397426789048,0.201009149147172,0.0852380968624996
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NAGK,N-acetyl-D-glucosamine kinase,13578,0.111759069379199,0.0649822117019988,-0.0156060655567184,0.239124204315117,0.0854841661098857
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RANBP1,Ran-specific GTPase-activating protein,13610,0.102730510367329,0.0597956433194885,-0.0144689505388683,0.219929971273526,0.0858145182522669
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SCGB3A1,Secretoglobin family 3A member 1,13684,-0.0492832667908856,0.0286865505250077,-0.105508905819901,0.00694237223812937,0.0858207043389872
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TSPYL1,Testis-specific Y-encoded-like protein 1,13552,0.0790862953610631,0.0460402245952345,-0.0111525448455966,0.169325135567723,0.0858623202278875
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TSLP,Thymic stromal lymphopoietin,15778,-0.11611539349205,0.0677524793711259,-0.248910253059456,0.016679466075357,0.0865818839381789
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ADM,Pro-adrenomedullin,16209,0.0506879283402439,0.0295981721423284,-0.00732448905871989,0.108700345739208,0.0868171218883539
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CPM,Carboxypeptidase M,16147,0.0672756448580912,0.0393525681041497,-0.00985538862604213,0.144406678342225,0.0873661758364547
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LIPF,Gastric triacylglycerol lipase,13610,-0.118057152215958,0.0691017911715279,-0.253496662912153,0.0173823584802363,0.0875751727627527
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GGT1,Glutathione hydrolase 1 proenzyme,16065,0.0966495817846337,0.0566251077313174,-0.0143356293687484,0.207634792938016,0.0878725067647067
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CTSC,Dipeptidyl peptidase 1,16055,0.0841490312999423,0.0493178136948735,-0.0125138835420097,0.180811946141894,0.087978968830143
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PLTP,Phospholipid transfer protein,16252,-0.0688145451334284,0.0403536740930112,-0.14790774635573,0.0102786560888735,0.0881602715878952
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CTSV,Cathepsin L2,16135,-0.0809376222320491,0.047469324638193,-0.173977498522907,0.0121022540588092,0.0882041685591465
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ECHS1,"Enoyl-CoA hydratase, mitochondrial",13610,0.187116687501637,0.109781408546605,-0.0280548732497087,0.402288248252982,0.088320295830639
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AHCY,Adenosylhomocysteinase,16102,0.131244269890905,0.0771227800608144,-0.0199163790282911,0.282404918810102,0.0888201566703356
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ABL1,Tyrosine-protein kinase ABL1,16008,0.130429799742193,0.076678294039005,-0.0198596565742565,0.280719256058643,0.0889623727725219
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CLINT1,Clathrin interactor 1,13480,0.0923975270095016,0.0544624940445271,-0.0143489613177714,0.199144015336775,0.0898077207672164
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DTYMK,Thymidylate kinase,13974,0.130851084867806,0.0771475216862199,-0.0203580576371845,0.282060227372797,0.0898863601773436
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,13927,0.166974794996665,0.0986127307298276,-0.0263061572337968,0.360255747227127,0.0904326144591774
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GNPDA2,Glucosamine-6-phosphate isomerase 2,13684,0.0709663474660946,0.0419588905054682,-0.0112730779246232,0.153205772856812,0.0907965092757815
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DDX58,Antiviral innate immune response receptor RIG-I,15724,0.111570220370336,0.0659907770750201,-0.0177717026967033,0.240912143437376,0.0909150703153382
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,16107,0.0572816144605035,0.0339532301228244,-0.00926671658023236,0.123829945501239,0.0916084887644839
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,13684,0.164026748221979,0.0973716671439803,-0.0268217193802219,0.354875215824181,0.0920996283928938
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DNAJC6,Putative tyrosine-protein phosphatase auxilin,13610,0.161965988199444,0.0961686640187819,-0.0265245932773682,0.350456569676257,0.0921685400270036
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,16230,0.0891858292957602,0.0531756230348851,-0.0150383918526145,0.193410050444135,0.0935238493349151
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EPGN,Epigen,13894,0.0923759570697898,0.0551141208603769,-0.0156477198165489,0.200399633956128,0.0937440455470701
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CFHR2,Complement factor H-related protein 2,13894,0.109020639622487,0.0651280128858987,-0.0186302656338741,0.236671544878849,0.0941641574115017
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CCL27,C-C motif chemokine 27,16102,-0.116678278370107,0.0698119560951311,-0.253509712316564,0.0201531555763503,0.0946774847566034
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LONP1,"Lon protease homolog, mitochondrial",13610,0.16425570253995,0.0984646036288943,-0.0287349205726824,0.357246325652583,0.0953050023112626
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",13946,0.0796054192762803,0.0477223943149035,-0.0139304735809305,0.173141312133491,0.0953196250098602
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TBCA,Tubulin-specific chaperone A,13684,0.162869677746317,0.0977026884738293,-0.0286275916623885,0.354366947155022,0.0955387452335952
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,16209,0.0488252440132828,0.0293605390901761,-0.00872141260346242,0.106371900630028,0.0963408707329903
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,UXS1,UDP-glucuronic acid decarboxylase 1,15724,0.0996840836590411,0.059988558352292,-0.0178934907114512,0.217261658029533,0.0965892273433916
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HSPA2,Heat shock-related 70 kDa protein 2,13894,0.065916043711387,0.0396938861841549,-0.0118839732095565,0.143716060632331,0.0968144907042177
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LTBR,Tumor necrosis factor receptor superfamily member 3,15998,0.0531000316618016,0.0319904666411752,-0.00960128295490179,0.115801346278505,0.0969601248144196
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KCTD5,BTB/POZ domain-containing protein KCTD5,13671,0.0839117058620487,0.0506219337497725,-0.0153072842875054,0.183130696011603,0.0974180514331069
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LSM8,U6 snRNA-associated Sm-like protein LSm8,13710,-0.171759444992947,0.103677056171363,-0.374966475088819,0.0314475851029252,0.0976076026041349
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,VAMP8,Vesicle-associated membrane protein 8,13552,0.164538419221043,0.0993391297366388,-0.0301662750627693,0.359243113504855,0.0976781045133938
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DUOX2,Dual oxidase 2,15778,0.13236474008363,0.0800898095061693,-0.0246112865484623,0.289340766715721,0.0984110554369215
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TSC22D1,TSC22 domain family protein 1,13946,0.124319294160908,0.0753697595107653,-0.0234054344801917,0.272044022802008,0.0990762726986633
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,UBXN1,UBX domain-containing protein 1,13684,0.129117933899106,0.0783858791847477,-0.0245183893029995,0.282754257101211,0.099538057318629
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ITGB1BP1,Integrin beta-1-binding protein 1,15724,0.0764385687640328,0.0464101478654772,-0.0145253210523024,0.167402458580368,0.0995733727882276
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RABEP1,Rab GTPase-binding effector protein 1,13684,0.145658062723751,0.0884638058749922,-0.0277309967912337,0.319047122238736,0.099678251225398
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TDRKH,Tudor and KH domain-containing protein,15688,0.155351239957064,0.0943560266813882,-0.0295865723384568,0.340289052252585,0.0996938982688113
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HIF1A,Hypoxia-inducible factor 1-alpha,13552,0.123133260680494,0.0750449084822577,-0.0239547599447313,0.270221281305719,0.100863345137483
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,VWA1,von Willebrand factor A domain-containing protein 1,16186,0.0783873058197972,0.0478410567957484,-0.0153811654998696,0.172155777139464,0.101338044944736
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",15826,0.113750593965288,0.0694742879054168,-0.0224190103293288,0.249920198259905,0.101586670999211
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FCAR,Immunoglobulin alpha Fc receptor,16073,-0.0875147042946234,0.0535681419984114,-0.19250826261151,0.017478854022263,0.102339771919193
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BOLA2_BOLA2B,BolA-like protein 2,13610,0.101544830448636,0.0621805598528299,-0.0203290668629104,0.223418727760183,0.102478704063686
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",16008,0.0768338721829557,0.0470689131993349,-0.0154211976877407,0.169088942053652,0.102621293942042
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SEPTIN9,Septin-9,16008,0.0529256108052524,0.0324536688764507,-0.0106835801925911,0.116534801803096,0.102951127072605
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,13590,0.103093003675893,0.0632543878518731,-0.0208855965137785,0.227071603865564,0.10316362303266
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL1R2,Interleukin-1 receptor type 2,16053,0.0361556101160796,0.0221898643198649,-0.00733652395085556,0.0796477441830148,0.103253296327283
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,13474,-0.114279912113815,0.07014438337728,-0.251762903533283,0.0232030793056542,0.103292028351887
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ITM2A,Integral membrane protein 2A,16073,-0.109029758768209,0.0669457082731954,-0.240243346983672,0.0221838294472543,0.103411079974315
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,WASHC3,WASH complex subunit 3,13927,0.141514137080591,0.0869885742596404,-0.0289834684683045,0.312011742629486,0.103799481143255
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RAPGEF2,Rap guanine nucleotide exchange factor 2,13710,0.0991527193226452,0.06098104570186,-0.0203701302530003,0.218675568898291,0.103981247651431
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CAPN3,Calpain-3,13894,-0.0674414460098279,0.0414928972484124,-0.148767524616716,0.0138846325970604,0.104105751752098
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CYB5R2,NADH-cytochrome b5 reductase 2,13745,0.106009245721301,0.0653081926490665,-0.0219948118708697,0.234013303313471,0.104566382504449
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CSRP3,Cysteine and glycine-rich protein 3,13486,-0.177253376340258,0.109236788092701,-0.391357481001953,0.0368507283214358,0.104687052335075
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LTA4H,Leukotriene A-4 hydrolase,16209,0.106458853693102,0.0656432356564375,-0.0222018881935152,0.23511959557972,0.104870036205603
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ANPEP,Aminopeptidase N,16147,0.0517907095144333,0.0319412783726674,-0.0108141960959947,0.114395615124861,0.104943902446096
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,13974,0.0492522228782166,0.0303960251453331,-0.0103239864066363,0.108828432163069,0.10517953400659
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ITGB2,Integrin beta-2,16023,-0.0542609694490977,0.0335066994403336,-0.119934100352152,0.0114121614539562,0.10537951012634
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PYDC1,Pyrin domain-containing protein 1,13610,-0.0744897843524346,0.0461709406728256,-0.164984828071173,0.0160052593663036,0.106692180562996
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CCDC80,Coiled-coil domain-containing protein 80,16102,-0.064073438603556,0.0397533326772681,-0.141989970651001,0.0138430934438895,0.107030466893897
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PKD1,Polycystin-1,13974,0.0476188605387015,0.0295448449070663,-0.0102890354791485,0.105526756556552,0.107039277255203
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TPSG1,Tryptase gamma,13552,0.0483887627893278,0.0300325457868198,-0.0104750269528391,0.107252552531495,0.107157091811463
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DGCR6,Protein DGCR6,13474,0.0784580110266584,0.0487329833105264,-0.0170586362619734,0.17397465831529,0.10743067845874
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DKK3,Dickkopf-related protein 3,16301,0.0532158835110797,0.0330562517293533,-0.0115743698784528,0.118006136900612,0.107448158861815
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ICAM4,Intercellular adhesion molecule 4,16073,-0.0944861296446469,0.0587585896728168,-0.209652965403368,0.020680706114074,0.107846199270806
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",13974,0.134390290228601,0.0835876846241689,-0.0294415716347699,0.298222152091972,0.107906816431925
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FSTL3,Follistatin-related protein 3,16059,0.0562681276561808,0.0349994193398652,-0.0123307342499549,0.124866989562316,0.107923321795304
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FGF3,Fibroblast growth factor 3,13552,-0.0558106855745398,0.0348045913122259,-0.124027684546503,0.0124063133974229,0.108837981437637
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TMEM132A,Transmembrane protein 132A,13610,0.113843830182063,0.0710282458205854,-0.0253715316262847,0.25305919199041,0.109002799630975
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL17RB,Interleukin-17 receptor B,15866,-0.0964567608784518,0.0602138200923863,-0.214475848259529,0.0215623265026254,0.109196759034223
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GIT1,ARF GTPase-activating protein GIT1,13552,0.174300625998728,0.108870174864782,-0.0390849167362447,0.3876861687337,0.109401317591636
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CCL4,C-C motif chemokine 4,16112,-0.120885860619019,0.0755734261748109,-0.269009775921649,0.02723805468361,0.109711061132999
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CA5A,"Carbonic anhydrase 5A, mitochondrial",15778,0.163069872372843,0.102023324485442,-0.0368958436186228,0.363035588364309,0.109983203363663
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TP53,Cellular tumor antigen p53,15724,0.0785869617994514,0.0491715994109167,-0.0177893730459454,0.174963296644848,0.110014459983544
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SCPEP1,Retinoid-inducible serine carboxypeptidase,13554,0.090940153303632,0.0569036598815689,-0.020591020064243,0.202471326671507,0.110034616546717
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AGR2,Anterior gradient protein 2 homolog,15567,0.18189704647074,0.113833716496501,-0.0412170378624006,0.405011130803882,0.110081342704205
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MDK,Midkine,16076,0.0932335226671372,0.0583614223989882,-0.0211548652348797,0.207621910569154,0.110169578576701
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MRPL24,"39S ribosomal protein L24, mitochondrial",13486,0.0708987960911955,0.0443858871773771,-0.0160975427764636,0.157895134958855,0.110216187729272
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DDHD2,Phospholipase DDHD2,13946,0.118747984654452,0.0743588733187224,-0.0269954070502441,0.264491376359148,0.110297787999009
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NECTIN2,Nectin-2,16085,0.0530847630727429,0.0332478114112432,-0.0120809472932938,0.11825047343878,0.110365789759903
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MPO,Myeloperoxidase,16101,-0.0842817421017668,0.0528733852282184,-0.187913577149075,0.0193500929455413,0.110949046424833
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GSTM4,Glutathione S-transferase Mu 4,13486,-0.128236397552617,0.08048822332944,-0.285993315278319,0.0295205201730858,0.111131657910211
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,REG1A,Lithostathine-1-alpha,16028,0.0896478308719567,0.0563248031262155,-0.0207487832554256,0.200044444999339,0.111489261738164
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ACYP1,Acylphosphatase-1,13626,0.119085301028588,0.0748301067305303,-0.0275817081632517,0.265752310220427,0.111540794280623
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BAMBI,BMP and activin membrane-bound inhibitor homolog,15724,0.0538156379017221,0.033833575823936,-0.0124981707131925,0.120129446516637,0.111720063801835
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,COMMD1,COMM domain-containing protein 1,13610,0.111037385455996,0.069818510280896,-0.0258068946945605,0.247881665606552,0.111774287189859
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,S100G,Protein S100-G,13946,-0.0838218006581532,0.0528276778756288,-0.187364049294386,0.0197204479780793,0.112602767780728
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ESYT2,Extended synaptotagmin-2,13927,0.148996894931217,0.0939257111130884,-0.0350974988504367,0.33309128871287,0.112687867846022
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD80,T-lymphocyte activation antigen CD80,13974,0.060609971236413,0.0382292482893973,-0.0143193554108058,0.135539297883632,0.112890285455282
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,APOD,Apolipoprotein D,13343,-0.07862342591441,0.0496852325062986,-0.176006481626755,0.0187596297979352,0.113575058851556
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TRPV3,Transient receptor potential cation channel subfamily V member 3,13486,0.0890015322517962,0.0563574668129242,-0.0214591027015352,0.199462167205128,0.11430625987738
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ERBB3,Receptor tyrosine-protein kinase erbB-3,16029,0.0345174737631209,0.0218752756731459,-0.00835806655624508,0.0773930140824868,0.114603332951589
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,13927,0.112367053122079,0.0713989461506518,-0.0275748813331981,0.252308987577357,0.11555840229701
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,REG1B,Lithostathine-1-beta,16301,0.101084986737527,0.0643957016543965,-0.0251305885050898,0.227300561980145,0.116493309603129
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,13552,0.141074274946268,0.0899056048355894,-0.0351407105314873,0.317289260424023,0.116639225305351
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ELN,Elastin,13974,0.0615692858958256,0.0392395076675477,-0.015340149132568,0.138478720924219,0.116655768477995
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SCRIB,Protein scribble homolog,13610,0.161230233629163,0.103000102834894,-0.0406499679272299,0.363110435185556,0.117526362125812
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ECI2,Enoyl-CoA delta isomerase 2,13486,0.109978943586839,0.0702785002910894,-0.0277669169836959,0.247724804157375,0.117629450858017
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HGFAC,Hepatocyte growth factor activator,13855,-0.0491839431899248,0.0314496737681954,-0.110825303775588,0.0124574173957382,0.117865422038785
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PROK1,Prokineticin-1,16073,-0.107551299150344,0.0687806557458245,-0.24236138441216,0.0272587861114722,0.117911199865278
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GUK1,Guanylate kinase,13486,-0.0700348946272497,0.044829156421967,-0.157900041214305,0.0178302519598056,0.118249731508192
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TCN1,Transcobalamin-1,13688,0.0591840232798718,0.037885124859053,-0.0150708214438721,0.133438868003616,0.118264760522018
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SMC3,Structural maintenance of chromosomes protein 3,13480,0.0990012113883135,0.0633829066734724,-0.0252292856916923,0.223231708468319,0.118322225383596
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,13946,0.188719259171725,0.121012409260975,-0.0484650629797867,0.425903581323236,0.118900003027359
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PRTN3,Myeloblastin,15719,-0.0896371148710778,0.057492710275508,-0.202322827011073,0.0230485972689179,0.118991915393023
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,POSTN,Periostin,13972,-0.0663414026436731,0.0426116452267836,-0.149860227288169,0.0171774220008228,0.119520622823106
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,13913,0.0864969688647956,0.0556646285044356,-0.0226057030038981,0.195599640733489,0.120232314487629
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,UROS,Uroporphyrinogen-III synthase,13590,0.122829525914652,0.0792105203620087,-0.0324230939948849,0.278082145824189,0.121003648287891
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NFE2,Transcription factor NF-E2 45 kDa subunit,13610,0.130871434910479,0.0845187706114496,-0.0347853554879625,0.29652822530892,0.121541978664395
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,THRAP3,Thyroid hormone receptor-associated protein 3,13486,0.199830290174769,0.129353176337523,-0.0537019354467765,0.453362515796314,0.122407841859069
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,13894,0.119528815161573,0.077701094568391,-0.032765330192473,0.27182296051562,0.123994233062305
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",15900,-0.0700022868828871,0.0455622388493228,-0.15930427502756,0.0192997012617856,0.124457730873072
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,C1S,Complement C1s subcomponent,13992,0.0361876592822438,0.0235545418220395,-0.00997924268895362,0.0823545612534412,0.124478953909521
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TNXB,Tenascin-X,16101,-0.045265987032345,0.0294782021218369,-0.103043263191145,0.0125112891264553,0.124662342290379
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ICA1,Islet cell autoantigen 1,15826,0.140276255243976,0.0913827411148565,-0.0388339173411428,0.319386427829095,0.124793762603316
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FOS,Proto-oncogene c-Fos,13450,-0.0637075840608091,0.0415923166523453,-0.145228524699406,0.0178133565777876,0.125616270539006
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL17C,Interleukin-17C,15826,-0.123058787387679,0.0807230128350686,-0.281275892544413,0.0351583177690558,0.127414511407145
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SPP1,Osteopontin,16277,-0.0793231560258719,0.0520589188795762,-0.181358637029841,0.0227123249780973,0.127598402572681
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,COL28A1,Collagen alpha-1(XXVIII) chain,13590,-0.134410477546179,0.0882519405220368,-0.307384280969371,0.0385633258770134,0.127774138561098
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IGFBP3,Insulin-like growth factor-binding protein 3,16174,-0.0509809554276662,0.0334836150881952,-0.116608841000529,0.0146469301451963,0.127887325441329
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TST,Thiosulfate sulfurtransferase,15669,0.128516069068654,0.0844111869550907,-0.0369298573633242,0.293961995500631,0.127903933839764
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,STAM,Signal transducing adapter molecule 1,13894,0.0662176157912659,0.0435033375362202,-0.0190489257797258,0.151484157362257,0.127999978205965
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PACS2,Phosphofurin acidic cluster sorting protein 2,13486,0.106259609260059,0.0698676569893692,-0.0306809984391044,0.243200216959223,0.128315983565365
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CEP170,Centrosomal protein of 170 kDa,13610,0.133701800893291,0.0879820309264017,-0.0387429797224564,0.306146581509038,0.128622481513829
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",16073,0.141378753929978,0.0930636290881755,-0.0410259590828464,0.323783466942802,0.128741342278748
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,15826,-0.0756873282032416,0.0498336609486811,-0.173361303662657,0.0219866472561733,0.1288330213776
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CLEC4A,C-type lectin domain family 4 member A,16073,-0.060264822204638,0.0397295440438237,-0.138134728530532,0.0176050841212565,0.129317484735512
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL1RL1,Interleukin-1 receptor-like 1,16251,-0.0799373093687509,0.0527157061703206,-0.183260093462579,0.0233854747250775,0.129441481243712
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TANK,TRAF family member-associated NF-kappa-B activator,15826,0.121827769598904,0.0803635494224344,-0.0356847872690674,0.279340326466876,0.129549950349661
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HTR1A,5-hydroxytryptamine receptor 1A,13474,-0.12843092471302,0.0847216022195016,-0.294485265063243,0.0376234156372033,0.129563801115244
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HAVCR1,Hepatitis A virus cellular receptor 1,16187,-0.106787297957039,0.0705265268953357,-0.245019290671897,0.0314446947578187,0.130008932959285
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NPHS2,Podocin,13552,0.174596052447647,0.115371661151925,-0.0515324034101257,0.400724508305419,0.130217754961866
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SDCCAG8,Serologically defined colon cancer antigen 8,13894,0.196983920033753,0.130199482336459,-0.0582070653457068,0.452174905413213,0.130317833443551
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,13486,-0.0819976138055231,0.05420689354787,-0.188243125159348,0.024247897548302,0.130384746940434
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,13710,0.122410191849612,0.0809595159705482,-0.0362704594526624,0.281090843151887,0.130558808449045
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RNASE3,Eosinophil cationic protein,16023,-0.195610658199996,0.1295929017929,-0.44961274571408,0.0583914293140889,0.131210155378721
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KHK,Ketohexokinase,13610,0.108759494523218,0.0721777640606183,-0.032708923035594,0.25022791208203,0.131877917229012
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IGFL4,Insulin growth factor-like family member 4,13552,-0.125131946488664,0.0830793421369358,-0.287967457077058,0.0377035640997298,0.132045838949526
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",16073,0.163705966367045,0.108765736690519,-0.0494748775463733,0.376886810280463,0.132311758826557
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TRIM24,Transcription intermediary factor 1-alpha,13678,0.11467582304046,0.076349033368769,-0.0349682823623273,0.264319928443247,0.133121654880264
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NT5E,5'-nucleotidase,16118,0.0953091375792443,0.0635730590443788,-0.0292940581477381,0.219912333306227,0.133839694954122
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DCTN2,Dynactin subunit 2,16008,0.159228312883214,0.106472538162447,-0.0494578619151827,0.36791448768161,0.134807080500641
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NEB,Nebulin,13486,-0.0634076141349214,0.0424044121323804,-0.146520261914387,0.0197050336445443,0.134857763096533
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,OPTC,Opticin,16008,-0.0768105203676574,0.0513692778814076,-0.177494305015216,0.0238732642799015,0.134865852606797
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,13113,-0.083293929836377,0.0557115913244967,-0.192488648832391,0.0259007891596365,0.134914638492685
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MMP13,Collagenase 3,15688,-0.0547214455676103,0.0366381872056087,-0.126532292490603,0.0170894013553828,0.135309971208576
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NLGN1,Neuroligin-1,13590,-0.119647636077045,0.0801520745376001,-0.276745702170741,0.0374504300166508,0.135523829776974
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,13710,0.183203566607838,0.122736155808665,-0.0573592987771463,0.423766431992821,0.135548781310817
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LSP1,Lymphocyte-specific protein 1,16073,-0.0677865457676846,0.0454419848179419,-0.156852836010851,0.0212797444754814,0.13579319816225
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DEFA1_DEFA1B,Neutrophil defensin 1,15773,-0.0910896554018449,0.0611241465765564,-0.210892982691896,0.0287136718882057,0.136181124916234
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ATXN2L,Ataxin-2-like protein,13946,0.0807595491324663,0.0542260754223871,-0.0255235586954125,0.187042656960345,0.136427844164082
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NRTN,Neurturin,15826,-0.0862886502520238,0.0580087238284494,-0.199985748955785,0.027408448451737,0.136899679372487
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EIF4E,Eukaryotic translation initiation factor 4E,13552,0.150991978210702,0.101602123037747,-0.048148182943282,0.350132139364687,0.137273191244425
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ADD1,Alpha-adducin,13684,0.118977149537079,0.0800916921926478,-0.0380025671605107,0.275956866234669,0.137431374006158
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DEFB118,Beta-defensin 118,13474,-0.0955243753445525,0.0643198981302281,-0.2215913756798,0.0305426249906945,0.137528835467132
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",15826,0.122736091737931,0.0827021898907997,-0.039360200448036,0.284832383923899,0.137809472978139
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SCAMP3,Secretory carrier-associated membrane protein 3,16008,0.142667382286843,0.0961363991700833,-0.0457599600865204,0.331094724660206,0.137825960906595
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TGFBI,Transforming growth factor-beta-induced protein ig-h3,16031,-0.0450721610667298,0.0303827750637721,-0.104622400191723,0.0144780780582634,0.137967284944458
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MTSS2,Protein MTSS 2,13894,0.166713241896021,0.112741226883127,-0.0542595627949087,0.387686046586951,0.139236588715206
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ADA,Adenosine deaminase,16272,0.0590842481664479,0.0399706406143018,-0.0192582074375836,0.137426703770479,0.139375987771248
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DDT,D-dopachrome decarboxylase,13972,0.0688709758499706,0.0465983844289143,-0.0224618576307014,0.160203809330643,0.139438592298647
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DNM3,Dynamin-3,13946,0.0907124771342685,0.0614317870560405,-0.0296938254955709,0.211118779764108,0.139795450254369
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ADAMTSL4,ADAMTS-like protein 4,13610,0.0390915462863795,0.0265102528140359,-0.0128685492291309,0.0910516418018898,0.140348063849664
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FGF23,Fibroblast growth factor 23,16181,0.0946233082714056,0.0642146516019965,-0.0312374088685076,0.220484025411319,0.140623065330477
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SLMAP,Sarcolemmal membrane-associated protein,13913,0.140540732962733,0.0953927921523737,-0.046429139655919,0.327510605581386,0.140696953095208
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SPART,Spartin,13684,0.130113129920527,0.0883405533196978,-0.0430343545860807,0.303260614427135,0.140812232781174
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EVI5,Ecotropic viral integration site 5 protein homolog,13552,0.148678334442089,0.10106805099759,-0.0494150455131866,0.346771714397364,0.141295010280016
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",13946,0.152749606081268,0.103861024262372,-0.0508180014729803,0.356317213635516,0.141391730086384
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD36,Platelet glycoprotein 4,13552,0.0748996172452993,0.0509730147520519,-0.0250074916687224,0.174806726159321,0.141748258838534
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FGFBP1,Fibroblast growth factor-binding protein 1,16118,-0.0538068811077178,0.0366769677398491,-0.125693737877822,0.0180799756623864,0.142382459718396
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LUZP2,Leucine zipper protein 2,13894,0.0770796391473471,0.0525811840703515,-0.0259794816305419,0.180138759925236,0.142693617470854
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CEMIP2,Cell surface hyaluronidase,13552,-0.0562190342729231,0.0383525015789095,-0.131389937367586,0.0189518688217395,0.142712240013836
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,STXBP1,Syntaxin-binding protein 1,13946,0.128377309826199,0.0877313891772665,-0.0435762129612432,0.300330832613642,0.143407966874054
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CA11,Carbonic anhydrase-related protein 11,15724,-0.0535703887474402,0.0366350808712339,-0.125375147255059,0.0182343697601781,0.143687171634574
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HEPH,Hephaestin,13974,0.0445052221253329,0.0304478371953528,-0.0151725387775586,0.104182983028224,0.143849381023519
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LHB,Lutropin subunit beta,15724,-0.147020601614741,0.101090187999719,-0.34515737009419,0.0511161668647072,0.145869034875728
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RCOR1,REST corepressor 1,15778,0.0768344333269616,0.0528711162466731,-0.0267929545165177,0.180461821170441,0.146176970571935
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GSAP,Gamma-secretase-activating protein,15724,0.141839439374698,0.0976198264931683,-0.049495420551912,0.333174299301308,0.146249894993316
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ICAM1,Intercellular adhesion molecule 1,16055,0.0474579734203159,0.0326637555745468,-0.0165629875057959,0.111478934346428,0.146264255765512
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,13974,0.0557761294585952,0.0383967639283028,-0.0194815278408784,0.131033786758069,0.14635015763984
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,COLEC12,Collectin-12,16076,0.0426006576977005,0.0293305634915551,-0.0148872467457474,0.100088562141148,0.146400975210281
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PPM1F,Protein phosphatase 1F,13974,0.0857033838035582,0.0591085315869502,-0.0301493381068643,0.201556105713981,0.147099795124359
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RAP1A,Ras-related protein Rap-1A,13552,-0.113337420895266,0.0782170736262842,-0.266642885202783,0.0399680434122514,0.147357598059222
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,JAM3,Junctional adhesion molecule C,13684,0.083144351446061,0.0573873485935037,-0.0293348517972062,0.195623554689328,0.147408783693812
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BSG,Basigin,16248,0.0331435471354904,0.0228816273561338,-0.0117044424825319,0.0779915367535127,0.14750256532359
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",13480,0.0845735174168195,0.0583953314895018,-0.029881332302604,0.199028367136243,0.147558562302863
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,XIAP,E3 ubiquitin-protein ligase XIAP,13552,0.0948462219260505,0.0655408256646517,-0.0336137963766668,0.223306240228768,0.147883129058873
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL31,Interleukin-31,13552,-0.0951745033143243,0.0658103295861973,-0.224162749303271,0.0338137426746223,0.14814594822345
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,13486,-0.0327861397135105,0.0226725184307666,-0.0772242758378131,0.011651996410792,0.148179706653888
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PSPN,Persephin,16073,0.153271243812113,0.106056509903022,-0.0545995155978107,0.361142003222037,0.148425529480486
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SH3GL3,Endophilin-A3,13627,-0.140298054394264,0.0971456514580362,-0.330703531252015,0.0501074224634865,0.148704857467494
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ASGR2,Asialoglycoprotein receptor 2,13982,0.0417887505495995,0.0289423476718053,-0.0149382508871389,0.098515751986338,0.148800278388131
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AGXT,Serine--pyruvate aminotransferase,16102,0.126992945284628,0.0880101544977205,-0.045506957530904,0.29949284810016,0.149058210011728
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,15459,-0.0607650740996279,0.0421177106403713,-0.143315786954756,0.0217856387555,0.149112879897193
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RBP5,Retinol-binding protein 5,16008,0.0918191384794589,0.0637093804525783,-0.0330512472075946,0.216689524166512,0.149542537388496
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CCL19,C-C motif chemokine 19,16230,-0.200264067675823,0.138980476355495,-0.472665801332594,0.0721376659809481,0.149617811671184
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ANGPTL1,Angiopoietin-related protein 1,15879,0.0485936744173151,0.0337728517689023,-0.0176011150497333,0.114788463884364,0.150216054507271
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PLXDC2,Plexin domain-containing protein 2,13927,0.045889920434478,0.0319704532119141,-0.0167721678608737,0.10855200872983,0.151199795880209
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PNMA1,Paraneoplastic antigen Ma1,13610,0.0916664251570193,0.0639126301806156,-0.0336023299969872,0.216935180311026,0.151525113305219
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FCRLB,Fc receptor-like B,15724,-0.0993832436099387,0.0694399288273502,-0.235485504111545,0.0367190168916676,0.152389422296299
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PLA2G1B,Phospholipase A2,16280,-0.0701268081025958,0.049062779440478,-0.166289855805933,0.0260362396007411,0.152929164490318
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AXIN1,Axin-1,16073,0.152580085365944,0.106852271893834,-0.0568503675459702,0.362010538277859,0.153324662993178
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KIAA1549,UPF0606 protein KIAA1549,13710,-0.117759666770149,0.0824801478500353,-0.279420756556218,0.0439014230159205,0.153391391912933
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CTSL,Cathepsin L1,16102,0.0391868101140256,0.0274526908867739,-0.0146204640240512,0.0929940842521023,0.15347523433742
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,VPS28,Vacuolar protein sorting-associated protein 28 homolog,13710,0.110226981694235,0.0772526680258873,-0.0411882476365041,0.261642211024974,0.153649617244586
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SUSD4,Sushi domain-containing protein 4,13894,0.0675979401345125,0.0474015863836279,-0.0253091691773982,0.160505049446423,0.153870871701953
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PDCD6,Programmed cell death protein 6,16102,-0.113523671034553,0.0797172956436279,-0.269769570496064,0.0427222284269572,0.15444320152394
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DRAXIN,Draxin,15950,0.0681042735620728,0.0478263685000764,-0.025635408698077,0.161843955822222,0.154468927691089
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CSNK1D,Casein kinase I isoform delta,13552,0.102043308447796,0.0716941276928328,-0.0384771818301559,0.242563798725749,0.154667981122916
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ATP5PO,"ATP synthase subunit O, mitochondrial",15688,-0.0666667755456054,0.046900314194124,-0.158591391366088,0.0252578402748777,0.155203868492865
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DTNB,Dystrobrevin beta,13870,0.0714009165027762,0.0502596087244005,-0.0271079165970489,0.169909749602601,0.155443332281278
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FCN2,Ficolin-2,16053,-0.0666343588791669,0.0469239861534748,-0.158605371739977,0.0253366539816437,0.15561285753194
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IGBP1,Immunoglobulin-binding protein 1,13946,0.0982188957812486,0.0691822420315668,-0.0373782986006223,0.23381609016312,0.155713763597782
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CASC3,Protein CASC3,13590,0.068711171827261,0.0484125278048047,-0.0261773826701562,0.163599726324678,0.155838918640113
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,C5,Complement C5,13992,-0.0237446591099195,0.0167323969289802,-0.0565401570907206,0.00905083887088157,0.155897133218708
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ITGAM,Integrin alpha-M,16101,-0.0508368622229914,0.035825255721415,-0.121054363436965,0.0193806389909819,0.15591168188771
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL19,Interleukin-19,15713,-0.113433080818879,0.0799468157022547,-0.270128839595298,0.0432626779575405,0.155960629693319
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CSNK2A1,Casein kinase II subunit alpha,13946,0.0719109514366158,0.050803734298123,-0.0276643677877053,0.171486270660937,0.156954304142712
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GUSB,Beta-glucuronidase,16179,0.0958827650684651,0.0677533146707207,-0.0369137316861475,0.228679261823078,0.157036594718332
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD58,Lymphocyte function-associated antigen 3,16046,0.0282375418255508,0.019954037267216,-0.0108723712181926,0.0673474548692943,0.157050026264344
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NCR1,Natural cytotoxicity triggering receptor 1,16045,0.0582883999095568,0.0412249702165934,-0.0225125417149662,0.13908934153408,0.157407732108205
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",15688,0.0855570924699929,0.0605318858255909,-0.0330854037481653,0.204199588688151,0.15755157189773
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PDCD1LG2,Programmed cell death 1 ligand 2,16008,-0.0504666524570399,0.0357764044783258,-0.120588405234558,0.0196551003204785,0.15837827726982
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,C19orf12,Protein C19orf12,15688,0.100896865629222,0.0716528055272187,-0.0395426332041264,0.241336364462571,0.15911075755808
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GDNF,Glial cell line-derived neurotrophic factor,15688,-0.0591411718462957,0.0420603046422726,-0.14157936894515,0.0232970252525585,0.159713003017411
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CXCL16,C-X-C motif chemokine 16,16274,-0.0368824989640923,0.0262329421922312,-0.0882990656608654,0.0145340677326808,0.159754754050793
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EBI3_IL27,Interleukin-27,16186,-0.0479572381162849,0.0341102908243465,-0.114813408132004,0.0188989318994342,0.159759275442787
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MYDGF,Myeloid-derived growth factor,13974,0.158200996289569,0.112537373084512,-0.0623722549560747,0.378774247535213,0.159816448272284
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,13684,-0.109513040386099,0.0779177610284738,-0.262231852001907,0.0432057712297098,0.159896796925704
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SLAMF8,SLAM family member 8,15724,-0.0860077843888129,0.0612551594302809,-0.206067896872163,0.0340523280945376,0.160311685032112
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IKBKG,NF-kappa-B essential modulator,16073,0.142551504548029,0.101699752228606,-0.0567800098200386,0.341883018916097,0.161027226862165
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CCL20,C-C motif chemokine 20,16272,-0.136970345442046,0.0977355476136482,-0.328532018764797,0.0545913278807041,0.161102117207096
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CLTA,Clathrin light chain A,15778,0.0741119451124076,0.0529376936942411,-0.0296459345283049,0.17786982475312,0.161537670931215
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CENPF,Centromere protein F,13710,0.089444107178921,0.0639459908213762,-0.0358900348309762,0.214778249188818,0.161912238544964
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BAG4,BAG family molecular chaperone regulator 4,13552,0.0790169341945636,0.0565185522826259,-0.0317594282793831,0.18979329666851,0.16211472944684
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD72,B-cell differentiation antigen CD72,13684,0.0673557526058725,0.0482063418468955,-0.0271286774140426,0.161840182625788,0.162364566532908
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TOP2B,DNA topoisomerase 2-beta,13552,0.124752243620321,0.0895636538819052,-0.0507925179882136,0.300297005228855,0.163676179649949
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL36G,Interleukin-36 gamma,13497,-0.106006732496362,0.0761272077255899,-0.255216059638519,0.0432025946457937,0.163795611538062
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LRP1,Prolow-density lipoprotein receptor-related protein 1,16008,0.0415937542940039,0.0299049446810855,-0.0170199372809237,0.100207445868932,0.164285581178043
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FGFBP2,Fibroblast growth factor-binding protein 2,13972,-0.0787314537460863,0.0566420454646443,-0.189749862856789,0.0322869553646165,0.164556348088652
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GJA8,Gap junction alpha-8 protein,13480,-0.10100226609903,0.0726881623215759,-0.243471064249318,0.041466532051259,0.164695103357755
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PLEKHO1,Pleckstrin homology domain-containing family O member 1,13927,0.109772657417957,0.0790304856011306,-0.045127094360259,0.264672409196173,0.164857625455589
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CRYGD,Gamma-crystallin D,13927,0.152857593810833,0.110053552614408,-0.0628473693134061,0.368562556935072,0.164873745505451
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,STAT2,Signal transducer and activator of transcription 2,13552,0.120441534784702,0.0867542488754646,-0.049596793011209,0.290479862580612,0.165066411429096
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PDLIM7,PDZ and LIM domain protein 7,16160,0.197718374531347,0.142436060762138,-0.0814563045624439,0.476893053625137,0.165119595992534
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CHP1,Calcineurin B homologous protein 1,13474,-0.115818327906791,0.0835100490152535,-0.279498023976688,0.0478613681631058,0.165501648214494
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MGMT,Methylated-DNA--protein-cysteine methyltransferase,16073,0.189973989226285,0.137050857540641,-0.0786456915533724,0.458593670005942,0.165718250252806
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BCAN,Brevican core protein,15950,-0.0533844361735546,0.0385191665634076,-0.128882002637834,0.0221131302907244,0.165791099578189
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FETUB,Fetuin-B,16155,0.0513805580227929,0.0372115429632582,-0.0215540661851933,0.124315182230779,0.167369008019712
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,15724,0.154295800861771,0.111845499450826,-0.0649213780618483,0.373512979785391,0.167746688938368
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EDN1,Endothelin-1,13610,0.0460836213597884,0.0334092379588323,-0.0193984850395228,0.1115657277591,0.167804121735185
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CHI3L1,Chitinase-3-like protein 1,15763,0.123553921778317,0.0896528838428799,-0.0521657305537276,0.299273574110362,0.168180691500981
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL17RA,Interleukin-17 receptor A,16101,0.0687694006915229,0.0500403624701867,-0.0293097097500429,0.166848511133089,0.16937434349452
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TGFBR2,TGF-beta receptor type-2,16118,0.0501218163295668,0.0365311772128885,-0.0214792910076947,0.121722923666828,0.170073676841431
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SELENOP,Selenoprotein P,13992,-0.0344817036003208,0.0251489838069309,-0.0837737118619054,0.0148103046612637,0.170366640858159
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LIFR,Leukemia inhibitory factor receptor,16073,-0.0378707265264301,0.0276669990341537,-0.0920980446333713,0.0163565915805112,0.17107938434034
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HDGF,Hepatoma-derived growth factor,16186,0.143703140662091,0.105035549104958,-0.0621665355836274,0.34957281690781,0.171287848680377
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LDLR,Low-density lipoprotein receptor,16128,-0.0809108551268021,0.0592106772132788,-0.196963782464829,0.0351420722112243,0.171803982967621
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CBLN4,Cerebellin-4,16209,-0.0494780617698694,0.0362264749927723,-0.120481952755703,0.0215258292159643,0.172021214067025
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,STX8,Syntaxin-8,16073,0.0745805744469998,0.0546225944237078,-0.0324797106234674,0.181640859517467,0.172152906891319
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PON3,Serum paraoxonase/lactonase 3,16160,-0.0437891120089391,0.0320726068361404,-0.106651421407774,0.0190731973898961,0.172174059652074
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DCLRE1C,Protein artemis,13480,0.0480477867736784,0.0351962824762629,-0.0209369268797969,0.117032500427154,0.172232449755898
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",13486,0.0769067045579184,0.0563459300826379,-0.0335313184040518,0.187344727519889,0.172306469630458
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SLC13A1,Solute carrier family 13 member 1,13894,0.0936541685209426,0.0686274950729737,-0.0408557218220859,0.228164058863971,0.172377610086854
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RLN1,Prorelaxin H1,13946,-0.106068566385193,0.0777762540109932,-0.258510024246739,0.046372891476354,0.172663437524544
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SARG,Specifically androgen-regulated gene protein,13926,0.166343028966081,0.121985998571354,-0.0727495282337721,0.405435586165934,0.172708014972649
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CLSTN1,Calsyntenin-1,15688,-0.078636522060592,0.0576785305584604,-0.191686441955174,0.0344133978339903,0.172789096399641
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TSNAX,Translin-associated protein X,13486,0.0615527036801612,0.0451739147936487,-0.0269881693153903,0.150093576675713,0.173040269206313
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ELAVL4,ELAV-like protein 4,13474,0.131633171399586,0.0966867144816652,-0.0578727889844779,0.32113913178365,0.17339743588392
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FAM3B,Protein FAM3B,16008,0.0550725235197612,0.040453751234637,-0.0242168289001273,0.13436187593965,0.173415967969516
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RSPO1,R-spondin-1,15950,-0.0532558416255802,0.0391357589082703,-0.12996192908579,0.0234502458346295,0.173596946337842
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AMOT,Angiomotin,13684,0.0621365826408174,0.0456631384319134,-0.027363168685733,0.151636333967368,0.173611908195481
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EFCAB14,EF-hand calcium-binding domain-containing protein 14,13913,0.043174106088731,0.0317579137184667,-0.0190714047994637,0.105419616976926,0.174018011019213
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MOCS2,Molybdopterin synthase catalytic subunit,13684,0.104416972121017,0.0768085849345859,-0.0461278543507714,0.254961798592805,0.174028351285149
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BTN1A1,Butyrophilin subfamily 1 member A1,13867,-0.059937941024786,0.0441817559265469,-0.146534182640818,0.0266583005912459,0.174923462293408
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,YWHAQ,14-3-3 protein theta,13684,0.113943133173704,0.084030203501668,-0.0507560656895653,0.278642332036973,0.175128467900358
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AGER,Advanced glycosylation end product-specific receptor,16053,0.0620513018089967,0.0457877294865092,-0.0276926479845612,0.151795251602555,0.175374523796244
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GSTA3,Glutathione S-transferase A3,15724,0.118306066885151,0.087513713934106,-0.0532208124256968,0.289832946195999,0.17644038115768
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CDKN1A,Cyclin-dependent kinase inhibitor 1,16008,0.162535164256578,0.120274345730701,-0.0732025533755961,0.398272881888752,0.176595994593122
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TMPRSS11B,Transmembrane protease serine 11B,13474,-0.114585267297462,0.0848507300820539,-0.280892698258287,0.0517221636633638,0.176899679735709
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TNFSF12,Tumor necrosis factor ligand superfamily member 12,16272,-0.0435686250182873,0.0322866622904876,-0.106850483107643,0.0197132330710684,0.177217339402625
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ARHGAP1,Rho GTPase-activating protein 1,15724,0.0709627887654938,0.0526211857415351,-0.032174735287915,0.174100312818903,0.177498004832645
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TALDO1,Transaldolase,13924,0.0679685874027351,0.0504403862186267,-0.0308945695857733,0.166831744391243,0.177840135401573
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,F11,Coagulation factor XI,13787,-0.0473174945439785,0.0351217894013823,-0.116156201770688,0.0215212126827307,0.177924975332105
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LRRC59,Leucine-rich repeat-containing protein 59,13974,0.0730658606454114,0.0543116462602221,-0.0333849660246238,0.179516687315447,0.178547830545843
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CASP7,Caspase-7,13927,0.128177694493975,0.095299490811505,-0.0586093074965749,0.314964696484525,0.178647566613598
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CYTH3,Cytohesin-3,13480,0.111688459915752,0.083044213344513,-0.0510781982394936,0.274455118070997,0.178671245693157
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,15611,0.131689364813761,0.0979619156750711,-0.0603159899093782,0.323694719536901,0.178873713390175
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,13946,0.122494612990083,0.0911709551975245,-0.0562004591970649,0.301189685177231,0.179109171075347
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SLC44A4,Choline transporter-like protein 4,13590,0.107048914609401,0.0799851891175568,-0.0497220560610102,0.263819885279813,0.180801782068965
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,OLR1,Oxidized low-density lipoprotein receptor 1,15948,-0.0923575014946741,0.0690775858850548,-0.227749569829382,0.0430345668400333,0.181238089420206
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,16073,0.0936733877828108,0.0701013839550838,-0.0437253247691534,0.231072100334775,0.181484579343919
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TMED1,Transmembrane emp24 domain-containing protein 1,13710,-0.0873038907081954,0.0653604503591357,-0.215410373412101,0.0408025919957106,0.181659853807028
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",13946,0.100476055208851,0.0755382879893317,-0.0475789892502389,0.248531099667941,0.183495854640112
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GBP1,Guanylate-binding protein 1,13901,0.0986387697729667,0.0742333584107819,-0.0468586127121658,0.244136152258099,0.18394698387642
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,APOBR,Apolipoprotein B receptor,13610,-0.0641417555090664,0.04827731035702,-0.158765283808826,0.0304817727906929,0.183998708528875
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DDX1,ATP-dependent RNA helicase DDX1,13913,0.0773972675947776,0.0583231292978296,-0.0369160658289684,0.191710601018523,0.184516444559666
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,16102,0.0757634743914953,0.0571616629059135,-0.0362733849040951,0.187800333687086,0.185049182466238
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,COL3A1,Collagen alpha-1(III) chain,13972,0.0346755824862225,0.026170478146042,-0.0166185546800198,0.0859697196524648,0.185196656525469
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TADA3,Transcriptional adapter 3,13894,0.0599921067987099,0.0453623287002911,-0.0289180574538606,0.14890227105128,0.186020366598964
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MYL3,Myosin light chain 3,13610,-0.109628102408155,0.0831036306236561,-0.272511218430521,0.053255013614211,0.187133350938161
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,OSCAR,Osteoclast-associated immunoglobulin-like receptor,16107,0.0499395481951197,0.0378844339218418,-0.0243139422916902,0.12419303868193,0.187452928318856
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PENK,Proenkephalin-A,13684,-0.0464352476418015,0.0352294927246384,-0.115485053382093,0.0226145580984896,0.187499355024907
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IGLC2,Immunoglobulin lambda constant 2,13967,-0.0369423088985437,0.028028607790971,-0.0918783801688468,0.0179937623717593,0.187518073712962
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,13974,0.0594040131696025,0.0451388003347879,-0.0290680354865817,0.147876061825787,0.188185599473824
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KLK11,Kallikrein-11,15955,0.0465159353239585,0.0354234348768434,-0.0229139970346545,0.115945867682571,0.189154621268046
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FGF16,Fibroblast growth factor 16,13552,-0.0705442648882172,0.053732236258994,-0.175859447955845,0.0347709181794111,0.189243843912962
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GSR,"Glutathione reductase, mitochondrial",13896,0.0330469570174847,0.0251745682219278,-0.0162951966974938,0.0823891107324633,0.189301723964681
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ENTR1,Endosome-associated-trafficking regulator 1,13610,0.0866856442025384,0.0660540717278315,-0.0427803363840113,0.216151624789088,0.189426351319023
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PSAP,Prosaposin,13830,0.0420216478908933,0.0320521186685151,-0.0208005046993964,0.104843800481183,0.189865636556207
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NOTCH2,Neurogenic locus notch homolog protein 2,13972,0.0311042261561535,0.0237250449805285,-0.0153968620056824,0.0776053143179894,0.189869474689705
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,F13B,Coagulation factor XIII B chain,13919,0.0386485681273722,0.0295102337792204,-0.0191914900798997,0.0964886263346441,0.190330278229066
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SUSD5,Sushi domain-containing protein 5,13607,0.0505922255980357,0.0386403987352679,-0.0251429559230894,0.126327407119161,0.190451800211681
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SRPK2,SRSF protein kinase 2,16073,0.12378883767745,0.0945811602654298,-0.0615902364427922,0.309167911797693,0.190617199187049
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GPD1,Glycerol-3-phosphate dehydrogenase,13894,0.0792443072798074,0.0605508233756809,-0.0394353065365271,0.197923921096142,0.19064957460406
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ERP44,Endoplasmic reticulum resident protein 44,15985,0.0383925478545842,0.0293377767257453,-0.0191094945278766,0.0958945902370451,0.190675620593495
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PRKCQ,Protein kinase C theta type,15826,0.0658824775101386,0.0503933237608168,-0.0328884370610623,0.16465339208134,0.191107722017732
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FES,Tyrosine-protein kinase Fes/Fps,15724,0.0705050483658534,0.0540251537636947,-0.0353842530109881,0.176394349742695,0.191897953063567
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PGLYRP1,Peptidoglycan recognition protein 1,16227,-0.0637587375986676,0.0488793381361686,-0.159562240345558,0.0320447651482228,0.192112063860409
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RBPMS2,RNA-binding protein with multiple splicing 2,13610,0.152889019498978,0.117247741278151,-0.0769165534061985,0.382694592404154,0.192261576829403
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TPSAB1,Tryptase alpha/beta-1,16249,0.0768885696172203,0.0589685482789337,-0.0386897850094897,0.19246692424393,0.19228917720485
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HEXIM1,Protein HEXIM1,16073,0.118377992201299,0.090931159322896,-0.0598470800715767,0.296603064474176,0.192989114134406
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TOP1,DNA topoisomerase 1,13913,-0.168147512724332,0.129179453756424,-0.421339242086922,0.0850442166382586,0.19305478186396
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AMOTL2,Angiomotin-like protein 2,13845,0.0714049299154491,0.0548651016664277,-0.0361306693507492,0.178940529181647,0.193121511269008
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SCGB1A1,Uteroglobin,16110,0.0813793845449536,0.0625336432919205,-0.0411865563072106,0.203945325397118,0.193150588603049
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AP1G2,AP-1 complex subunit gamma-like 2,13894,0.119524579461386,0.0918634648181603,-0.0605278115822078,0.29957697050498,0.193242005393432
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DCTD,Deoxycytidylate deaminase,13684,0.140683555367314,0.108300845848953,-0.0715861024966349,0.352953213231262,0.193963441107105
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ATP6V1G2,V-type proton ATPase subunit G 2,13486,-0.143103284478792,0.11025531863681,-0.359203709006939,0.0729971400493551,0.194334861651661
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ARF6,ADP-ribosylation factor 6,13913,0.158944863216331,0.12252488342405,-0.0812039082948079,0.399093634727469,0.194568234851208
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TREML2,Trem-like transcript 2 protein,16101,0.0493230308608953,0.0380397328455241,-0.0252348455163319,0.123880907238123,0.194780995896746
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PCNA,Proliferating cell nuclear antigen,13480,-0.0952291693259494,0.0734856581149024,-0.239261059231158,0.0488027205792593,0.195036346797762
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EFNB2,Ephrin-B2,13590,-0.0871588756732232,0.0672892408810725,-0.219045787800125,0.044728036453679,0.19524328390232
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CNTN3,Contactin-3,16101,0.0468210448911659,0.0361578131827454,-0.024048268947015,0.117690358729347,0.195370520644936
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FSHB,Follitropin subunit beta,13610,-0.0948366956837305,0.073352263881683,-0.238607132891829,0.0489337415243682,0.196069721220513
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ISM1,Isthmin-1,16073,0.0566308293261356,0.0438399613070779,-0.029295494835737,0.142557153488008,0.196457906566499
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EEF1D,Elongation factor 1-delta,13974,0.133670996978327,0.103519023620241,-0.0692262893173445,0.336568283273999,0.196631492561434
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KLK3,Prostate-specific antigen,13972,0.129378670805692,0.100314664629344,-0.0672380718678218,0.325995413479207,0.197166348004959
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ST13,Hsc70-interacting protein,13684,0.0820934695033942,0.0636897020769988,-0.0427383465675234,0.206925285574312,0.197433852933008
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CLEC11A,C-type lectin domain family 11 member A,16076,-0.0698507558874781,0.0541974347294847,-0.176077727957268,0.036376216182312,0.197479117466337
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NPPB,Natriuretic peptides B,15778,0.192942007482387,0.149786491411566,-0.100639515684282,0.486523530649056,0.197725350046427
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,13480,-0.0647516395325039,0.0503342810177567,-0.163406830327307,0.0339035512622992,0.198314385208757
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,16248,0.0541714533617628,0.0421313238923727,-0.0284059414672877,0.136748848190813,0.198539519859982
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SNU13,NHP2-like protein 1,13486,0.0935874733765567,0.0728136592250162,-0.0491272987044751,0.236302245457589,0.198709194783603
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MSLNL,Mesothelin-like protein,13590,-0.0558919817208659,0.0435005938329123,-0.141153145633374,0.0293691821916423,0.198864668837858
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FUOM,Fucose mutarotase,13684,0.0916314071308886,0.0713824215450632,-0.0482781390974353,0.231540953359213,0.199279527229733
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,15724,0.0952259546144192,0.0742374326055157,-0.0502794132923916,0.24073132252123,0.199608571833728
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PNLIPRP1,Inactive pancreatic lipase-related protein 1,13927,0.11665294637946,0.0909988137278388,-0.0617047285271037,0.295010621286025,0.199893047197504
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TLR4,Toll-like receptor 4,13552,-0.041071845546811,0.0320491228648915,-0.103888126361998,0.0217444352683764,0.200030250538139
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,13913,0.158457864364173,0.123685139313147,-0.0839650086895954,0.400880737417941,0.200166197377089
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,13913,0.205347025681316,0.160503408660325,-0.10923965529292,0.519933706655553,0.200779861302969
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SAMD9L,Sterile alpha motif domain-containing protein 9-like,16073,0.104502018418847,0.0817497158574836,-0.0557274246618206,0.264731461499515,0.201156293852403
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RRM2,Ribonucleoside-diphosphate reductase subunit M2,15724,0.0746700892637901,0.0584167623675998,-0.0398267649767054,0.189166943504286,0.201187038187156
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DTD1,D-aminoacyl-tRNA deacylase 1,13684,0.127237670392433,0.0996073170586779,-0.0679926710425755,0.322468011827442,0.201485296925038
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BCL7A,B-cell CLL/lymphoma 7 protein family member A,13480,0.0936384249387727,0.0733045450007909,-0.0500384832627774,0.237315333140323,0.2014869426106
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD2AP,CD2-associated protein,16102,0.092809793935611,0.0726894501137032,-0.0496615282872473,0.235281116158469,0.201691760197921
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BECN1,Beclin-1,13610,0.0874373728478414,0.0685665637506679,-0.0469530921034677,0.221827837799151,0.202253589665453
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NRGN,Neurogranin,13982,0.130452577505551,0.102310823980241,-0.0700766374957209,0.330981792506823,0.202308735226627
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KRT18,"Keratin, type I cytoskeletal 18",16008,0.117080021299891,0.0918395850785328,-0.0629255654540337,0.297085608053815,0.20238731046997
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RALB,Ras-related protein Ral-B,13552,0.0428898073275592,0.033801208210006,-0.0233605607640526,0.109140175419171,0.20450430761921
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD8A,T-cell surface glycoprotein CD8 alpha chain,16230,-0.0712067266032736,0.0562462329590687,-0.181449343203048,0.0390358899965011,0.205537661941438
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SELE,E-selectin,16301,-0.0725520809549683,0.0573519904253778,-0.184961982188709,0.0398578202787722,0.205878094768205
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,UROD,Uroporphyrinogen decarboxylase,13684,0.0996544051249558,0.0788056251814051,-0.0548046202305983,0.25411343048051,0.206050823396125
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MFAP5,Microfibrillar-associated protein 5,16301,-0.0577108600838193,0.0456571863047502,-0.14719894524113,0.0317772250734911,0.206246728448529
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FGF19,Fibroblast growth factor 19,16160,0.109229849940995,0.0864484865507932,-0.0602091836985596,0.27866888358055,0.206418703395959
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",13946,0.067837054825382,0.0537460525533541,-0.037505208179192,0.173179317829956,0.206906074084938
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MARS1,"Methionine--tRNA ligase, cytoplasmic",13654,0.122463196496161,0.0972125915248146,-0.0680734828924751,0.312999875884798,0.207782473341966
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GRIK2,"Glutamate receptor ionotropic, kainate 2",13946,-0.0605822576388894,0.0481069943214286,-0.154871966508889,0.0337074512311107,0.207934687315896
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HCG22,Protein PBMUCL2,13486,0.0774051854885636,0.0615568262667786,-0.0432461939943224,0.19805656497145,0.20860927201442
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RCC1,Regulator of chromosome condensation,13894,0.0739001275474848,0.0587695040591814,-0.0412881004085107,0.18908835550348,0.208609336560967
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TNIP1,TNFAIP3-interacting protein 1,13927,0.126515695287876,0.100693313991383,-0.0708432001352354,0.323874590710987,0.208975466699766
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CRYBB2,Beta-crystallin B2,13927,0.0980135754404713,0.0780430794312608,-0.0549508602448,0.250978011125743,0.209176700502649
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MRC1,Macrophage mannose receptor 1,13982,0.0401463697371425,0.031986158899003,-0.0225465017049034,0.102839241179188,0.20945731135126
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CES1,Liver carboxylesterase 1,16140,0.113800362175436,0.0907436539433606,-0.0640571995535512,0.291657923904422,0.209828861944899
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SPINK2,Serine protease inhibitor Kazal-type 2,13684,0.0527948927101397,0.0421304906994173,-0.0297808690607182,0.135370654480998,0.210180602855495
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,15724,0.0694877765248695,0.0556371255683758,-0.039560989589147,0.178536542638886,0.211703361930122
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IFNW1,Interferon omega-1,13486,-0.0496322363253158,0.0397951936929081,-0.127630815963416,0.028366343312784,0.212348886706661
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CTSZ,Cathepsin Z,16119,0.0447291858497246,0.0358971294200598,-0.0256291878135926,0.115087559513042,0.212768585241654
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KIT,Mast/stem cell growth factor receptor Kit,16155,-0.0414288466818249,0.0332586781829878,-0.106615855920481,0.0237581625568312,0.212909074718455
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LGMN,Legumain,16160,-0.0499648790597656,0.0401228633257514,-0.128605691178238,0.0286759330587072,0.213040690849353
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CTRL,Chymotrypsin-like protease CTRL-1,13927,-0.0972245764980362,0.0781309972806067,-0.250361331168025,0.0559121781719529,0.213381050312925
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PRG2,Bone marrow proteoglycan,13972,0.0733398515882445,0.0589475799568414,-0.0421974051271646,0.188877108303654,0.213463880706853
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,VPS37A,Vacuolar protein sorting-associated protein 37A,16008,0.112429610048565,0.0903751545464988,-0.0647056928625726,0.289564912959703,0.213505912250605
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FOXO3,Forkhead box protein O3,15724,0.136811409655159,0.110096060273235,-0.0789768684803805,0.352599687790699,0.214013574229016
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DAAM1,Disheveled-associated activator of morphogenesis 1,13684,0.117307804636208,0.0944270529969836,-0.0677692192378797,0.302384828510296,0.214143001057276
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ACHE,Acetylcholinesterase,13684,0.0464941560355039,0.0374684788890821,-0.0269440625870969,0.119932374658105,0.21466871485715
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,C1QA,Complement C1q subcomponent subunit A,16200,-0.0312583651027353,0.0252151371928942,-0.0806800340008079,0.0181633037953373,0.215116683442606
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AIF1L,Allograft inflammatory factor 1-like,13610,-0.0802415552841183,0.0647872857746922,-0.207224635402515,0.0467415248342784,0.215537795866095
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,16039,-0.261548244240191,0.211347545697513,-0.675789433807317,0.152692945326936,0.21590971666474
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,APPL2,DCC-interacting protein 13-beta,13684,0.157540839692348,0.127330378376941,-0.0920267019264566,0.407108381311153,0.216011662932497
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LAMA1,Laminin subunit alpha-1,13486,0.0729428409859831,0.0589612355068379,-0.0426211806074192,0.188506862579385,0.21605958331292
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ARHGEF12,Rho guanine nucleotide exchange factor 12,16073,0.142558409422191,0.115255948836902,-0.083343250298137,0.36846006914252,0.216147689241742
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CFHR4,Complement factor H-related protein 4,13965,0.101795007365348,0.0823145933071619,-0.0595415955166898,0.263131610247385,0.216234863382534
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,C1GALT1C1,C1GALT1-specific chaperone 1,13486,0.0444192723707701,0.0359299047029136,-0.0260033408469406,0.114841885588481,0.216377609477693
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SYTL4,Synaptotagmin-like protein 4,13974,0.10164664490129,0.0823231345568903,-0.0597066988302152,0.262999988632795,0.216952689052396
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BTN3A2,Butyrophilin subfamily 3 member A2,16073,0.0519684836666857,0.0421068179446374,-0.0305608795048036,0.134497846838175,0.217144245388791
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EP300,Histone acetyltransferase p300,13552,0.04312444855151,0.0349470903175273,-0.0253718484708435,0.111620745573864,0.217227107330272
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CTRC,Chymotrypsin-C,16082,-0.0896255669143762,0.0726369852339254,-0.23199405797287,0.0527429241441175,0.217264420677419
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,13610,0.0596091099377073,0.0483423540705698,-0.0351419040406094,0.154360123916024,0.217574028320289
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PLAU,Urokinase-type plasminogen activator,16101,0.0418677911085499,0.0340056208762984,-0.0247832258089949,0.108518808026095,0.218265293199255
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CDC25A,M-phase inducer phosphatase 1,13480,0.0558171952387961,0.0454141595770727,-0.0331945575322665,0.144828948009859,0.219066921832968
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,F11R,Junctional adhesion molecule A,16101,0.0782184053822358,0.0637124884969852,-0.0466580720718552,0.203094882836327,0.219585920408874
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,VASH1,Tubulinyl-Tyr carboxypeptidase 1,16073,0.113295118615094,0.0923409975839069,-0.0676932366493631,0.294283473879552,0.219870232981437
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NFKB2,Nuclear factor NF-kappa-B p100 subunit,13710,0.0761101583465413,0.0620439637849982,-0.0454960106720551,0.197716327365138,0.219951437903399
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SYT1,Synaptotagmin-1,13927,-0.0556619790660823,0.0453933842703176,-0.144633012235905,0.0333090541037401,0.220139108008294
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TP53I3,Quinone oxidoreductase PIG3,13374,0.0738698153674222,0.0602970564706449,-0.0443124153150417,0.192052046049886,0.220559821369344
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TNNI3,"Troponin I, cardiac muscle",15778,-0.113067267946875,0.0923537158314846,-0.294080550976585,0.0679460150828351,0.220863033764175
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,15950,0.108696445270804,0.0887882344977381,-0.065328494344763,0.28272138488637,0.22088686499986
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,16085,-0.0451815725404231,0.0369094665363108,-0.117524126951592,0.0271609818707461,0.220925353054914
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NRCAM,Neuronal cell adhesion molecule,16102,-0.0391856880001032,0.032024441022252,-0.101953592403717,0.0235822164035108,0.221114221685062
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RABGAP1L,Rab GTPase-activating protein 1-like,15826,0.0854831745678745,0.0698947857740079,-0.0515106055491811,0.22247695468493,0.221337918229657
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SLC4A1,Band 3 anion transport protein,13972,0.0658269685428494,0.0538411018576787,-0.0397015910982008,0.1713555281839,0.221495579283326
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL1RN,Interleukin-1 receptor antagonist protein,16053,-0.0753528533370986,0.0617321963041837,-0.196347958093299,0.0456422514191015,0.222239898694077
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ICAM2,Intercellular adhesion molecule 2,16301,-0.0438056291514133,0.0359211343186072,-0.114211052415884,0.0265997941130569,0.22267418571173
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MDH1,"Malate dehydrogenase, cytoplasmic",13893,0.0551768514119199,0.0452886142122678,-0.033588832444125,0.143942535267965,0.223116166293018
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FHIP2A,FHF complex subunit HOOK interacting protein 2A,13486,-0.0666477342241858,0.0547536786711217,-0.173964944419584,0.0406694759712127,0.223538638241267
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RGS10,Regulator of G-protein signaling 10,13946,0.0827091372737836,0.0680804675989358,-0.0507285792201306,0.216146853767698,0.2244350359243
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CLEC3B,Tetranectin,13668,-0.0294710728931436,0.0243235638336256,-0.0771452580070499,0.0182031122207626,0.225676379118937
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TSHB,Thyrotropin subunit beta,16102,-0.106190114209059,0.087659759523879,-0.278003242875862,0.065623014457744,0.225763946153154
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PER3,Period circadian protein homolog 3,13552,0.163370935384585,0.134901553092731,-0.101036108677167,0.427777979446338,0.225901900811511
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EGFLAM,Pikachurin,13913,0.0432729607092225,0.0357865739250477,-0.026868724183871,0.113414645602316,0.226608351320395
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TBC1D5,TBC1 domain family member 5,16073,0.107375472635743,0.0888098887641694,-0.0666919093420286,0.281442854613515,0.226661970607276
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL18R1,Interleukin-18 receptor 1,16272,0.0447231790065929,0.0370015220015147,-0.027799804116376,0.117246162129562,0.226801523405772
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,F2,Prothrombin,13992,0.0201588034617253,0.0166789059858682,-0.0125318522705764,0.052849459194027,0.226821384474729
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NUCB2,Nucleobindin-2,16185,0.051210665346863,0.0423747924055001,-0.0318439277679172,0.134265258461643,0.226866056273884
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,16230,0.0777223890631857,0.0644228547482407,-0.048546406243366,0.203991184369737,0.227665001265699
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,13894,0.114695746232645,0.0952165921999831,-0.0719287744793214,0.301320266944612,0.228387060486918
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PSRC1,Proline/serine-rich coiled-coil protein 1,15724,0.0820723130039974,0.0681423381212271,-0.0514866697136076,0.215631295721602,0.228443627013997
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,OSBPL2,Oxysterol-binding protein-related protein 2,13927,-0.0543386685354626,0.0451305424466416,-0.14279453173088,0.0341171946599549,0.228597255059268
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SUGP1,SURP and G-patch domain-containing protein 1,13913,0.0558716657655427,0.0464215108045397,-0.0351144954113551,0.146857826942441,0.228775252594619
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CX3CL1,Fractalkine,15950,-0.0450213170919266,0.0374138523426014,-0.118352467683425,0.0283098334995722,0.22886542234188
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DNAJB6,DnaJ homolog subfamily B member 6,13549,0.116583503571913,0.096889059667097,-0.0733190533755966,0.306486060519424,0.228893679638307
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GPHA2,Glycoprotein hormone alpha-2,13913,0.0663407953849178,0.0551404532577808,-0.0417344930003325,0.174416083770168,0.228948883238643
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PAMR1,Inactive serine protease PAMR1,16101,-0.0373868471091829,0.0310760092645573,-0.0982958252677152,0.0235221310493495,0.228964041787745
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RILPL2,RILP-like protein 2,13974,0.132656037100249,0.110289204006883,-0.0835108027532413,0.348822876953739,0.2290734834281
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SDHB,Succinate dehydrogenase,13913,0.0935898052852171,0.0779042681072772,-0.0591025602050462,0.24628217077548,0.229638358031603
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AKR7L,Aflatoxin B1 aldehyde reductase member 4,13552,0.0950399608639471,0.0791884146758992,-0.0601693319008153,0.25024925362871,0.230092357708949
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BPIFA2,BPI fold-containing family A member 2,13126,-0.148721449591699,0.123960134327598,-0.39168331287379,0.094240413690393,0.230257253218139
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,UNG,Uracil-DNA glycosylase,13894,0.0472737858252443,0.0395602984329489,-0.0302643991033355,0.124811970753824,0.232115060455623
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,13684,0.0867843923364011,0.0727489317272282,-0.0558035138489661,0.229372298521768,0.232917443948245
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",13610,0.0941499794860695,0.0789653503929806,-0.0606221072841724,0.248922066256311,0.233166467699594
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FAP,Prolyl endopeptidase FAP,16301,-0.0368672049649123,0.0309428809791897,-0.0975152516841241,0.0237808417542996,0.233490412431938
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TWF2,Twinfilin-2,13972,0.112864757730437,0.0948347007482272,-0.0730112557360878,0.298740771196963,0.234019125195135
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CGA,Glycoprotein hormones alpha chain,16101,-0.106473999978299,0.0895206161240801,-0.281934407581496,0.0689864076248977,0.2343078554602
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,13894,0.0727994466912689,0.0612105550360628,-0.0471732411794141,0.192772134561952,0.234330839605804
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NIT2,Omega-amidase NIT2,13931,0.0980150620994038,0.0826868762921102,-0.0640512154331321,0.26008133963194,0.235888944128958
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FABP3,"Fatty acid-binding protein, heart",13974,0.0667065594946505,0.0563121289876056,-0.0436652133210565,0.177078332310358,0.236201342943584
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NCS1,Neuronal calcium sensor 1,16209,0.0383099211878513,0.0324048767468235,-0.0252036372359227,0.101823479611625,0.23713298756511
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TCL1B,T-cell leukemia/lymphoma protein 1B,15778,-0.107607990380767,0.0911298674191213,-0.286222530522244,0.0710065497607109,0.23769196403667
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MAPT,Microtubule-associated protein tau,15688,-0.0693738365971069,0.0588009990672525,-0.184623794768922,0.0458761215747079,0.238094848231494
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CXADR,Coxsackievirus and adenovirus receptor,16073,0.0686000818518901,0.0582164553068956,-0.0455041705496252,0.182704334253405,0.238669621940508
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,OLFM4,Olfactomedin-4,13170,0.163847465138941,0.139117850462571,-0.108823521767698,0.43651845204558,0.238913530475082
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PAM,Peptidyl-glycine alpha-amidating monooxygenase,16229,-0.0372572847910594,0.031674000437845,-0.0993383256492356,0.0248237560671168,0.239502902455074
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IDO1,"Indoleamine 2,3-dioxygenase 1",13610,0.0856636288466896,0.0728435710757756,-0.0571097704618306,0.22843702815521,0.239617720236266
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MUC2,Mucin-2,13972,0.121051243233738,0.103116931900019,-0.0810579432902992,0.323160429757775,0.240446266683403
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PDIA4,Protein disulfide-isomerase A4,13972,0.0807769686331108,0.0688169621419805,-0.054104277165171,0.215658214431393,0.240497392891603
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MTSS1,Protein MTSS 1,13913,0.149184177407403,0.127097304353395,-0.0999265391252515,0.398294893940057,0.240503573565594
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,VWA5A,von Willebrand factor A domain-containing protein 5A,13480,0.107136781164133,0.0912911102313158,-0.0717937948892459,0.286067357217512,0.240586861666466
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NGFR,Tumor necrosis factor receptor superfamily member 16,13974,0.0396494825146186,0.0338125724932127,-0.0266231595720782,0.105922124601315,0.240966054342017
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,C9,Complement component C9,13982,-0.0691246918505105,0.0589497187546404,-0.184666140609606,0.0464167569085847,0.240974534279736
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,13486,0.0372193474819013,0.0317822360886588,-0.02507383525187,0.0995125302156726,0.241589782370635
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PPL,Periplakin,13552,0.042900457609639,0.0366698153943112,-0.0289723805632109,0.114773295782489,0.242056973734811
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NTproBNP,N-terminal prohormone of brain natriuretic peptide,16102,0.136304565077315,0.116546738650576,-0.0921270426778142,0.364736172832443,0.242208670298342
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CASP1,Caspase-1,15688,-0.0906387976372999,0.0775035637819794,-0.242545782649979,0.0612681873753796,0.242228442597386
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FABP6,Gastrotropin,15749,0.0730461633197545,0.062465961895507,-0.0493871219954393,0.195479448634948,0.242270103393397
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD46,Membrane cofactor protein,16019,0.0376023576583768,0.0321576877913607,-0.0254267104126902,0.100631425729444,0.242295521410061
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,H2AP,Huntingtin-interacting protein M,13480,-0.0662870212241057,0.0566917494344048,-0.177402850115539,0.0448288076673277,0.242322245345077
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD302,CD302 antigen,16008,0.0402425815339972,0.0344295974365506,-0.0272394294416421,0.107724592509636,0.242486798694878
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CACYBP,Calcyclin-binding protein,13654,0.136890108541575,0.117158702542307,-0.0927409484413467,0.366521165524498,0.242659404466771
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SPINT3,Kunitz-type protease inhibitor 3,13913,0.195514755579874,0.167459064314357,-0.132705010476265,0.523734521636012,0.243013357820039
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CLMP,CXADR-like membrane protein,16209,0.0278013792155325,0.0238428708703876,-0.0189306476904271,0.0745334061214922,0.243621581939873
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FAM13A,Protein FAM13A,13913,0.0895641927075044,0.0768755434851792,-0.0611118725234469,0.240240257938456,0.244016954716253
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SH2D1A,SH2 domain-containing protein 1A,16073,0.0764999280221271,0.0656846567503021,-0.0522419992084652,0.205241855252719,0.244176192918132
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ASPN,Asporin,13974,-0.0359000766179107,0.0308293317864177,-0.0963255669192894,0.024525413683468,0.244250279625315
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,13486,0.0684946532548006,0.0588396194528043,-0.0468310008726958,0.183820307382297,0.244407875632461
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MAEA,E3 ubiquitin-protein transferase MAEA,15724,0.0519837158889591,0.0447343817419723,-0.0356956723253066,0.139663104103225,0.245231650609027
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MYOM1,Myomesin-1,13474,-0.061698733817547,0.0531305644967244,-0.165834640231127,0.0424371725960328,0.245554214822135
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",13927,0.129746323558711,0.111784825748567,-0.089351934908481,0.348844582025903,0.245792293103187
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,VASP,Vasodilator-stimulated phosphoprotein,13982,0.0944988593142173,0.0814972885535054,-0.0652358262506532,0.254233544879088,0.246258494816763
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CEBPB,CCAAT/enhancer-binding protein beta,15778,-0.0500649988427338,0.0432665817998585,-0.134867499170456,0.0347375014849889,0.247237360152233
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CCL21,C-C motif chemokine 21,16160,-0.0540605092365567,0.0467469917258775,-0.145684613019277,0.0375635945461632,0.247514681749631
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SLC16A1,Monocarboxylate transporter 1,15688,0.0741080037377932,0.0641131306606254,-0.0515537323570325,0.199769739832619,0.24774200378752
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TACSTD2,Tumor-associated calcium signal transducer 2,14241,-0.0397465609042376,0.0344069152166165,-0.107184114728806,0.0276909929203307,0.248031595380553
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FXYD5,FXYD domain-containing ion transport regulator 5,15826,0.0876025610871996,0.0758983816400812,-0.0611582669273596,0.236363389101759,0.24843212199199
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TFPI,Tissue factor pathway inhibitor,16074,-0.0413324993163087,0.0358108896439097,-0.111521843018372,0.0288568443857543,0.248440273357793
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,C1QL2,Complement C1q-like protein 2,13552,-0.056347156158637,0.0488365401944474,-0.152066774939754,0.0393724626224798,0.24860627008816
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FCRL6,Fc receptor-like protein 6,16073,-0.0882931566385455,0.0766197639442647,-0.238467893969304,0.0618815806922133,0.24919243950809
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IGFBP7,Insulin-like growth factor-binding protein 7,16301,-0.0385372336465937,0.0334652149140013,-0.104129054878036,0.0270545875848488,0.249518452429425
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SERPINA12,Serpin A12,15622,0.145944236075393,0.126818646608797,-0.102620311277849,0.394508783428635,0.24982781475911
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,13913,-0.226552342442721,0.196865985520042,-0.612409674062002,0.159304989176561,0.249836482908011
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,16152,0.14529123724091,0.126341685109527,-0.102338465573763,0.392920940055582,0.250166456379717
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ANK2,Ankyrin-2,13486,-0.0927470191211116,0.0807110487346822,-0.250940674641089,0.0654466363988654,0.250525172581325
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GLO1,Lactoylglutathione lyase,15778,-0.075846140507386,0.0660090282044141,-0.205223835788038,0.0535315547732656,0.250562375481933
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FKBPL,FK506-binding protein-like,13913,0.0769855628440533,0.0670844749538163,-0.0545000080654265,0.208471133753533,0.251157056773399
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TLR3,Toll-like receptor 3,16272,-0.0792648774459647,0.0691396599606128,-0.214778610968766,0.0562488560768365,0.251627585944225
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MRPL46,"39S ribosomal protein L46, mitochondrial",15688,0.0349940182360615,0.0305299492235985,-0.0248446822421915,0.0948327187143146,0.251721906104232
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,13474,0.0431870886576876,0.0376868698659211,-0.0306791762795178,0.117053353594893,0.251838188516515
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BRK1,Protein BRICK1,15688,-0.0574753199638487,0.0501646190312062,-0.155797973265013,0.0408473333373155,0.251922638130917
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MERTK,Tyrosine-protein kinase Mer,16272,0.032915460490027,0.0287327174184085,-0.0234006656500536,0.0892315866301076,0.25198822920548
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,THTPA,Thiamine-triphosphatase,13869,0.114602850704626,0.100095874651687,-0.0815850636126809,0.310790765021933,0.252257597872422
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,UPK3BL1,Uroplakin-3b-like protein 1,13686,-0.0712260931882099,0.062211306635202,-0.193160254193206,0.050708067816786,0.252268173577815
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,13913,0.155016212239963,0.135463584694319,-0.110492413760903,0.420524838240829,0.252502937080761
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LPP,Lipoma-preferred partner,13486,0.0861892688923168,0.0753288637781674,-0.0614553041128913,0.233833841897525,0.252572133922643
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TDO2,"Tryptophan 2,3-dioxygenase",13590,-0.0505415193611524,0.0442146353287065,-0.137202204605417,0.0361191658831123,0.253019393585742
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,P4HB,Protein disulfide-isomerase,15982,0.0501779876793809,0.0439227954002195,-0.0359106913050493,0.136266666663811,0.253299375347099
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",16008,0.124882105627738,0.109387939629327,-0.0895182560457429,0.33928246730122,0.253619040024652
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GLB1,Beta-galactosidase,15950,0.05412963187766,0.0474270312584165,-0.0388273493888363,0.147086613144156,0.253752067892767
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PDLIM5,PDZ and LIM domain protein 5,13946,0.152817978193752,0.133966040607703,-0.109755461397346,0.415391417784851,0.254005334848986
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ASAH1,Acid ceramidase,13833,0.0601070838076799,0.0527183897837741,-0.0432209601685174,0.163435127783877,0.254241901891896
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ACE,Angiotensin-converting enzyme,13982,0.0332090714415074,0.0291374757633161,-0.0239003810545922,0.0903185239376069,0.254415256275609
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,13894,0.140908777596772,0.123638373818736,-0.101422435087951,0.383239990281495,0.254437301197645
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DCTPP1,dCTP pyrophosphatase 1,16102,0.0414641379451862,0.0364736532516539,-0.0300242224280556,0.112952498318428,0.255628645010707
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD5L,CD5 antigen-like,13919,-0.0608202044360619,0.0535264235537069,-0.165731994601328,0.0440915857292037,0.25586523485137
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,REST,RE1-silencing transcription factor,13480,0.0459728668682359,0.0404701405762078,-0.0333486086611313,0.125294342397603,0.255989323176358
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",13486,-0.0810266027209031,0.0713788907159503,-0.220929228524166,0.0588760230823595,0.256327652810471
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TMPRSS5,Transmembrane protease serine 5,15876,0.0486971182922805,0.0429005616665165,-0.0353879825740918,0.132782219158653,0.256343828080949
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MAMDC4,Apical endosomal glycoprotein,13894,0.0724242968591323,0.063827748096181,-0.0526780894093823,0.197526683127647,0.256527519989803
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL4R,Interleukin-4 receptor subunit alpha,16073,-0.0457962306098375,0.0404212814080271,-0.125021942169571,0.0334294809498956,0.257242401161939
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SHPK,Sedoheptulokinase,13710,0.0547226453970808,0.0483104227653399,-0.0399657832229854,0.149411074017147,0.257347656656651
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LGALS8,Galectin-8,16230,0.0783350970914756,0.0691739579056376,-0.0572458604035741,0.213916054586525,0.257467818519892
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IFNG,Interferon gamma,15826,0.149599013926036,0.132115287018798,-0.109346948630809,0.408544976482881,0.257509994977494
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BGLAP,Osteocalcin,13972,-0.113655739818026,0.100479040555355,-0.310594659306521,0.0832831796704697,0.258016116361784
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MYH7B,Myosin-7B,13480,-0.058366886530087,0.0516001214812736,-0.159503124633383,0.0427693515732093,0.258016925657883
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MATN2,Matrilin-2,16107,-0.0377150763142145,0.0333923807486116,-0.103164142581493,0.0277339899530642,0.258724230245145
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ART3,Ecto-ADP-ribosyltransferase 3,16174,0.0433657072570569,0.038409066074696,-0.0319160622493473,0.118647476763461,0.25889403761277
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TFAP2A,Transcription factor AP-2-alpha,13474,0.0757651853796689,0.0671417501085831,-0.0558326448331539,0.207363015592492,0.259155834024091
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,13486,0.0712343287402017,0.0631302692320561,-0.0525009989546282,0.194969656435032,0.259183606016766
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GNAS,Neuroendocrine secretory protein 55,13946,0.1121598968337,0.0994041911348843,-0.0826723177906733,0.306992111458073,0.259203550301085
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ATOX1,Copper transport protein ATOX1,16118,0.0913618594843369,0.0810406109025538,-0.0674777378846686,0.250201456853342,0.259607536706024
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,16118,-0.0581424840318201,0.0515901539292746,-0.159259185733198,0.0429742176695582,0.259756154554366
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TRIM26,Tripartite motif-containing protein 26,13480,-0.0760766196292092,0.0675047854140517,-0.208385999040751,0.0562327597823322,0.259770539035373
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,13610,0.0679020734168514,0.0602929608169678,-0.0502721297844056,0.186076276618108,0.260099762092712
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CCN4,CCN family member 4,16209,0.0507819212817084,0.0451139753747453,-0.0376414704527923,0.139205313016209,0.260336243321172
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CMC1,COX assembly mitochondrial protein homolog,13974,0.115301942829062,0.102443067761682,-0.0854864699838358,0.316090355641959,0.260387182130366
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FN1,Fibronectin,13992,-0.0341309104382069,0.0303255255705746,-0.0935689405565332,0.0253071196801193,0.260403085557979
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,C3,Complement C3,13270,0.0567322214418933,0.0504917501846885,-0.0422316089200962,0.155696051803883,0.261205701477321
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,13946,0.107042581371514,0.0953791743511763,-0.079900600356791,0.29398576309982,0.261760780103801
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CPE,Carboxypeptidase E,16068,-0.0481456497641094,0.04290503328883,-0.132239515010216,0.0359482154819974,0.261817762347191
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MET,Hepatocyte growth factor receptor,16132,-0.0249072766318054,0.0221964129544745,-0.0684122460225755,0.0185976927589646,0.261823583967831
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,OBP2B,Odorant-binding protein 2b,15895,-0.0794846616630861,0.0708830764349873,-0.218415491475661,0.059446168149489,0.26215632224813
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BOLA1,BolA-like protein 1,13474,0.0693564914603981,0.0618652579955955,-0.051899414210969,0.190612397131765,0.26226976638058
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TPSD1,Tryptase delta,13946,0.0471691166746209,0.042141310653323,-0.0354278522058921,0.129766085555134,0.263027954395562
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",13974,0.112267263207478,0.100327588682579,-0.084374810610377,0.308909337025333,0.263156452483094
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LETM1,Mitochondrial proton/calcium exchanger protein,13946,0.0670549093676225,0.0599401340584145,-0.05042775338687,0.184537572122115,0.263288277478847
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD99L2,CD99 antigen-like protein 2,16101,0.0302975235632049,0.0271254162882379,-0.0228682923617414,0.0834633394881511,0.26403569873009
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,APP,Amyloid-beta precursor protein,16072,0.0839846572390388,0.0751953104992764,-0.063398151339543,0.231367465817621,0.264059397404705
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RNF41,E3 ubiquitin-protein ligase NRDP1,15724,0.0857480864425497,0.0770046981029358,-0.0651811218392045,0.236677294724304,0.265492083477483
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,13474,-0.0400963020147351,0.0360101169336658,-0.11067613120472,0.0304835271752499,0.265525113428347
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,COL18A1,Collagen alpha-1(XVIII) chain,16184,-0.0292310562888767,0.0262865781105067,-0.0807527493854699,0.0222906368077165,0.266148443957954
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NFX1,Transcriptional repressor NF-X1,13486,0.0833912741352745,0.0750219291189601,-0.0636517069378872,0.230434255208436,0.266347796626716
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GIGYF2,GRB10-interacting GYF protein 2,13946,0.0958642316097464,0.0862813202913277,-0.0732471561612557,0.264975619380749,0.266559164249179
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",13684,0.112038893781606,0.10089178269177,-0.0857090002942627,0.309786787857475,0.266809268758421
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AHNAK2,Protein AHNAK2,13610,0.0367207386310731,0.0330693458917737,-0.0280951793168034,0.10153665657895,0.266839342282339
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NRP2,Neuropilin-2,16101,-0.0362627318333346,0.0326640599684382,-0.100284289371474,0.0277588257048043,0.266941416773783
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,16230,0.0657755788479851,0.0592761477817468,-0.0504056708042385,0.181956828500209,0.267167775370745
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AGBL2,Cytosolic carboxypeptidase 2,13474,-0.115665201783849,0.104277071147352,-0.320048261232658,0.0887178576649602,0.2673592859348
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ITGAL,Integrin alpha-L,13552,0.0556621717066356,0.0501851230586257,-0.0427006694882709,0.154025012901542,0.267390831538186
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BSND,Barttin,13480,0.0433583297796647,0.0391480144242276,-0.0333717784918215,0.120088438051151,0.268076581441884
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PRRT3,Proline-rich transmembrane protein 3,13610,0.0473047026147404,0.0427647737674792,-0.0365142539695188,0.131123659199,0.268676637506645
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,VAV3,Guanine nucleotide exchange factor VAV3,13474,0.12452602312452,0.112634251641271,-0.0962371100923709,0.345289156341411,0.268928698408769
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NPDC1,Neural proliferation differentiation and control protein 1,16102,-0.039271563248925,0.0355421012482412,-0.108934081695478,0.0303909551976278,0.269206088704257
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SFTPA2,Pulmonary surfactant-associated protein A2,15724,-0.0643229743478516,0.0582166414875019,-0.178427591663355,0.0497816429676522,0.269224256657707
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PKD2,Polycystin-2,13486,0.0733588800066697,0.0664485909939035,-0.0568803583413811,0.203598118354721,0.269615235009967
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DBNL,Drebrin-like protein,16160,0.11522309647156,0.104479163762701,-0.0895560645033327,0.320002257446454,0.270116020078771
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NUMB,Protein numb homolog,13552,0.10367467531338,0.0940267733365864,-0.0806178004263293,0.287967151053089,0.270217021860187
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,16118,0.0438516981616703,0.0397758480500949,-0.0341089640165158,0.121812360339856,0.270273662194055
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,13486,-0.0485313387135821,0.0440214885324361,-0.134813456237157,0.0377507788099926,0.270287271837868
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,15688,0.0787798120081695,0.0714850072991645,-0.061330802298193,0.218890426314532,0.270458317830749
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BST2,Bone marrow stromal antigen 2,16230,0.0656659361239427,0.0595961211801035,-0.0511424613890601,0.182474333636945,0.270543607194069
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ARMCX2,Armadillo repeat-containing X-linked protein 2,13474,0.0764267195288875,0.0693991296017928,-0.0595955744906265,0.212449013548401,0.270801740002413
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CDHR5,Cadherin-related family member 5,16102,-0.0485267576113291,0.0441325057048629,-0.13502646879286,0.0379729535702022,0.271536186738495
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GFER,FAD-linked sulfhydryl oxidase ALR,15724,0.0806062258540296,0.0733329636120728,-0.0631263828256331,0.224338834533692,0.271705816470555
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GMPR2,GMP reductase 2,13684,0.0835351509180368,0.07600332420124,-0.0654313645163936,0.232501666352467,0.271744395731509
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NBN,Nibrin,15826,0.0697671461912804,0.063551732221977,-0.0547942489637944,0.194328541346355,0.272308173299987
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LPCAT2,Lysophosphatidylcholine acyltransferase 2,16008,0.0516288650687146,0.0470773150987171,-0.0406426725247709,0.1439004026622,0.272796744289424
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD276,CD276 antigen,16076,-0.0436547031858919,0.0398865503075647,-0.121832341788719,0.0345229354169348,0.273764535525989
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PVALB,Parvalbumin alpha,16140,0.140544133807251,0.128471344837056,-0.11125970207338,0.392347969687881,0.273983326783308
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PSMC3,26S proteasome regulatory subunit 6A,13480,0.0377048196677248,0.0344682436754446,-0.0298529379361465,0.105262577271596,0.274018305038584
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CLEC7A,C-type lectin domain family 7 member A,16272,0.0733366731935159,0.0671907208897386,-0.0583571397503718,0.205030486137404,0.275082188391719
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,S100A14,Protein S100-A14,13946,0.0652663114115754,0.0598570587053298,-0.052053523650871,0.182586146474022,0.275569267585518
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,13486,-0.0318427926400843,0.0292063877987357,-0.0890873127256062,0.0254017274454377,0.275614567359868
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GOLGA3,Golgin subfamily A member 3,13946,0.094938184301761,0.0871694968569965,-0.0759140295379521,0.265790398141474,0.276119092087048
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CTBS,Di-N-acetylchitobiase,13778,0.0323584997735208,0.0297186227291195,-0.0258900007755535,0.090607000322595,0.276248341994476
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,16073,-0.103646513726585,0.0952095284805372,-0.290257189548438,0.0829641620952681,0.276340068738709
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DFFA,DNA fragmentation factor subunit alpha,16272,0.0827774008484007,0.0760691158462167,-0.0663180662101839,0.231872867906985,0.276528821704908
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KLKB1,Plasma kallikrein,13706,0.030878843278261,0.0283809803740111,-0.0247478782548007,0.0865055648113227,0.27660902238463
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LCN2,Neutrophil gelatinase-associated lipocalin,15628,-0.0493152179594815,0.0453295802655007,-0.138161195279863,0.0395307593608998,0.276644676499652
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,15778,-0.0263516354107989,0.0242487155774249,-0.0738791179425518,0.0211758471209539,0.277175890162043
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",15826,0.147606033845424,0.13583742847511,-0.118635325965792,0.41384739365664,0.277213641923518
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PRUNE2,Protein prune homolog 2,13710,0.0349565798748371,0.0321717115417242,-0.0280999747469424,0.0980131344966166,0.277249265362774
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",16008,0.0551059168421849,0.0507316554842636,-0.0443281279069717,0.154539961591342,0.277396489158058
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AHNAK,Neuroblast differentiation-associated protein AHNAK,13610,0.0393366210319521,0.0362347798900798,-0.0316835475526044,0.110356789616509,0.277673488802852
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BRDT,Bromodomain testis-specific protein,13486,0.0445674725718412,0.0410889197561295,-0.0359668101501726,0.125101755293855,0.278092058645568
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,WASF1,Wiskott-Aldrich syndrome protein family member 1,15778,0.114520197974275,0.105600299566011,-0.0924563891751061,0.321496785123656,0.278173713335003
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CES2,Cocaine esterase,16008,0.0672611690757142,0.0620297878357851,-0.0543172150824245,0.188839553233853,0.278231928953001
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RARRES2,Retinoic acid receptor responder protein 2,16205,0.0593345369527468,0.054721767972114,-0.0479201282725967,0.16658920217809,0.278250186651348
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PPM1A,Protein phosphatase 1A,15724,0.0391506784324768,0.0361178684513908,-0.0316403437322492,0.109941700597203,0.278394826914016
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NCAM2,Neural cell adhesion molecule 2,16101,-0.0330691723213092,0.0305086360246922,-0.0928660989297059,0.0267277542870875,0.27841285952111
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,C4BPB,C4b-binding protein beta chain,16118,-0.0496802524332611,0.0458345822220399,-0.139516033588459,0.0401555287219372,0.278423927614634
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SERPINA11,Serpin A11,16301,-0.0495321149256674,0.0457234840419265,-0.139150143647843,0.0400859137965086,0.278692635429342
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AP3B1,AP-3 complex subunit beta-1,13913,0.0948574107040596,0.0876316555452734,-0.0769006341646763,0.266615455572796,0.279068738434238
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ZPR1,Zinc finger protein ZPR1,13474,-0.118732789566318,0.109711119637764,-0.333766584056334,0.0963010049236989,0.27916922444512
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HLA_DRA,,16025,0.0438934248597659,0.0405806703700811,-0.035644689065593,0.123431538785125,0.279431568126681
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,WFDC2,WAP four-disulfide core domain protein 2,15235,0.0483432508412883,0.0446966830938019,-0.0392622480225635,0.13594874970514,0.279454218712946
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SLC12A2,Solute carrier family 12 member 2,13486,-0.0335571356480087,0.0310671113891462,-0.0944486739707353,0.0273344026747179,0.28009479359703
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,13974,0.0873039468522742,0.0808435122675711,-0.0711493371921651,0.245757230896714,0.280199652152206
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,COL24A1,Collagen alpha-1(XXIV) chain,13913,0.0690841135965106,0.0640145449494438,-0.0563843945043992,0.194552621697421,0.280519975734933
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PPIE,Peptidyl-prolyl cis-trans isomerase E,13710,0.0765748043828235,0.0709694834237265,-0.0625253831276805,0.215674991893328,0.280614695456471
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GLA,Alpha-galactosidase A,13654,-0.0456547642774586,0.0423271282623639,-0.128615935671692,0.0373064071167746,0.280777529338816
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LGALS3BP,Galectin-3-binding protein,13992,0.036454073323313,0.0338063133981869,-0.0298063009371333,0.102714447583759,0.28090892971811
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PGA4,Pepsin A-4,13982,-0.0841747845410281,0.0780980583277822,-0.237246978863481,0.068897409781425,0.281137647295926
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MASP1,Mannan-binding lectin serine protease 1,15925,-0.0289617703224644,0.0268852570667568,-0.0816568741733077,0.0237333335283789,0.281391119348249
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LYPLA2,Acyl-protein thioesterase 2,13474,-0.130508549429715,0.121174148886134,-0.368009881246536,0.106992782387107,0.281484854189095
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CCL25,C-C motif chemokine 25,16272,0.059413146627837,0.0553210057577012,-0.0490160246572574,0.167842317912931,0.282851693449412
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IGFBP4,Insulin-like growth factor-binding protein 4,15880,0.0514458586925071,0.0479296639141796,-0.0424962825792848,0.145387999964299,0.283125250291389
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GGA1,ADP-ribosylation factor-binding protein GGA1,15688,0.0823982065870657,0.0768406988290992,-0.0682095631179687,0.2330059762921,0.283590566741919
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PAGR1,PAXIP1-associated glutamate-rich protein 1,13610,0.0533098590863037,0.0497944020120056,-0.0442871688572272,0.150906887029835,0.284368578610999
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NOS3,"Nitric oxide synthase, endothelial",15688,-0.0618561891509739,0.0577779478809235,-0.175100966997584,0.0513885886956362,0.284372674262915
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AGRN,Agrin,16160,0.0411598452896812,0.0384471583660255,-0.0341965851077288,0.116516275687091,0.284385011424083
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SNCA,Alpha-synuclein,13684,0.140024893477638,0.130817970859434,-0.116378329406853,0.39642811636213,0.284467355104812
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",13552,-0.0749880606649671,0.070163383492965,-0.212508292311178,0.0625321709812442,0.285195323187346
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,OPHN1,Oligophrenin-1,13927,0.130644034347946,0.122247746971905,-0.108961549716988,0.370249618412879,0.285231276847781
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PYY,Peptide YY,13486,0.11749723119473,0.110014512081171,-0.0981312124843658,0.333125674873826,0.285532546082802
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IGSF8,Immunoglobulin superfamily member 8,16102,0.0369653497015529,0.0346175497599476,-0.0308850478279444,0.10481574723105,0.285617245585547
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,VEGFD,Vascular endothelial growth factor D,16239,0.0422051147317945,0.0395544558645397,-0.0353216187627032,0.119731848226292,0.285981886113732
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",15981,0.126363425341117,0.118473615553457,-0.10584486114366,0.358571711825893,0.286170659773364
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CCL15,C-C motif chemokine 15,16301,0.0521256531281858,0.0488746064574665,-0.0436685755284486,0.14791988178482,0.28620530342307
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BID,BH3-interacting domain death agonist,16073,0.0807423448399982,0.0757539863705475,-0.0677354684462748,0.229220158126271,0.28650772627793
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",13972,0.0752255811569956,0.0706334049746918,-0.0632158925934003,0.213667054907392,0.286887914515139
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CDC42BPB,Serine/threonine-protein kinase MRCK beta,13913,0.125080843436866,0.11744552880691,-0.105112393024677,0.355274079898408,0.286889208574582
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SPINT2,Kunitz-type protease inhibitor 2,16160,0.0486282095044011,0.0456761828069388,-0.0408971087971989,0.138153527806001,0.287059566914571
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SCP2,Non-specific lipid-transfer protein,15724,0.0931499067666981,0.0876479070807308,-0.0786399911115342,0.26493980464493,0.287900841018432
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CALCB,Calcitonin gene-related peptide 2,13927,-0.0474430064809989,0.0446854343447537,-0.135026457796716,0.0401404448347184,0.288385441637375
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PPM1B,Protein phosphatase 1B,13552,0.0753212469285802,0.071040639740214,-0.0639184069622391,0.2145609008194,0.289047178387923
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PDGFRB,Platelet-derived growth factor receptor beta,16301,-0.0417119665526451,0.0393561033633265,-0.118849929144765,0.0354259960394749,0.289223933477915
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD207,C-type lectin domain family 4 member K,15727,0.046136058654796,0.0435578737471302,-0.0392373738895791,0.131509491199171,0.289529598817791
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,13974,0.107175897243722,0.101285416614992,-0.091343519321662,0.305695313809105,0.290002069776521
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LY6D,Lymphocyte antigen 6D,16002,0.0455816210409782,0.0430907977763728,-0.0388763426007124,0.130039584682669,0.290160761181372
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TXNDC15,Thioredoxin domain-containing protein 15,16118,-0.0327588121401818,0.0309749402937715,-0.0934696951159739,0.0279520708356102,0.290257898653605
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD2,T-cell surface antigen CD2,13486,0.0470031551014836,0.0444743925148973,-0.0401666542277152,0.134172964430682,0.290594964148215
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SLC51B,Organic solute transporter subunit beta,13486,0.0905507632693709,0.0857395668388178,-0.0774987877347121,0.258600314273454,0.29093503913193
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KCNIP4,Kv channel-interacting protein 4,15688,0.0607103639953666,0.0575082280847065,-0.0520057630506581,0.173426491041391,0.291130090824325
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NHLRC3,NHL repeat-containing protein 3,13328,0.0382072236939695,0.0361936135159222,-0.032732258797238,0.109146706185177,0.291154430377296
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,13710,0.0445483706794006,0.042327051884135,-0.038412651013504,0.127509392372305,0.292598002787641
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SAT1,Diamine acetyltransferase 1,13486,0.0590660897151783,0.056213867775477,-0.0511130911247565,0.169245270555113,0.29339743636896
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD4,T-cell surface glycoprotein CD4,16042,-0.0350496894624348,0.0333661123506045,-0.10044726966962,0.0303478907447499,0.293523569362047
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LYPD3,Ly6/PLAUR domain-containing protein 3,15985,0.0409638766665482,0.0390038206890198,-0.0354836118839307,0.117411365217027,0.293617734805079
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AKAP12,A-kinase anchor protein 12,13684,0.0251287353292718,0.0239280187324874,-0.0217701813864035,0.0720276520449471,0.293653762442973
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CERT,Ceramide transfer protein,15688,-0.0718799280483136,0.0684512351776131,-0.206044348996435,0.0622844928998081,0.293693124105975
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PTPRC,Receptor-type tyrosine-protein phosphatase C,13972,0.0271876318788592,0.0259025820859337,-0.0235814290095708,0.0779566927672893,0.293915227124595
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,13946,0.0354062738147526,0.0337486569344402,-0.0307410937767502,0.101553641406255,0.294142688046315
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TNFSF10,Tumor necrosis factor ligand superfamily member 10,16272,-0.0309400466190212,0.0295181242980143,-0.0887955702431292,0.0269154770050867,0.294575336423387
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ABO,Histo-blood group ABO system transferase,13982,0.170439298447308,0.162631939566869,-0.148319303103756,0.489197899998371,0.2946538341719
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,15778,-0.0679593379375641,0.0648608543594573,-0.1950866124821,0.0591679366069722,0.294760079063405
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FGF21,Fibroblast growth factor 21,16186,0.14095495201893,0.134564642835396,-0.122791747938447,0.404701651976307,0.294889864254136
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TDGF1,Teratocarcinoma-derived growth factor 1,15688,-0.167405585180716,0.160121563681235,-0.481243849995937,0.146432679634506,0.295812418598883
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CNGB3,Cyclic nucleotide-gated cation channel beta-3,13474,-0.0633691928012463,0.0606615034061423,-0.182265739477285,0.0555273538747926,0.296209975378719
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SLAMF6,SLAM family member 6,15724,0.0450759313322661,0.0431748439471002,-0.0395467628040503,0.129698625468582,0.296486513558148
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TIMP3,Metalloproteinase inhibitor 3,16160,0.154752974749528,0.148302383169527,-0.135919696262745,0.445425645761801,0.296734158320016
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PHACTR2,Phosphatase and actin regulator 2,13946,0.135197773009244,0.1296730744962,-0.118961453003308,0.389356999021796,0.297149445096843
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ACY1,Aminoacylase-1,16102,0.0728536885577808,0.0699087566455069,-0.0641674744674126,0.209874851582974,0.297369219600456
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",13913,0.122669860065094,0.117779093777132,-0.108177163738085,0.353516883868273,0.297650114256995
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FAM3C,Protein FAM3C,16085,0.0350496957488561,0.0336712327457567,-0.030945920432827,0.101045311930539,0.297919568637682
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BTN2A1,Butyrophilin subfamily 2 member A1,16160,0.0304331582489721,0.0292467515602097,-0.0268904748090389,0.0877567913069831,0.298092869402233
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SCN4B,Sodium channel subunit beta-4,13610,0.0500140271650793,0.0481080046453321,-0.0442776619397717,0.14430571626993,0.298535129148907
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FAM172A,Cotranscriptional regulator FAM172A,13610,0.0724502923934559,0.0697004447636265,-0.064162579343252,0.209063164130164,0.298612883858366
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SCGB2A2,Mammaglobin-A,13486,-0.0353650797006285,0.0340531296306162,-0.102109213776636,0.0313790543753792,0.299043613445303
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TRIM21,E3 ubiquitin-protein ligase TRIM21,16073,0.0902128405006669,0.086874116626775,-0.0800604280878121,0.260486109089146,0.299084731598466
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MYO6,Unconventional myosin-VI,13946,0.0434168678229849,0.0418184959921292,-0.0385473843215883,0.125381119967558,0.299184894602589
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CRYZL1,Quinone oxidoreductase-like protein 1,13610,0.107775477386726,0.103855094493328,-0.0957805078201971,0.311331462593649,0.299405574453735
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CHEK2,Serine/threonine-protein kinase Chk2,15778,0.0395995550854251,0.0381655577234206,-0.0352049380524792,0.11440404822333,0.299484773200984
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CHCHD6,MICOS complex subunit MIC25,13894,0.033169808114034,0.0319771626247071,-0.0295054306303919,0.0958450468584598,0.299615631953703
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PTPRF,Receptor-type tyrosine-protein phosphatase F,16301,-0.0338034254898207,0.0326018068504392,-0.0977029669166815,0.0300961159370401,0.299817701847044
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NARS1,"Asparagine--tRNA ligase, cytoplasmic",13946,0.0556679155548815,0.0537069191647415,-0.049597646008012,0.160933477117775,0.299980905185036
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PCDH9,Protocadherin-9,13913,0.0404968971372372,0.0391135402210927,-0.0361656416961045,0.117159435970579,0.300515225924007
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GPI,Glucose-6-phosphate isomerase,13982,0.0553357821622661,0.0534579704431937,-0.0494418399063936,0.160113404230926,0.300627580975739
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RABEPK,Rab9 effector protein with kelch motifs,15724,0.0695862898375436,0.0673078809374894,-0.0623371567999356,0.201509736475023,0.301221949033723
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TREML1,Trem-like transcript 1 protein,13982,0.060996643722238,0.0590058365486028,-0.0546547959130235,0.1766480833575,0.301276019281451
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,15724,0.0515946661784164,0.0499433155636608,-0.0462942323263588,0.149483564683192,0.301589619036817
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PSMG3,Proteasome assembly chaperone 3,16073,0.0599770770866892,0.0580882010438151,-0.0538757969591884,0.173829951132567,0.30184535960698
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CASP8,Caspase-8,16164,0.0725291935611137,0.0702501669684224,-0.0651611336969942,0.210219520819222,0.301880760916713
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MFAP3,Microfibril-associated glycoprotein 3,15778,-0.0568114413244737,0.0551110567517276,-0.16482911255786,0.0512062299089124,0.302625207977139
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CTSH,Pro-cathepsin H,15733,-0.0861533811207131,0.0836557711505842,-0.250118692575858,0.0778119303344319,0.30309354778081
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RAB11FIP3,Rab11 family-interacting protein 3,13974,0.124200760039875,0.120623739625977,-0.11222176962704,0.360623289706791,0.303190123900229
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LRP2BP,LRP2-binding protein,13590,0.0968211045010107,0.0942430961608367,-0.0878953639742292,0.281537572976251,0.304271694235089
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CTNNA1,Catenin alpha-1,13474,-0.0408947933381213,0.0398256020304438,-0.118952973317791,0.0371633866415485,0.304511045097556
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LBP,Lipopolysaccharide-binding protein,16174,-0.0679143734292595,0.0661769373574369,-0.197621170649836,0.0617924237913168,0.304787044200356
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NAA10,N-alpha-acetyltransferase 10,13486,0.0586155459191313,0.0571623886594172,-0.0534227358533264,0.170653827691589,0.305182729371104
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CDH1,Cadherin-1,15568,0.0468679957306371,0.0457236438117981,-0.0427503461404871,0.136486337601761,0.30536611764528
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PTTG1,Securin,13710,-0.0486592609689371,0.0475195235331231,-0.141797527093858,0.0444790051559842,0.305860627575384
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CNST,Consortin,16102,0.125884827196385,0.122945804176071,-0.115088948988715,0.366858603381484,0.30589552994369
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NXPH1,Neurexophilin-1,15688,-0.042340058977672,0.0413563255793021,-0.123398457113104,0.03871833915776,0.305951800868344
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,16008,0.0524835301589949,0.0513008354124597,-0.048066107249426,0.153033167567416,0.306297739144366
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",16023,0.077803012863548,0.0761260480084925,-0.0714040412330974,0.227010066960193,0.306782717204332
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CDH5,Cadherin-5,16301,-0.0350885773775973,0.0343623165833515,-0.102438717880966,0.0322615631257717,0.307205467399189
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SLC34A3,Sodium-dependent phosphate transport protein 2C,13480,-0.0577754413034383,0.0565926244361038,-0.168696985198202,0.0531461025913253,0.307319899653593
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PRC1,Protein regulator of cytokinesis 1,13894,0.053216988726952,0.0522063760276585,-0.0491075082872587,0.155541485741163,0.308050789508622
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CSF2,Granulocyte-macrophage colony-stimulating factor,13486,0.0415686855066306,0.0407833731800888,-0.0383667259263435,0.121504096939605,0.308099893310083
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GFRA3,GDNF family receptor alpha-3,15897,0.0325244649443441,0.0319258555534558,-0.0300502119404293,0.0950991418291176,0.308337191750552
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AP3S2,AP-3 complex subunit sigma-2,13927,0.0548239342218099,0.0538237666300161,-0.0506706483730216,0.160318516816641,0.308419038074348
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FOLR3,Folate receptor gamma,16061,-0.21677675716818,0.213101396918598,-0.634455495128633,0.200901980792272,0.309051277893344
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DNAJC21,DnaJ homolog subfamily C member 21,13927,0.0445181048572139,0.0437865212566504,-0.0413034768058208,0.130339686520249,0.309310055714329
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IMPG1,Interphotoreceptor matrix proteoglycan 1,13474,-0.0343609531238182,0.0338092167291432,-0.100627017912939,0.0319051116653025,0.309495717953807
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GGH,Gamma-glutamyl hydrolase,15841,0.0402386040999159,0.0395939949925139,-0.0373656260854112,0.117842834285243,0.309511377972353
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ARHGAP45,Rho GTPase-activating protein 45,13684,0.0948137675675984,0.0933133490725729,-0.0880803966146445,0.277707931749841,0.309609581955877
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ACTA2,"Actin, aortic smooth muscle",15778,0.0498566956968406,0.049183572893001,-0.0465431071734414,0.146256498567123,0.310748199122824
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PSAPL1,Proactivator polypeptide-like 1,13913,-0.0592735272992417,0.0584749077698206,-0.17388434652809,0.0553372919296067,0.3107638677176
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PRKG1,cGMP-dependent protein kinase 1,13684,0.145930637662788,0.144270212086238,-0.136838978026238,0.428700253351813,0.311790713474853
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GOT1,"Aspartate aminotransferase, cytoplasmic",13972,0.0474961120138036,0.0469803057456175,-0.0445852872476067,0.139577511275214,0.312043908771322
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CFH,Complement factor H,13168,0.0259814527147643,0.0257852016912011,-0.0245575425999899,0.0765204480295185,0.313659783137505
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LAMA4,Laminin subunit alpha-4,16160,0.037817579532741,0.037570856936533,-0.0358213000628636,0.111456459128346,0.314158050483019
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DOC2B,Double C2-like domain-containing protein beta,13590,-0.0411656215237183,0.0409014609859425,-0.121332485056166,0.0390012420087291,0.314213021101694
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MDM1,Nuclear protein MDM1,13590,0.0357532495993072,0.0355798430821736,-0.0339832428417532,0.105489742040368,0.314975565638398
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CLEC4D,C-type lectin domain family 4 member D,16073,-0.0697480668006505,0.0694543612028841,-0.205878614758303,0.0663824811570023,0.315283495155008
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LY75,Lymphocyte antigen 75,16073,0.0437722399880779,0.0435965885600473,-0.0416770735896147,0.129221553565771,0.315379755040463
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CLUL1,Clusterin-like protein 1,16077,-0.0516872969160506,0.0514810275758472,-0.152590110964711,0.04921551713261,0.315390505141471
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,UNC5D,Netrin receptor UNC5D,13552,-0.0300224931631818,0.0299715045281264,-0.0887666420383095,0.0287216557119459,0.316505812532045
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KCNC4,Potassium voltage-gated channel subfamily C member 4,13474,-0.0653761385633012,0.0652895325309,-0.193343622323865,0.0625913451972627,0.316686989763174
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LGALS7_LGALS7B,Galectin-7,16014,0.0468579012221687,0.0468444491567645,-0.0449572191250896,0.138673021569427,0.317186684261803
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,16101,0.0673226744794801,0.0673639041482993,-0.0647105776511866,0.199355926610147,0.317621823872733
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GRPEL1,"GrpE protein homolog 1, mitochondrial",16008,0.0687195275418325,0.0688291401274035,-0.0661855871078784,0.203624642191543,0.31809691811859
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD40LG,CD40 ligand,16272,0.0881259057922598,0.0882676225897611,-0.0848786344836719,0.261130446068192,0.318102975791464
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FTCD,Formimidoyltransferase-cyclodeaminase,13903,0.096361655032576,0.0965730134429569,-0.0929214513156195,0.285644761380772,0.318388197956923
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CTRB1,Chymotrypsinogen B,16101,-0.0624079287017915,0.0626786362751085,-0.185258055801004,0.0604421983974211,0.319420129382987
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SERPINH1,Serpin H1,13710,0.149544780883091,0.150248259879196,-0.144941808480134,0.444031370246315,0.319599263859031
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,15724,0.0875941494519845,0.0880641163675046,-0.0850115186283246,0.260199817532294,0.319915342438086
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,USP8,Ubiquitin carboxyl-terminal hydrolase 8,15778,0.107340746951819,0.107926818755834,-0.104195817809616,0.318877311713254,0.31996084168171
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BTD,Biotinidase,13992,0.0231550194583518,0.0232981239084516,-0.0225093034022133,0.0688193423189169,0.320309362287238
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CDH17,Cadherin-17,16102,0.0770932166360668,0.0776067229124046,-0.0750159602722462,0.22920239354438,0.320538174059005
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,13185,0.122458920519668,0.123395026747381,-0.119395331905199,0.364313172944536,0.321013968278638
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LSM1,U6 snRNA-associated Sm-like protein LSm1,15724,0.0622770185287353,0.0628010180120309,-0.0608129767748452,0.185367013832316,0.321380539854206
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ADA2,Adenosine deaminase 2,16028,-0.0473452965940423,0.0477658487129165,-0.140966360071359,0.046275766883274,0.321605080125143
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HTRA2,"Serine protease HTRA2, mitochondrial",16118,0.069452989856883,0.0700794438357575,-0.0679027200612017,0.206808699774968,0.321670781790016
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NOP56,Nucleolar protein 56,13486,-0.126492230624882,0.127970425794908,-0.377314265182902,0.124329803933138,0.322950585537797
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RAB37,Ras-related protein Rab-37,15826,0.0936119410639627,0.0947339997391785,-0.0920666984248271,0.279290580552752,0.323091524599071
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CAPG,Macrophage-capping protein,15959,-0.0654977895193493,0.0663551337163749,-0.195553851603444,0.0645582725647455,0.323618664326846
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CSF3R,Granulocyte colony-stimulating factor receptor,13552,-0.0338457246886632,0.0343318584190887,-0.101136167190077,0.0334447178127506,0.324229174943659
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LTBP2,Latent-transforming growth factor beta-binding protein 2,16301,0.0346767396807151,0.0351771677879048,-0.0342705091835784,0.103623988545009,0.324258638865952
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SIGLEC9,Sialic acid-binding Ig-like lectin 9,16187,-0.0334586412301293,0.0339500208416813,-0.100000682079825,0.0330833996195662,0.324380321928054
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CRHR1,Corticotropin-releasing factor receptor 1,15778,-0.0697496303970161,0.0708318950341405,-0.208580144663931,0.0690808838698992,0.324776414916685
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RPGR,X-linked retinitis pigmentosa GTPase regulator,13590,0.0463610568753611,0.0471232677190317,-0.0460005478539411,0.138722661604663,0.325219013902299
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NAGA,Alpha-N-acetylgalactosaminidase,13524,0.0653874264059465,0.066541523544308,-0.0650339597408972,0.19580881255279,0.325794376911956
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SHMT1,"Serine hydroxymethyltransferase, cytosolic",16132,0.0956227619344205,0.0973124430291567,-0.0951096264027266,0.286355150271568,0.325801105153758
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AFAP1,Actin filament-associated protein 1,13684,-0.0943092834116998,0.0960459646533221,-0.282559374132211,0.0939408073088115,0.32615751261788
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GLRX,Glutaredoxin-1,15977,0.0636216827238596,0.0648318667413456,-0.0634487760891777,0.190692141536897,0.326443180148686
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RTN4R,Reticulon-4 receptor,16209,0.0372942199117558,0.0380213310582921,-0.0372275889624968,0.111816028786008,0.326668432496603
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DOCK9,Dedicator of cytokinesis protein 9,13474,-0.129317002598251,0.13185151368449,-0.387745969419851,0.12911196422335,0.326720086672699
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BHLHE40,Class E basic helix-loop-helix protein 40,13474,-0.0789902212404855,0.080583903385335,-0.236934671875742,0.0789542293947712,0.326993513934484
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RNF5,E3 ubiquitin-protein ligase RNF5,13610,0.0807317877126928,0.0823712631722473,-0.0807158881049119,0.242179463530297,0.327055920047356
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CCN5,CCN family member 5,16101,0.0425937051137642,0.0434903555818117,-0.0426473918265867,0.127834802054115,0.327405612959025
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ANGPT1,Angiopoietin-1,16038,0.0934820255595847,0.0955179050420756,-0.0937330683228834,0.280697119442053,0.327749982878326
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",16073,0.105694153665423,0.108034371726181,-0.106053214917892,0.317441522248738,0.327921816088092
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",13578,0.0879220294416148,0.0898855946800401,-0.0882537361312639,0.264097795014493,0.328015193382079
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DNAJA2,DnaJ homolog subfamily A member 2,16224,0.0898924357129275,0.092109521871837,-0.090642227155873,0.270427098581728,0.329113771457447
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ARNT,Aryl hydrocarbon receptor nuclear translocator,15826,0.0413271923802665,0.0424078861504554,-0.0417922644746261,0.124446649235159,0.329814969678596
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CBLIF,Cobalamin binding intrinsic factor,16085,-0.0807728970362999,0.0829012520054614,-0.243259350967004,0.0817135568944045,0.329909053850028
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,UBAC1,Ubiquitin-associated domain-containing protein 1,16008,0.0384703104959961,0.0395490200922931,-0.0390457688848983,0.115986389876891,0.330704833844583
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PRR4,Proline-rich protein 4,13573,-0.0773373167699788,0.0795354301429562,-0.233226759850173,0.0785521263102155,0.33088729216496
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TMED10,Transmembrane emp24 domain-containing protein 10,13486,-0.0536029804299911,0.0551523906132594,-0.16170166603198,0.0544957051719973,0.331114393304998
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LACRT,Extracellular glycoprotein lacritin,13865,-0.0546830214236885,0.0562800916920944,-0.164992001140193,0.0556259582928165,0.331255192105041
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KLK12,Kallikrein-12,15724,0.153358494610408,0.157916590175706,-0.156158022133976,0.462875011354792,0.331495482209137
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HPSE,Heparanase,13783,0.102237016453352,0.105320599691644,-0.104191358942271,0.308665391848974,0.331703816730127
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,UMOD,Uromodulin,16255,-0.0582598396940656,0.0600816315709947,-0.176019837573215,0.059500158185084,0.332221432162879
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,15950,0.0806175213774874,0.0831425023450913,-0.0823417832188915,0.243576825973866,0.33224532870222
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ITGAV,Integrin alpha-V,16209,-0.0180442747506762,0.0186201969204935,-0.0545398607148435,0.0184513112134911,0.332524722568444
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KLRK1,NKG2-D type II integral membrane protein,13927,-0.0514795022323843,0.053151759979467,-0.15565695179214,0.0526979473273709,0.332792559005399
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RTBDN,Retbindin,16008,0.0322588568696652,0.0333610568177804,-0.0331288144931843,0.0976465282325148,0.333577911360695
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FRZB,Secreted frizzled-related protein 3,15898,-0.0282317968645138,0.0292098862434245,-0.0854831739016258,0.0290195801725981,0.333801197202693
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TSPAN1,Tetraspanin-1,15778,0.0615576520938066,0.0637175198877836,-0.0633286868862492,0.186443991073862,0.334007739152615
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL24,Interleukin-24,15826,0.0522332732648622,0.0540852694011379,-0.053773854761368,0.158240401291092,0.334180136719949
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HNMT,Histamine N-methyltransferase,15875,0.0513364703500565,0.0531787258733785,-0.0528938323617654,0.155566773061878,0.334380607420017
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CCL8,C-C motif chemokine 8,16187,0.0663929873661991,0.0687864788299647,-0.0684285111405318,0.20121448587293,0.334457055041835
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TSC1,Hamartin,13552,0.0822431269360739,0.0852314466982169,-0.0848105085924312,0.249296762464579,0.334592719495776
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CNTN2,Contactin-2,16209,-0.0489765324901413,0.0507827177425802,-0.148510659265598,0.0505575942853158,0.334843248379047
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",13946,0.0850584181341492,0.0882340445692029,-0.0878803092214886,0.257997145489787,0.335058116813861
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,13946,0.0635712797129884,0.065957913262574,-0.0657062302816566,0.192848789707633,0.335155006328428
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BCHE,Cholinesterase,13720,0.0302224637610212,0.0313897180781302,-0.031301383672114,0.0917463111941565,0.335657799867472
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ACOT13,Acyl-coenzyme A thioesterase 13,13913,0.125349811090985,0.130258460577626,-0.129956771641163,0.380656393823133,0.335907595489406
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SPOCK1,Testican-1,15950,-0.0278184258361359,0.0289102203711117,-0.0844824577635148,0.028845606091243,0.335946172611671
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DPEP2,Dipeptidase 2,16008,0.0315350043629171,0.0328280733496284,-0.0328080194023547,0.0958780281281888,0.336762378703645
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CTLA4,Cytotoxic T-lymphocyte protein 4,13972,0.0309569978247994,0.032227359122614,-0.032208626055524,0.0941226217051228,0.336779384965419
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NEO1,Neogenin,13946,-0.0244311579092047,0.0254390215671211,-0.074291640180762,0.0254293243623526,0.336880066049335
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NFKB1,Nuclear factor NF-kappa-B p105 subunit,13486,0.0802375784424598,0.0835657150727297,-0.0835512231000903,0.24402637998501,0.336985173726269
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NPC2,NPC intracellular cholesterol transporter 2,13725,0.0346664784077486,0.0361061603194383,-0.0361015958183504,0.105434552633848,0.337008524253256
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,15950,-0.0382098456766941,0.0398150623203657,-0.116247367824611,0.0398276764712226,0.337229250222208
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL20RB,Interleukin-20 receptor subunit beta,13552,0.0465579274922785,0.0485920092955301,-0.0486824107269604,0.141798265711517,0.338009488344083
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL34,Interleukin-34,15663,-0.0385571027051819,0.0402443205141012,-0.11743597091282,0.0403217655024565,0.338039424528712
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PTGDS,Prostaglandin-H2 D-isomerase,16003,-0.032442572355478,0.0338720512320881,-0.0988317927703707,0.0339466480594147,0.33817926727015
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TF,Serotransferrin,13992,0.0235867967564868,0.0246471217978493,-0.0247215619672978,0.0718951554802713,0.338594020629548
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TCN2,Transcobalamin-2,16277,-0.0315691933882389,0.0329900492954856,-0.0962296900073905,0.0330913032309128,0.338616422013778
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,15950,-0.075404772811857,0.0788006857431482,-0.229854116868427,0.0790445712447135,0.338629706554412
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FGF20,Fibroblast growth factor 20,13552,-0.0486787038682231,0.0509103705446015,-0.148463030135642,0.0511056223991959,0.339006058103438
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LMNB1,Lamin-B1,13881,0.0682714278722278,0.0715767371966943,-0.072018977033293,0.208561832777749,0.340190651270274
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LTB,Lymphotoxin-beta,13894,-0.0379256066741115,0.039779030255078,-0.115892505974064,0.0400412926258413,0.340400488988504
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CST6,Cystatin-M,15672,-0.0518811934881524,0.0544283371814237,-0.158560734363743,0.054798347387438,0.340502506754254
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CRX,Cone-rod homeobox protein,15778,-0.113806031150675,0.119399911491342,-0.347829857673706,0.120217795372355,0.340528666718873
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ANGPT2,Angiopoietin-2,16209,-0.0411243440566463,0.0431689078739384,-0.125735403489565,0.0434867153762729,0.340787710871701
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DNPEP,Aspartyl aminopeptidase,13927,0.0626223953794132,0.0658119151002821,-0.0663689582171398,0.191613748975966,0.341348967421094
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,S100A12,Protein S100-A12,15852,-0.0818576482909244,0.0860993390389655,-0.250612352807297,0.0868970562254479,0.341753464013618
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,13710,-0.0780704579831643,0.0821663560622125,-0.239116515865101,0.0829755998987722,0.342052220134387
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RNASE6,Ribonuclease K6,13874,-0.0318184110913923,0.0334919445849329,-0.0974626224778607,0.0338258002950761,0.34211267977641
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CPPED1,Serine/threonine-protein phosphatase CPPED1,16230,0.070975638165099,0.0747254681096439,-0.075486279329803,0.217437555660001,0.342218597491107
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CANT1,Soluble calcium-activated nucleotidase 1,16057,0.0218210881054995,0.0229780028507627,-0.0232157974819954,0.0668579736929943,0.342303816021431
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PRTG,Protogenin,16209,0.026762136174363,0.0282024623633038,-0.0285146900577124,0.0820389624064384,0.342670851752922
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ARHGEF10,Rho guanine nucleotide exchange factor 10,13946,0.100125911153956,0.105526984092488,-0.10670697766732,0.306958799975233,0.342729598838486
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DCTN1,Dynactin subunit 1,16209,0.0692634406648634,0.0730586824223145,-0.073931576882873,0.2124584582126,0.343117054071701
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PLG,Plasminogen,13628,0.0238710105665933,0.0251824303905249,-0.0254865529988355,0.073228574132022,0.343185367125089
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LMNB2,Lamin-B2,13927,0.0309247936653476,0.0326322279018276,-0.0330343730222346,0.0948839603529297,0.34331065625167
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FBN2,Fibrillin-2,13590,-0.0655318656393373,0.0691665672341085,-0.20109833741819,0.0700346061395153,0.343426375562564
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PCBP2,Poly(rC)-binding protein 2,13946,0.0770625778018991,0.0813385404544351,-0.0823609614887938,0.236486117092592,0.343436114840945
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,13590,0.0353754381391872,0.0373574573003487,-0.0378451781694963,0.108596054447871,0.343683922764319
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,13946,0.0707064476511907,0.0747618868373516,-0.0758268505500185,0.2172397458524,0.344289832340357
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,13913,-0.0889404999466106,0.0940530814070693,-0.273284539504466,0.0954035396112452,0.34434789230355
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ABRAXAS2,BRISC complex subunit Abraxas 2,13486,0.0711094223513977,0.0752029939515767,-0.0762884457936927,0.218507290496488,0.344386759944549
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MEGF9,Multiple epidermal growth factor-like domains protein 9,16251,0.0217797522919794,0.023046014647797,-0.0233904364177028,0.0669499410016616,0.344644839760294
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SLITRK6,SLIT and NTRK-like protein 6,15778,0.0363669608415221,0.0385038777607064,-0.0391006395694624,0.111834561252507,0.344928036765485
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ADAMTSL2,ADAMTS-like protein 2,13972,0.0347907589926677,0.0368478767382548,-0.0374310794143116,0.107012597399647,0.345097749835376
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,13913,0.0763194799724995,0.081025042087088,-0.0824896025181929,0.235128562463192,0.346247617685065
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",13946,0.0853945062630005,0.0907315784504761,-0.0924393874999325,0.263228400025934,0.346630302026676
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CILP,Cartilage intermediate layer protein 1,13972,-0.0568309222763142,0.0603927436951748,-0.175200699918857,0.0615388553662285,0.346709685201929
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ADGRF5,Adhesion G protein-coupled receptor F5,13974,0.0300294034098115,0.0319417705516614,-0.0325764668714448,0.0926352736910679,0.347167362948853
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LATS1,Serine/threonine-protein kinase LATS1,13552,0.0897268761082334,0.0958138152957903,-0.0980682018715156,0.277521954087982,0.349047352102127
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,METAP1,Methionine aminopeptidase 1,15688,0.0309988781039562,0.0331087078949851,-0.0338941893702145,0.0958919455781269,0.349145689882795
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",13974,0.0777743030147101,0.0830888689853818,-0.0850798801966383,0.240628486226058,0.349270036171847
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LAP3,Cytosol aminopeptidase,15826,0.0524484641728656,0.0560389055336074,-0.057387790673005,0.162284719018736,0.34932378698385
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IGF2R,Cation-independent mannose-6-phosphate receptor,16101,0.0246610702287651,0.0264014124040729,-0.0270856980832178,0.076407838540748,0.350275887089371
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EFHD1,EF-hand domain-containing protein D1,13946,-0.0368162832360121,0.0394401223776942,-0.114118923096293,0.0404863566242686,0.350592062009797
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DNMBP,Dynamin-binding protein,15950,0.0648647433918832,0.0694936966255156,-0.0713429019941273,0.201072388777894,0.350632620643296
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD82,CD82 antigen,13710,0.0448117264403669,0.0480362528296608,-0.0493393291057682,0.138962781986502,0.350901955290455
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BIN2,Bridging integrator 2,16101,0.0949132642562033,0.101747345946644,-0.104511533799219,0.294338062311626,0.35092028975622
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PF4,Platelet factor 4,13887,-0.102091537342724,0.109472378648564,-0.316657399493909,0.112474324808461,0.351054100727971
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IFT20,Intraflagellar transport protein 20 homolog,13590,0.0476844828159483,0.0511853361262951,-0.05263877599159,0.148007741623487,0.351557590101527
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FARSA,Phenylalanine--tRNA ligase alpha subunit,13590,0.0751689863711122,0.0807561056096175,-0.0831129806237381,0.233450953365963,0.351965872154832
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DSC2,Desmocollin-2,15940,0.0358195259754219,0.0385702312366467,-0.0397781272484057,0.11141717919925,0.353067361716267
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BANK1,B-cell scaffold protein with ankyrin repeats,16073,0.109635116989007,0.118065362891435,-0.121772994278206,0.34104322825622,0.353112042863375
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,16102,0.0331616212582662,0.035717901944476,-0.0368454665529067,0.103168709069439,0.353197772404938
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,POLR2A,DNA-directed RNA polymerase II subunit RPB1,13552,-0.0312523672658501,0.0337023341642327,-0.0973089422277462,0.0348042076960461,0.353784356288941
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SNAP25,Synaptosomal-associated protein 25,13474,0.0499346270835836,0.0538887252245039,-0.0556872743564441,0.155556528523611,0.354138008754851
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TOR1AIP1,Torsin-1A-interacting protein 1,13610,0.0556333571774889,0.0600497997561246,-0.0620642503445153,0.173330964699493,0.354226709808142
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,C7,Complement component C7,13662,0.0332210924513835,0.0359317606392831,-0.0372051584016114,0.103647343304378,0.355210828937049
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,THBD,Thrombomodulin,16102,0.0294268003625219,0.0318387458172855,-0.0329771414393578,0.0918307421644016,0.355372654029984
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CBX2,Chromobox protein homolog 2,13486,-0.0419296755603662,0.0453821255917862,-0.130878641720267,0.0470192905995348,0.355541968870334
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,YES1,Tyrosine-protein kinase Yes,16008,0.119340206777504,0.129250206692304,-0.133990198339413,0.37267061189442,0.355850745459661
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL17F,Interleukin-17F,15826,0.0828546402037704,0.0899292403744501,-0.0934066709301518,0.259115951337692,0.356891446578844
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LAT2,Linker for activation of T-cells family member 2,16008,0.130466596657784,0.141671202188042,-0.147208959630779,0.408142152946347,0.357110681066942
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AKT3,RAC-gamma serine/threonine-protein kinase,15646,0.0606192274568754,0.0658778655928492,-0.0685013891051091,0.18973984401886,0.357495020143608
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,APCS,Serum amyloid P-component,13880,0.0360377043365618,0.0391928229628597,-0.0407802286706433,0.112855637343767,0.35785138638498
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LPL,Lipoprotein lipase,16102,0.0492854028503267,0.0536319968110686,-0.0558333108993678,0.154404116600021,0.3581327779291
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,13684,-0.0297978648587696,0.032433365795957,-0.0933672618188453,0.033771532101306,0.358247238102651
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RAD23B,UV excision repair protein RAD23 homolog B,15724,0.0485659172693238,0.0528629817371064,-0.0550455269354047,0.152177361474052,0.358259726703346
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LRP2,Low-density lipoprotein receptor-related protein 2,13590,0.0388758631463641,0.0423263279205739,-0.0440837395779608,0.121835465870689,0.358384220794403
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GCC1,GRIP and coiled-coil domain-containing protein 1,13927,0.112757630847317,0.122845551894966,-0.128019650866816,0.353534912561451,0.358696940959276
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,USP25,Ubiquitin carboxyl-terminal hydrolase 25,13894,0.0753725150163614,0.0821720057819965,-0.0856846163163518,0.236429646349075,0.359026041268066
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,13486,0.0706500094821319,0.077027003731164,-0.0803229178309495,0.221622936795213,0.359048541134121
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,13684,0.0626620810039989,0.0683487695454138,-0.0713015073050121,0.19662566931301,0.359264169861903
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RGS8,Regulator of G-protein signaling 8,15826,0.0679594546328285,0.0741667270954142,-0.0774073304741833,0.21332623973984,0.359520130576519
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,13652,0.0490676337551546,0.0535557638294051,-0.0559016633504794,0.154036930860789,0.359579743400604
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MMP8,Neutrophil collagenase,16198,-0.0762603950257146,0.0832718720200446,-0.239473264185002,0.0869524741335727,0.359785356491888
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TARBP2,RISC-loading complex subunit TARBP2,15688,0.0808017044551139,0.088293916627195,-0.0922543721341884,0.253857781044416,0.360129781535208
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TJP3,Tight junction protein ZO-3,13474,-0.0427695483824715,0.0467393134887712,-0.134378602820463,0.0488395060555199,0.360173467934638
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DOK2,Docking protein 2,16102,0.127828147685145,0.139705232930963,-0.145994108859543,0.401650404229834,0.360213386851223
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MYH4,Myosin-4,13486,0.0473178608579348,0.0517454254755427,-0.0541031730741289,0.148738894789999,0.360504351555679
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CTSF,Cathepsin F,16118,0.0418801122007945,0.0458054139847605,-0.0478984992093361,0.131658723610925,0.360570371274842
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PAPPA,Pappalysin-1,15826,-0.0490880245626592,0.053699828111424,-0.15433968766105,0.0561636385357318,0.360668342730628
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RELT,Tumor necrosis factor receptor superfamily member 19L,16101,-0.0291012428148071,0.0318617963558861,-0.0915503636723439,0.0333478780427296,0.361067707702794
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,16230,0.0466302642198916,0.0511569228915679,-0.0536373046475816,0.146897833087365,0.362038030322453
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,XCL1,Lymphotactin,16209,-0.0562112806597761,0.0616710963430018,-0.17708662949206,0.0646640681725074,0.362061979944541
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ANGPTL4,Angiopoietin-related protein 4,16132,0.046653744846067,0.0511917022127043,-0.0536819914908334,0.146989481182967,0.362122694468009
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HS1BP3,HCLS1-binding protein 3,13610,0.0930491268586945,0.102146443239412,-0.107157901890554,0.293256155607943,0.362343933207538
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CASQ2,Calsequestrin-2,13486,0.050257889169652,0.055176246891252,-0.0578875547372019,0.158403333076506,0.362384935247218
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EPHA1,Ephrin type-A receptor 1,16130,0.0341702248072056,0.0375147378844374,-0.0393586614462917,0.107699111060703,0.362389078745688
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,13974,0.0646963091190657,0.0710708184645881,-0.074602495071527,0.203995113309658,0.362676006765354
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MNAT1,CDK-activating kinase assembly factor MAT1,13710,0.0458601248866131,0.0503809877172018,-0.0528866110391024,0.144606860812329,0.362698005094898
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CHRDL1,Chordin-like protein 1,16132,-0.0322464898823564,0.0354555817798066,-0.101739430170777,0.0372464504060646,0.363105240464565
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,16073,0.102401056760087,0.112696434890379,-0.118483955625057,0.323286069145231,0.363551158735329
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FCER2,Low affinity immunoglobulin epsilon Fc receptor,16101,0.0513908756014632,0.0565813475424338,-0.0595085655817069,0.162290316784633,0.363751667603582
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",13552,-0.035868047284967,0.0395054941016499,-0.113298815724201,0.0415627211542669,0.363933721016192
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD83,CD83 antigen,16073,0.0340537439162564,0.0375167647922274,-0.0394791150765094,0.107586602909022,0.364053512450187
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HBEGF,Proheparin-binding EGF-like growth factor,16164,-0.074645999306979,0.082278758311517,-0.235912365597552,0.0866203669835942,0.364297167344797
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DCDC2C,Doublecortin domain-containing protein 2C,13480,-0.0652330168821628,0.0719047379911634,-0.206166303344843,0.0757002695805174,0.364309640843529
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DDI2,Protein DDI1 homolog 2,13684,0.080719023935806,0.0889788894184042,-0.0936795993242663,0.255117647195878,0.364332629868757
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,15724,-0.0353258547555984,0.038980746587605,-0.111728118067304,0.0410764085561075,0.364823508499818
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ATP5F1D,"ATP synthase subunit delta, mitochondrial",13486,-0.0527411364870754,0.0582004935736355,-0.166814103891401,0.0613318309172501,0.364847580997871
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PSMG4,Proteasome assembly chaperone 4,13552,0.0591951984529379,0.0653616929650244,-0.0689137197585099,0.187304116664386,0.365134164456489
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LAMP2,Lysosome-associated membrane glycoprotein 2,15563,0.0204080339083936,0.0225361026314647,-0.0237627272492773,0.0645787950660645,0.365177162191217
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LEFTY2,Left-right determination factor 2,16186,-0.053607994450287,0.0592383261350811,-0.169715113675046,0.062499124774472,0.36550293199503
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AFM,Afamin,13992,0.0199474196865313,0.0220472528226942,-0.0232651958459493,0.0631600352190118,0.365609408721626
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CEP20,Centrosomal protein 20,15724,0.0771958406869813,0.0853939361256994,-0.0901762741193895,0.244567955493352,0.366010986605806
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ADGRD1,Adhesion G-protein coupled receptor D1,13684,0.0400247534251303,0.0442860123957554,-0.0467758308705502,0.126825337720811,0.366128699756859
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IFNGR1,Interferon gamma receptor 1,16160,0.0209911236185878,0.0232381950176329,-0.0245557386159726,0.0665379858531482,0.366378755694082
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,13450,0.0569336374225477,0.0630780223584226,-0.0666992863999605,0.180566561245056,0.366759335532691
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TFF3,Trefoil factor 3,16104,0.0475851939978341,0.0527503939546164,-0.055805578153214,0.150975966148882,0.367026681067377
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,VPS53,Vacuolar protein sorting-associated protein 53 homolog,16008,0.0788986709984651,0.087572333810759,-0.0927431032706224,0.250540445267553,0.367626182597236
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AKT2,RAC-beta serine/threonine-protein kinase,13946,0.129208488788719,0.14347254128914,-0.151997692137996,0.410414669715433,0.367827285138602
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,15950,-0.0296173749785191,0.0328972267441313,-0.0940959393970164,0.0348611894399781,0.367974197467509
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MZT1,Mitotic-spindle organizing protein 1,15724,0.0531407001133016,0.0590854181245088,-0.0626667194107356,0.168948119637339,0.368459957280221
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CLEC10A,C-type lectin domain family 10 member A,15950,-0.0365126977597126,0.0406188194221596,-0.116125583827145,0.0431001883077203,0.368713726491302
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ERP29,Endoplasmic reticulum resident protein 29,13684,0.12187576603139,0.135586010761402,-0.143872815060957,0.387624347123737,0.368731578947339
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SULT2A1,Bile salt sulfotransferase,16073,0.0571785444657847,0.06362883325087,-0.0675339687059205,0.18189105763749,0.368865205960041
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PCDH7,Protocadherin-7,13913,-0.0372719285254983,0.0415186001940804,-0.118648384905896,0.0441045278548992,0.369352310707513
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SGSH,N-sulphoglucosamine sulphohydrolase,13751,0.0569132696820977,0.0634076436020404,-0.0673657117779015,0.181192251142097,0.369426607537416
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TBR1,T-box brain protein 1,13590,-0.0497485456630731,0.0555435161839241,-0.158613837383564,0.0591167460574182,0.370446028411626
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TXNL1,Thioredoxin-like protein 1,13442,-0.102271877019794,0.114206606796376,-0.326116826340691,0.121573072301103,0.370536569751268
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AP2B1,AP-2 complex subunit beta,13590,0.050778657770444,0.0567170751075617,-0.0603868094403769,0.161944124981265,0.370643928503601
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ENAH,Protein enabled homolog,15826,0.0492618063150053,0.0550616389246978,-0.0586590059774025,0.157182618607413,0.370978985056783
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",13486,-0.0875635159679377,0.0979621271224086,-0.279569285127859,0.104442253191983,0.371417745393882
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,16189,0.0300422377395309,0.0336108870631059,-0.0358351009041566,0.0959195763832185,0.371429042816386
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SYAP1,Synapse-associated protein 1,13684,0.0580186165725098,0.0649324958203478,-0.069249075235372,0.185286308380391,0.371593400838055
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,APOH,Beta-2-glycoprotein 1,16101,0.0359714112574619,0.0402818230900219,-0.0429809619989809,0.114923784513905,0.371873944102575
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PPY,Pancreatic prohormone,16045,-0.103463695486739,0.115871194793976,-0.330571237282933,0.123643846309454,0.371913473641967
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TPRKB,EKC/KEOPS complex subunit TPRKB,13480,0.0639556955873667,0.0717417548864692,-0.076658143990113,0.204569535164846,0.372692458771321
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DSCAM,Down syndrome cell adhesion molecule,13946,-0.0363410384628291,0.0407654239277137,-0.116241269361148,0.0435591924354898,0.372693973980722
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TBC1D23,TBC1 domain family member 23,16008,0.0913286549442998,0.102548408077377,-0.10966622488736,0.292323534775959,0.373162205221054
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,APOL1,Apolipoprotein L1,13982,-0.0595540125657006,0.0669193038339562,-0.190715848080255,0.0716078229488536,0.373514656386881
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ADAMTSL5,ADAMTS-like protein 5,13974,0.0392142579120888,0.0440739464544771,-0.0471706771386864,0.125599192962864,0.373622002609463
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ANXA11,Annexin A11,16046,0.0663590113904094,0.0746639394076759,-0.0799823098486354,0.212700332629454,0.374140454372621
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SPRY2,Protein sprouty homolog 2,15826,0.0956256543258799,0.107673949584443,-0.115415286859629,0.306666595511389,0.37449837519962
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TSPAN15,Tetraspanin-15,13486,-0.0493265239601145,0.0555548150571056,-0.158213961472041,0.0595609135518124,0.374616170503701
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EZR,Ezrin,16230,-0.0245179673959961,0.0276223212543866,-0.0786577170545938,0.0296217822626015,0.374761422424319
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,APOE,Apolipoprotein E,13992,-0.0729704584635441,0.082292036543544,-0.23426285008889,0.0883219331618021,0.375241888154072
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SCT,Secretin,13590,-0.0472148897158621,0.0532666285081675,-0.15161748159187,0.0571877021601463,0.375424291226139
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MST1,Hepatocyte growth factor-like protein,13769,0.0661854148314864,0.0747306580261791,-0.0802866748998245,0.212657504562797,0.375820144656138
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,13992,0.0195307294259578,0.0220596842125042,-0.0237062516305503,0.062767710482466,0.375978525203478
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CLEC4G,C-type lectin domain family 4 member G,16073,-0.0328870731762616,0.0371707369318509,-0.105741717562689,0.0399675712101661,0.376300901685264
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ISM2,Isthmin-2,13972,0.0422876101790126,0.0478048870917496,-0.0514099685208166,0.135985188878842,0.376394335860353
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CLU,Clusterin,13992,-0.0310288738219575,0.0351644838470167,-0.0999512621621101,0.0378935145181952,0.377579810008703
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TRAF3,"TNF receptor-associated factor 3, Isoform 2",13552,0.0373666827980128,0.0423868609975051,-0.0457115647570972,0.120444930353123,0.378028892829216
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,THAP12,52 kDa repressor of the inhibitor of the protein kinase,13450,-0.0904686773801794,0.10267483379417,-0.291711351616753,0.110773996856394,0.378269541797824
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DNAJA1,DnaJ homolog subfamily A member 1,13480,0.0459798984437655,0.0522735272700954,-0.0564762150056215,0.148436011893152,0.379090658354001
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IGSF3,Immunoglobulin superfamily member 3,16008,0.0349662530307909,0.0397643990211815,-0.0429719690507249,0.112904475112307,0.379232531171124
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MMP3,Stromelysin-1,16101,-0.0483439329116762,0.0550743094735974,-0.156289579479927,0.0596017136565748,0.380068290323087
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SEPTIN7,Septin-7,13710,0.0559361683295964,0.0637547997164229,-0.0690232391145925,0.180895575773785,0.380304330701973
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,STAB2,Stabilin-2,13972,-0.02818929948438,0.0321299725597415,-0.0911640457014733,0.0347854467327132,0.380310512254294
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SCGB3A2,Secretoglobin family 3A member 2,16132,0.0813088993099933,0.0926829395849467,-0.100349662276502,0.262967460896489,0.380347589186537
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MAP2,Microtubule-associated protein 2,13927,0.0466053871591009,0.0531474273739799,-0.0575635704938998,0.150774344812102,0.3805519259272
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SH3BP1,SH3 domain-binding protein 1,13913,0.0499999772636244,0.0570328733972261,-0.0617844545949387,0.161784409122187,0.380671834993055
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GASK1A,Golgi-associated kinase 1A,13486,-0.0423976712369282,0.0484466322733106,-0.137353070492617,0.0525577280187607,0.381512376854234
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,S100A16,Protein S100-A16,15663,-0.0603239245620589,0.0689353553641414,-0.195437221075776,0.0747893719516583,0.381544015534952
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ASPSCR1,Tether containing UBX domain for GLUT4,13946,0.0670317854231532,0.0766128092266548,-0.0831293206610902,0.217192891507397,0.381620399267682
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MAVS,Mitochondrial antiviral-signaling protein,15724,0.0918829134452391,0.105171820813216,-0.114253855348664,0.298019682239143,0.382324561423893
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RASA1,Ras GTPase-activating protein 1,15688,0.0327539348110702,0.0374933693067419,-0.0407330690301438,0.106240938652284,0.382353471029662
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NOS1,"Nitric oxide synthase, brain",15688,-0.0525766438944653,0.0602380561379777,-0.170643233924902,0.0654899461359709,0.382777610302476
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ARG1,Arginase-1,15952,0.0518770777507868,0.0594957992168466,-0.0647346887142326,0.168488844215806,0.383251397348767
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TMPRSS15,Enteropeptidase,16008,0.089829397081517,0.103100661716105,-0.112247899882049,0.291906694045084,0.383615146355091
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,15950,0.0928535274340259,0.106602449919421,-0.116087274408039,0.301794329276091,0.383752965803834
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL2RA,Interleukin-2 receptor subunit alpha,15954,0.0392863693540093,0.0451533022167046,-0.0492141029907317,0.12778684169875,0.38427724138359
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NPHS1,Nephrin,13552,-0.0336151837283979,0.0386441650186003,-0.109357747164854,0.0421273797080587,0.384389930439124
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,13552,-0.0328942233007496,0.0378161628924965,-0.107013902570043,0.0412254559685435,0.384400203977222
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ITGB7,Integrin beta-7,16209,-0.0446901259168814,0.0514515846173143,-0.145535231766817,0.0561549799330546,0.385086487619423
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MYOM2,Myomesin-2,13486,-0.0502725305782396,0.0578977474294826,-0.163752115540026,0.0632070543835462,0.385246378723345
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CA12,Carbonic anhydrase 12,16008,0.0321122474767633,0.0369894192151287,-0.0403870141848889,0.104611509138416,0.385326976384694
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PRSS22,Brain-specific serine protease 4,13552,-0.0344277856311127,0.0396968817330153,-0.112233673827823,0.0433781025655972,0.385811241486793
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LAMB1,Laminin subunit beta-1,13610,0.0301408169867058,0.034760051585822,-0.0379888841215054,0.0982705180949169,0.38589659314833
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KEL,Kell blood group glycoprotein,15688,0.0348647611396199,0.0402789267493815,-0.0440819352891678,0.113811457568408,0.386732035919639
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",13913,0.10172634916017,0.117573804182809,-0.128718307038136,0.332171005358475,0.38693698626709
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL22RA1,Interleukin-22 receptor subunit alpha-1,15826,0.0425353876060662,0.0491711605756984,-0.0538400871223027,0.138910862334435,0.387025863285393
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SORD,Sorbitol dehydrogenase,16138,0.0658521089052501,0.0761546203582294,-0.0834109469968796,0.21511516480738,0.387207620183336
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LCP1,Plastin-2,13972,-0.0460934218870341,0.0533180814722058,-0.150596861572558,0.0584100177984894,0.387328749831362
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",13590,-0.049770383091229,0.0576249133475828,-0.162715213252491,0.0631744470700332,0.387770399615893
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CALB2,Calretinin,15688,0.0293007210894881,0.0339543287743538,-0.0372497633082454,0.0958512054872216,0.388180864796641
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TGOLN2,Trans-Golgi network integral membrane protein 2,13982,0.0249911574139988,0.02896211554536,-0.0317745890549068,0.0817569038829044,0.388212051794945
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GMFG,Glia maturation factor gamma,13974,0.0696467837858082,0.0807167997952536,-0.0885581438128889,0.227851711384505,0.388232770506748
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NPL,N-acetylneuraminate lyase,13974,0.0435225301543646,0.0504864418815173,-0.0554308959334093,0.142475956242139,0.388667259390952
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IQGAP2,Ras GTPase-activating-like protein IQGAP2,16008,0.052989414450247,0.0615664430276967,-0.0676808138840386,0.173659642784533,0.38942355975463
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CNDP1,Beta-Ala-His dipeptidase,16174,-0.0452354017301691,0.0526369999915726,-0.148403921713651,0.0579331182533132,0.390141377627482
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,15663,0.0464009394777536,0.0541099101586707,-0.059654484433241,0.152456363388748,0.391164478379696
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TNFSF11,Tumor necrosis factor ligand superfamily member 11,16073,-0.0593428667878318,0.0692133681965128,-0.195001068452997,0.0763153348773333,0.391242042897324
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL17D,Interleukin-17D,15826,-0.0332863382967892,0.038833100338391,-0.109399214960036,0.0428265383664571,0.391367207837851
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL13RA1,Interleukin-13 receptor subunit alpha-1,15874,0.0218303825364524,0.0254973196245382,-0.0281443639276425,0.0718051290005473,0.391909262327951
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KITLG,Kit ligand,16102,-0.0360734231934513,0.0421768858892619,-0.118740119536405,0.0465932731495021,0.392403956720414
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SWAP70,Switch-associated protein 70,13913,0.0356935007208555,0.0417407964654447,-0.0461184603514161,0.117505461793127,0.392497988240428
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CELA3A,Chymotrypsin-like elastase family member 3A,16281,-0.0564312440694005,0.066021991721528,-0.185834347843595,0.0729718597047943,0.392710985961555
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD14,Monocyte differentiation antigen CD14,15789,0.0400786583649856,0.046911088525366,-0.0518670751447318,0.132024391874703,0.392922058878684
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ATXN10,Ataxin-10,15688,-0.0691265996021191,0.0809538574107313,-0.227796160127153,0.0895429609229143,0.393172759611013
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FOLR1,Folate receptor alpha,16047,0.0276316172635447,0.0323647286836689,-0.0358032509564462,0.0910664854835357,0.393252337911923
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SFRP1,Secreted frizzled-related protein 1,15899,-0.0414822114062664,0.0486209059028161,-0.136779186975786,0.0538147641632533,0.393574330751475
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,COX6B1,Cytochrome c oxidase subunit 6B1,13974,0.0312889405624288,0.03669330676233,-0.040629940691738,0.103207821816596,0.39383188663584
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FBLN2,Fibulin-2,13972,0.0297182972267129,0.0349268830610223,-0.0387383935728908,0.0981749880263166,0.394855209340798
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HLA_A,,13946,0.0313524670012832,0.0369558813485831,-0.0410810604419396,0.103785994444506,0.396243417576614
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AMPD3,AMP deaminase 3,13927,0.0699551374584797,0.0824779994550626,-0.091701741473443,0.231612016390402,0.396359428234472
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,13486,0.0303412491760575,0.0357933439434654,-0.0398137049531346,0.10049620330525,0.396632085752883
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,16118,0.0921274140989371,0.10875309723298,-0.121028656477703,0.305283484675578,0.396938314252681
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LAYN,Layilin,15925,0.032913501922935,0.0388541634207672,-0.0432406583817686,0.109067662227639,0.396950116819639
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,13946,-0.0316339122256748,0.0374028667434102,-0.104943531042759,0.0416757065914091,0.397700219701809
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL4,Interleukin-4,15826,0.0870825955794794,0.103094523105514,-0.114982669707328,0.289147860866287,0.398298442278401
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CA14,Carbonic anhydrase 14,16209,-0.0337418911685391,0.0399960989652899,-0.112134245140507,0.0446504628034292,0.398888903890323
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PTN,Pleiotrophin,15778,0.0474954551416647,0.056328332778896,-0.0629080771049715,0.157898987388301,0.399135299199315
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DAG1,Dystroglycan,16160,0.0452412228779075,0.0536964715024124,-0.0600038612668208,0.150486307022636,0.399500346741873
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SERPINB8,Serpin B8,16272,-0.0554435586212596,0.0659717975373096,-0.184748281794386,0.0738611645518671,0.400689201860294
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NDRG1,Protein NDRG1,15688,-0.0639098908094655,0.0760535575767806,-0.212974863659956,0.0851550820410245,0.400737642169145
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,13946,0.0946753509492127,0.112782262486812,-0.126377883524938,0.315728585423364,0.401229843679846
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,13894,0.044188664369252,0.0527836641246655,-0.0592673173150923,0.147644646053596,0.40251394142195
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PDIA5,Protein disulfide-isomerase A5,13480,-0.0585151569369131,0.0700352377566506,-0.195784222939948,0.078753909066122,0.403445318595866
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,15950,-0.0570484425420775,0.0684330022493347,-0.191177126950774,0.0770802418666186,0.404496747102501
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,13486,-0.031451019610713,0.0377405538754618,-0.105422505206618,0.0425204659851921,0.404663199074141
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PRCP,Lysosomal Pro-X carboxypeptidase,16208,-0.0294974038114801,0.0354299636809952,-0.0989401326262306,0.0399453250032705,0.405107859042156
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PPIB,Peptidyl-prolyl cis-trans isomerase B,16119,0.0905274756501554,0.108825394921435,-0.122770298395857,0.303825249696168,0.405500396043309
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PGLYRP4,Peptidoglycan recognition protein 4,13486,0.0580099118660718,0.0697385271838561,-0.0786776014142861,0.19469742514643,0.405525214232878
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",13552,-0.0420919465618177,0.0506965791717631,-0.141457241738473,0.057273348614838,0.406399696498053
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TPD52L2,Tumor protein D54,13684,0.102476980379637,0.123482585399775,-0.139548887003921,0.344502847763196,0.406615390798857
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ITPA,Inosine triphosphate pyrophosphatase,13486,0.0633102805372644,0.0762958651477425,-0.086229615152311,0.21285017622684,0.40666678425677
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TJAP1,Tight junction-associated protein 1,16118,0.077985987418512,0.0940094332478961,-0.106272501747364,0.262244476584388,0.406802772309264
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SORT1,Sortilin,16085,0.0353412288640576,0.0426226762573677,-0.0481992166003832,0.118881674328498,0.407023394950728
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SMS,Spermine synthase,13474,0.06089588480791,0.073462861730569,-0.0830913241840052,0.204883093799825,0.407156292279798
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BCL2L1,Bcl-2-like protein 1,13927,0.0937772521147333,0.1131893791223,-0.128073930964975,0.315628435194442,0.407402349576651
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GPC5,Glypican-5,15950,-0.0521675665602037,0.063046215070016,-0.175738148097435,0.0714030149770276,0.407994657495075
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL31RA,Interleukin-31 receptor subunit alpha,13489,0.0373614542735222,0.045181144507038,-0.0511935889602723,0.125916497507317,0.408293758972866
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ZFYVE19,Abscission/NoCut checkpoint regulator,13913,0.0849588627001895,0.102775612201813,-0.116481337215364,0.286399062615743,0.408452953238859
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SORCS2,VPS10 domain-containing receptor SorCS2,15724,0.0331602922567977,0.0401640265653672,-0.0455611998113221,0.111881784324917,0.409031253464772
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SEL1L,Protein sel-1 homolog 1,13610,0.0297945566282932,0.0361099936677717,-0.0409810309605393,0.100570144217126,0.409326138287781
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ARHGAP5,Rho GTPase-activating protein 5,13480,-0.0728191355433473,0.0882647061091389,-0.24581795951726,0.100179688430565,0.409381361250215
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,13913,0.0607585431661926,0.0737757165863069,-0.0838418613429689,0.205358947675354,0.410205175412183
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EGF,Pro-epidermal growth factor,16050,0.0964794468401644,0.117174981151363,-0.133183516216507,0.326142409896836,0.41030460981897
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,UBE2B,Ubiquitin-conjugating enzyme E2 B,13894,0.0273401129467338,0.0332422464051943,-0.0378146900074471,0.0924949159009147,0.410834492090395
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CBLN1,Cerebellin-1,13474,0.0915882250235887,0.111376449278156,-0.126709615561597,0.309886065608774,0.410903523255518
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AHSP,Alpha-hemoglobin-stabilizing protein,16074,0.0799427259807406,0.0973252369594943,-0.110814738459868,0.270700190421349,0.411431965089606
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HDDC2,5'-deoxynucleotidase HDDC2,13913,0.0413908290404259,0.0504899578687993,-0.0575694883824208,0.140351146463273,0.412353656502526
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LCN15,Lipocalin-15,13946,0.0563903303386677,0.0688936961812774,-0.0786413141766359,0.191421974853971,0.413078782138877
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CORO1A,Coronin-1A,15799,0.0860094721342879,0.105085268046836,-0.119957653237511,0.291976597506087,0.413099413241144
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,COL5A1,Collagen alpha-1(V) chain,13684,0.0371384985004038,0.0455043330705547,-0.0520499943178835,0.126326991318691,0.414426848447657
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ATXN2,Ataxin-2,13474,0.101302728142467,0.124271184344786,-0.142268793173313,0.344874249458247,0.414986728466895
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CCL14,C-C motif chemokine 14,16074,0.0372791650169571,0.0457554067083375,-0.0524014321313844,0.126959762165299,0.415228165980603
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SNX18,Sorting nexin-18,13913,0.0412212841319114,0.0506876305973397,-0.0581264718388745,0.140569040102697,0.416093547244516
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MINK1,Misshapen-like kinase 1,13927,0.0859778036523529,0.105856382474538,-0.121500705997742,0.293456313302448,0.416684002257159
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ELAC1,Zinc phosphodiesterase ELAC protein 1,13946,0.0784423114213345,0.0966491251540368,-0.110989973880578,0.267874596723247,0.417023883451853
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BCAM,Basal cell adhesion molecule,16101,0.0220862503100761,0.0272149735900681,-0.0312550979264574,0.0754275985466096,0.417063196026751
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PARD3,Partitioning defective 3 homolog,13710,0.0701329620400693,0.0864625034532934,-0.0993335447283857,0.239599468808524,0.417300919926016
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RBM19,Probable RNA-binding protein 19,13486,-0.0427731174413369,0.0527591814630128,-0.146181113108842,0.0606348782261681,0.417538696087004
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ARHGAP25,Rho GTPase-activating protein 25,15724,0.0555141775365375,0.0684878433188695,-0.0787219953684468,0.189750350441522,0.417625043624043
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD274,Programmed cell death 1 ligand 1,15950,0.0306710894530392,0.0378581193153493,-0.0435308244050455,0.104873003311124,0.417860996435256
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CLSTN3,Calsyntenin-3,13927,-0.0278468586980144,0.0343877964177613,-0.0952469396768264,0.0395532222807977,0.418075314618928
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CAT,Catalase,13763,0.0496965394112189,0.0613762495451837,-0.0706009096973412,0.169993988519779,0.41812484968483
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HSPA1A,Heat shock 70 kDa protein 1A,16130,0.0656573889883165,0.0810937662630501,-0.0932863928872618,0.224601170863895,0.418154584267489
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NFYA,Nuclear transcription factor Y subunit alpha,13486,-0.0364312572472654,0.044996414891909,-0.124624230435407,0.0517617159408763,0.418156813004294
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NUB1,NEDD8 ultimate buster 1,16073,0.0763817069932516,0.0943701217387729,-0.108583731614743,0.261347145601246,0.41830604822762
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CLNS1A,Methylosome subunit pICln,13590,0.0316943467287877,0.0391833375688518,-0.0451049949061618,0.108493688363737,0.418602332729547
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MSRA,Mitochondrial peptide methionine sulfoxide reductase,16118,0.066904926544721,0.0827191536086091,-0.0952246145281529,0.229034467617595,0.418630495020114
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LYAR,Cell growth-regulating nucleolar protein,15724,-0.0493998755870537,0.0610840393873977,-0.169124592786353,0.0703248416122458,0.418688550484292
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TIE1,Tyrosine-protein kinase receptor Tie-1,16301,-0.0374591691925011,0.0463218609392299,-0.128250016633392,0.0533316782483895,0.418715932400981
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EIF5,Eukaryotic translation initiation factor 5,13486,0.0394936545865646,0.0488602820521457,-0.0562724982356409,0.13525980740877,0.418933487305676
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KLK14,Kallikrein-14,16209,-0.0419680036796746,0.0519594220698751,-0.14380847093663,0.0598724635772806,0.419270972447892
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GGACT,Gamma-glutamylaminecyclotransferase,13974,0.0640521543316284,0.0794079230493451,-0.0915873748450881,0.219691683508345,0.419898205703419
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,STK4,Serine/threonine-protein kinase 4,16102,0.0802044996896925,0.0994502496761253,-0.114717989675513,0.275126989054898,0.419978854570353
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BRSK2,Serine/threonine-protein kinase BRSK2,13946,0.0351883731397336,0.0436323192109411,-0.050330972513711,0.120707718793178,0.419982803071499
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SERPINI2,Serpin I2,13913,0.0528189610886997,0.0655805114583057,-0.0757188413695794,0.181356763546979,0.420599000102767
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",13474,0.0416967052325533,0.0517822058064284,-0.0597964181480463,0.143189828613153,0.420699858174807
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",15778,0.0815629981434422,0.101333498878278,-0.117050659657983,0.280176655944867,0.42089143599672
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ATRAID,All-trans retinoic acid-induced differentiation factor,13913,0.0274616604218821,0.0341210934730433,-0.0394156827852827,0.0943390036290469,0.420931879250305
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CTSO,Cathepsin O,16272,-0.0275861636073787,0.034284973972615,-0.0947847125937041,0.0396123853789468,0.421054334711562
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,16076,-0.0265739534439774,0.033080270511114,-0.0914112836457608,0.038263376757806,0.421803251019435
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DLG4,Disks large homolog 4,13927,0.0655994487393005,0.0817736605008368,-0.0946769258423396,0.22587582332094,0.422446605206484
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,15505,-0.0590739024784401,0.0737082267764037,-0.203542026960191,0.0853942220033111,0.422879984931383
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SLC39A14,Zinc transporter ZIP14,15688,-0.0295735157371535,0.0369456348435289,-0.10198696003047,0.0428399285561631,0.423456260404034
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,WASF3,Wiskott-Aldrich syndrome protein family member 3,15688,0.0760517893974143,0.0950506422651857,-0.11024746944235,0.262351048237178,0.423654196146631
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CASP2,Caspase-2,16073,0.0615048937491258,0.0768699638491993,-0.0891602353953048,0.212170022893556,0.423655384000394
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CCS,Copper chaperone for superoxide dismutase,15950,0.0432742773829915,0.0540912377523965,-0.0627445486117056,0.149293103377689,0.423708935320348
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EXTL1,Exostosin-like 1,13486,-0.0421197967607617,0.0526812932355717,-0.145375131502482,0.0611355379809588,0.42400250948849
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,VSIG10,V-set and immunoglobulin domain-containing protein 10,13894,-0.0322985349631788,0.0404400815874062,-0.111561094874495,0.0469640249481373,0.424491794715832
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ECE1,Endothelin-converting enzyme 1,15688,0.03179448560275,0.0398191070288472,-0.0462509641737906,0.109839935379291,0.424608098541396
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MSMB,Beta-microseminoprotein,16076,0.0621486987222886,0.07786054060042,-0.0904579608545347,0.214755358299112,0.4247631443329
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,16209,-0.0286052010335596,0.0358380997605947,-0.0988478765643251,0.0416374744972059,0.424778610679465
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,B4GALT1,"Beta-1,4-galactosyltransferase 1",16160,0.0245920514540545,0.0308436693492299,-0.0358615404704361,0.0850456433785451,0.425281130234276
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AARSD1,Alanyl-tRNA editing protein Aarsd1,16008,0.0506563980817755,0.0635368928782619,-0.0738759119596179,0.175188708123169,0.425302972490359
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CEP85,Centrosomal protein of 85 kDa,15724,0.0574785152594572,0.0721005502747091,-0.0838385632789727,0.198795593797887,0.425347283867142
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NOTCH1,Neurogenic locus notch homolog protein 1,16301,-0.0142998966982803,0.0179734919955559,-0.04952794100957,0.0209281476130093,0.426270129515861
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CLSPN,Claspin,15663,-0.0310820622014239,0.0390835717565651,-0.107685862844292,0.0455217384414437,0.426467479287564
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SPARC,SPARC,16118,0.0642251417961597,0.0807596618737904,-0.0940637954764695,0.222514079068789,0.426472462503417
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MYBPC1,"Myosin-binding protein C, slow-type",13974,-0.0626365067257621,0.0787913684826579,-0.217067588951772,0.0917945755002475,0.426646443152204
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PDGFRA,Platelet-derived growth factor receptor alpha,16102,0.0253104702983386,0.0318424403582934,-0.0371007128039166,0.0877216534005937,0.426703232546185
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ADGRB3,Adhesion G protein-coupled receptor B3,15924,-0.0299395888550297,0.0376952701285877,-0.103822318307062,0.0439431405970023,0.427059890716142
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CSPG4,Chondroitin sulfate proteoglycan 4,13972,0.0293719895801088,0.0369903303306017,-0.0431290578678705,0.101873037028088,0.427182690711227
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,13610,0.0558654163338138,0.0703659410083884,-0.0820518280426275,0.193782660710255,0.427251820493091
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CPA1,Carboxypeptidase A1,16301,0.0547222366465102,0.0689266197049315,-0.0803739379751556,0.189818411268176,0.427253447957118
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PI16,Peptidase inhibitor 16,13982,0.0218669426980467,0.0275519332887649,-0.0321348465479326,0.0758687319440259,0.42740528262021
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CRELD1,Protein disulfide isomerase CRELD1,13684,0.0336459794817644,0.0424063792761834,-0.0494705238995551,0.116762482863084,0.427548168763506
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL15RA,Interleukin-15 receptor subunit alpha,15826,-0.0316883041579245,0.0399655833767929,-0.110020847576439,0.0466442392605896,0.427853916200746
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,13684,0.0372903241180011,0.0470881577095781,-0.055002464992772,0.129583113228774,0.428417719078852
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KYNU,Kynureninase,16272,0.0406742951059023,0.0513812727725593,-0.0600329995283139,0.141381589740118,0.428595511135941
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ENOPH1,Enolase-phosphatase E1,13894,-0.0491516694046703,0.0621654944401929,-0.170996038507448,0.0726926996981077,0.429156875603972
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MB,Myoglobin,16301,-0.0466914836686832,0.0590716946808137,-0.162472005243078,0.0690890379057117,0.42929369075231
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ARFIP1,Arfaptin-1,13946,0.0616482735106713,0.078087215099714,-0.091402668084768,0.214699215106111,0.429845107656693
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MAPRE3,Microtubule-associated protein RP/EB family member 3,13480,0.132292356243565,0.167586112863186,-0.196176424968278,0.460761137455409,0.429892577360318
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RNF149,E3 ubiquitin-protein ligase RNF149,13610,0.0273278498647602,0.0346414864596227,-0.0405694635961003,0.0952251633256206,0.430198027123186
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,13927,0.0422387397731122,0.0535522022948198,-0.0627235767247346,0.147201056270959,0.430277688210687
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CSF1R,Macrophage colony-stimulating factor 1 receptor,13982,-0.0353437763199993,0.0448164631189171,-0.123184044033077,0.0524964913930782,0.430339471131666
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL16,Pro-interleukin-16,16272,-0.0373491186814443,0.047361227884063,-0.130177125334208,0.0554788879713192,0.430356658339325
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GFAP,Glial fibrillary acidic protein,15700,-0.0418670513038388,0.0531883442918863,-0.146116206115936,0.0623821035082584,0.431207649153607
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MESD,LRP chaperone MESD,16101,0.108363183083942,0.137728397319817,-0.161584475662899,0.378310841830783,0.431417004973831
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,16008,0.0250573650708316,0.0318519207675758,-0.037372399633617,0.0874871297752803,0.431479105048948
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,C2orf69,UPF0565 protein C2orf69,13590,0.0527791779691714,0.0671496604417864,-0.0788341564967299,0.184392512435073,0.431885176031887
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SFRP4,Secreted frizzled-related protein 4,13684,0.0371977690378378,0.0473338622801093,-0.0555766010311765,0.129972139106852,0.431963379087488
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TNFSF13,Tumor necrosis factor ligand superfamily member 13,16160,0.0237914073971526,0.0302748221392818,-0.0355472439958397,0.0831300587901449,0.431968093867796
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PAK4,Serine/threonine-protein kinase PAK 4,15688,0.0535692795095899,0.0682130779779104,-0.0801283533271146,0.187266912346294,0.432276251978186
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CGN,Cingulin,13590,0.0359529971519964,0.0457822900007713,-0.0537802912495153,0.125686285553508,0.432289289833585
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GLI2,Zinc finger protein GLI2,13552,-0.0297914641781131,0.0379455005867736,-0.104164645328189,0.0445817169719631,0.432401700245728
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CLEC6A,C-type lectin domain family 6 member A,15724,-0.0423657984626946,0.0540081755871577,-0.148221822613524,0.0634902256881345,0.432797873477112
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,QSOX1,Sulfhydryl oxidase 1,13685,-0.0364100389785592,0.0465484115817227,-0.127644925678736,0.0548248477216172,0.434112214650222
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PRAME,Melanoma antigen preferentially expressed in tumors,13480,0.0230709621279527,0.0295575265086059,-0.0348617898289149,0.0810037140848202,0.4350842174043
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,13710,0.0347068202909291,0.0444770834827019,-0.0524682633351666,0.121881903917025,0.435209909687958
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PNMA2,Paraneoplastic antigen Ma2,13474,0.0387957319725774,0.0497344904732492,-0.0586838693549911,0.136275333300146,0.435371106217586
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ITGB6,Integrin beta-6,15826,0.0271996503038932,0.0349299666561546,-0.0412630843421698,0.0956623849499562,0.436173417785882
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NPR1,Atrial natriuretic peptide receptor 1,13486,0.03647280273422,0.0468854157499418,-0.0554226121356659,0.128368217604106,0.43663360883291
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NADK,NAD kinase,16102,-0.0506624346600269,0.0651371188145255,-0.178331187536497,0.0770063182164432,0.436709375853773
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TIA1,Nucleolysin TIA-1 isoform p40,15593,0.107776494219949,0.13865056932117,-0.163978621649544,0.379531610089441,0.436979105552057
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,COPB2,Coatomer subunit beta',13486,0.0383894321700742,0.0494039525518686,-0.0584423148315883,0.135221179171737,0.437141830400704
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ATP6V1F,V-type proton ATPase subunit F,15663,0.0585798989811307,0.0754091970701154,-0.0892221272762955,0.206381925238557,0.437272597093085
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PLA2G15,Phospholipase A2 group XV,16118,0.0234673815125799,0.0302590816862226,-0.0358404185924164,0.0827751816175761,0.438027082829289
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SHC1,SHC-transforming protein 1,13480,0.102167456865744,0.131857108564958,-0.156272475921574,0.360607389653062,0.438450975171272
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PRDX1,Peroxiredoxin-1,15622,0.0790952635265837,0.102084193475648,-0.120989755685686,0.279180282738853,0.438467094762599
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TSPAN7,Tetraspanin-7,13474,0.0819014954543944,0.105708925838635,-0.12528799918933,0.289090990098119,0.438481412453617
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,OTOA,Otoancorin,13474,-0.0462183559880978,0.0597309202668729,-0.163290959711169,0.0708542477349731,0.4390768231506
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD244,Natural killer cell receptor 2B4,16272,0.0234460856244127,0.0303547699687515,-0.0360492635143403,0.0829414347631656,0.439887586027306
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ATP5IF1,"ATPase inhibitor, mitochondrial",16160,0.0961614890526108,0.124733322136951,-0.148315822335812,0.340638800441034,0.440755765370516
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PTGR1,Prostaglandin reductase 1,13974,0.0703023141045832,0.0912658736783518,-0.108578798304986,0.249183426514153,0.441133616516426
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,15826,0.0371087308224926,0.0482186065823745,-0.0573997380789613,0.131617199723947,0.441552501383394
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CRKL,Crk-like protein,16102,0.0923401312746358,0.120055868138025,-0.142969370275893,0.327649632825165,0.441819711813286
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SPAG1,Sperm-associated antigen 1,13946,-0.0510619991968205,0.0663943634007032,-0.181194951462199,0.0790709530685578,0.441864023648935
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SH3GLB2,Endophilin-B2,13927,0.058945842866042,0.0766565423636573,-0.0913009801667262,0.20919266589881,0.441929892494156
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HBQ1,Hemoglobin subunit theta-1,16209,0.0530712365374159,0.0690715234700014,-0.0823089494637868,0.188451422538619,0.442289349891374
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SEZ6L,Seizure 6-like protein,16118,0.0239022064941728,0.0311114354112282,-0.0370762069118346,0.0848806199001801,0.44233378260592
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NCK2,Cytoplasmic protein NCK2,16160,0.0918726368993592,0.119636600198792,-0.142615099490272,0.326360373288991,0.442539494540868
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,13946,-0.023098861878892,0.0301268357195307,-0.0821474598891721,0.0359497361313881,0.443260717107534
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CHIT1,Chitotriosidase-1,16180,0.133289569525388,0.17385965868949,-0.207475361506012,0.474054500556788,0.443300621241774
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RAB6B,Ras-related protein Rab-6B,15688,0.040295974442962,0.0525929219734314,-0.0627861526249635,0.143378101510887,0.443577018130152
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,OSTN,Osteocrin,13590,-0.0376170341918525,0.0491159572251461,-0.133884310353139,0.0586502419694338,0.443759751934699
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TMED8,Protein TMED8,13913,0.0902035579738337,0.117813937321011,-0.140711759175347,0.321118875123015,0.443901037507588
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RGCC,Regulator of cell cycle RGCC,13946,0.0657367913333356,0.0860437843874833,-0.102909026066132,0.234382608732803,0.4448847514017
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FLT1,Vascular endothelial growth factor receptor 1,15975,-0.0191018571176753,0.0250238756059274,-0.068148653305293,0.0299449390699425,0.445268792118279
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CHGB,Secretogranin-1,16175,-0.0350246011914635,0.0458833128259144,-0.124955894330256,0.0549066919473288,0.445271364260581
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ROBO1,Roundabout homolog 1,16107,0.0203860866458028,0.0267074125861824,-0.0319604420231148,0.0727326153147203,0.445288578256661
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AOC1,Amiloride-sensitive amine oxidase [copper-containing],15826,0.0493255503309763,0.0646211655098401,-0.0773319340683102,0.175983034730263,0.445293909142918
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,16132,0.0658100239914194,0.0863460527417769,-0.103428239382463,0.235048287365302,0.445972099653993
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ASGR1,Asialoglycoprotein receptor 1,15950,-0.0251451188587762,0.0331192274458041,-0.0900588046525522,0.0397685669349998,0.447726071915685
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CCDC28A,Coiled-coil domain-containing protein 28A,13590,-0.0260273416551295,0.0343053030240429,-0.0932657355822537,0.0412110522719946,0.448046808422057
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,13480,-0.0582744721331076,0.0768876980559332,-0.208974360322737,0.0924254160565214,0.44851410152983
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RAB27B,Ras-related protein Rab-27B,13974,0.0699390765242222,0.0923604339750175,-0.111087374066812,0.250965527115256,0.448918471656012
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TK1,"Thymidine kinase, cytosolic",13710,0.039841527928824,0.0526436062605074,-0.0633399403417705,0.143022996199418,0.449173073979879
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ADGRE1,Adhesion G protein-coupled receptor E1,13913,-0.0476628953454247,0.0630255623356566,-0.171192997523312,0.0758672068324621,0.449513907785831
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TGFBR3,Transforming growth factor beta receptor type 3,16301,0.0270019936058407,0.0357435805186594,-0.0430554242107316,0.097059411422413,0.449998241404324
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DCC,Netrin receptor DCC,13590,0.0193067859281564,0.0255919131609003,-0.0308533638672081,0.0694669357235209,0.450616371709767
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,F7,Coagulation factor VII,16151,0.0259289873468692,0.0344012081826258,-0.0414973806910773,0.0933553553848157,0.451026468997892
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GTPBP2,GTP-binding protein 2,13590,0.0700476127776226,0.0930427341868026,-0.11231614622851,0.252411371783756,0.451550589651677
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GOLM2,Protein GOLM2,16230,-0.0186609765862609,0.0248068390063522,-0.0672823810387113,0.0299604278661895,0.451910874708388
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IGSF21,Immunoglobulin superfamily member 21,13610,-0.0338786600542897,0.0450451889277325,-0.122167230352645,0.054409910244066,0.452001628211072
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HEBP1,Heme-binding protein 1,15778,-0.0456179486550863,0.0606801353718626,-0.164551013983937,0.0733151166737644,0.452196215758579
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IGF1R,Insulin-like growth factor 1 receptor,16008,0.0182819410336462,0.0243234729666039,-0.0293920659808975,0.0659559480481898,0.45229234662467
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LPA,Apolipoprotein(a),13678,-0.151213537024626,0.201423661826523,-0.546003914204612,0.24357684015536,0.452831823486176
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HDGFL2,Hepatoma-derived growth factor-related protein 2,13927,0.0544013222216135,0.0726826804133354,-0.0880567313885239,0.196859375831751,0.454185081989815
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PMVK,Phosphomevalonate kinase,15664,0.0922742375280937,0.123438131026908,-0.149664499284646,0.334212974340833,0.454752334691703
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NACC1,Nucleus accumbens-associated protein 1,13894,0.0478256128996299,0.0639844988201733,-0.0775840047879098,0.17323523058717,0.45480087051364
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SEPTIN3,Neuronal-specific septin-3,13946,-0.0642128220888793,0.0859827527186549,-0.232739017417443,0.104313373239684,0.455190562217412
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PRG3,Proteoglycan 3,13972,0.0419649645882486,0.0562283397461392,-0.0682425813141843,0.152172510490682,0.455479934829419
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,15925,0.0940212773564763,0.126012015089921,-0.152962272219768,0.341004826932721,0.455600235157779
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ART5,Ecto-ADP-ribosyltransferase 5,13474,0.0535454424948175,0.0717705337785405,-0.0871248037111218,0.194215688700757,0.455641523335958
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AKR1B10,Aldo-keto reductase family 1 member B10,13590,0.0541819348081173,0.0726413420147542,-0.088195095540801,0.196558965157036,0.455751070381553
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DEFB103A_DEFB103B,Beta-defensin 103,13441,-0.0347081713269982,0.0465978443488498,-0.126039946250744,0.0566236035967475,0.456378464578908
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PDIA3,Protein disulfide-isomerase A3,13684,-0.0213817947117452,0.0287156119358357,-0.0776643941059832,0.0349008046824928,0.456523207806355
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD55,Complement decay-accelerating factor,15547,0.0226558146328205,0.030433281642756,-0.0369934173869812,0.0823050466526222,0.456620348324509
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LRRC25,Leucine-rich repeat-containing protein 25,16008,0.0325087397949256,0.0436723549196604,-0.0530890758476088,0.11810655543746,0.4566587667137
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MILR1,Allergin-1,15826,-0.0438997013402318,0.0590116842284489,-0.159562602427992,0.071763199747528,0.456938705422667
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SEC31A,Protein transport protein Sec31A,13610,0.0649172713384,0.0873250754563685,-0.106239876556082,0.236074419232882,0.457253704986789
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FGFR4,Fibroblast growth factor receptor 4,13684,0.0447597954065344,0.0602439001158172,-0.0733182488204674,0.162837839633536,0.457508742527472
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,15724,0.0727460720757058,0.0979157290287467,-0.119168756820638,0.264660900972049,0.457525651288492
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL5,Interleukin-5,15826,-0.120432605338569,0.162304254245406,-0.438548943659565,0.197683732982426,0.458087723017863
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,JCHAIN,Immunoglobulin J chain,15826,0.0520078651499252,0.0701046555248266,-0.0853972596787349,0.189412989978585,0.458182962405606
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KLK7,Kallikrein-7,13290,-0.032274842384162,0.043656370495763,-0.117841328555857,0.0532916437875333,0.459742263445441
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",13946,0.0615856313584841,0.0833094064209928,-0.101700805226662,0.22487206794363,0.459773833912703
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ACAN,Aggrecan core protein,15945,-0.0240282792292757,0.0325276110239543,-0.0877823968362261,0.0397258383776747,0.460097585533472
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DNAJC9,DnaJ homolog subfamily C member 9,13913,0.0649572404303174,0.0879406051835434,-0.107406345729428,0.237320826590062,0.460132631806287
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CKB,Creatine kinase B-type,13972,0.0492107598197979,0.0666817419558092,-0.0814854544135881,0.179906974053184,0.46053018910263
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,13474,0.0620581611872588,0.0841103303598393,-0.102798086318026,0.226914408692544,0.460637587489418
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RFC4,Replication factor C subunit 4,13894,0.0184155481403852,0.024961263963873,-0.0305085292288058,0.0673396255095763,0.460669707518323
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LACTB2,Endoribonuclease LACTB2,16102,0.055535651127567,0.0752886762879774,-0.0920301543968686,0.203101456652003,0.460746325348906
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",13610,0.0311156680293482,0.0422218655629385,-0.0516391884740112,0.113870524532708,0.461161667137427
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MCFD2,Multiple coagulation factor deficiency protein 2,16032,0.0372317320170036,0.0506041022105859,-0.0619523083157448,0.136415772349752,0.46189646890825
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,THSD1,Thrombospondin type-1 domain-containing protein 1,13445,-0.0283056955988401,0.0385978807645343,-0.103957541897327,0.0473461506996472,0.463358738059494
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EPO,Erythropoietin,16073,0.0628993842956967,0.0857733120159226,-0.105216307255512,0.231015075846905,0.463373279296754
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LMOD1,Leiomodin-1,13946,0.0295509961901758,0.040340183994269,-0.0495157644385914,0.108617756818943,0.463848369385268
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RYR1,Ryanodine receptor 1,13486,-0.0282201709532591,0.03854698415782,-0.103772259902586,0.0473319179960681,0.464121474791
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CCDC50,Coiled-coil domain-containing protein 50,13946,0.0636623338880982,0.0870180212680212,-0.106892987797223,0.23421765557342,0.464425407432224
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,13610,0.0392477891043735,0.053808889142724,-0.0662176336153655,0.144713211824113,0.46577429499883
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SPRR1B,Cornifin-B,13710,-0.0720629916958919,0.0988206216332422,-0.265751410097047,0.121625426705263,0.465873268750492
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CCL22,C-C motif chemokine 22,15904,-0.0425465518127881,0.0583727945493159,-0.156957229129447,0.0718641255038711,0.466088019909829
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,16167,0.0839689658631789,0.115299775232568,-0.142018593592654,0.309956525319012,0.466461010853002
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,16101,0.0223791851576591,0.0307312794225753,-0.0378541225105884,0.0826124928259067,0.466488471654866
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CCL24,C-C motif chemokine 24,16132,0.0682197898311386,0.0938443902038274,-0.115715214968363,0.25215479463064,0.467269687003957
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ATG16L1,Autophagy-related protein 16-1,13913,0.0708134306980089,0.0974827367886769,-0.120252733407798,0.261879594803816,0.467593434664017
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SIGLEC6,Sialic acid-binding Ig-like lectin 6,16209,0.0270967780947824,0.0373969934526781,-0.0462013290724666,0.100394885262031,0.46872570385148
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RRAS,Ras-related protein R-Ras,13590,0.109179787468242,0.150869528577771,-0.18652448854419,0.404884063480674,0.469280678490324
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EGLN1,Egl nine homolog 1,16073,0.045383123555067,0.0627605876588181,-0.0776276282562165,0.16839387536635,0.469619754055276
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CHMP6,Charged multivesicular body protein 6,13974,0.0456604537074101,0.0632197866601332,-0.078250328146451,0.169571235561271,0.47015324739768
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LGALS9,Galectin-9,16084,0.0256948753462771,0.0356346687185452,-0.0441490753420715,0.0955388260346256,0.47088065306967
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",13974,0.0432307948381504,0.0601448203700956,-0.074653053087237,0.161114642763538,0.47228952869666
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],16008,0.0454516741521974,0.0632747486863737,-0.078566833273095,0.16947018157749,0.47256896746423
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SIGLEC15,Sialic acid-binding Ig-like lectin 15,15688,0.0628960558265801,0.0876026626367126,-0.108805162941377,0.234597274594537,0.472786681612303
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EGFL7,Epidermal growth factor-like protein 7,15724,0.032367247880356,0.0450897707603593,-0.0560087028099484,0.12074319857066,0.472866527167229
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CCL2,C-C motif chemokine 2,15924,0.0426017873445016,0.0593644854664817,-0.0737526041698026,0.158956178858806,0.472995454659465
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TXNDC5,Thioredoxin domain-containing protein 5,16230,0.0552474053567535,0.077021602839482,-0.0957149362086313,0.206209746922138,0.473200863776619
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TCL1A,T-cell leukemia/lymphoma protein 1A,15921,-0.0792027291485966,0.110459815680389,-0.295703967882159,0.137298509584966,0.473367635964823
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NCLN,Nicalin,15826,0.0429128700293979,0.0598574587215684,-0.0744077490648762,0.160233489123672,0.473435485668246
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",16118,0.0284424323676149,0.0396750014230094,-0.0493205704214835,0.106205435156713,0.473455159829929
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CHL1,Neural cell adhesion molecule L1-like protein,16152,-0.0250394767141565,0.0349566358324332,-0.0935544829457255,0.0434755295174126,0.473815812460838
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SLA2,Src-like-adapter 2,13946,0.0851219840634144,0.118958086241592,-0.148035864970106,0.318279833096934,0.474273327790049
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TEX101,Testis-expressed protein 101,13590,0.0407741860657206,0.0570497150345639,-0.0710432554020246,0.152591627533466,0.474798550610827
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TTF2,Transcription termination factor 2,13590,0.0409746538489923,0.0573909124264172,-0.0715115345067855,0.15346084220477,0.475265933499855
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DEFB4A_DEFB4B,Beta-defensin 4A,15851,0.118439340215744,0.166214060820282,-0.207340218992009,0.444218899423497,0.476121683118234
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ERBIN,Erbin,16008,0.0831425290977005,0.116697162257664,-0.145583908927321,0.311868967122722,0.476187878398318
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,15991,0.020727847822534,0.0291071710887612,-0.0363222075114379,0.0777779031565059,0.476399823273738
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CCN2,CCN family member 2,16082,0.0462601255829868,0.0649744925833635,-0.0810898798804056,0.173610131046379,0.476491440110813
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PALLD,Palladin,13552,-0.0314342053192627,0.0441719798189615,-0.118011285764427,0.0551428751259018,0.476704793822398
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,13486,-0.0473499943214538,0.066559930568341,-0.177807458235402,0.0831074695924945,0.47685560613602
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,OGA,Protein O-GlcNAcase,13913,0.0574282936863676,0.080755026052843,-0.100851557377205,0.21570814474994,0.477008156753531
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CXCL14,C-X-C motif chemokine 14,15826,0.0502275577796985,0.0707022674035984,-0.0883488863313543,0.188804001890751,0.47746075188748
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RELB,Transcription factor RelB,13552,0.0397518873542405,0.0560231087816684,-0.0700534058578296,0.149557180566311,0.47798780944448
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SCARB1,Scavenger receptor class B member 1,15688,0.045953598319766,0.0647834759977114,-0.0810220146357484,0.17292921127528,0.478123225158506
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ARHGEF1,Rho guanine nucleotide exchange factor 1,13927,0.0721424061567991,0.101757436157576,-0.12730216871205,0.271586981025648,0.47835840867105
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SOX9,Transcription factor SOX-9,13590,-0.0223381546997244,0.0315168166533942,-0.0841111153403771,0.0394348059409283,0.478479770377831
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TPR,Nucleoprotein TPR,13486,0.0408905156677517,0.0577462890008834,-0.0722922107739797,0.154073242109483,0.478891448558712
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AOC3,Membrane primary amine oxidase,16174,0.0241580627506289,0.0341184490745037,-0.0427140974353983,0.0910302229366561,0.478915413103158
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DRG2,Developmentally-regulated GTP-binding protein 2,16008,0.045316370550023,0.0640941216361373,-0.0803081078568061,0.170940848956852,0.479559068819635
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FST,Follistatin,16132,-0.0401163433097691,0.0567702500642876,-0.151386033435773,0.0711533468162346,0.479798098559091
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,REPS1,RalBP1-associated Eps domain-containing protein 1,13552,0.0309071040946611,0.0437505191081235,-0.0548439133572609,0.116658121546583,0.479926889963515
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CEBPA,CCAAT/enhancer-binding protein alpha,13552,-0.0294848206270899,0.0417453748680573,-0.111305755368482,0.0523361141143024,0.48001281940633
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CPLX2,Complexin-2,13480,-0.0247534500120787,0.0350705150144966,-0.0934916594404921,0.0439847594163347,0.480312663366659
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TYMP,Thymidine phosphorylase,15995,0.0538457113719815,0.0762964179817198,-0.0956952678721893,0.203386690616152,0.480357867050798
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LRRN1,Leucine-rich repeat neuronal protein 1,15826,-0.0318223980310125,0.0451111498124385,-0.120240251663392,0.0565954556013669,0.480558041562279
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NID1,Nidogen-1,16123,0.030334944454595,0.0430085174826978,-0.0539617498114927,0.114631638720683,0.480618756021753
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MCTS1,Malignant T-cell-amplified sequence 1,13913,0.0205222466968907,0.0291020257702258,-0.0365177238127518,0.0775622172065332,0.480708329136118
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SPINK5,Serine protease inhibitor Kazal-type 5,16101,-0.0269369557178306,0.038198965147538,-0.101806927407005,0.047933015971344,0.480711539330179
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HMOX2,Heme oxygenase 2,15688,0.0364534007728996,0.0517909258172066,-0.0650568138288253,0.137963615374624,0.481532347165313
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ERBB2,Receptor tyrosine-protein kinase erbB-2,16118,0.020036881997833,0.0285042715112129,-0.0358314901641444,0.0759052541598104,0.482101349043771
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MYL4,Myosin light chain 4,13610,0.0430110228048654,0.0612048992398847,-0.0769505797053086,0.16297262531504,0.482230927363614
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",13946,0.0346057260338589,0.0492961129102247,-0.0620146552701815,0.131226107337899,0.482692727720754
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SCIN,Adseverin,13474,-0.0583483928245712,0.0831905559138731,-0.221401882415763,0.10470509676662,0.483076520498145
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PRKD2,Serine/threonine-protein kinase D2,13486,0.0359263858013302,0.0512267420752523,-0.0644780286661644,0.136330800268825,0.483114875775949
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,15904,0.0395548197921598,0.0564126024625646,-0.0710138810344668,0.150123520618786,0.483207249126836
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,16045,-0.0469899298918282,0.0670464744522055,-0.178401019818151,0.0844211600344945,0.483403002347819
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GRN,Progranulin,16017,-0.0191180484044528,0.0273115008734739,-0.0726485901164617,0.034412493307556,0.483937530407996
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HAO1,Hydroxyacid oxidase 1,16209,0.101206233886678,0.144581631615325,-0.182173764079359,0.384586231852715,0.483941282294983
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NFKBIE,NF-kappa-B inhibitor epsilon,15724,0.0393249293393603,0.0562078256122936,-0.0708424088607352,0.149492267539456,0.48416600166642
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PSCA,Prostate stem cell antigen,13913,-0.208786674223539,0.298514126978179,-0.793874363100771,0.376301014653692,0.484301457048939
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SNX2,Sorting nexin-2,13894,-0.0660689659873488,0.0945257269642604,-0.251339390837299,0.119201458862602,0.48459360732601
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DSG3,Desmoglein-3,16170,-0.0265919489090623,0.0380797387255121,-0.101228236811066,0.0480443389929414,0.484985408724128
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ACTN4,Alpha-actinin-4,15826,0.0257712501723562,0.0369377291975717,-0.0466266990548843,0.0981691993995967,0.485378532913444
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD86,T-lymphocyte activation antigen CD86,13913,0.0241139836632937,0.0346424910210208,-0.043785298737907,0.0920132660644944,0.486389673887582
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SNAP29,Synaptosomal-associated protein 29,16118,0.0721043136136385,0.103711650794849,-0.131170521944266,0.275379149171543,0.486915994146391
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GAL,Galanin peptides,16160,-0.0507668531816802,0.0730421163995891,-0.193929401324875,0.0923956949615145,0.487043148128641
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PBK,Lymphokine-activated killer T-cell-originated protein kinase,13480,0.0245492102982157,0.0353357601436487,-0.0447088795833358,0.0938073001797672,0.487229456336559
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RBM25,RNA-binding protein 25,13480,-0.0361349187197284,0.0521241852098168,-0.138298321730969,0.0660284842915125,0.488166710066349
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,VSNL1,Visinin-like protein 1,13927,0.0300408986410884,0.0433447537984814,-0.0549148188039352,0.114996616086112,0.488277914191173
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GORASP2,Golgi reassembly-stacking protein 2,13913,0.0376908947056685,0.0543958755438481,-0.0689250213602738,0.144306810771611,0.488383972865849
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CCL17,C-C motif chemokine 17,16059,-0.0709679206472553,0.10246976798283,-0.271808665893601,0.129872824599091,0.488586810456888
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL7R,Interleukin-7 receptor subunit alpha,16101,-0.0407337066657865,0.0588389515327335,-0.156058051669944,0.0745906383383712,0.488764272286552
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,COL4A4,Collagen alpha-4(IV) chain,13688,-0.0426103498274352,0.06160471891976,-0.163355598910165,0.0781348992552944,0.489154153320389
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TRIM40,E3 ubiquitin ligase TRIM40,13590,0.0578427101294035,0.0837879669585006,-0.106381705109258,0.222067125368065,0.489988260872613
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,QPCT,Glutaminyl-peptide cyclotransferase,16137,-0.0209300112299777,0.0303836712934382,-0.0804820069651166,0.0386219845051612,0.490923037479516
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MANSC1,MANSC domain-containing protein 1,16118,0.0216845504708354,0.0314842397349631,-0.0400245594096923,0.0833936603513631,0.490994918314302
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PON1,Serum paraoxonase/arylesterase 1,13982,0.0200048083948662,0.0290774758012577,-0.036987044175599,0.0769966609653314,0.491474925129236
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,VWF,von Willebrand factor,16301,0.0564303011483413,0.0821309937439313,-0.104546446589764,0.217407048886447,0.492044109824368
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CDH6,Cadherin-6,16102,0.0293075181653088,0.0428280406145476,-0.0546354414392046,0.113250477769822,0.493791329525298
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,13532,0.0275340986155616,0.040297437496176,-0.0514488788769433,0.106517076108067,0.494446883635282
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FABP1,"Fatty acid-binding protein, liver",16076,0.0715264134295024,0.104863517807915,-0.134006081474011,0.277058908333015,0.4951915379749
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SHISA5,Protein shisa-5,13972,0.0193885579312368,0.0284531872582631,-0.036379689094959,0.0751568049574325,0.495617363940046
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CTAG1A_CTAG1B,Cancer/testis antigen 1,13678,-0.0393354284065853,0.0577741979138922,-0.152572856317814,0.0739019995046434,0.495979416020345
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AZU1,Azurocidin,15634,-0.062922554242863,0.0924401754391832,-0.244105298103662,0.118260189617936,0.49608151193049
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,13474,0.0431603007653433,0.063663573268761,-0.0816203028414283,0.167940904372115,0.497819219999234
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CASP10,Caspase-10,15688,0.0540649573134723,0.0797787745050994,-0.102301440716523,0.210431355343467,0.497980817969405
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NTF3,Neurotrophin-3,16073,0.0267116130568984,0.0395032528664584,-0.05071476256136,0.104137988675157,0.49893122910021
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FCRL2,Fc receptor-like protein 2,16200,-0.0372537868944552,0.0551208575315599,-0.145290667656313,0.0707830938674023,0.49914144838403
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EVI2B,Protein EVI2B,13480,-0.0304582623719257,0.0450785320405881,-0.118812185171478,0.0578956604276269,0.499261076585927
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GP5,Platelet glycoprotein V,13684,0.0278566504011009,0.0412358903191498,-0.0529656946244328,0.108678995426635,0.499341754967337
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LZTFL1,Leucine zipper transcription factor-like protein 1,13684,0.0550817406973113,0.0815408424969015,-0.104738310596616,0.214901791991238,0.499362555236533
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SLK,STE20-like serine/threonine-protein kinase,13710,0.0616633473220274,0.0913583440340814,-0.117399006984772,0.240725701628827,0.499711741822196
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,POMC,Pro-opiomelanocortin,13610,0.0536693832460749,0.0796461493906064,-0.102437069559514,0.209775836051664,0.500419531583196
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,13474,-0.0459749453689995,0.0682874412322391,-0.179818330184188,0.0878684394461891,0.50079585171555
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,C1RL,Complement C1r subcomponent-like protein,13968,0.0148099664075412,0.0220230381248444,-0.0283551883171538,0.0579751211322361,0.501291796253651
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ERI1,3'-5' exoribonuclease 1,13710,-0.0267083183208858,0.0397255319766112,-0.104570360995044,0.0511537243532723,0.501390561971169
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GLOD4,Glyoxalase domain-containing protein 4,16054,0.0269972696789412,0.0401788902052766,-0.0517533551234009,0.105747894481283,0.501640030152726
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PALM2,Paralemmin-2,13927,0.0288482601214423,0.0429357995451152,-0.0553059069869834,0.113002427229868,0.501663018544752
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,THPO,Thrombopoietin,15778,-0.0292270601039539,0.0435611381173048,-0.114606890813871,0.0561527706059635,0.502266388144549
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PFDN4,Prefoldin subunit 4,13480,0.0423103786378203,0.0630707494939301,-0.0813082903702826,0.165929047645923,0.502333997918977
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SERPINF2,Alpha-2-antiplasmin,13717,0.0102738009761796,0.0153207579985305,-0.0197548847009401,0.0403024866532993,0.502499134054109
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GFRA2,GDNF family receptor alpha-2,16008,-0.0160223108329743,0.0238966137412612,-0.0628596737658462,0.0308150520998977,0.502558619278475
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DAB2,Disabled homolog 2,16209,0.084562798329616,0.126174155806124,-0.162738547050387,0.331864143709619,0.502735419172368
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,13552,-0.0263253331127907,0.0393666494721233,-0.103483966078152,0.0508332998525708,0.503684418739329
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DNAJB1,DnaJ homolog subfamily B member 1,16008,0.0660191174824183,0.0988115977216753,-0.127651614052065,0.259689849016902,0.504059449261879
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PLA2G4A,Cytosolic phospholipase A2,16160,0.0662523837471776,0.0991919593981766,-0.128163856673248,0.260668624167604,0.50419362639174
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,APOB,Apolipoprotein B-100,13982,0.0166437717550535,0.0249396333910987,-0.0322379096915,0.065525453201607,0.5045517488477
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,YOD1,Ubiquitin thioesterase OTU1,13486,0.0477187573120543,0.0715051283976643,-0.0924312943473677,0.187868808971476,0.504561723976977
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,16174,0.0319411618688177,0.0478685325929105,-0.0618811620132869,0.125763485750922,0.504610198759816
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,THBS2,Thrombospondin-2,16101,0.028084321143507,0.0421429910016526,-0.054515941219732,0.110684583506746,0.505161502168277
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MOG,Myelin-oligodendrocyte glycoprotein,16209,-0.0246525718975103,0.0370102042998721,-0.0971925723252596,0.047887428530239,0.505355380319274
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HYOU1,Hypoxia up-regulated protein 1,16301,0.0166203254004299,0.0249757819170406,-0.0323322071569697,0.0655728579578295,0.505767239046868
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,16144,0.0427522043488102,0.0643057480042562,-0.0832870617395319,0.168791470437152,0.506170587959943
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",13927,0.0197283726472984,0.0296854786945871,-0.0384551655940923,0.077911910888689,0.506330239197032
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GSTT2B,Glutathione S-transferase theta-2B,13927,0.179638249227613,0.270332493533349,-0.350213438097752,0.709489936552978,0.506375901101779
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RNASE10,Inactive ribonuclease-like protein 10,13610,0.035674499303009,0.0536908734647672,-0.0695596126879347,0.140908611293953,0.506418394362982
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SERPING1,Plasma protease C1 inhibitor,13968,0.0141043846901567,0.0212295363732442,-0.027505506601402,0.0557142759817153,0.506460962067952
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AREG,Amphiregulin,16008,-0.0340092283349092,0.0512039235250951,-0.134368918444096,0.0663504617742772,0.506577108249753
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,REG3A,Regenerating islet-derived protein 3-alpha,16301,-0.0465354871755067,0.0701188643197394,-0.183968461242196,0.0908974868911825,0.506913672513581
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TIMP1,Metalloproteinase inhibitor 1,15938,0.021182234092257,0.0319833465206223,-0.0415051250881626,0.0838695932726767,0.507795299012485
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SERPINA7,Thyroxine-binding globulin,13992,-0.0138852510482499,0.0209792588890125,-0.0550045984707144,0.0272340963742145,0.508074341526585
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FURIN,Furin,16118,-0.0251906221990927,0.0382113272898361,-0.100084823687171,0.049703579288986,0.509747952382887
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TPM3,Tropomyosin alpha-3 chain,13486,-0.0337706896760391,0.0513695467066049,-0.134455001220985,0.0669136218689065,0.510930607161722
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,13486,0.0504505808644879,0.0767903890637717,-0.100058581700505,0.20095974342948,0.511198040549943
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ELOA,Elongin-A,16008,-0.0403058845335971,0.0613595793567575,-0.160570660072842,0.0799588910056475,0.51126748808718
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SMAD2,Mothers against decapentaplegic homolog 2,13894,0.0522693810602403,0.0795833035688076,-0.103713893934623,0.208252656055103,0.511327950317363
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,OTUD6B,Deubiquitinase OTUD6B,13913,0.0437189604523494,0.06672747997756,-0.0870669003036683,0.174504821208367,0.512358370096967
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,C7orf50,Uncharacterized protein C7orf50,13927,-0.0170042050972313,0.0259841750698673,-0.0679331882341713,0.0339247780397086,0.51286096238295
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD33,Myeloid cell surface antigen CD33,16118,0.05948522756804,0.0909571860989747,-0.11879085718595,0.23776131232203,0.513126613307245
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SDC4,Syndecan-4,16102,-0.0341742416454732,0.0522667233160624,-0.136617019344956,0.0682685360540091,0.513222176189694
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PPT1,Palmitoyl-protein thioesterase 1,13590,-0.0572647078131818,0.0876341982866525,-0.229027736455021,0.114498320828657,0.513476243742865
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,15591,-0.0628725582526072,0.0962676317628969,-0.251557116507885,0.125812000002671,0.513700326686946
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CEP290,Centrosomal protein of 290 kDa,13710,0.0394509844757957,0.0605591323113692,-0.079244914854488,0.158146883806079,0.514769768446578
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",13927,-0.0412129567039854,0.0633425661891008,-0.165364386434623,0.0829384730266521,0.515292201223484
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,16073,-0.109121042762487,0.16772304450818,-0.437858209998519,0.219616124473546,0.515312382797876
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,S100A11,Protein S100-A11,15965,-0.0357332733984424,0.0549790679148113,-0.143492246511472,0.0720256997145877,0.515738247427431
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FGF7,Fibroblast growth factor 7,13480,-0.0590732295116722,0.0910369981293318,-0.237505745845162,0.119359286821818,0.516418898910894
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,C8B,Complement component C8 beta chain,13992,0.0220644908608065,0.0340369410296714,-0.0446479135573495,0.0887768952789625,0.516833082841964
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,WDR46,WD repeat-containing protein 46,13894,-0.0276215962785518,0.0426259393604429,-0.11116843742502,0.0559252448679162,0.516995857433896
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL10RA,Interleukin-10 receptor subunit alpha,15826,0.0445626106010891,0.0688639761024328,-0.0904107825596792,0.179536003761857,0.517569743210467
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,13552,-0.0351730948138802,0.0543543180105627,-0.141707558114583,0.0713613684868228,0.517573248340482
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PLA2G10,Group 10 secretory phospholipase A2,15950,0.0434102802202748,0.0671561533998425,-0.0882157804434166,0.175036340883966,0.518024417483558
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CCND2,G1/S-specific cyclin-D2,13710,0.0276434191696169,0.0427662218428317,-0.0561783756423333,0.111465213981567,0.518041263691718
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GZMH,Granzyme H,15778,-0.0572125045315679,0.0885319593550597,-0.230735144867485,0.116310135804349,0.518136190160786
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TEK,Angiopoietin-1 receptor,16118,-0.0161706782796863,0.0250274204094227,-0.0652244222821548,0.0328830657227822,0.518211849446099
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FLT4,Vascular endothelial growth factor receptor 3,16118,-0.0248604470167564,0.0384778355778349,-0.100277004749313,0.0505561107158,0.518225191286781
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",16164,0.0531398459435883,0.0823570252393949,-0.108279923525626,0.214559615412802,0.518782415878813
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FUCA1,Tissue alpha-L-fucosidase,16208,0.0599180371337129,0.0928635766797133,-0.122094573158525,0.241930647425951,0.518789580372509
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ACE2,Angiotensin-converting enzyme 2,15778,0.037389432347063,0.0579889094072562,-0.0762688300911591,0.151047694785285,0.51908648637332
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL20,Interleukin-20,15826,0.0383465134466684,0.059593294394736,-0.0784563435670141,0.155149370460351,0.519928329417115
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NAAA,N-acylethanolamine-hydrolyzing acid amidase,15885,-0.0430432832866474,0.0669561348763143,-0.174277307644224,0.0881907410709287,0.520325566714619
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FGFBP3,Fibroblast growth factor-binding protein 3,13927,0.0272241258251983,0.0423801749227831,-0.0558410170234565,0.110289268673853,0.52063784714257
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HHEX,Hematopoietically-expressed homeobox protein HHEX,13927,0.0558978452543883,0.0870371492487631,-0.114694967273187,0.226490657781964,0.52073461101868
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RP2,Protein XRP2,16008,0.0308635091609964,0.0480749820161103,-0.0633634555905797,0.125090473912573,0.520890882996022
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NPTN,Neuroplastin,15724,-0.0591254479307728,0.0920988272346924,-0.23963914931077,0.121388253449224,0.520896644045923
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GC,Vitamin D-binding protein,13992,0.0186086561961966,0.0289865835516492,-0.0382050475650359,0.075422359957429,0.52090007247958
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FOSB,Protein fosB,15688,0.0279956759691124,0.0436270248392811,-0.0575132927158786,0.113504644654103,0.521074185635711
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SAG,S-arrestin,13474,0.0374625659227532,0.058439983078374,-0.0770798009108598,0.152004932756366,0.52150539490647
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SERPINI1,Neuroserpin,13654,-0.0220693985950807,0.0344400171641876,-0.0895718322368884,0.0454330350467269,0.521658953356722
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD48,CD48 antigen,16132,-0.0214383576631379,0.0334573482962316,-0.0870147603237519,0.044138044997476,0.521683322609738
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FAS,Tumor necrosis factor receptor superfamily member 6,16251,-0.0244586400324247,0.0382125275548193,-0.0993551940398706,0.0504379139750212,0.522137015932305
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FNDC1,Fibronectin type III domain-containing protein 1,13927,-0.0339455279989736,0.0531646235307476,-0.138148190119239,0.0702571341212918,0.523159793483015
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,A1BG,Alpha-1B-glycoprotein,13992,0.0124374558317857,0.0194862515985257,-0.0257555973013247,0.0506305089648962,0.523309528360914
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SPINT1,Kunitz-type protease inhibitor 1,16041,0.0184260346131404,0.0289118458468161,-0.0382411832466191,0.0750932524728999,0.523926948493714
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PCDH17,Protocadherin-17,16102,-0.0257549312476717,0.0404180483949091,-0.104974306101694,0.0534644436063502,0.523994769542468
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD99,CD99 antigen,16101,0.0139689992055097,0.0219272902681622,-0.0290084897200882,0.0569464881311077,0.524094837427567
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,15733,0.0563735111185991,0.0885623411464201,-0.117208677528384,0.229955699765582,0.524433503855342
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD3E,T-cell surface glycoprotein CD3 epsilon chain,13710,0.0251281807816138,0.0395317801090856,-0.0523541082321939,0.102610469795421,0.525018412638982
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MIA,Melanoma-derived growth regulatory protein,16118,-0.0266991354725803,0.0420495998195871,-0.109116351118971,0.0557180801738103,0.525474046922934
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KIAA1549L,UPF0606 protein KIAA1549L,13710,0.0211333429319731,0.0333231387947539,-0.0441800091057446,0.0864466949696907,0.52596465324211
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,VWC2,Brorin,15899,-0.0285010441200655,0.0449431803611452,-0.11658967762791,0.0595875893877791,0.525987328801589
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TREM2,Triggering receptor expressed on myeloid cells 2,16076,0.0367711493619792,0.0579974222036706,-0.0769037981572151,0.150446096881173,0.526081032490171
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EPHB6,Ephrin type-B receptor 6,15925,-0.0227985238610812,0.035963284265845,-0.0932865610221374,0.0476895132999751,0.526129829029355
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,13474,-0.0456996166302648,0.07221884970869,-0.187248562059297,0.0958493287987675,0.526879270272365
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ITGB1BP2,Integrin beta-1-binding protein 2,15778,0.0799671404510721,0.126429294063547,-0.16783427591348,0.327768556815624,0.527066220376754
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AK2,"Adenylate kinase 2, mitochondrial",13927,0.0767219064281203,0.121340736453645,-0.161105937021024,0.314549749877264,0.527211167089425
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL1RAP,Interleukin-1 receptor accessory protein,16101,-0.0314415436473303,0.0497382434930651,-0.128928500893738,0.0660454135990773,0.527304246369733
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,13974,0.0521684443283271,0.0825706189130143,-0.109669968741181,0.214006857397835,0.527525328959568
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ROBO2,Roundabout homolog 2,16230,-0.0164272861621723,0.0260055648146121,-0.067398193198812,0.0345436208744674,0.527602617402794
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,STX16,Syntaxin-16,15724,0.042143627189775,0.0667407184948319,-0.0886681810600956,0.172955435439646,0.527753555792029
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ASS1,Argininosuccinate synthase,13486,-0.0565175444542657,0.0895904190352088,-0.232114765763275,0.119079676854743,0.528153479159752
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SEMA6C,Semaphorin-6C,13552,-0.0189025645390502,0.0299816219045691,-0.0776665434720055,0.0398614143939052,0.528396645880205
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,13982,0.0297082543579039,0.0471438910089199,-0.0626937720195791,0.122110280735387,0.52859938274605
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,16272,0.0701428746603219,0.111401756896878,-0.148204568857558,0.288490318178202,0.528939743797934
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD84,SLAM family member 5,16073,0.0222616100643684,0.0353672620863993,-0.0470582236249742,0.0915814437537111,0.529069240316917
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GPR101,Probable G-protein coupled receptor 101,13474,-0.0429152851752845,0.0682382170787949,-0.176662190649723,0.0908316202991535,0.529422603603843
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LRRC37A2,Leucine-rich repeat-containing protein 37A2,13913,0.0309313736971621,0.0491870275128587,-0.0654752002280409,0.127337947622365,0.529456113418378
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD101,Immunoglobulin superfamily member 2,13913,0.0302030640423463,0.0480613496050081,-0.0639971811834695,0.124403309268162,0.529734385663363
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PLIN1,Perilipin-1,15688,-0.0244397084934184,0.0388932095588677,-0.100670399228799,0.0517909822419624,0.529764301611701
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,16160,0.0303754480722716,0.0483400746441232,-0.0643710982302098,0.125121994374753,0.529770535951233
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NT5C3A,Cytosolic 5'-nucleotidase 3A,16046,0.0615531060237841,0.0980280952803805,-0.130581960725762,0.25368817277333,0.530069940692021
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CHM,Rab proteins geranylgeranyltransferase component A 1,13590,0.0440681332303498,0.0702168908653551,-0.0935569728657462,0.181693239326446,0.530276447405931
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD70,CD70 antigen,16073,0.0298440267275628,0.0476349046301417,-0.0635203863475149,0.123208439802641,0.53098549489483
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GPR158,Probable G-protein coupled receptor 158,13946,0.02590675322513,0.0413589396429161,-0.0551567684749854,0.106970274925245,0.531070586712449
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PRDX2,Peroxiredoxin-2,13744,0.0443783768697299,0.0708608577825649,-0.0945089043840973,0.183265658123557,0.531145055825068
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PTPRB,Receptor-type tyrosine-protein phosphatase beta,13974,0.02072401050067,0.0330917674492039,-0.0441358536997696,0.0855838747011096,0.531155446117787
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ESAM,Endothelial cell-selective adhesion molecule,16301,0.0224229933781387,0.0358267084411951,-0.0477973551666036,0.092643341922881,0.53140657831321
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RNASET2,Ribonuclease T2,16231,0.0186762950824709,0.0298540670100565,-0.0398376762572399,0.0771902664221817,0.531595135663499
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EHD3,EH domain-containing protein 3,13610,0.0826725943628444,0.132416147687983,-0.176863055105602,0.342208243831291,0.532415307962021
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HTR1B,5-hydroxytryptamine receptor 1B,13474,-0.0305288373282835,0.0489043992387118,-0.126381459836159,0.0653237851795916,0.532470422084444
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CFC1,Cryptic protein,15724,-0.0336485830456334,0.0539175202526111,-0.139326922740751,0.0720297566494843,0.532587312776401
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CDC27,Cell division cycle protein 27 homolog,15724,0.043278752799301,0.0694539175630641,-0.0928509256243046,0.179408431222907,0.533208775047702
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,13974,0.0544456614321251,0.0875346953968297,-0.117122341545661,0.226013664409911,0.533958930060544
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KLK8,Kallikrein-8,15486,0.0261196001318053,0.0420837727564168,-0.0563645944707716,0.108603794734382,0.534834282096724
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NRN1,Neuritin,13946,-0.0244332520222975,0.0394540300382447,-0.101763150897257,0.052896646852662,0.535739367914816
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD226,CD226 antigen,13552,0.0293704209257926,0.0474346344198577,-0.0636014625371285,0.122342304388714,0.535810371331501
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",13552,-0.0333374538933486,0.0538630859785325,-0.138909102411272,0.072234194624575,0.535973205255312
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PPP1R2,Protein phosphatase inhibitor 2,16102,0.0565953319408282,0.0915053858914869,-0.122755224406486,0.235945888288143,0.536259949670499
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IMPACT,Protein IMPACT,13927,0.0393885484841852,0.0637894802588452,-0.0856388328231514,0.164415929791522,0.536930133163127
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ITGA2,Integrin alpha-2,13684,0.0239695915892969,0.0388201454324529,-0.0521178934583107,0.100057076636904,0.536946659713266
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DLL1,Delta-like protein 1,16118,0.0208964905762699,0.0338790820441166,-0.0455065102301986,0.0872994913827384,0.537377848759681
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CA9,Carbonic anhydrase 9,16209,-0.0314840757720118,0.0510655995337318,-0.131572650858126,0.0686044993141025,0.537545670547833
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FGL1,Fibrinogen-like protein 1,13982,-0.0444768090633982,0.072145954008876,-0.185882878920795,0.0969292607939987,0.537585333266931
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ESM1,Endothelial cell-specific molecule 1,16076,0.023847555851536,0.0387144633805051,-0.052032792374254,0.0997279040773261,0.537912686159582
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NCAM1,Neural cell adhesion molecule 1,16174,-0.0210964634817831,0.0343098277532776,-0.0883437258782072,0.0461507989146411,0.538641925061648
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HIP1,Huntingtin-interacting protein 1,13486,-0.0231945396758516,0.0377219939094183,-0.0971296477383114,0.0507405683866082,0.538643655456217
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NRP1,Neuropilin-1,16205,0.0192975947767525,0.0313931504377936,-0.042232980081323,0.0808281696348279,0.538756759702947
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,STC1,Stanniocalcin-1,16230,-0.0298012044713433,0.0484816998984021,-0.124825336272211,0.0652229273295248,0.538768248303578
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LTA,Lymphotoxin-alpha,16073,0.0276155964026426,0.0449281436033754,-0.0604435650599732,0.115674757865258,0.53878705377422
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PDIA2,Protein disulfide-isomerase A2,13480,-0.0283018397407354,0.0460452261918511,-0.118550483076764,0.0619468035952927,0.538794242440368
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SELL,L-selectin,13992,0.0160810031233575,0.0261686548718745,-0.0352095604255164,0.0673715666722315,0.538885768563911
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CLEC4M,C-type lectin domain family 4 member M,13947,0.0338004076766244,0.0550681962766991,-0.0741332570257058,0.141734072378955,0.539362932876811
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BCL7B,B-cell CLL/lymphoma 7 protein family member B,13894,0.0320382258240109,0.0521996231841001,-0.0702730356168253,0.134349487264847,0.5393816480152
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CCN3,CCN family member 3,16271,-0.0230995846993921,0.0377408746672097,-0.0970716990471231,0.050872529648339,0.540508287045257
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,USO1,General vesicular transport factor p115,16008,0.0624301036311859,0.102042684054596,-0.137573557115821,0.262433764378193,0.540676260124041
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RANBP2,E3 SUMO-protein ligase RanBP2,13474,0.0235155639066959,0.0384513919311674,-0.0518491642783923,0.098880292091784,0.540835268558034
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MRPS16,"28S ribosomal protein S16, mitochondrial",13552,-0.0198917759297645,0.0326091774479529,-0.083805763727752,0.0440222118682231,0.541868436591527
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,15826,-0.0295428618506881,0.0485055347823528,-0.1246137100241,0.0655279863227233,0.542492315303053
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,COL2A1,Collagen alpha-1(II) chain,13610,0.0546684766293554,0.0900095834970764,-0.121750307024914,0.231087260283625,0.5436202841387
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TG,Thyroglobulin,13894,-0.0779480944304393,0.128396855869334,-0.329605931934334,0.173709743073455,0.543802940023997
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CLIP2,CAP-Gly domain-containing linker protein 2,16073,0.0769423114698398,0.126864608192586,-0.171712320587629,0.325596943527309,0.544196972267111
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TNR,Tenascin-R,15950,-0.0286692837822363,0.0473147255246716,-0.121406145810593,0.0640675782461199,0.54457166155636
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,13946,0.0336759933331415,0.0557360039743352,-0.0755665744565555,0.142918561122838,0.545716944467644
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CDK1,Cyclin-dependent kinase 1,13480,0.025387528255721,0.0420527371181836,-0.0570358364959188,0.107810893007361,0.546048683988547
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,WAS,Wiskott-Aldrich syndrome protein,15826,0.0461774995833503,0.076531549526156,-0.103824337487915,0.196179336654616,0.546265506755524
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NIT1,Deaminated glutathione amidase,13610,0.0320503159536084,0.0532102204527791,-0.0722417161338386,0.136342348041055,0.546961990392463
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SPTLC1,Serine palmitoyltransferase 1,13927,-0.0254318349209163,0.042370671073142,-0.108478350224275,0.057614680382442,0.5483676608808
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EFNA1,Ephrin-A1,16065,0.018829167358407,0.0314379633983516,-0.0427892409023623,0.0804475756191762,0.549227424780029
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD6,T-cell differentiation antigen CD6,16248,0.035399732681229,0.0591395188941877,-0.0805137243513789,0.151313189713837,0.549461353877099
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BRME1,Break repair meiotic recombinase recruitment factor 1,13474,-0.0272473614987321,0.0455458522298871,-0.116517231869311,0.0620225088718466,0.549689711901545
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KLRF1,Killer cell lectin-like receptor subfamily F member 1,13552,-0.0298343867533865,0.0498822580409502,-0.127603612513649,0.0679348390068759,0.549785780610131
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RTKN2,Rhotekin-2,13486,0.0347400432872094,0.0581462544314409,-0.0792266153984147,0.148706701972834,0.550210552172802
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KIRREL1,Kin of IRRE-like protein 1,13474,-0.0408161206513638,0.0683526850486901,-0.174787383346796,0.0931551420440688,0.550423974854088
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,15950,0.0706115068134623,0.118394684495465,-0.161442074797649,0.302665088424574,0.550911339200959
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GH2,Growth hormone variant,15724,-0.114255269246167,0.191597397527401,-0.489786168399874,0.261275629907539,0.550963409373287
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SERPINB5,Serpin B5,15778,0.0327119294405632,0.0548998484661799,-0.0748917735531495,0.140315632434276,0.551285760426886
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HEPACAM2,HEPACAM family member 2,13927,-0.0285000711514249,0.0478737272323425,-0.122332576526816,0.0653324342239664,0.551640893523848
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MUC16,Mucin-16,16008,0.126411163544602,0.212405065445282,-0.289902764728149,0.542725091817354,0.551757013464857
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,16073,0.0676208185888809,0.11373866727048,-0.15530696926126,0.290548606439022,0.552167418448773
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL32,Interleukin-32,16073,0.0289313340401316,0.048684108149335,-0.0664895179325649,0.124352186012828,0.552342259530471
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CST1,Cystatin-SN,12109,0.0694063648460573,0.11687563082188,-0.159669871564828,0.298482601256942,0.552624857264607
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,UBQLN3,Ubiquilin-3,13486,0.0338673801367251,0.0570349220075595,-0.0779210669980915,0.145655827271542,0.552655349285239
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,16093,0.0156705389365231,0.0264200291841822,-0.0361127182644741,0.0674537961375203,0.553101812484393
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GRAP2,GRB2-related adapter protein 2,16102,0.0867820132758898,0.146374469716538,-0.200111947368524,0.373675973920303,0.553272002551704
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CPXM1,Probable carboxypeptidase X1,16118,0.0463512717872541,0.0782812879987902,-0.107080052690375,0.199782596264883,0.553784060265862
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CRHBP,Corticotropin-releasing factor-binding protein,16076,0.0184308591083717,0.0311311007944313,-0.0425860984487136,0.079447816665457,0.553832089357704
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TPP1,Tripeptidyl-peptidase 1,15976,0.0306937869450864,0.0519061639794758,-0.0710422944546863,0.132429868344859,0.554306221946061
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,16227,0.0232893214664848,0.0394065877595099,-0.0539475905421546,0.100526233475124,0.554528181834356
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AMFR,E3 ubiquitin-protein ligase AMFR,15688,0.0426333982566804,0.0722916784080798,-0.0990582914231561,0.184325087936517,0.555372511431306
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",15663,0.0312212499293099,0.0529978310430641,-0.0726544989150958,0.135096998773716,0.555799815553256
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CXCL13,C-X-C motif chemokine 13,16230,-0.0400794687826317,0.0681772211927532,-0.173706822320428,0.0935478847551646,0.556626502322181
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,15778,0.0371032772487767,0.0631153753707791,-0.0866028584779503,0.160809412975504,0.556631787683855
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SDK2,Protein sidekick-2,13684,-0.0260274909825908,0.0443428534382509,-0.112939483721563,0.060884501756381,0.557240117406057
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TINAGL1,Tubulointerstitial nephritis antigen-like,16056,0.0146138775819045,0.0248985176143824,-0.0341872169422851,0.063414972106094,0.557253837645448
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ANKRD54,Ankyrin repeat domain-containing protein 54,15724,0.0386511132281648,0.0658821785219471,-0.0904779566748515,0.167780183131181,0.557433630959912
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PROCR,Endothelial protein C receptor,13486,-0.0227427871514165,0.0387699030933395,-0.0987317972143619,0.053246222911529,0.557475939232083
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PCSK7,Proprotein convertase subtilisin/kexin type 7,13894,-0.0301197163592782,0.0513609226713257,-0.130787124795077,0.0705476920765201,0.557594418938406
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HARS1,"Histidine--tRNA ligase, cytoplasmic",16101,0.0510533420539901,0.0871264103976317,-0.119714422325368,0.221821106433348,0.557904826411041
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LEPR,Leptin receptor,16102,0.0209680073285124,0.0358083471270693,-0.0492163530405434,0.0911523676975683,0.558178104944615
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL21R,Interleukin-21 receptor,13552,0.0356788303844513,0.0609492388057586,-0.0837816776748355,0.155139338443738,0.558297965302939
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,13480,-0.0552875285473869,0.0946770781914862,-0.2408546018027,0.130279544707926,0.559257702078702
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KLF4,Krueppel-like factor 4,13474,0.026375447652216,0.0452046317069598,-0.0622256304934252,0.114976525797857,0.559588194082152
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GSTA1,Glutathione S-transferase A1,16073,0.0559935494573204,0.0960179881378576,-0.13220170729288,0.244188806207521,0.559795891270031
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CASP3,Caspase-3,16301,0.0580776873509206,0.0996129497283884,-0.137163694116721,0.253319068818562,0.559878816795237
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EDAR,Tumor necrosis factor receptor superfamily member EDAR,16073,-0.0597848074590768,0.102733417149681,-0.261142305072452,0.141572690154299,0.560614460742068
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MYL6B,Myosin light chain 6B,13590,-0.0637427764820835,0.109570562020828,-0.278501078042906,0.151015525078739,0.560744119346449
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EIF4B,Eukaryotic translation initiation factor 4B,15950,0.0375460943861282,0.0645497474579201,-0.0889714106313952,0.164063599403652,0.56080302563233
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GIPR,Gastric inhibitory polypeptide receptor,13552,0.0309191575740092,0.0531618824981473,-0.0732781321223596,0.135116447270378,0.560843206787797
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SLC28A1,Sodium/nucleoside cotransporter 1,13480,0.0402907339279749,0.0692805050583407,-0.0954990559863729,0.176080523842323,0.560873182944128
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,13710,0.0761192852846988,0.131087952481926,-0.180813101579877,0.333051672149274,0.561470155718261
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MBL2,Mannose-binding protein C,13789,-0.0710233886843714,0.122321220840834,-0.310772981532406,0.168726204163664,0.561499246637392
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LARP1,La-related protein 1,13894,0.0417765818780228,0.0719855923146962,-0.0993151790587817,0.182868342814827,0.561690440494824
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DNER,Delta and Notch-like epidermal growth factor-related receptor,16053,-0.0168021496491144,0.0290023093130181,-0.0736466759026298,0.040042376604401,0.562369038787429
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PTS,6-pyruvoyl tetrahydrobiopterin synthase,15618,0.0359750311147543,0.0621441778373302,-0.0858275574464129,0.157777619675921,0.562667540798773
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HCLS1,Hematopoietic lineage cell-specific protein,16272,0.0361653423066939,0.0624764126975935,-0.0862884265805894,0.158619111193977,0.562689003710371
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PTK7,Inactive tyrosine-protein kinase 7,15688,0.0243842854695972,0.0422667041672669,-0.058458454698246,0.10722702563744,0.564005324872824
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL7,Interleukin-7,16073,0.0420873442941708,0.0730326158002178,-0.101056582674256,0.185231271262598,0.564433011709903
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MAX,Protein max,15688,0.0676437746121858,0.117477580163704,-0.162612282508674,0.297899831733045,0.564757581687714
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MEGF11,Multiple epidermal growth factor-like domains protein 11,13486,-0.0217963780385859,0.0378814582623798,-0.0960440362328502,0.0524512801556785,0.565041356277761
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CHGA,Chromogranin-A,13972,-0.0567316348388822,0.0986311312183707,-0.250048652026889,0.136585382349124,0.565172114483689
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BATF,Basic leucine zipper transcriptional factor ATF-like,13590,-0.0577111208982401,0.100441515335989,-0.254576490956778,0.139154249160298,0.56558870706149
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FXN,"Frataxin, mitochondrial",16209,0.0474262978871895,0.0827660709256138,-0.114795201127014,0.209647796901393,0.566641693624612
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GHRHR,Growth hormone-releasing hormone receptor,15688,-0.035822351406981,0.0625265523071655,-0.158374393929025,0.0867296911150633,0.566710989243101
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PRL,Prolactin,16230,-0.048351969059602,0.0844020067353117,-0.213779902260813,0.117075964141609,0.566735916451285
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ATP1B4,Protein ATP1B4,13480,-0.027226359478093,0.0475766996436527,-0.120476690779652,0.0660239718234662,0.567153726942689
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,13710,-0.0561581701997468,0.0984031939932074,-0.249028430426433,0.13671209002694,0.568216051162932
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PROS1,Vitamin K-dependent protein S,13992,0.0160885757303287,0.0282060351752178,-0.0391952532130982,0.0713724046737556,0.568419125430885
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RBFOX3,RNA binding protein fox-1 homolog 3,13946,0.0249040848629269,0.0436696842485336,-0.0606884962641989,0.110496665990053,0.568494867500667
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ATP2B4,Plasma membrane calcium-transporting ATPase 4,13486,-0.0409751102236204,0.0721351052559397,-0.182359916525262,0.100409696078021,0.57002212150329
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,13486,-0.0237955449641253,0.0419312824410495,-0.105980858548582,0.0583897686203318,0.570391398689548
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PROC,Vitamin K-dependent protein C,16155,0.0164706274497861,0.0290534576705582,-0.0404741495845081,0.0734154044840802,0.570784808696238
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CSTB,Cystatin-B,15863,0.0278441935578769,0.0491535078244367,-0.068496681778019,0.124185068893773,0.571079494360035
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GYS1,"Glycogen [starch] synthase, muscle",15778,0.058765073535258,0.103741494478305,-0.14456825564222,0.262098402712736,0.571091365682418
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD163,Scavenger receptor cysteine-rich type 1 protein M130,16174,0.0276135179890018,0.0487565404800047,-0.0679493013518075,0.123176337329811,0.571160239135399
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,VIT,Vitrin,13974,-0.0238462808694807,0.0421332675414163,-0.106427485250657,0.0587349235116953,0.571421409080342
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SCLY,Selenocysteine lyase,16164,0.0306181184773748,0.0541450159578685,-0.0755061128000475,0.136742349754797,0.571752732618007
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PDAP1,28 kDa heat- and acid-stable phosphoprotein,13974,0.0621326944184292,0.109921119034251,-0.153312698888702,0.27757808772556,0.571914165338494
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SERPINF1,Pigment epithelium-derived factor,13782,0.0167221898190257,0.0295858854658705,-0.0412661456940804,0.0747105253321319,0.571941260275987
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KLB,Beta-klotho,15688,-0.0469959570863424,0.0831831695368434,-0.210034969378556,0.116043055205871,0.572102567733039
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TFPI2,Tissue factor pathway inhibitor 2,16070,0.0245553834633086,0.0434712296583309,-0.0606482266670199,0.109758993593637,0.572173368465768
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MMP15,Matrix metalloproteinase-15,13974,-0.0321197748780815,0.0568767998370798,-0.143598302558758,0.0793587528025949,0.572269612808632
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MORN4,MORN repeat-containing protein 4,13480,-0.0512868159353302,0.0909025919951623,-0.229455896245848,0.126882264375188,0.57263061675914
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,JPT2,Jupiter microtubule associated homolog 2,13913,0.0563094173610641,0.099825174558209,-0.139347924773026,0.251966759495154,0.572708565874245
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IGFBP1,Insulin-like growth factor-binding protein 1,16267,-0.0766382152779435,0.135908753754293,-0.343019372636358,0.189742942080471,0.57283363092262
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GPKOW,G-patch domain and KOW motifs-containing protein,15688,-0.0186014518935793,0.0330176136315068,-0.0833159746113325,0.046113070824174,0.573184444728435
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LAMTOR5,Ragulator complex protein LAMTOR5,13894,0.0268300706277561,0.0477166104178761,-0.0666944857912811,0.120354627046793,0.573934700815713
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PRDX5,"Peroxiredoxin-5, mitochondrial",16272,0.0428013195046692,0.0761311053859352,-0.106415647051764,0.192018286061102,0.573983825045205
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EPHX2,Bifunctional epoxide hydrolase 2,15778,0.0391723626051016,0.0696884601255779,-0.097417019241031,0.175761744451234,0.574051196023355
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NAA80,N-alpha-acetyltransferase 80,13590,0.0784951186790603,0.139697349806711,-0.195311686942092,0.352301924300213,0.574197439883739
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,COPE,Coatomer subunit epsilon,15688,-0.0284758233009634,0.0507224195776347,-0.127891765673127,0.0709401190712006,0.574529457722266
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HRG,Histidine-rich glycoprotein,13919,0.0200336653754697,0.0356946469592443,-0.049927842664649,0.0899951734155885,0.574635311417718
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CCL18,C-C motif chemokine 18,15887,-0.0452027171253669,0.0805536156182427,-0.203087803737123,0.112682369486389,0.574702735074261
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TET2,Methylcytosine dioxygenase TET2,13686,-0.0642046828146374,0.114464712552312,-0.28855551941717,0.160146153787895,0.574866411777992
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CLIC5,Chloride intracellular channel protein 5,13590,0.0207083450722313,0.0369482773252487,-0.0517102784852561,0.0931269686297187,0.575169177584335
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DMP1,Dentin matrix acidic phosphoprotein 1,13610,0.0387145094383908,0.0690916627745163,-0.0967051495996613,0.174134168476443,0.57525986941971
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,STOML2,"Stomatin-like protein 2, mitochondrial",13480,-0.0603035583150629,0.107627173104948,-0.271252817600761,0.150645700970635,0.575283811131296
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GLYR1,Putative oxidoreductase GLYR1,13894,0.0384404647010984,0.0687752335380442,-0.0963589930334683,0.173239922435665,0.57621927140317
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,13913,0.0139982170769883,0.0251373191670632,-0.0352709284904556,0.0632673626444322,0.577625269515212
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RAB39B,Ras-related protein Rab-39B,13486,-0.0578968496718671,0.104300295784917,-0.262325429410305,0.146531730066571,0.578837082478341
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ATF4,Cyclic AMP-dependent transcription factor ATF-4,13480,0.0220917336209191,0.0398127493901707,-0.0559412551838154,0.100124722425654,0.578978480976568
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MANF,Mesencephalic astrocyte-derived neurotrophic factor,16160,0.0749379731107912,0.135434452586784,-0.190513553959305,0.340389500180887,0.580055094576168
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",13913,0.09291356663444,0.167929076870509,-0.236227424031758,0.422054557300638,0.580073389255126
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SH2B3,SH2B adapter protein 3,15724,0.0618736013790541,0.111855120680403,-0.157362435154535,0.281109637912643,0.580162810183262
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,INHBC,Inhibin beta C chain,16101,0.025882824498674,0.0468062644286282,-0.0658574537814373,0.117623102778785,0.580286304894085
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ITGB5,Integrin beta-5,16118,0.0236813683980247,0.0428277859527317,-0.0602610920693296,0.107623828865379,0.580309414240368
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MORF4L1,Mortality factor 4-like protein 1,13710,-0.0263909593874664,0.0477408812826142,-0.11996308670139,0.0671811679264575,0.580412256196484
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KLK10,Kallikrein-10,16063,-0.0249102075333002,0.0450946832616717,-0.113295786726177,0.0634753716595764,0.580683473922956
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GIP,Gastric inhibitory polypeptide,13610,0.0323531996493139,0.0585991844582843,-0.0825012018889234,0.147207601187551,0.580882020267821
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ARSB,Arylsulfatase B,16008,0.0346481436775124,0.0627689738864887,-0.0883790451400054,0.15767533249503,0.580959666837801
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BRAP,BRCA1-associated protein,13783,0.0687806670260338,0.1246383299071,-0.175510459591882,0.31307179364395,0.58106555512874
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SMARCA2,Probable global transcription activator SNF2L2,15688,-0.0446580171097288,0.0809624617702408,-0.203344442179401,0.114028407959943,0.581237721207831
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BTLA,B- and T-lymphocyte attenuator,13480,-0.0552257313118268,0.100168164058743,-0.251555332866964,0.14110387024331,0.581416505188835
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LTO1,Protein LTO1 homolog,15826,0.0267260380744539,0.0484808313820902,-0.068296391434443,0.121748467583351,0.581456246398201
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ECSCR,Endothelial cell-specific chemotaxis regulator,13474,-0.0316166396397147,0.0573562245853149,-0.144034839826932,0.0808015605475025,0.581483159851371
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RAB2B,Ras-related protein Rab-2B,13894,0.0385585389802535,0.0699533006061171,-0.098549930207736,0.175667008168243,0.581502712011798
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",16101,0.0286936623663457,0.0520839483682016,-0.0733908764353295,0.130778201168021,0.581701780383485
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KDM3A,Lysine-specific demethylase 3A,13552,-0.0565671048056289,0.102688100790029,-0.257835782354086,0.144701572742829,0.581736485826302
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DTX2,Probable E3 ubiquitin-protein ligase DTX2,13590,-0.0410220518960197,0.0744968010873942,-0.187035782027312,0.104991678235273,0.581879112402848
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PSMD5,26S proteasome non-ATPase regulatory subunit 5,13590,-0.0339064767021367,0.0618090217404954,-0.155052159313508,0.0872392059092344,0.583310691480772
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,16073,0.0745929532520704,0.136112846442381,-0.192188225774997,0.341374132279138,0.58368381408944
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SDC1,Syndecan-1,16102,0.0245886951354481,0.0448773193992928,-0.0633708508871657,0.112548241158062,0.583761868847409
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PILRB,Paired immunoglobulin-like type 2 receptor beta,16102,-0.0358585124323758,0.0654476994823334,-0.164136003417749,0.0924189785529976,0.583771130176892
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ENO3,Beta-enolase,13610,-0.0371425117766198,0.0678803146086989,-0.17018792840967,0.0959029048564301,0.584266472381415
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GIMAP7,GTPase IMAP family member 7,13684,0.0204916102634851,0.0374619068160576,-0.0529337270959879,0.093916947622958,0.584388628705774
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PADI4,Protein-arginine deiminase type-4,15663,-0.045609306638991,0.0834074572945443,-0.209087922936298,0.117869309658316,0.584506566706862
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ENO2,Gamma-enolase,16230,0.0404378122469582,0.0739603379602686,-0.104524450155168,0.185400074649085,0.584558044786565
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ANG,Angiogenin,16074,0.0208611177624879,0.038186748374489,-0.0539849090515106,0.0957071445764864,0.584872776123086
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DENR,Density-regulated protein,13552,0.0348114583859438,0.0637430934556519,-0.0901250047871339,0.159747921559022,0.584991587288909
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EPHA10,Ephrin type-A receptor 10,15688,0.0397161254910562,0.0727486436955762,-0.102871216152273,0.182303467134386,0.585117493508655
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BCR,Breakpoint cluster region protein,16073,0.0556002907503395,0.101918181088142,-0.144159344182419,0.255359925683098,0.585390791995754
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PRELP,Prolargin,16076,-0.0143374310244455,0.0262823288578782,-0.0658507955858868,0.0371759335369958,0.585406251575087
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,15724,-0.0765860499372297,0.140524533570078,-0.352014135734582,0.198842035860123,0.585760377390395
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CST3,Cystatin-C,16149,0.0172338635178325,0.0316819967041352,-0.0448628500222725,0.0793305770579376,0.586473808771379
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AMIGO2,Amphoterin-induced protein 2,16008,0.0141358318627043,0.0260025458429742,-0.0368291579895252,0.0651008217149338,0.586701891818968
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PDGFB,Platelet-derived growth factor subunit B,16160,0.0528803209145085,0.0972838279271086,-0.137795981822624,0.243556623651641,0.586746678156849
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",13684,0.0642930004366232,0.118293967588607,-0.167563176037047,0.296149176910294,0.586793120755503
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GRP,Gastrin-releasing peptide,13610,-0.0338770861336006,0.0623510613531282,-0.156085166385732,0.0883309941185308,0.586912800990452
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CFP,Properdin,13992,-0.0139152697891704,0.0256335741231572,-0.0641570750705584,0.0363265354922177,0.587239481058075
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NAP1L4,Nucleosome assembly protein 1-like 4,13889,0.0256448905805418,0.0473139509592946,-0.0670904532996756,0.118380234460759,0.58781659339909
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,STIP1,Stress-induced-phosphoprotein 1,16077,0.0400664651302484,0.0739367041009301,-0.104849474907575,0.184982405168071,0.587893374295206
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DBH,Dopamine beta-hydroxylase,13954,0.0658880728145712,0.121591507356448,-0.172431281604066,0.304207427233209,0.587909457813369
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,STX3,Syntaxin-3,13927,-0.0245886130147703,0.0453856893662846,-0.113544564172688,0.0643673381431475,0.587985513453773
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,VCAM1,Vascular cell adhesion protein 1,16155,0.0164052632798532,0.0303190649928869,-0.0430201041062052,0.0758306306659115,0.588454827213249
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MITD1,MIT domain-containing protein 1,15950,0.0591346726378961,0.109413384663728,-0.155315561303011,0.273584906578803,0.588880367955862
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SCARB2,Lysosome membrane protein 2,15638,-0.0188252709936873,0.0348472118189123,-0.0871258061587554,0.0494752641713808,0.589050840447466
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FCRL3,Fc receptor-like protein 3,15826,-0.0336850061604409,0.062438932160464,-0.15606531319495,0.0886953008740686,0.589558306868031
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KLRB1,Killer cell lectin-like receptor subfamily B member 1,16272,0.0227799883980501,0.0422765430586575,-0.0600820359969186,0.105642012793019,0.590009601463101
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,APRT,Adenine phosphoribosyltransferase,15929,0.0288620552091569,0.0535815808762102,-0.0761578433082151,0.133881953726529,0.590131577664874
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PTPRH,Receptor-type tyrosine-protein phosphatase H,13913,-0.029557999765048,0.0549575474646874,-0.137274792795835,0.0781587932657393,0.590700743167323
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CST7,Cystatin-F,16112,-0.0569477312373073,0.105898477456938,-0.264508747052906,0.150613284578291,0.590751709934705
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CTSS,Cathepsin S,12621,-0.0150472237715164,0.027987046639397,-0.0699018351847345,0.0398073876417017,0.590828486778782
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,APOA4,Apolipoprotein A-IV,13992,0.0213438726623335,0.039724111679808,-0.0565153862300902,0.0992031315547573,0.591067090042112
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,OMP,Olfactory marker protein,13474,-0.0297038378609131,0.0554752974698355,-0.138435420901791,0.0790277451799644,0.592352681224193
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CDC37,Hsp90 co-chaperone Cdc37,16118,0.0510962566338186,0.0954602276495757,-0.13600578955935,0.238198302826987,0.592475914441074
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ADH1B,All-trans-retinol dehydrogenase,13684,0.0460755212388395,0.0861439998539489,-0.1227667184749,0.214917760952579,0.592751022516141
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,15688,0.0666380495659653,0.124642726008294,-0.177661693410291,0.310937792542221,0.592911603684644
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CSF2RB,Cytokine receptor common subunit beta,13552,-0.0260321197280157,0.0486979320959253,-0.121480066636029,0.0694158271799978,0.592960753022529
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,16198,-0.0173769523791082,0.0325651896260401,-0.0812047240461467,0.0464508192879304,0.593622083524479
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DEFB116,Beta-defensin 116,13474,-0.04479186320129,0.0839943568943108,-0.209420802714139,0.119837076311559,0.593853910009718
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SCN3A,Sodium channel protein type 3 subunit alpha,13590,0.0229173961329257,0.043002115992749,-0.0613667512128623,0.107201543478714,0.594086277930681
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MENT,Protein MENT,13684,0.0134535296193153,0.0252493988573962,-0.0360352921411813,0.0629423513798119,0.594162875503617
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RHOC,Rho-related GTP-binding protein RhoC,15845,0.0704249932122765,0.132510005334753,-0.18929461724384,0.330144603668393,0.595101101091743
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,13521,-0.0230986057752782,0.0434792816529943,-0.108317997815147,0.0621207862645907,0.595250501383218
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SLC1A4,Neutral amino acid transporter A,13590,-0.031491403392988,0.0593581814702105,-0.147833439074601,0.0848506322886246,0.595751938397921
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KIFBP,KIF-binding protein,16008,0.0496704919000296,0.0937208704910906,-0.134022414262508,0.233363398062567,0.596130898454547
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CEP43,Centrosomal protein 43,15640,0.0412212133706653,0.0778492761302888,-0.111363367844701,0.193805794586031,0.596465973733512
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ATP6AP2,Renin receptor,15724,0.0242897210268436,0.045943178309027,-0.0657589084588493,0.114338350512536,0.597027650585044
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,APOF,Apolipoprotein F,13982,-0.0146087282600729,0.0276320033635892,-0.0687674548527078,0.0395499983325621,0.597029809387759
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CA3,Carbonic anhydrase 3,16267,-0.0366210747266483,0.0692863796270614,-0.172422378795689,0.0991802293423921,0.597127285970035
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,15950,0.0262729617716391,0.0497234839568681,-0.0711850667838224,0.123730990327101,0.59724203445153
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PMCH,Pro-MCH,13486,-0.0498656234926464,0.094399199716829,-0.234888054937631,0.135156807952339,0.597340072291066
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CFI,Complement factor I,13992,0.0119363797262378,0.0226050406037174,-0.0323694998570483,0.0562422593095238,0.597479523268304
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SERPINE2,Glia-derived nexin,13974,0.038089358148978,0.0721794603488742,-0.103382384134815,0.179561100432771,0.597713489217288
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,APOM,Apolipoprotein M,16155,0.0164351238122598,0.0311556433771318,-0.0446299372069185,0.0775001848314381,0.597842036796569
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PCARE,Photoreceptor cilium actin regulator,13474,0.0503672703220229,0.0956355055194119,-0.137078320496024,0.23781286114007,0.598439304178365
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TXK,Tyrosine-protein kinase TXK,13710,-0.0465359237801737,0.088429829985648,-0.219858390552044,0.126786542991696,0.598725193856287
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ESR1,Estrogen receptor,13552,-0.0343417406192053,0.0652674649116843,-0.162265971846106,0.0935824906076959,0.598779155888321
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NME3,Nucleoside diphosphate kinase 3,16107,-0.0137791605321055,0.0261895555155593,-0.0651106893426017,0.0375523682783907,0.598803817984676
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TFF2,Trefoil factor 2,16132,-0.0341171576927735,0.0648650680355564,-0.161252691042464,0.0930183756569172,0.598915453615187
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,YY1,Transcriptional repressor protein YY1,13552,0.0167904503020859,0.0319778808056441,-0.0458861960769765,0.0794670966811484,0.599546945121896
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RNF4,E3 ubiquitin-protein ligase RNF4,13710,-0.0402268256446529,0.0767881088399479,-0.190731518970951,0.110277867681645,0.60037889653472
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,13486,0.024131401302451,0.0460935226485487,-0.0662119030887044,0.114474705693606,0.600613194666517
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NUDC,Nuclear migration protein nudC,16272,0.0373739571174305,0.0713955410564443,-0.1025613033532,0.177309217588061,0.600649161156874
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PITHD1,PITH domain-containing protein 1,13450,0.047834577801987,0.0914357253674259,-0.131379443918168,0.227048599522142,0.600878666937463
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ABHD14B,Protein ABHD14B,15898,0.0336756935464404,0.0646091787521731,-0.0929582968078189,0.1603096839007,0.602219739632787
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MAG,Myelin-associated glycoprotein,13590,-0.0285852775645978,0.0548555134045703,-0.136102083837556,0.07893152870836,0.602304727499199
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GRK5,G protein-coupled receptor kinase 5,15778,0.0298784598387529,0.0573902152829519,-0.0826063621158328,0.142363281793339,0.602639239312252
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IMPA1,Inositol monophosphatase 1,15950,0.0360278626119558,0.0692747722626127,-0.0997506910227652,0.171806416246677,0.603020685258413
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL9,Interleukin-9,13710,0.0323145939938785,0.0621371322782728,-0.0894741852715362,0.154103373259293,0.603035131211713
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CPB1,Carboxypeptidase B,16301,0.0346077984722088,0.066590085643832,-0.0959087693897019,0.165124366334119,0.603270004167841
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ZNF75D,Zinc finger protein 75D,13710,0.0374885308405669,0.0721646226035916,-0.103954129462473,0.178931191143607,0.603430077761424
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SERPINB9,Serpin B9,15950,-0.0193234839512573,0.0372097878342022,-0.0922546681062936,0.053607700203779,0.60355049957028
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MPRIP,Myosin phosphatase Rho-interacting protein,13871,-0.0261182967690203,0.0504643817476394,-0.125028484994394,0.0727918914563529,0.604774230732928
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",13610,0.0407292321872763,0.078836453168426,-0.113790216022839,0.195248680397391,0.605423267450254
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FASLG,Tumor necrosis factor ligand superfamily member 6,16272,0.0212577397262804,0.0411874337922406,-0.0594696305065112,0.101985109959072,0.605776239036931
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,13913,0.0527738311703154,0.102264402003236,-0.147664396756027,0.253212059096658,0.605825740512565
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TPT1,Translationally-controlled tumor protein,15826,-0.0375850702306553,0.0731492501165544,-0.180957600459102,0.105787459997791,0.607389587379421
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",13865,0.0647069288767849,0.12595935450739,-0.1821734059577,0.31158726371127,0.607461017151109
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GPR15L,Protein GPR15L,13913,-0.0364177887329022,0.0709374238967977,-0.175455139570626,0.102619562104821,0.607694343231111
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ANGPTL2,Angiopoietin-related protein 2,16109,-0.0227883333037244,0.0444183503244543,-0.109848299939655,0.064271633332206,0.60793128187485
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ALMS1,Alstrom syndrome protein 1,13710,-0.0262395511407566,0.0511818295882281,-0.126555937133684,0.0740768348521705,0.608188224078062
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MTIF3,"Translation initiation factor IF-3, mitochondrial",13913,0.0515329140215778,0.100798161897901,-0.146031483298308,0.249097311341464,0.609185148268977
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CLEC1B,C-type lectin domain family 1 member B,16230,0.0556616522597663,0.108949714538371,-0.15787978823544,0.269203092754973,0.609432901165027
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,F3,Tissue factor,16101,0.0157841050695522,0.0309693824673551,-0.0449158845664638,0.0764840947055681,0.610291025014687
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PPP3R1,Calcineurin subunit B type 1,15950,-0.0237937540382785,0.0467755094146651,-0.115473752491022,0.067886244414465,0.610983766616642
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NELL1,Protein kinase C-binding protein NELL1,16118,-0.0241692357115988,0.0476361696965915,-0.117536128316918,0.0691976568937206,0.611901114433734
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",13474,-0.0316771761239566,0.0624962214264098,-0.15416977011972,0.0908154178718067,0.612257524169853
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NTRK2,BDNF/NT-3 growth factors receptor,16102,-0.0146840874044251,0.0289790753822562,-0.0714830751536473,0.0421149003447971,0.612362832931221
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,16272,-0.0217234338491745,0.0428902126187134,-0.105788250581853,0.0623413828835038,0.612520066206972
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GIPC3,PDZ domain-containing protein GIPC3,13913,0.0569278369239774,0.112470092259627,-0.163513543904891,0.277369217752846,0.612752516625962
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PPME1,Protein phosphatase methylesterase 1,16008,0.0349392564699165,0.0690287566566858,-0.100357106577188,0.170235619517021,0.612754756420469
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FZD10,Frizzled-10,13590,-0.035164455697306,0.069475711041175,-0.171336849338009,0.101007937943397,0.612766395389478
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TIMP2,Metalloproteinase inhibitor 2,13974,-0.0146736707682219,0.0290276318652047,-0.0715678292240231,0.0422204876875794,0.613210772214873
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SMPD3,Sphingomyelin phosphodiesterase 3,13552,-0.0331559958835165,0.0657348092219117,-0.161996221958463,0.0956842301914304,0.613995387443788
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RSPO3,R-spondin-3,16209,-0.0159255708926439,0.0316119709487172,-0.0778850339521296,0.0460338921668418,0.614420787059629
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,13972,-0.0147422365203649,0.0292642633180048,-0.0721001926236544,0.0426157195829245,0.614436279311908
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MPI,Mannose-6-phosphate isomerase,16008,0.0489547786282472,0.0972260607006143,-0.141608300344957,0.239517857601451,0.614609180979391
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,13684,0.0284316882437531,0.0567187314546611,-0.0827370254073826,0.139600401894889,0.616185592946524
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SERPINA3,Alpha-1-antichymotrypsin,13939,-0.00839603855155331,0.016750295406044,-0.0412266175473995,0.0244345404442928,0.616205088239923
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NLGN2,Neuroligin-2,13474,-0.0264657415643295,0.0528201405327217,-0.129993217008464,0.077061733879805,0.616341328066843
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DSG4,Desmoglein-4,15961,-0.0280706077273457,0.0560519762101261,-0.137932481099193,0.0817912656445014,0.616521584486057
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,C9orf40,Uncharacterized protein C9orf40,13913,0.0469642678396534,0.0941075901967289,-0.137486608945935,0.231415144625242,0.617752994747868
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",16073,0.0243258508913152,0.0487660458123344,-0.0712555989008602,0.119907300683491,0.617907655786432
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,13590,-0.0240425619411698,0.0482404314717789,-0.118593807625857,0.0705086837435169,0.618217063399791
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CLEC14A,C-type lectin domain family 14 member A,16101,-0.0177164262319721,0.0355988488706416,-0.0874901700184297,0.0520573175544856,0.618724506066258
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CXCL3,C-X-C motif chemokine 3,16084,0.0532687043274416,0.107090759385358,-0.156629184067859,0.263166592722743,0.618902220063538
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FABP4,"Fatty acid-binding protein, adipocyte",16301,0.0277957286233695,0.0558816299245811,-0.0817322660288094,0.137323723275548,0.618911122544748
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TEX33,Testis-expressed protein 33,13710,0.0227410499389163,0.045726298172884,-0.0668824944799364,0.112364594357769,0.618964496318014
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HPCAL1,Hippocalcin-like protein 1,16272,0.0413463050179396,0.0831507934677594,-0.121629250178869,0.204321860214748,0.619023111544783
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CALB1,Calbindin,16008,-0.024308963845778,0.0489070094413224,-0.12016670235077,0.071548774659214,0.619164448365087
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,16073,0.0346009361797705,0.0696327699210878,-0.101879292865562,0.171081165225103,0.619262192992956
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,16073,0.0222400726311671,0.0447862893674722,-0.0655410545290785,0.110021199791413,0.619490528316553
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KCNH2,Potassium voltage-gated channel subfamily H member 2,13590,0.043730705564714,0.0881459486604558,-0.129035353809779,0.216496764939207,0.619819881797891
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",13927,0.0227465980091849,0.0460335179295516,-0.0674790971327363,0.112972293151106,0.621221317233171
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IDS,Iduronate 2-sulfatase,16272,0.00499498475754025,0.0101244474690695,-0.0148489322818359,0.0248389017969164,0.621765786658164
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,13913,0.0173599435927717,0.035211180228428,-0.0516539696549473,0.0863738568404906,0.622003685773509
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PSIP1,PC4 and SFRS1-interacting protein,16073,0.0362861923305237,0.0736592517864734,-0.108085941170964,0.180658325832012,0.62228620111962
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CLEC1A,C-type lectin domain family 1 member A,15778,-0.0184134530829053,0.0374180906582655,-0.0917529107731057,0.0549260046072951,0.622655303304398
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PRSS27,Serine protease 27,16052,-0.0222991578323055,0.0453211085559506,-0.111128530601969,0.0665302149373576,0.622707790286133
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL2RB,Interleukin-2 receptor subunit beta,15826,-0.0214108671341612,0.0435246086972286,-0.106719100180729,0.0638973659124069,0.622778803479524
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EGFR,Epidermal growth factor receptor,16301,-0.00913446632553968,0.0185897918815415,-0.0455704584133611,0.0273015257622818,0.623171388860298
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BOC,Brother of CDO,15778,-0.013020163070558,0.0265177369396238,-0.0649949274722207,0.0389546013311046,0.623434503249069
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NBL1,Neuroblastoma suppressor of tumorigenicity 1,16118,0.0148515801587393,0.0302504260597938,-0.0444392549184566,0.0741424152359352,0.623465380847153
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HSBP1,Heat shock factor-binding protein 1,13610,0.0530666426936072,0.108230052505871,-0.159064260217899,0.265197545605114,0.623920073739837
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SUMF1,Formylglycine-generating enzyme,13552,-0.036779638107904,0.0753017693699785,-0.184371106073062,0.110811829857254,0.625253255797409
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,13992,-0.0140400258195846,0.0288351868573778,-0.0705569920600451,0.0424769404208759,0.626332573391008
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ZHX2,Zinc fingers and homeoboxes protein 2,13927,0.0188754719288501,0.0387710858118831,-0.0571158562624408,0.0948668001201409,0.626376529642343
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CRNN,Cornulin,15628,-0.0365873965062242,0.0752115489162658,-0.184002032382105,0.110827239369657,0.62664801457609
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LTBP3,Latent-transforming growth factor beta-binding protein 3,15724,-0.029959250769202,0.061589572939109,-0.150674813729856,0.0907563121914517,0.6266664076185
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,13946,0.0214846738832919,0.0442043120846521,-0.0651557778026263,0.10812512556921,0.626952704677318
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL18RAP,Interleukin-18 receptor accessory protein,15847,-0.0934550322394353,0.192317146798039,-0.470396639963591,0.28348657548472,0.627014817412451
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CORO6,Coronin-6,13474,-0.0204970748227823,0.0422600630761202,-0.103326798451978,0.0623326488064132,0.627668389683637
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,13946,0.0131364501472316,0.027087200046545,-0.0399544619439966,0.0662273622384598,0.627706017456088
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CSDE1,Cold shock domain-containing protein E1,13486,0.0661834295304047,0.136570439561735,-0.201494632010596,0.333861491071405,0.627960747797441
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CDCP1,CUB domain-containing protein 1,15950,0.0279993421049903,0.057796721563006,-0.0852822321585014,0.141280916368482,0.628076632046407
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TBC1D17,TBC1 domain family member 17,15688,0.0243812505997342,0.0505026520350448,-0.0746039473889536,0.123366448588422,0.629264597513128
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KIRREL2,Kin of IRRE-like protein 2,15688,-0.0217000309815524,0.0449920414000341,-0.109884432125619,0.0664843701625144,0.629593750428737
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HJV,Hemojuvelin,13946,0.0237344364622188,0.0492980963115038,-0.0728898323083287,0.120358705232766,0.630206172117178
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CAPS,Calcyphosin,13927,0.0510279921481202,0.106217101219524,-0.157157526242148,0.259213510538388,0.630941868491596
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL11,Interleukin-11,15826,-0.0349023283726252,0.0726529441743939,-0.177302098954437,0.107497442209187,0.630951069016393
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,15778,-0.0173081345232664,0.0360342830232517,-0.0879353292488397,0.053319060202307,0.631003620569874
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",13610,0.014015636051513,0.0292065391736781,-0.0432291807288961,0.071260452831922,0.631320393436242
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DUSP29,Dual specificity phosphatase 29,13590,0.0370582053141154,0.0772905553854731,-0.114431283241412,0.188547693869643,0.631614764426253
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CCL13,C-C motif chemokine 13,16239,0.0370509586086982,0.0773344303676106,-0.114524524911819,0.188626442129215,0.631873642795549
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,APOA2,Apolipoprotein A-II,13982,0.0258353619199404,0.0541531994175453,-0.0803049089384485,0.131975632778329,0.633313230590312
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BLNK,B-cell linker protein,13552,-0.0210502624635566,0.0441488788764938,-0.107582065061485,0.0654815401343712,0.633510999282573
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AMIGO1,Amphoterin-induced protein 1,13590,0.0285479828525785,0.0598788794769388,-0.0888146209222215,0.145910586627379,0.633539180162588
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ATXN3,Ataxin-3,13927,0.0338580264983944,0.0711403925180173,-0.105577142836919,0.173293195833708,0.634129923870241
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MMP7,Matrilysin,15755,-0.0262432378476789,0.0551702551481487,-0.13437693793805,0.0818904622426925,0.634310898459501
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",13474,-0.0173368782467453,0.0365386540075127,-0.0889526401014701,0.0542788836079795,0.63516500889334
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GPC1,Glypican-1,16209,-0.0155111886633244,0.0328727529848797,-0.0799417845136887,0.0489194071870398,0.637036303846206
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SKAP1,Src kinase-associated phosphoprotein 1,15925,0.0387840221574541,0.0823039179860527,-0.122531657095209,0.200099701410117,0.637483419008055
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,C2,Complement C2,16155,-0.0123625728035457,0.0262908129319408,-0.0638925661501497,0.0391674205430583,0.638201299210094
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,13590,-0.0279493535696108,0.0594740515226715,-0.144518494554047,0.0886197874148254,0.638404018451452
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EREG,Proepiregulin,15925,-0.0423928476207125,0.0904827357740085,-0.219739009737769,0.134953314496344,0.639420168116494
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,13684,0.0198805423527088,0.0424365696027057,-0.0632951340685945,0.103056218774012,0.639451228514779
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,13806,-0.016017814959013,0.0342430136051276,-0.0831341216250631,0.0510984917070372,0.639957292689282
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ASAH2,Neutral ceramidase,15950,-0.0274531967452931,0.0587311475402752,-0.142566245924233,0.0876598524336464,0.640192608079688
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PLIN3,Perilipin-3,16102,0.022862619298294,0.0490175891037057,-0.0732118553449693,0.118937093941557,0.640923617050553
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",16107,-0.0176498758442736,0.0378654170613693,-0.0918660932845573,0.0565663415960102,0.641135016428182
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,15724,0.0237787466306975,0.0510715380175551,-0.0763214678837105,0.123878961145106,0.641510560765984
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AGT,Angiotensinogen,13982,-0.011848059525612,0.0254538987873191,-0.0617377011487574,0.0380415820975334,0.641601237285951
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MFGE8,Lactadherin,16101,0.0229147373557024,0.0492990261638132,-0.0737113539253715,0.119540828636776,0.642072988698683
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GP1BA,Platelet glycoprotein Ib alpha chain,16054,0.0173139710284421,0.0373109998509979,-0.0558155886795138,0.090443530736398,0.642622031432943
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CA8,Carbonic anhydrase-related protein,13552,-0.0136448060517003,0.0294331146274336,-0.0713337107214702,0.0440440986180695,0.642951202351075
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FCRL1,Fc receptor-like protein 1,16102,-0.0236435675391912,0.0510308796410922,-0.123664091635732,0.0763769565573495,0.643142116881298
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PARP1,Poly [ADP-ribose] polymerase 1,16073,0.0302485344736767,0.0653677709784799,-0.0978722966441439,0.158369365591497,0.643554247983307
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BABAM1,BRISC and BRCA1-A complex member 1,13552,-0.0148544680315244,0.0322511762541982,-0.0780667734897528,0.0483578374267041,0.645102438101487
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CHRM1,Muscarinic acetylcholine receptor M1,13590,0.0190834859536114,0.0414810148693419,-0.0622193031902986,0.100386275097522,0.645485189460019
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FGF5,Fibroblast growth factor 5,15826,0.0177687136526589,0.0386294381275278,-0.0579449850772955,0.0934824123826133,0.645537928302692
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CXCL8,Interleukin-8,15950,-0.0357477215103552,0.0777333196117203,-0.188105027949327,0.116609584928617,0.645611193040551
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PRSS53,Serine protease 53,13927,0.0197046398359412,0.0428487240777597,-0.0642788593564678,0.10368813902835,0.645620119806648
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL3,Interleukin-3,13480,-0.0321203788727466,0.0699454298379606,-0.169213421355149,0.104972663609656,0.646083206222581
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MAPK9,Mitogen-activated protein kinase 9,16073,0.0219585100226712,0.0478427283709105,-0.0718132375843135,0.115730257629656,0.646259925337953
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,16209,-0.0176584802368417,0.0384992532586686,-0.0931170166238321,0.0578000561501488,0.646476797979426
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CPTP,Ceramide-1-phosphate transfer protein,13486,0.0206662480272522,0.0450748745133729,-0.0676805060189587,0.109013002073463,0.646609931583864
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BLMH,Bleomycin hydrolase,16301,-0.0161643682359192,0.0353738078110641,-0.0854970315456047,0.0531682950737664,0.647706845506035
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RAB10,Ras-related protein Rab-10,13974,0.0276863155173709,0.0606303040576329,-0.0911490804355896,0.146521711470331,0.647935819781244
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,13486,0.0355268919481709,0.0779334028529001,-0.117222577643513,0.188276361539855,0.648496425428672
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PDGFC,Platelet-derived growth factor C,15724,0.0146792475275837,0.0322208622052523,-0.0484736423947108,0.0778321374498782,0.648696825985046
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,UHRF2,E3 ubiquitin-protein ligase UHRF2,13486,-0.0178841058962721,0.0392621583743689,-0.0948379363100351,0.0590697245174909,0.648753377515923
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CELA2A,Chymotrypsin-like elastase family member 2A,13972,0.031425796719349,0.0691531781484021,-0.104114432451519,0.166966025890217,0.649521040518951
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MEP1B,Meprin A subunit beta,16102,0.0601961894515924,0.13246998102544,-0.199444973358271,0.319837352261456,0.649537141544045
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CDHR1,Cadherin-related family member 1,15688,0.0217970365386146,0.0480339632846161,-0.072349531499233,0.115943604576462,0.649990695201549
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LCAT,Phosphatidylcholine-sterol acyltransferase,13982,-0.0111733839161966,0.0246392894318595,-0.0594663912026411,0.037119623370248,0.650211385966628
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CDH23,Cadherin-23,13927,0.013786699665159,0.0304067365266287,-0.0458105039270332,0.0733839032573513,0.650261052099092
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SRP14,Signal recognition particle 14 kDa protein,16008,0.0312175490853834,0.0688528244972718,-0.103733986929269,0.166169085100036,0.650270249648995
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,QDPR,Dihydropteridine reductase,16016,0.0223166361657201,0.0493183145615026,-0.0743472603748249,0.118980532706265,0.650913512207302
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KAZN,Kazrin,13913,0.0533640941129823,0.118325964381678,-0.178554796075106,0.285282984301071,0.652002162936575
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",16008,0.0175250476485607,0.0388928747717245,-0.0587049869040194,0.0937550822011408,0.652285489342532
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IRAK4,Interleukin-1 receptor-associated kinase 4,16073,0.0527700025038127,0.117134775287024,-0.176814157058754,0.282354162066379,0.652351197264734
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL25,Interleukin-25,13428,-0.0178490989752638,0.0396967966292643,-0.0956548203686218,0.0599566224180942,0.652980370205139
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FAM171A2,Protein FAM171A2,13946,-0.0807154706504968,0.18012415322884,-0.433758810979024,0.27232786967803,0.65408063385501
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FGF12,Fibroblast growth factor 12,13552,-0.0234930541927051,0.052471159918983,-0.126336527633912,0.0793504192485016,0.654353281838015
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD3G,T-cell surface glycoprotein CD3 gamma chain,13552,0.0450518872652026,0.10076750897206,-0.152452430320035,0.24255620485044,0.654819082185951
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BRD3,Bromodomain-containing protein 3,13486,0.0240139783061393,0.0537495260714029,-0.0813350927938104,0.129363049406089,0.655044251315157
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD300C,CMRF35-like molecule 6,16230,-0.0174356760427035,0.0390363067870683,-0.0939468373453573,0.0590754852599504,0.655131725122935
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,16301,-0.0354662465527429,0.0794890551461042,-0.191264794639107,0.120332301533621,0.655474796349582
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,13474,-0.0286790723017912,0.064461256132697,-0.155023134321877,0.097664989718295,0.656396267872754
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ACP5,Tartrate-resistant acid phosphatase type 5,16179,-0.0163385834666434,0.0367577180378628,-0.0883837108208545,0.0557065438875677,0.656691449056821
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DOK1,Docking protein 1,13927,0.0686082663189753,0.154406263420165,-0.234028009984547,0.371244542622498,0.656806565607025
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DPY30,Protein dpy-30 homolog,16166,0.0301381717547045,0.0679191125146008,-0.102983288773913,0.163259632283322,0.657239233463847
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FOLR2,Folate receptor beta,16230,0.0147797779811725,0.0333288670882536,-0.0505448015118046,0.0801043574741497,0.657444199984272
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FHIT,Bis(5'-adenosyl)-triphosphatase,15688,0.0363364093201617,0.0819732332520304,-0.124331127853818,0.197003946494141,0.657575386215959
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FDX1,"Adrenodoxin, mitochondrial",13486,0.0314767126146749,0.0711066819015957,-0.107892383912453,0.170845809141802,0.658012388724972
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PHLDB2,Pleckstrin homology-like domain family B member 2,13480,0.0465936899831309,0.105347792132116,-0.159887982595817,0.253075362562078,0.658290487327339
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KRT17,"Keratin, type I cytoskeletal 17",13486,-0.0196145544116745,0.0444017095986126,-0.106641905224955,0.0674127964016061,0.658675597256591
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PDCL2,Phosducin-like protein 2,13480,-0.0268951179119658,0.0610179283693176,-0.146490257515828,0.0927000216918968,0.659383675336593
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LEO1,RNA polymerase-associated protein LEO1,13946,-0.0155024584911671,0.0351807188589525,-0.084456667454714,0.0534517504723797,0.659471698300913
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KLRD1,Natural killer cells antigen CD94,16272,0.0232094314643165,0.0527113063012235,-0.0801047288860816,0.126523591814715,0.659716856467413
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KDR,Vascular endothelial growth factor receptor 2,16118,0.0127868574317254,0.0291776567845518,-0.0444013498659961,0.0699750647294469,0.661217171832393
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,16274,-0.0138226034373277,0.0315776952990629,-0.075714886223491,0.0480696793488355,0.661585563783568
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LGALS3,Galectin-3,16149,-0.0147743690474422,0.0337609796126447,-0.0809458890882259,0.0513971509933414,0.661670008665011
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PDCD1,Programmed cell death protein 1,16180,0.0207645716834865,0.0477282794211082,-0.0727828559818855,0.114311999348859,0.663526107189094
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NMRK2,Nicotinamide riboside kinase 2,13480,0.0209643853483091,0.0482078227100856,-0.0735229471634586,0.115451717860077,0.663660003514888
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DKKL1,Dickkopf-like protein 1,16008,-0.0425118051873081,0.0977792767372392,-0.234159187592297,0.149135577217681,0.663732954065062
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ARAF,Serine/threonine-protein kinase A-Raf,13710,0.0336447392754037,0.0774045273187044,-0.118068134269257,0.185357612820064,0.663815264660829
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FRMD7,FERM domain-containing protein 7,13590,0.016477327488798,0.0380399901493702,-0.0580810532039676,0.0910357081815635,0.664906843087178
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DDX25,ATP-dependent RNA helicase DDX25,13590,-0.019498005440762,0.0450216969890743,-0.107740531539348,0.0687445206578235,0.664963388358935
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PTX3,Pentraxin-related protein PTX3,16073,-0.0238444638236334,0.0550767667381138,-0.131794926630336,0.0841059989830698,0.665070394048521
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CETN3,Centrin-3,13913,0.0387431623330255,0.0894959864210248,-0.136668971052183,0.214155295718234,0.665091297485002
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,13590,0.0243933736303713,0.0563519012115461,-0.086056352744259,0.134843100005002,0.66511188720833
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",13687,0.0318898742173064,0.0737329892663607,-0.112626784744761,0.176406533179373,0.665381361389775
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IST1,IST1 homolog,13811,0.048977435734527,0.113305279849394,-0.173100912770285,0.271055784239338,0.665558598878811
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BAP18,Chromatin complexes subunit BAP18,13927,-0.0338163501641947,0.0782627525389282,-0.187211345140494,0.119578644812105,0.665684579784876
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,C2CD2L,Phospholipid transfer protein C2CD2L,15663,-0.0202628067730813,0.0469069727520193,-0.112200473367039,0.0716748598208764,0.665762943927202
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LELP1,Late cornified envelope-like proline-rich protein 1,13474,0.0361232797797218,0.0837202074439411,-0.127968326810403,0.200214886369846,0.666129040379617
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DDX4,Probable ATP-dependent RNA helicase DDX4,13552,-0.0263911187397262,0.0612064659397855,-0.146355791981706,0.0935735545022535,0.666342997243278
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AMBP,Protein AMBP,16187,-0.00967440627196929,0.0224426838831488,-0.053662066682941,0.0343132541390024,0.66642197015121
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,16122,-0.0239333627997895,0.0555510557561499,-0.132813432081843,0.0849467064822643,0.666593803238691
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MN1,Transcriptional activator MN1,13590,-0.0290009479209799,0.0673343353291359,-0.160976245166086,0.102974349324127,0.666692819666071
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BIRC2,Baculoviral IAP repeat-containing protein 2,15724,0.031227567387538,0.0725059296421378,-0.110884054711052,0.173339189486128,0.666699814351537
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TNFSF8,Tumor necrosis factor ligand superfamily member 8,13972,-0.0174092873164159,0.0405354429083996,-0.0968587554168792,0.0620401807840473,0.667578325845157
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,15950,0.0457451953958791,0.106521818422047,-0.163037568711333,0.254527959503092,0.667605674338216
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MTUS1,Microtubule-associated tumor suppressor 1,13710,-0.0282717575146385,0.0658809486242251,-0.15739841681812,0.100854901788843,0.667832432531599
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DHPS,Deoxyhypusine synthase,13894,-0.0200937514782973,0.0468456080681933,-0.111911143291956,0.0717236403353616,0.667976710246015
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RBPMS,RNA-binding protein with multiple splicing,13552,-0.0320671157801223,0.074817435049523,-0.178709288477187,0.114575056916943,0.668217632080615
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,XPNPEP2,Xaa-Pro aminopeptidase 2,16118,-0.047982844317977,0.112057846145515,-0.267616222763187,0.171650534127233,0.668513356743666
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,16102,0.0318374090965666,0.0744402991314631,-0.114065577201101,0.177740395394234,0.668882188456963
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD248,Endosialin,13972,0.0191253761056766,0.0449149881958423,-0.0689080007581744,0.107158752969527,0.67025083726156
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SKAP2,Src kinase-associated phosphoprotein 2,16160,0.0503016211294929,0.118236253860241,-0.18144143643658,0.282044678695566,0.670526619464658
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DNM1,Dynamin-1,13913,-0.0555158455701403,0.130528710065436,-0.311352117298395,0.200320426158114,0.670613492732037
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DKK1,Dickkopf-related protein 1,16230,-0.0284532610459424,0.0673307723516184,-0.160421574855115,0.10351505276323,0.6726005693874
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD200R1,Cell surface glycoprotein CD200 receptor 1,16016,0.0164228149509712,0.038951102771622,-0.0599213464814079,0.0927669763833503,0.673303364929259
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CWC15,Spliceosome-associated protein CWC15 homolog,13835,0.030655538860605,0.0728587274270575,-0.112147566896428,0.173458644617638,0.673941889683307
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EPHA2,Ephrin type-A receptor 2,15478,0.014895308577413,0.0354927784226791,-0.054670537131038,0.084461154285864,0.674731256922138
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PLXDC1,Plexin domain-containing protein 1,15724,0.0165741980657466,0.0395582371251764,-0.0609599466995992,0.0941083428310924,0.675234853729351
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NUDT5,ADP-sugar pyrophosphatase,16101,0.0243083168391768,0.0580743143506464,-0.0895173392880902,0.138133972966444,0.675534104529705
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TLR2,Toll-like receptor 2,13710,-0.0113392520138604,0.0271073501442023,-0.0644696582964969,0.0417911542687761,0.675727674965253
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DXO,Decapping and exoribonuclease protein,13927,0.0216460096865645,0.051809901356521,-0.0799013969722166,0.123193416345346,0.676102156662919
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LDLRAP1,Low density lipoprotein receptor adapter protein 1,13946,0.0461664740311631,0.11063544710738,-0.170679002299302,0.263011950361628,0.676476643238512
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AKR1B1,Aldo-keto reductase family 1 member B1,15724,0.035857641726753,0.0859369941494485,-0.132578866806166,0.204294150259672,0.676497590813039
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GLP1R,Glucagon-like peptide 1 receptor,13474,0.0176310487900682,0.042286688906814,-0.0652508614672873,0.100512959047424,0.676728308856008
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NECTIN4,Nectin-4,16118,0.0149165440838294,0.0358123725567639,-0.0552757061274279,0.0851087942950866,0.677035604210874
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DARS1,"Aspartate--tRNA ligase, cytoplasmic",15925,0.0342189067338235,0.0821994743982544,-0.126892063086755,0.195329876554402,0.677202645030968
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FGF6,Fibroblast growth factor 6,13552,-0.0192192636989265,0.0462315203855602,-0.109833043654624,0.0713945162567715,0.677623139188483
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KLK1,Kallikrein-1,15898,0.0598622536737293,0.144172547666455,-0.222715939752523,0.342440447099981,0.677991907813811
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BCL2L15,Bcl-2-like protein 15,13552,-0.0273722139598653,0.0659834570190393,-0.156699789717182,0.101955361797452,0.67826964012847
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,13486,-0.0243580609440486,0.058773384655173,-0.139553894868188,0.0908377729800905,0.678558256550621
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,UNC79,Protein unc-79 homolog,13480,0.0267480415327936,0.0646488494049371,-0.0999637033008831,0.15345978636647,0.679068551488457
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NENF,Neudesin,13894,-0.0534305520298833,0.1293978988592,-0.307050433793916,0.200189329734149,0.679674031064656
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CTSE,Cathepsin E,13684,0.0243384105059141,0.0596644118349427,-0.0926038366905736,0.141280657702402,0.683337522239821
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD300LG,CMRF35-like molecule 9,16101,0.0171027388622944,0.04193067985523,-0.0650813936539564,0.0992868713785452,0.683366273871241
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HAVCR2,Hepatitis A virus cellular receptor 2,16101,-0.0160550026415769,0.0394277669518233,-0.0933334258671506,0.0612234205839968,0.683866222633785
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DPP4,Dipeptidyl peptidase 4,15812,-0.0140923640824714,0.0346468722718541,-0.0820002337353055,0.0538155055703627,0.684202449261198
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EDF1,Endothelial differentiation-related factor 1,13946,0.0322005186864889,0.0792921432688665,-0.123212082120489,0.187613119493467,0.68467555456047
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MEP1A,Meprin A subunit alpha,13913,0.0331316893319696,0.0817371406147239,-0.127073106272889,0.193336484936829,0.685230638936852
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SRPX,Sushi repeat-containing protein SRPX,13974,-0.0161930358369001,0.0399760743820759,-0.0945461416257688,0.0621600699519686,0.685433599501
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CIRBP,Cold-inducible RNA-binding protein,13913,0.0444269189290165,0.10972847862102,-0.170640899168183,0.259494737026216,0.685571599352116
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CSPG5,Chondroitin sulfate proteoglycan 5,13474,-0.0225862693707068,0.0558988868002696,-0.132148087499235,0.0869755487578216,0.686178106883457
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,VGF,Neurosecretory protein VGF,13946,0.0138622874121141,0.0343367326843732,-0.0534377086492574,0.0811622834734855,0.686427789207932
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TTN,Titin,13486,-0.0315796577110029,0.0783011475337142,-0.185049906877083,0.121890591455077,0.68672638088966
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PLAT,Tissue-type plasminogen activator,16251,0.0231687852035563,0.0574493808049721,-0.0894320011741891,0.135769571581302,0.686739895028572
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DLL4,Delta-like protein 4,13610,-0.0404804613568659,0.100389778935441,-0.237244428070329,0.156283505356597,0.686783242011979
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PARK7,Parkinson disease protein 7,16101,0.0240106256843025,0.0595457625076868,-0.0926990688307636,0.140720320199369,0.686784540752726
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SMPD1,Sphingomyelin phosphodiesterase,16140,0.0226927648607137,0.0562927589272229,-0.0876410426366432,0.133026572358071,0.686864928147753
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL13,Interleukin-13,15826,-0.0222738958231134,0.0552828509189769,-0.130628283624308,0.0860804919780812,0.687021447263111
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TBL1X,F-box-like/WD repeat-containing protein TBL1X,15724,0.0390013080244351,0.0968543465983122,-0.150833211308257,0.228835827357127,0.687189129973748
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CDH4,Cadherin-4,13474,-0.0217014462987302,0.0540338070589868,-0.127607708134344,0.0842048155368839,0.687964789850549
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GNLY,Granulysin,16101,0.0237353187432859,0.0591284814712704,-0.0921565049404042,0.139627142426976,0.688116710717691
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SERPINA9,Serpin A9,15923,-0.0328680232319049,0.0819136226676674,-0.193418723660533,0.127682677196723,0.68823982408923
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,13894,0.0204930414260228,0.0510736756599336,-0.0796113628674471,0.120597445719493,0.688246153843425
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DIABLO,"Diablo homolog, mitochondrial",16052,0.0502806149894379,0.125435356389437,-0.195572683533858,0.296133913512734,0.68853677037608
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CPXM2,Inactive carboxypeptidase-like protein X2,13974,-0.0114618463085132,0.0286644178911527,-0.0676441053751724,0.044720412758146,0.689263384677155
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HLA_E,,16073,0.0129079252181888,0.0323051003860002,-0.0504100715383716,0.0762259219747491,0.689483672211144
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CTF1,Cardiotrophin-1,15778,-0.0377474899460355,0.0945238582073884,-0.223014252032517,0.147519272140446,0.689645516536925
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,VSIG4,V-set and immunoglobulin domain-containing protein 4,16081,0.0181302353005115,0.0454095064995488,-0.0708723974386041,0.107132868039627,0.689706364050559
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TP73,Tumor protein p73,13590,0.0158103719838892,0.0396249610719714,-0.0618545517171747,0.0934752956849532,0.689899247274261
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,L1CAM,Neural cell adhesion molecule L1,16118,-0.0130972306785705,0.03298072971076,-0.0777394609116601,0.0515449995545192,0.691285949878619
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GDF2,Growth/differentiation factor 2,16102,-0.0160317067282161,0.0403955539408041,-0.0952069924521923,0.06314357899576,0.691469993568955
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",15724,0.0375858667951453,0.0948375937004682,-0.148295816857772,0.223467550448063,0.691875666723492
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GAS6,Growth arrest-specific protein 6,16203,-0.0113467603111747,0.0287096003376901,-0.0676175769730473,0.0449240563506979,0.692681832495598
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DPP6,Dipeptidyl aminopeptidase-like protein 6,16008,-0.0150601255581164,0.0381198583508372,-0.0897750479257573,0.0596547968095245,0.69279430691384
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SRC,Proto-oncogene tyrosine-protein kinase Src,16090,0.0543760924873172,0.137661403764198,-0.21544025889051,0.324192443865145,0.692848997052107
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ENPEP,Glutamyl aminopeptidase,13486,-0.0195109237071341,0.0496476427539088,-0.116820303504795,0.0777984560905271,0.694334623898551
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MSR1,Macrophage scavenger receptor types I and II,16230,0.0202778863328747,0.0517046934110933,-0.0810633127528682,0.121619085418618,0.694925521098955
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD59,CD59 glycoprotein,15496,-0.00983972743261949,0.0251035803805615,-0.0590427449785201,0.0393632901132811,0.6950893948199
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SBSN,Suprabasin,13939,-0.0150913469144403,0.0385637037606476,-0.0906762062853095,0.0604935124564289,0.695555237478722
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FMNL1,Formin-like protein 1,15688,-0.028045940507136,0.0716884230304429,-0.168555249646804,0.112463368632532,0.695639988837538
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MORC3,MORC family CW-type zinc finger protein 3,13927,0.0128090656673836,0.0327980583112017,-0.0514751286225717,0.0770932599573389,0.696140738432147
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TBCB,Tubulin-folding cofactor B,15950,0.0440714349844078,0.11336957827201,-0.178132938428733,0.266275808397548,0.697472735879447
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",13710,-0.0319000885313979,0.082164113320477,-0.192941750639533,0.129141573576737,0.697838226216474
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,VWC2L,von Willebrand factor C domain-containing protein 2-like,13946,-0.0207478673666382,0.0534467671551273,-0.125503530990688,0.0840077962574113,0.697876285521893
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ALDH2,"Aldehyde dehydrogenase, mitochondrial",13894,0.0232504924207131,0.0599891510027361,-0.0943282435446496,0.140829228386076,0.698334082329407
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PTPRM,Receptor-type tyrosine-protein phosphatase mu,16047,-0.0106514923608454,0.0274939091915189,-0.0645395543762225,0.0432365696545317,0.698455771249778
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DNLZ,DNL-type zinc finger protein,13474,-0.0387399216661661,0.100013004436806,-0.234765410362305,0.157285567029973,0.69850409432362
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TFF1,Trefoil factor 1,16009,0.0346885853080538,0.0895568155239581,-0.140842773118904,0.210219943735012,0.698512576339773
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NCF2,Neutrophil cytosol factor 2,16048,-0.0371288710627384,0.096116031716333,-0.225516293226751,0.151258551101274,0.69928541982702
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,WASL,Neural Wiskott-Aldrich syndrome protein,13552,0.0262572367669696,0.0679959911351748,-0.107014905857973,0.159529379391912,0.699385280709138
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MXRA8,Matrix remodeling-associated protein 8,13684,0.0132928824431822,0.0344251014846048,-0.0541803164666433,0.0807660813530077,0.699399561055592
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SLIT2,Slit homolog 2 protein,15688,0.0223615281263355,0.05795810615503,-0.0912363599375232,0.135959416190194,0.699633536596175
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NRXN3,Neurexin-3,13590,-0.0158180361779128,0.0410302839114495,-0.0962373926443538,0.0646013202885283,0.69985748943134
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CCL3,C-C motif chemokine 3,16073,0.027339085607273,0.0709583166060647,-0.111739214940614,0.16641738615516,0.700032309893652
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DTX3,Probable E3 ubiquitin-protein ligase DTX3,16008,0.010529850554791,0.0273406560898331,-0.0430578353812818,0.0641175364908637,0.700142330553524
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SIAE,Sialate O-acetylesterase,16092,0.0203626464046859,0.0530472556175663,-0.0836099746057442,0.124335267415116,0.701088312534182
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CRH,Corticoliberin,15693,-0.0380112538345297,0.0993392409734477,-0.232716166142487,0.156693658473428,0.701991247395528
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,15688,-0.0194892821983484,0.0509342514261478,-0.119320414993598,0.0803418505969013,0.701994804402886
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CR1,Complement receptor type 1,13921,0.0153657856460789,0.0401800603790899,-0.0633871326969372,0.094118703989095,0.702153358530099
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SEZ6L2,Seizure 6-like protein 2,16008,-0.0103430726280173,0.0270722666769322,-0.0634047153148044,0.0427185700587699,0.702426253920025
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FIS1,Mitochondrial fission 1 protein,16082,0.033521465141231,0.08774165279424,-0.138452174335479,0.205495104617941,0.70243130265951
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PLXNA4,Plexin-A4,16073,0.0350384450477884,0.0917824832384967,-0.144855222099665,0.214932112195242,0.702647963877202
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",15925,0.0412165022441086,0.10825564491589,-0.170964561791036,0.253397566279253,0.703406422605585
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,OGN,Mimecan,16101,-0.0178658857569262,0.0470168598472983,-0.110018931057631,0.0742871595437786,0.703958656947418
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TMOD4,Tropomodulin-4,13480,0.0176737523679551,0.04656114714854,-0.0735860960431833,0.108933600779093,0.704262044764945
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,JAM2,Junctional adhesion molecule B,16230,0.0111449930139958,0.029384261723427,-0.0464481599639211,0.0687381459919127,0.704481625376041
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,13474,0.0207677648340248,0.0547865704784482,-0.0866139133037337,0.128149442971783,0.70464430822393
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ENO1,Alpha-enolase,16063,-0.0338253025340696,0.0892896013227424,-0.208832921126645,0.141182316058506,0.704821424361481
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RBP7,Retinoid-binding protein 7,13913,0.0268313362930457,0.0709220411690849,-0.112175864398361,0.165838536984452,0.705197518946501
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RAB44,Ras-related protein Rab-44,13894,-0.0197465734810491,0.052284393980966,-0.122223985683742,0.0827308387216443,0.70567689319123
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DLK1,Protein delta homolog 1,16301,-0.0235265309005299,0.0624018034349777,-0.145834065633086,0.0987810038320263,0.7061660003013
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,16166,-0.0248206156331287,0.0658516458797984,-0.153889841557534,0.104248610291276,0.706240116790891
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SCG3,Secretogranin-3,16107,-0.0140426121486362,0.0372584916137236,-0.0870692557115345,0.058984031414262,0.706255151555611
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LGALS4,Galectin-4,16076,0.0229679077322112,0.0609517673318261,-0.0964975562381679,0.14243337170259,0.706311589181273
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",16043,0.0279739776005497,0.0744466178007504,-0.117941393288921,0.173889348490021,0.707101134005275
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DCN,Decorin,15778,-0.00957327289144047,0.025492662250266,-0.0595388909019619,0.0403923451190809,0.707271000263711
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TGFB2,Transforming growth factor beta-2 proprotein,13894,-0.0228897990570151,0.0611140774969602,-0.142673390951057,0.0968937928370269,0.708006712349966
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ICOSLG,ICOS ligand,16008,0.00806123369445108,0.0215574868445454,-0.0341914405208579,0.05031390790976,0.708452978741058
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,STEAP4,Metalloreductase STEAP4,13474,-0.0308216977628508,0.0824561247794905,-0.192435702330652,0.130792306804951,0.708562631457238
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SCARF2,Scavenger receptor class F member 2,16230,0.0122345832804292,0.0327421620250473,-0.0519400542886634,0.0764092208495219,0.70865883229163
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MGLL,Monoglyceride lipase,16132,0.036790677760972,0.0985321130295057,-0.156332263776859,0.229913619298803,0.708864833040865
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MARCO,Macrophage receptor MARCO,16102,-0.0112280996879193,0.0300727753038961,-0.0701707392835555,0.047714539907717,0.708882270495363
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,13486,-0.0207774339039756,0.0557729210905323,-0.130092359241419,0.0885374914334677,0.709499500691625
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SPARCL1,SPARC-like protein 1,16121,-0.011801556759025,0.0317069713150724,-0.0739472205365669,0.0503441070185169,0.709743629423349
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MTPN,Myotrophin,15778,-0.0139277634006624,0.0374524536027115,-0.0873345724619769,0.0594790456606521,0.709988289399355
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD300E,CMRF35-like molecule 2,16163,0.0172177278664022,0.0463154303505921,-0.0735605156207584,0.107995971353563,0.710084407841039
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ACSL1,Long-chain-fatty-acid--CoA ligase 1,13486,0.0156615319483602,0.0421858817455352,-0.0670227962728887,0.0983458601696091,0.710456760880726
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LEG1,Protein LEG1 homolog,13208,-0.0290974170562226,0.0784276255222843,-0.1828155630799,0.124620728967455,0.710636194865363
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RBKS,Ribokinase,15699,0.0215232206121558,0.0580996520524681,-0.0923520974106816,0.135398538634993,0.711049604918636
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,15950,0.0223047551270463,0.0604797198692115,-0.0962354958166082,0.140845006070701,0.71228374453668
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SIRT1,NAD-dependent protein deacetylase sirtuin-1,13552,0.0363939707914411,0.0988898568289322,-0.157430148593266,0.230218090176148,0.712860111391641
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GMPR,GMP reductase 1,16272,0.0206278460180691,0.0560902177396234,-0.0893089807515927,0.130564672787731,0.713055554927985
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NCAN,Neurocan core protein,16230,-0.0153880688630814,0.0418830126605475,-0.0974787736777545,0.0667026359515917,0.713321014296168
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PEBP1,Phosphatidylethanolamine-binding protein 1,16101,0.0242263043993155,0.0659853516959573,-0.105104984924761,0.153557593723392,0.713514420596401
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,13610,-0.0174107232934804,0.0476040686094786,-0.110714697768058,0.0758932511810978,0.714564609111338
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL15,Interleukin-15,16073,-0.0135619251860738,0.0370932223863855,-0.0862646410633894,0.0591407906912418,0.714655452108606
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FGF9,Fibroblast growth factor 9,13450,0.0171728697634017,0.0469827117296508,-0.0749132452267139,0.109258984753517,0.714733021724199
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CCAR2,Cell cycle and apoptosis regulator protein 2,13927,-0.0234162347574051,0.0643552300050907,-0.149552485567383,0.102720016052573,0.715968771728758
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EDDM3B,Epididymal secretory protein E3-beta,13894,0.021705532161289,0.0596890854490846,-0.0952850753189167,0.138696139641495,0.716129975033908
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,VIPR1,Vasoactive intestinal polypeptide receptor 1,13610,0.0100700054772711,0.027710438200007,-0.0442424533947425,0.0643824643492848,0.71631088284678
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,STK24,Serine/threonine-protein kinase 24,15688,0.0250313480290641,0.069114678235637,-0.110433421312784,0.160496117370913,0.717228960024193
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,APLP1,Amyloid-like protein 1,16102,-0.0209494067597824,0.0578974460981938,-0.134428401112242,0.0925295875926773,0.717478998941101
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CPQ,Carboxypeptidase Q,13952,-0.0148154635596623,0.0409756400673884,-0.0951277180917435,0.0654967909724189,0.717680666005556
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PREB,Prolactin regulatory element-binding protein,15826,0.0121525591609271,0.0336420503706008,-0.0537858595654505,0.0780909778873047,0.71793142576372
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SNRPB2,U2 small nuclear ribonucleoprotein B'',13927,0.0188711764846965,0.0522724337273076,-0.0835827936208264,0.121325146590219,0.718093088449392
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",13552,0.0111294636604746,0.0308646026791445,-0.0493651575906487,0.0716240849115978,0.718411674615073
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL22,Interleukin-22,13894,0.0276277531557827,0.0766548184655052,-0.122615691036608,0.177871197348173,0.718540278530198
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EPN1,Epsin-1,13710,0.0178072586588728,0.0494727141435653,-0.0791592610625151,0.114773778380261,0.718896798514381
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GUCY2C,Heat-stable enterotoxin receptor,13710,-0.0345957355436175,0.0965833207886617,-0.223899044289394,0.15470757320216,0.720202343901001
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,13480,-0.0231835580482964,0.0647323843443332,-0.15005903136319,0.103691915266597,0.720240669526379
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IFNLR1,Interferon lambda receptor 1,16073,-0.0147999130641129,0.0413244954138653,-0.0957959240752888,0.066196097947063,0.720244008808409
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MKI67,Proliferation marker protein Ki-67,13552,-0.0165980847639629,0.0464915126681872,-0.10772144959361,0.074525280065684,0.721087471465868
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LECT2,Leukocyte cell-derived chemotaxin-2,13974,0.0260187067786598,0.0728956378818006,-0.116856743469669,0.168894157026989,0.721148919637514
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD1C,T-cell surface glycoprotein CD1c,16118,0.00981886509115146,0.0275919299086099,-0.0442613175297239,0.0638990477120268,0.721950049285563
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FABP2,"Fatty acid-binding protein, intestinal",16102,-0.0314133006183397,0.0884396806868115,-0.20475507476449,0.141928473527811,0.722448435655396
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MFAP3L,Microfibrillar-associated protein 3-like,13590,0.027000285003714,0.0760981642514124,-0.122152116929054,0.176152686936482,0.722738477961533
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NTRK3,NT-3 growth factor receptor,16230,0.0085929731287373,0.0242769038885202,-0.0389897584927622,0.0561757047502368,0.72337592494549
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,16008,0.00787063304431993,0.0222478130076265,-0.0357350804506281,0.051476346539268,0.723515104583115
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CA1,Carbonic anhydrase 1,15748,0.0243813542922966,0.0689956248669518,-0.110850070446929,0.159612779031522,0.723811784395707
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CCL23,C-C motif chemokine 23,16160,0.0164476563189884,0.0466234319395627,-0.0749342702825545,0.107829582920531,0.724260524455352
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ERBB4,Receptor tyrosine-protein kinase erbB-4,16118,-0.00968773746478632,0.027466940934003,-0.0635229416954321,0.0441474667658595,0.724313951801839
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CA7,Carbonic anhydrase 7,13710,0.0141513683215982,0.0401593497529465,-0.0645609571941769,0.0928636938373733,0.724558410053203
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LGALS1,Galectin-1,16102,0.0137304055967553,0.0390191724863144,-0.0627471724764209,0.0902079836699316,0.724926348287966
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CABP2,Calcium-binding protein 2,13590,-0.0264952387485673,0.0753261396166831,-0.174134472397266,0.121143994900132,0.725038495483703
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TFRC,Transferrin receptor protein 1,16176,-0.0152934155443786,0.0435189673898205,-0.100590591628427,0.0700037605396696,0.725278205524597
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,B4GAT1,"Beta-1,4-glucuronyltransferase 1",16101,-0.00972036555266418,0.0277362954778211,-0.0640835046891935,0.0446427735838651,0.726000705167694
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FH,"Fumarate hydratase, mitochondrial",13474,-0.0328866927151265,0.0941433789843286,-0.217407715524411,0.151634330094158,0.726850343318976
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FUT8,"Alpha-(1,6)-fucosyltransferase",15950,-0.0226430933671644,0.0650025211766282,-0.150048034873356,0.104761848139027,0.727588128304712
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SPRR3,Small proline-rich protein 3,13927,0.026831798693532,0.0771063329268397,-0.124296613843074,0.177960211230138,0.727857186213473
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DDA1,DET1- and DDB1-associated protein 1,13486,0.0155133124996636,0.0445826929430993,-0.0718687656688109,0.102895390668138,0.727870292464324
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD5,T-cell surface glycoprotein CD5,16187,0.0134862460879258,0.0387809334914792,-0.0625243835553735,0.0894968757312252,0.728029050839333
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MTR,Methionine synthase,13486,-0.0256368426720022,0.0738199040416347,-0.170323854593606,0.119050169249602,0.728379618326039
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SNX9,Sorting nexin-9,16102,0.0269398689152287,0.0778403466284287,-0.125627210476492,0.179506948306949,0.729278606373795
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CHMP1A,Charged multivesicular body protein 1a,15950,-0.0306161267895123,0.0885441481645383,-0.204162657192007,0.142930403612983,0.729518297671564
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,WNT9A,Protein Wnt-9a,15826,-0.0113855833392486,0.0329813055011439,-0.0760289421214906,0.0532577754429933,0.729938657588234
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,VSTM2B,V-set and transmembrane domain-containing protein 2B,13710,0.0170651893958813,0.0494398375609555,-0.0798368922235915,0.113967271015354,0.729971253239075
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CRTAM,Cytotoxic and regulatory T-cell molecule,15950,-0.0196959523509336,0.0571349895175365,-0.131680531805305,0.092288627103438,0.730304445818136
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HMCN2,Hemicentin-2,13658,0.0225252489839656,0.0654021280261158,-0.105662921947221,0.150713419915153,0.730542104010032
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DNAJB8,DnaJ homolog subfamily B member 8,15778,0.0216505115286286,0.0629280568410583,-0.101688479879846,0.144989502937103,0.730811915884285
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ALPI,Intestinal-type alkaline phosphatase,13552,-0.0476698320228488,0.139155404812749,-0.320414425455837,0.22507476141014,0.731930726136453
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,COL6A3,Collagen alpha-3(VI) chain,16301,-0.013239558324073,0.0386511074044194,-0.088995728836735,0.0625166121885891,0.73194881159306
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL17A,Interleukin-17A,15796,-0.0172637574629077,0.0504311531443679,-0.116108817625869,0.0815813027000534,0.732112180812904
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MEPE,Matrix extracellular phosphoglycoprotein,16076,-0.00966927553066324,0.0282644314203406,-0.0650675611145309,0.0457290100532044,0.732279752835496
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GABARAP,Gamma-aminobutyric acid receptor-associated protein,13894,0.0191539197857071,0.0561042596149595,-0.0908104290596136,0.129118268631028,0.732808641860192
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CIAPIN1,Anamorsin,16118,0.0242484174535192,0.0712118120916968,-0.115326734246207,0.163823569153245,0.733476053995553
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RAD51,DNA repair protein RAD51 homolog 1,13710,-0.0215523958938124,0.0636354426120291,-0.146277863413389,0.103173071625765,0.734851925769848
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD300A,CMRF35-like molecule 8,13684,0.0115808356789252,0.0342290198877401,-0.0555080433010453,0.0786697146588957,0.735116822373513
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TMEM106A,Transmembrane protein 106A,13894,0.0275490792986933,0.0814378274903058,-0.132069062582306,0.187167221179693,0.73515461778661
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ZNF830,Zinc finger protein 830,13894,0.0306487617384141,0.0906268970263102,-0.146979956433154,0.208277479909982,0.735228024337322
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FABP5,Fatty acid-binding protein 5,16182,0.0260976041499058,0.0771732955912405,-0.125162055208926,0.177357263508737,0.735240343988746
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TLR1,Toll-like receptor 1,13552,0.0100287234667393,0.0297047074341663,-0.0481925031042266,0.0682499500377053,0.735659366343872
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GNPDA1,Glucosamine-6-phosphate isomerase 1,13610,0.0134514411768828,0.039849277622502,-0.0646531429632211,0.0915560253169867,0.735701532595124
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CNTNAP2,Contactin-associated protein-like 2,16073,-0.0158109291461789,0.0469178126020433,-0.107769841846184,0.0761479835538261,0.736127308297797
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SOST,Sclerostin,16085,0.0149588848212008,0.0443946755228576,-0.0720546792036002,0.101972448846002,0.736157312934979
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD160,CD160 antigen,16272,0.0176444812408654,0.0525711368895732,-0.0853949470626981,0.120683909544429,0.737153790566296
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ULBP2,UL16-binding protein 2,15950,-0.0143281783375523,0.0427200661913895,-0.0980595080726757,0.0694031513975711,0.737330111016486
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TXLNA,Alpha-taxilin,15950,0.0332070885998427,0.0990779322233009,-0.160985658557827,0.227399835757512,0.737507824766213
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,13972,-0.0147283178131123,0.0441087891701494,-0.101181544586605,0.0717249089603804,0.738453310618634
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TPMT,Thiopurine S-methyltransferase,15724,-0.027681839278387,0.0829318673782385,-0.190228299339734,0.13486462078296,0.73854238249875
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,13710,-0.0246017198235879,0.073901242798694,-0.169448155709028,0.120244716061852,0.739214904686989
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NEDD9,Enhancer of filamentation 1,13552,0.0128725929467572,0.0386738351494118,-0.0629281239460899,0.0886733098396044,0.739252532499821
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,STAMBP,STAM-binding protein,15925,0.0239564931474752,0.072286938973436,-0.117725907240459,0.16563889353541,0.740340444353862
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PTPRR,Receptor-type tyrosine-protein phosphatase R,13927,-0.01368286834341,0.0413733884634507,-0.0947747097317733,0.0674089730449534,0.740863506202518
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,COMT,Catechol O-methyltransferase,15630,0.0313682700678301,0.0948975200685374,-0.154630869266503,0.217367409402163,0.740989691074195
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SMAD1,Mothers against decapentaplegic homolog 1,15724,0.0310232245166101,0.0941121914006778,-0.153436670628718,0.215483119661939,0.741675733243965
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TRIM5,Tripartite motif-containing protein 5,16073,0.0318221953697548,0.0969543495533461,-0.158208329754804,0.221852720494313,0.742750863440279
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ADGRG2,Adhesion G-protein coupled receptor G2,16102,0.0100698671859386,0.0307006247260255,-0.0501033572770714,0.0702430916489486,0.742914397298768
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,UPB1,Beta-ureidopropionase,13974,0.0334994055287553,0.10222627964942,-0.166864102584108,0.233862913641619,0.743144499788389
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KLK13,Kallikrein-13,15695,0.0165921050896146,0.0506661093661787,-0.0827134692680956,0.115897679447325,0.743309722753946
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CA13,Carbonic anhydrase 13,15899,0.0388515660339099,0.118845483555897,-0.194085581735648,0.271788713803468,0.74374160752439
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ADGRE2,Adhesion G protein-coupled receptor E2,16160,0.0103188141013414,0.0316979196520667,-0.0518091084167094,0.0724467366193922,0.744779656250976
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SEZ6,Seizure protein 6 homolog,13590,0.0115962519615657,0.0356499945256987,-0.0582777373088038,0.0814702412319352,0.744973717323918
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NOMO1,Nodal modulator 1,16101,0.00853265163832411,0.0263998788196349,-0.0432111108481603,0.0602764141248085,0.746541934982136
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DCXR,L-xylulose reductase,16118,-0.0195987473743178,0.0608169062615669,-0.138799883646989,0.0996023888983534,0.747261272195246
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,13655,-0.0178168540887253,0.0553260649136544,-0.126255941319488,0.0906222331420374,0.747432144347266
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CNTN4,Contactin-4,16101,-0.00872955867993947,0.0271414061364962,-0.0619267147074719,0.044467597347593,0.747735288054404
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NSFL1C,NSFL1 cofactor p47,16230,0.0238884201939703,0.0743049778700048,-0.121749336431239,0.16952617681918,0.747842081969686
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TMSB10,Thymosin beta-10,16101,0.0275861373348202,0.0860346000498784,-0.141041678762941,0.196213953432582,0.748487358028991
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SERPINE1,Plasminogen activator inhibitor 1,16301,0.0244242532358398,0.0763139791109269,-0.125151145821577,0.173999652293256,0.748934888660198
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ENSA,Alpha-endosulfine,13894,0.0194727844194444,0.0608976675596997,-0.0998866439975671,0.138832212836456,0.74915326434836
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PRSS2,Trypsin-2,16174,0.0193063577466317,0.0603868801127105,-0.0990519272742808,0.137664642767544,0.749191453888097
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GM2A,Ganglioside GM2 activator,13624,0.0140796127716265,0.0441733307495885,-0.072500115497567,0.10065934104082,0.749931913050895
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,13894,0.0138510008645607,0.0435726823448181,-0.0715514565312828,0.0992534582604042,0.750578716166777
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,UPK3A,Uroplakin-3a,13474,0.0176624534985765,0.0555763295920184,-0.0912671525017796,0.126592059498932,0.750637541062029
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,13552,-0.0158921262024795,0.0500223109020095,-0.113935855570418,0.0821516031654591,0.750716834340078
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,METAP2,Methionine aminopeptidase 2,16186,0.0205498166828921,0.0647298613314382,-0.106320711526727,0.147420344892511,0.750890774565909
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EPHA4,Ephrin type-A receptor 4,13684,-0.0103404229064738,0.0327138721882937,-0.0744596123955294,0.0537787665825819,0.751941457702751
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ATF2,Cyclic AMP-dependent transcription factor ATF-2,15688,-0.0243718396306186,0.0773942602533444,-0.176064589727174,0.127320910465937,0.75283797597299
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,16174,0.0135185684188796,0.0430758819211557,-0.0709101601465855,0.0979472969843448,0.753653073267222
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GGCT,Gamma-glutamylcyclotransferase,13953,0.016929327994598,0.0539707852005481,-0.0888534109984763,0.122712066987672,0.753771993602176
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SLITRK2,SLIT and NTRK-like protein 2,16209,0.0138275860726483,0.0441901466473814,-0.0727851013562193,0.100440273501516,0.754352256188936
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KIAA2013,Uncharacterized protein KIAA2013,13894,-0.0200968482893609,0.0642779467156216,-0.146081623851979,0.105887927273258,0.754547167031585
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NPTX2,Neuronal pentraxin-2,13972,0.0116697946492711,0.0373478307571669,-0.0615319536347761,0.0848715429333182,0.754693764801848
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,13480,0.0197883465607244,0.0633716766204179,-0.104420139615295,0.143996832736743,0.754848888833287
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SUSD2,Sushi domain-containing protein 2,16101,0.0101811974511568,0.0327214983910298,-0.0539529393952615,0.0743153342975751,0.755692871614653
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PCDHB15,Protocadherin beta-15,13894,-0.0142043579265287,0.045725959827372,-0.103827239188178,0.0754185233351203,0.756078218399623
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MSTN,Growth/differentiation factor 8,15778,-0.0184969592247972,0.0598453988752142,-0.135793941020217,0.0988000225706226,0.75726547739574
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MYOC,Myocilin,16101,0.0160312076392895,0.0518889943735061,-0.0856712213327825,0.117733636611361,0.757362054960772
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TP53BP1,TP53-binding protein 1,13552,-0.030515952774667,0.0988047058285854,-0.224173176198694,0.16314127064936,0.757439466083591
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,16301,-0.00804545445361697,0.0261340928904865,-0.0592682765189705,0.0431773676117366,0.758198256566493
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PECAM1,Platelet endothelial cell adhesion molecule,16101,0.0105411132258213,0.0342516236089374,-0.0565920690476959,0.0776742954993386,0.758272642964306
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ERMAP,Erythroid membrane-associated protein,13552,0.0156004237530097,0.0507862971678329,-0.0839407186959427,0.115141566201962,0.758712756229692
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KIAA0319,Dyslexia-associated protein KIAA0319,13927,0.0108963786857512,0.0354766749173275,-0.0586379041522106,0.0804306615237131,0.758739848574939
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CNPY4,Protein canopy homolog 4,16008,0.0263309446126772,0.0858666728628747,-0.141967734198557,0.194629623423912,0.759114409333955
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EPHB4,Ephrin type-B receptor 4,16301,-0.00855987517147391,0.0279941833955221,-0.0634284746266972,0.0463087242837494,0.759781130592891
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RANGAP1,Ran GTPase-activating protein 1,15724,-0.0170044716500326,0.055741960093959,-0.126258713434192,0.092249770134127,0.760326828877839
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL2RG,Cytokine receptor common subunit gamma,13894,0.0128728472447362,0.0422600711183115,-0.0699568921471544,0.0957025866366267,0.760667643899794
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ATG4A,Cysteine protease ATG4A,15724,-0.0208538320113678,0.0684820493623989,-0.15507864876167,0.113370984738934,0.760739369421783
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PILRA,Paired immunoglobulin-like type 2 receptor alpha,16101,-0.0145586493575935,0.0478413212865646,-0.10832763907926,0.0792103403640731,0.760894757825946
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SPINK1,Serine protease inhibitor Kazal-type 1,16101,0.0145088046201988,0.0478260526575204,-0.0792302585885412,0.108247867828939,0.761614775747124
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,16301,0.00928579466360877,0.0306953411395095,-0.0508770739698299,0.0694486632970474,0.762263524029179
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PSME1,Proteasome activator complex subunit 1,15929,-0.0126771015747065,0.0421252592013493,-0.0952426096093511,0.069888406459938,0.763465517275333
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LPO,Lactoperoxidase,15527,0.0204097011164854,0.0678839777927473,-0.112642895357299,0.15346229759027,0.763681124011802
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,REG3G,Regenerating islet-derived protein 3-gamma,13894,0.0140129394781701,0.0466972869986013,-0.0775137430390884,0.105539621995429,0.764120340718864
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SAA4,Serum amyloid A-4 protein,13992,-0.0107535162903503,0.0358469142864372,-0.0810134682917673,0.0595064357110666,0.764193489852251
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MAGED1,Melanoma-associated antigen D1,15724,-0.0164742985934387,0.0549354586539874,-0.124147797555254,0.0911992003683766,0.764269141402145
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ARHGAP30,Rho GTPase-activating protein 30,13710,0.0137540783669743,0.0459032503002512,-0.0762162922215181,0.103724448955467,0.764462491331448
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BAG6,Large proline-rich protein BAG6,15778,-0.0123145358812043,0.0411368881247206,-0.0929428366056568,0.0683137648432482,0.764673089197866
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PZP,Pregnancy zone protein,13992,0.0179868865896227,0.0601144993936243,-0.0998375322218809,0.135811305401126,0.764783922588041
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TNF,Tumor necrosis factor,15757,0.0130854672480587,0.0437364460610584,-0.0726379670316158,0.0988089015277333,0.76479972691195
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FAM20A,Pseudokinase FAM20A,13974,-0.00953847288515596,0.0319037696851378,-0.072069861468026,0.0529929156977141,0.76496253452809
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KRT14,"Keratin, type I cytoskeletal 14",15195,-0.00957576026440092,0.0321601998897476,-0.0726097520483062,0.0534582315195043,0.765896611390846
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TTR,Transthyretin,13839,0.00855051459542225,0.0287964606600064,-0.0478905482981904,0.0649915774890348,0.766524902284607
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EDNRB,Endothelin receptor type B,13552,0.0152426029783646,0.0513694324209263,-0.085441484566651,0.11592669052338,0.766680899914621
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GALNT7,N-acetylgalactosaminyltransferase 7,16008,0.00706020549915545,0.0238320761429519,-0.0396506637410303,0.0537710747393412,0.767044521328357
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,13610,0.00694899480820975,0.0234889391426928,-0.039089325911468,0.0529873155278875,0.767355912477549
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NPTXR,Neuronal pentraxin receptor,16102,0.0114950180875759,0.0388781510596594,-0.0647061579893566,0.0876961941645083,0.767487592350542
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SIT1,Signaling threshold-regulating transmembrane adapter 1,15826,0.0187005998593422,0.063279435036023,-0.105327092811263,0.142728292529947,0.767597403920904
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DIPK2B,Divergent protein kinase domain 2B,13684,0.00935849488073221,0.0317236240167473,-0.0528198081920925,0.0715367979535569,0.767997738486696
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CINP,Cyclin-dependent kinase 2-interacting protein,13710,0.0154394529377622,0.0523652970221175,-0.0871965292255881,0.118075435101113,0.768119574035415
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ALCAM,CD166 antigen,16301,-0.00649546314367082,0.0220306415031392,-0.0496755204898237,0.0366845942024821,0.768121641591565
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,WARS,"Tryptophan--tRNA ligase, cytoplasmic",16101,-0.0125984786989795,0.0428166615074836,-0.0965191352536473,0.0713221778556883,0.768576453740758
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ADGRE5,Adhesion G protein-coupled receptor E5,16227,-0.0100097184926926,0.0340733229256322,-0.0767934314269317,0.0567739944415465,0.768937456494574
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CADPS,Calcium-dependent secretion activator 1,13590,-0.0142311613781828,0.0484912215877152,-0.109273955690105,0.080811632933739,0.769160437715439
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CCL5,C-C motif chemokine 5,16174,-0.0338326192270209,0.115406122344818,-0.260028619022864,0.192363380568822,0.769402558897122
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,VEGFA,Vascular endothelial growth factor A,16216,0.0191652924760394,0.0653902798026984,-0.10899965593725,0.147330240889328,0.769456466558362
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,13486,0.0172868981194896,0.0591886934522539,-0.0987229410469279,0.133296737285907,0.770242039062581
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,YJU2,Splicing factor YJU2,13894,0.0107515012506965,0.0368529354498752,-0.0614802522310589,0.082983254732452,0.770489246650025
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LYN,Tyrosine-protein kinase Lyn,16008,0.0280468449363251,0.0963536755331593,-0.160806359108667,0.216900048981317,0.770992187259844
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CTSD,Cathepsin D,15078,0.0136277385453856,0.0470368585524071,-0.0785645042173323,0.105819981308103,0.772030865335737
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ACTN2,Alpha-actinin-2,13486,-0.0191468630277049,0.0662598886175137,-0.149016244718032,0.110722518662622,0.772611749383699
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD164L2,CD164 sialomucin-like 2 protein,13590,-0.0121889519169107,0.0422654722171358,-0.0950292774624969,0.0706513736286754,0.773052400024672
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,F12,Coagulation factor XII,13992,-0.0135993588945806,0.0471638825379358,-0.106040568668935,0.0788418508797736,0.773088737849545
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TREH,Trehalase,13972,0.0242835923439522,0.0842425192744059,-0.140831745433883,0.189398930121788,0.77315342344138
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BLVRB,Flavin reductase,16101,0.0219234035480371,0.076130815825934,-0.127292995470793,0.171139802566868,0.773373286794301
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SERPIND1,Heparin cofactor 2,13968,0.00914516846758182,0.031799871919078,-0.053182580493811,0.0714729174289746,0.773668643539807
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SMNDC1,Survival of motor neuron-related-splicing factor 30,13913,-0.0207955772700907,0.0725157827634738,-0.162926511486499,0.121335356946318,0.774290320618157
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL13RA2,Interleukin-13 receptor subunit alpha-2,13474,0.00942133735742366,0.0328926061440104,-0.0550481706848368,0.0738908453996841,0.774555346220576
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IPCEF1,Interactor protein for cytohesin exchange factors 1,15924,0.0286386968267707,0.100021214971796,-0.16740288451795,0.224680278171491,0.774632002573915
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SPINK4,Serine protease inhibitor Kazal-type 4,16073,0.0207383771333392,0.0724753182312304,-0.121313246599872,0.162790000866551,0.774771527076026
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TGM2,Protein-glutamine gamma-glutamyltransferase 2,16086,0.0246011283873858,0.086005389011916,-0.14396943407597,0.193171690850741,0.774849863559132
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,OMG,Oligodendrocyte-myelin glycoprotein,16008,0.0212761372712252,0.0745113343578078,-0.124766078070078,0.167318352612528,0.775232404898531
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",15724,0.0255544328345857,0.0897732752213181,-0.150401186599198,0.201510052268369,0.775912040896978
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ADIPOQ,Adiponectin,13992,0.0215723510060872,0.0764472204001803,-0.128264200978266,0.171408902990441,0.777804913332678
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AKT1S1,Proline-rich AKT1 substrate 1,15688,-0.0209105155533149,0.0741524300556073,-0.166249278462305,0.124428247355675,0.777952090574588
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CA6,Carbonic anhydrase 6,16046,-0.0202245259256037,0.0718145727069826,-0.16098108843129,0.120532036580082,0.778237406195432
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,15950,0.017563796007119,0.0625016639021715,-0.104939465241137,0.140067057255375,0.778703881662315
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NPY,Pro-neuropeptide Y,16209,-0.0206392111679224,0.073961062081988,-0.165602892848619,0.124324470512774,0.780206107309826
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ARSA,Arylsulfatase A,16101,-0.0141581716957029,0.0507648523017233,-0.113657282207081,0.0853409388156748,0.780327354828467
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SMOC2,SPARC-related modular calcium-binding protein 2,16160,-0.012065746373043,0.0433878155814663,-0.0971058649127169,0.0729743721666309,0.780946324374367
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SIGLEC8,Sialic acid-binding Ig-like lectin 8,13610,-0.0144439969462244,0.0519653790381763,-0.11629613986105,0.0874081459686011,0.781051719973169
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CREBZF,CREB/ATF bZIP transcription factor,13480,0.00844572453958638,0.0304248325058162,-0.0511869471718134,0.0680783962509861,0.781328966444978
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GZMA,Granzyme A,16272,0.0108684940063571,0.0391749917135959,-0.0659144897522908,0.087651477765005,0.781450025721827
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CRADD,Death domain-containing protein CRADD,15925,0.0237688651491899,0.0856926824871935,-0.144188792525709,0.191726522824089,0.781497057572867
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CALY,Neuron-specific vesicular protein calcyon,13486,-0.0119212360178553,0.04307362695569,-0.0963455448510078,0.0725030728152971,0.781965451591902
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,15724,0.0181704144633533,0.0656544099207619,-0.11051222898134,0.146853057908047,0.781969208124024
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,13710,0.0162757935721351,0.0588640782824068,-0.0990977998613822,0.131649387005652,0.782169850562646
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PLAUR,Urokinase plasminogen activator surface receptor,15969,0.0085811441123608,0.0310669913567918,-0.0523101589469511,0.0694724471716727,0.782387130176727
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FADD,FAS-associated death domain protein,16102,0.0239933751817662,0.0873668769943734,-0.147245703727206,0.195232454090738,0.783605715012599
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",13590,0.0247702207193083,0.0902789121109781,-0.152176447018209,0.201716888456825,0.783801102727864
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EPB41L5,Band 4.1-like protein 5,13590,0.0202755232408671,0.0739303216592324,-0.124627907211228,0.165178953692963,0.783895301258673
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL6,Interleukin-6,16008,0.0225157684846444,0.0821381732539838,-0.138475051093164,0.183506588062453,0.783995454036751
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ENG,Endoglin,16301,-0.0053160641152057,0.0194211148508494,-0.0433814492228706,0.0327493209924592,0.784298665272895
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BPIFB1,BPI fold-containing family B member 1,16087,0.0194448627245936,0.0713797257572106,-0.120459399759539,0.159349125208726,0.785306927246972
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PI3,Elafin,15905,0.0165565127973823,0.0610534094450436,-0.103108169714903,0.136221195309668,0.78625549681997
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PCYT2,Ethanolamine-phosphate cytidylyltransferase,13913,0.0236508017589967,0.0872652397429718,-0.147389068137228,0.194690671655221,0.786378119180243
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MLN,Promotilin,16073,0.0270284444938656,0.0997301757402466,-0.168442699957018,0.222499588944749,0.786382431876825
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,15724,0.0237303324368082,0.0880707277646723,-0.14888829398195,0.196348958855566,0.787589793435781
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL20RA,Interleukin-20 receptor subunit alpha,15826,-0.0135915015628965,0.0504654247653388,-0.11250373410296,0.0853207309771675,0.787684618571161
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RGMB,RGM domain family member B,16230,0.00809327680316575,0.0300657974675008,-0.0508356862331358,0.0670222398394673,0.787790360663295
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AMN,Protein amnionless,15826,0.0145092639463234,0.053907559158115,-0.0911495520035821,0.120168079896229,0.787817133113053
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SHH,Sonic hedgehog protein,13552,0.0131366751082352,0.0488387155460347,-0.0825872073619927,0.108860557578463,0.787948582963082
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NELL2,Protein kinase C-binding protein NELL2,16160,0.00869747000592014,0.0324776788429815,-0.0549587805263237,0.0723537205381639,0.788857933211052
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SMOC1,SPARC-related modular calcium-binding protein 1,16209,-0.00986529817348968,0.0368687277679619,-0.0821280045986949,0.0623974082517156,0.789026786653036
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ARID4B,AT-rich interactive domain-containing protein 4B,15688,-0.0124767187279297,0.0467355768695893,-0.104078449392325,0.0791250119364653,0.789500355406737
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ZBTB16,Zinc finger and BTB domain-containing protein 16,15724,0.0216918766520989,0.0813530272651499,-0.137760056787595,0.181143810091793,0.789750749079946
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,13610,0.0101034107417327,0.0378947991393493,-0.064170395571392,0.0843772170548574,0.789767842767266
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CXCL1,Growth-regulated alpha protein,16055,0.0282976316649539,0.106306092737849,-0.18006231010123,0.236657573431138,0.790096212348538
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD164,Sialomucin core protein 24,16101,-0.00828457563839325,0.0311785552359449,-0.0693945439008452,0.0528253926240587,0.790462959206935
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CLPS,Colipase,16074,-0.0211743384679044,0.0797279419895391,-0.177441104767401,0.135092427831592,0.790564247844207
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FGA,Fibrinogen alpha chain,13679,-0.00917855343573208,0.0345876442272798,-0.0769703361212005,0.0586132292497363,0.790727772916937
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,STC2,Stanniocalcin-2,16081,-0.00760254248123276,0.0286971234022442,-0.0638489043496314,0.0486438193871659,0.791071790073686
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BTC,Probetacellulin,15724,-0.0224679475867898,0.0848316333183493,-0.188737948890754,0.143802053717175,0.791125862985726
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CETN2,Centrin-2,15688,0.0199529673086793,0.0755270218934855,-0.128079995602552,0.167985930219911,0.791642259955408
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HGF,Hepatocyte growth factor,16272,-0.0103005431355076,0.0390076023088966,-0.0867554436609449,0.0661543573899297,0.791733167358388
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,13894,0.0187555150079236,0.0711781182644568,-0.120753596790412,0.158264626806259,0.792168259739308
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RPE,Ribulose-phosphate 3-epimerase,13710,0.0218584663522542,0.08304721024222,-0.140914065722497,0.184630998427005,0.792396301003368
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ADRA2A,Alpha-2A adrenergic receptor,13486,0.021611126196092,0.0822921830647383,-0.139681552610795,0.182903805002979,0.792851685194788
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SLC39A5,Zinc transporter ZIP5,16073,-0.0158952494835554,0.0605449259725099,-0.134563304389675,0.102772805422564,0.792911260879161
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NMI,N-myc-interactor,13836,0.0215788248895801,0.0829039901141384,-0.140912995734131,0.184070645513291,0.794646332462396
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GUCA2A,Guanylin,16024,0.00984845976931361,0.0379077995642778,-0.0644508273766708,0.0841477469152981,0.795021118083314
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SPON2,Spondin-2,16043,-0.0100820262855853,0.0388163939426498,-0.086162158413179,0.0659981058420083,0.795070530919337
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AHSG,Alpha-2-HS-glycoprotein,13982,0.00780468090874668,0.0300543515676678,-0.0511018481638822,0.0667112099813755,0.795110164677392
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TOP1MT,"DNA topoisomerase I, mitochondrial",13480,-0.0144364523074907,0.0556254363963444,-0.123462307644326,0.0945894030293444,0.795230544065203
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DNAJB14,DnaJ homolog subfamily B member 14,13913,0.0193864191932335,0.0747638890782827,-0.127150803400201,0.165923641786668,0.795406146525746
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GART,Trifunctional purine biosynthetic protein adenosine-3,13946,0.00753952565170354,0.0290781645486034,-0.049453676863559,0.0645327281669661,0.795419348563017
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TPPP3,Tubulin polymerization-promoting protein family member 3,15688,0.0113935792895499,0.0439796693364789,-0.0748065726099487,0.0975937311890484,0.795588732296434
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CDH22,Cadherin-22,13710,0.00856556618955082,0.0331210175143849,-0.0563516281386436,0.0734827605177453,0.795936794818429
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DUSP3,Dual specificity protein phosphatase 3,15688,-0.0245963857586905,0.0951262057769578,-0.211043749081528,0.161850977564147,0.795973650468592
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CGREF1,Cell growth regulator with EF hand domain protein 1,16102,0.0124816221072543,0.0482845808621025,-0.0821561563824666,0.107119400596975,0.796023429601821
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD69,Early activation antigen CD69,16036,0.0258314194832087,0.100200175713328,-0.170560924914914,0.222223763881332,0.796566006709407
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,INSL5,Insulin-like peptide INSL5,13913,0.0284716302888879,0.110479831209008,-0.188068838880768,0.245012099458544,0.796635430448817
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SKIV2L,Helicase SKI2W,13486,-0.0117329807116972,0.0455991977370889,-0.101107408276391,0.077641446852997,0.796945922981664
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RAC3,Ras-related C3 botulinum toxin substrate 3,13590,-0.0201173771650799,0.0782657400755688,-0.173518227713195,0.133283473383035,0.797152269923698
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IFNAR1,Interferon alpha/beta receptor 1,13913,-0.00752906022099155,0.0293425852243481,-0.0650405272607138,0.0499824068187307,0.797497875586897
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EXOSC10,Exosome component 10,13486,-0.0173203363832439,0.067686883713426,-0.149986628461559,0.115345955695071,0.79804037107135
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SEMA3G,Semaphorin-3G,13684,0.0129237045717216,0.0506036453265342,-0.0862594402682856,0.112106849411729,0.798425131682298
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FOXO1,Forkhead box protein O1,16073,0.0243514328140206,0.0957259067450245,-0.163271344406227,0.211974210034269,0.799199797261315
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,16107,0.00967444809336272,0.0380612930557749,-0.0649256862959561,0.0842745824826816,0.799359167466065
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,13590,0.0156580076767327,0.0619771774282663,-0.105817260082669,0.137133275436135,0.800549075044902
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PMS1,PMS1 protein homolog 1,13590,0.0148353901714115,0.0587977709517414,-0.100408240894002,0.130079021236825,0.800803641262966
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TACC3,Transforming acidic coiled-coil-containing protein 3,16008,0.0334951803938107,0.132794277835437,-0.226781604163646,0.293771964951268,0.800863740029622
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NOS2,"Nitric oxide synthase, inducible",13486,-0.0112757499047386,0.045119834023487,-0.0997106245907732,0.077159124781296,0.802663293640688
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BDNF,Brain-derived neurotrophic factor,13972,0.0234590233504309,0.0939610673090644,-0.160704668575335,0.207622715276197,0.802848179327487
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",13710,0.0143391881145749,0.0575276175241497,-0.0984149422327584,0.127093318461908,0.803165368866521
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SCARA5,Scavenger receptor class A member 5,16230,-0.00833317696346757,0.0335555222043676,-0.0741020004840281,0.057435646557093,0.803874530053252
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MTDH,Protein LYRIC,13552,0.0258904422776977,0.104333778017401,-0.178603762636408,0.230384647191804,0.804022001274899
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FYB1,FYN-binding protein 1,16074,0.0257696045664359,0.103968256807111,-0.178008178775502,0.229547387908374,0.804245657076326
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,16132,0.0250069824692221,0.101059008873073,-0.173068674922001,0.223082639860445,0.80456366491403
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,UGDH,UDP-glucose 6-dehydrogenase,13486,-0.0279538173497572,0.113010940297864,-0.249455260333571,0.193547625634056,0.804637292329967
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TPBGL,Trophoblast glycoprotein-like,13590,-0.0117034597311674,0.0474428184616345,-0.104691383915971,0.0812844644536362,0.805155288221911
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PGM2,Phosphoglucomutase-2,13590,-0.0169406374597277,0.0687988536068073,-0.15178639052907,0.117905115609615,0.805504588972334
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KLK15,Kallikrein-15,13871,-0.0144395339891345,0.0586832486251841,-0.129458701294495,0.100579633316226,0.805640303851014
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,16230,-0.0197363195651322,0.0805576203235242,-0.17762925539924,0.138156616268975,0.806462390095739
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL1R1,Interleukin-1 receptor type 1,16065,0.00622058915528752,0.0256063861672029,-0.0439679277324302,0.0564091060430053,0.808061828644774
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PPCDC,Phosphopantothenoylcysteine decarboxylase,16230,0.0129285249376263,0.0532434965913114,-0.091428728381344,0.117285778256597,0.808148798683936
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",13486,0.0119472305920488,0.049285292983662,-0.0846519436559288,0.108546404840026,0.808466448237604
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LAT,Linker for activation of T-cells family member 1,16272,0.0207624973586113,0.0858813675019693,-0.147564982945249,0.189089977662471,0.808970826636936
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GFRA1,GDNF family receptor alpha-1,16186,-0.0076507503639041,0.0317622563173556,-0.069904772745921,0.0546032720181128,0.809654640603448
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CKAP4,Cytoskeleton-associated protein 4,16200,0.00734586203022199,0.030504438644744,-0.0524428377134763,0.0671345617739203,0.809703188785561
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SCN3B,Sodium channel subunit beta-3,13474,0.0130125449332099,0.0541024741723196,-0.0930283044445365,0.119053394310956,0.809933433269299
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GKN1,Gastrokine-1,15371,0.00747857206683036,0.0311807171257554,-0.0536356334996502,0.0685927776333109,0.81045280141513
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IGFBP2,Insulin-like growth factor-binding protein 2,16277,0.0168204260187437,0.0701402411619135,-0.120654446658607,0.154295298696094,0.810479528928109
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,16102,0.0227490799560178,0.0948868719953011,-0.163229189154772,0.208727349066808,0.810527514060531
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IGHMBP2,DNA-binding protein SMUBP-2,13486,0.0155853385078363,0.0654149782164493,-0.112628018796404,0.143798695812077,0.811688214865455
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,F2R,Proteinase-activated receptor 1,16132,0.015378990947506,0.0647787041872554,-0.111587269259515,0.142345251154526,0.812343201520174
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SPINK8,Serine protease inhibitor Kazal-type 8,13486,-0.00982476653106682,0.0414238024388031,-0.091015419311121,0.0713658862489874,0.812523209724092
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,THOP1,Thimet oligopeptidase,16013,-0.00846150830355299,0.0356822181997365,-0.0783986559750366,0.0614756393679306,0.812554977351931
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,13710,0.014538608838084,0.0613479491845663,-0.105703371563666,0.134780589239834,0.812671148233555
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DYNLT1,Dynein light chain Tctex-type 1,13590,-0.021912886643436,0.092682493565181,-0.203570574031191,0.159744800744319,0.813102881817085
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TIMP4,Metalloproteinase inhibitor 4,16101,0.0106748574658534,0.0452170634698849,-0.077950586935121,0.0993003018668277,0.813373373327233
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL10,Interleukin-10,15826,-0.0217356017157294,0.0920760537591272,-0.202204667083619,0.15873346365216,0.813388087070011
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SCN2A,Sodium channel protein type 2 subunit alpha,13474,-0.0133595457189355,0.0567225277432297,-0.124535700095666,0.0978166086577947,0.8138052385015
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PSG1,Pregnancy-specific beta-1-glycoprotein 1,15950,0.029975101158696,0.127345296717984,-0.219621680408552,0.279571882725944,0.813913387682476
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD300LF,CMRF35-like molecule 1,16209,0.0160917720670559,0.0684171650892882,-0.118005871507949,0.150189415642061,0.81405585767851
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ING1,Inhibitor of growth protein 1,15663,0.0123568851730105,0.0525650771856088,-0.0906706661107828,0.115384436456804,0.81415138829852
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,16148,-0.00820650209682665,0.0349222102916857,-0.0766540342685307,0.0602410300748773,0.814216545496479
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CLSTN2,Calsyntenin-2,16272,-0.0103650471765432,0.0441894649680055,-0.0969763985138341,0.0762463041607476,0.814553804984356
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DIPK1C,Divergent protein kinase domain 1C,13590,-0.0118300313913339,0.0504544166169265,-0.11072068796051,0.087060625177842,0.81462389762743
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,13710,0.0121963471619663,0.05204874736438,-0.0898191976722185,0.114211891996151,0.814735817108353
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SELP,P-selectin,16174,0.0152321349579348,0.0651114945512172,-0.112386394362451,0.142850664278321,0.815035095847565
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL1RL2,Interleukin-1 receptor-like 2,15826,-0.0105862374746308,0.0452587511981877,-0.0992933898230787,0.0781209148738172,0.815061943584932
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,16101,-0.00984521555843373,0.0421225985235026,-0.0924055086644989,0.0727150775476314,0.815199402158096
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,COMMD9,COMM domain-containing protein 9,13894,0.0105533670760699,0.0452561614094287,-0.0781487092864103,0.0992554434385501,0.815615888734988
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GIMAP8,GTPase IMAP family member 8,13480,-0.0134706823801069,0.0577678291148291,-0.126695627445172,0.0997542626849582,0.815620072216007
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SF3B4,Splicing factor 3B subunit 4,16008,0.0195398061081659,0.083865490960489,-0.144836556174392,0.183916168390724,0.815772287864171
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,VPS4B,Vacuolar protein sorting-associated protein 4B,13894,0.0253807929679863,0.108994470464179,-0.188248369141804,0.239009955077776,0.815871127119165
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,13974,0.00845030654597936,0.0364055784953586,-0.0629046273049234,0.0798052403968822,0.816451548952776
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CCL16,C-C motif chemokine 16,16301,0.0138659887787851,0.0597432548467521,-0.103230790720849,0.130962768278419,0.81646872972461
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RNF168,E3 ubiquitin-protein ligase RNF168,13552,0.0108050069243939,0.0465776006675408,-0.080487090383986,0.102097104232774,0.816558135969201
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CXCL10,C-X-C motif chemokine 10,16160,-0.0173523597193664,0.0750030220295393,-0.164358282897263,0.129653563458531,0.817041585009237
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ADGRG1,Adhesion G-protein coupled receptor G1,16008,0.0178965957410682,0.0774665714170756,-0.1339378842364,0.169731075718536,0.817299527798341
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DENND2B,DENN domain-containing protein 2B,13486,0.0128239253831045,0.0555578138536804,-0.0960693897701091,0.121717240536318,0.817457158129272
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GP1BB,Platelet glycoprotein Ib beta chain,13486,0.0178058032001076,0.0771739013514758,-0.133455043448785,0.169066649849,0.817533415421129
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SPESP1,Sperm equatorial segment protein 1,13974,0.00776445225679086,0.0338458205575466,-0.0585733560360005,0.0741022605495822,0.818556321910514
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,13992,0.00475803795025584,0.0207693153146299,-0.0359498200664188,0.0454658959669305,0.818802485487894
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PDRG1,p53 and DNA damage-regulated protein 1,13590,-0.0141421389611234,0.0618476246147431,-0.13536348320602,0.107079205283773,0.819135862480422
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RWDD1,RWD domain-containing protein 1,16230,0.0163504913104977,0.0715725895754568,-0.123931784257398,0.156632766878393,0.819302200545575
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MAPK13,Mitogen-activated protein kinase 13,13480,-0.0115018194280827,0.0504624811179462,-0.110408282419257,0.0874046435630919,0.819705566982076
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD27,CD27 antigen,16118,-0.0105890624313357,0.0464586983816621,-0.101648111259393,0.0804699863967221,0.819708049728035
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CDH3,Cadherin-3,16230,-0.00920103574452821,0.0404311392370955,-0.0884460686492354,0.0700439971601789,0.819981079297675
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,13552,-0.0079903534180732,0.0352441612445376,-0.0770689094573668,0.0610882026212204,0.820649372368843
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SERPINB6,Serpin B6,16171,-0.0153142216512097,0.0676000229847424,-0.147810266701305,0.117181823398885,0.820783024545174
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SCGN,Secretagogin,15826,-0.0113581802584437,0.0503343938214453,-0.110013592148476,0.0872972316315892,0.821473099603877
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PALM3,Paralemmin-3,13486,0.0195969054201584,0.0874264615661679,-0.151758959249531,0.190952770089848,0.822641636775706
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",13480,0.0146395943322289,0.0654793646953929,-0.113699960470741,0.142979149135199,0.82309087065773
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,S100A13,Protein S100-A13,13552,0.00897908897128177,0.0401981898555866,-0.069809363145668,0.0877675410882315,0.823250547541479
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BRD2,Bromodomain-containing protein 2,13474,-0.0087202924512163,0.039149565049159,-0.0854534399475678,0.0680128550451352,0.823738895043504
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RALY,RNA-binding protein Raly,13894,-0.012685287420634,0.0570768077680164,-0.124555830645946,0.0991852558046781,0.824122994337302
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NECTIN1,Nectin-1,13552,-0.00835025937716935,0.0376317027485069,-0.0821083967642429,0.0654078780099042,0.824399534726595
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PQBP1,Polyglutamine-binding protein 1,15724,0.0144684759402617,0.0652972524599467,-0.113514138881234,0.142451090761757,0.824644797351049
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,COL15A1,Collagen alpha-1(XV) chain,13972,0.00652047747521873,0.0295017752757475,-0.0513030020652463,0.0643439570156838,0.825080222402764
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ENDOU,Poly(U)-specific endoribonuclease,12870,-0.0141395064833727,0.0640997672203742,-0.139775050235306,0.111496037268561,0.825418363675249
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BAG3,BAG family molecular chaperone regulator 3,15924,-0.00980038889088202,0.0444994460931351,-0.0970193032334268,0.0774185254516628,0.825690031220454
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DCUN1D1,DCN1-like protein 1,13474,0.0190803117635604,0.0866801344237091,-0.150812751706909,0.18897337523403,0.825778516480475
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CLEC4C,C-type lectin domain family 4 member C,16073,-0.0118228478814414,0.0537477421454607,-0.117168422486544,0.0935227267236616,0.825897937460191
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CEP112,Centrosomal protein of 112 kDa,13486,-0.0113948055674013,0.0518239322989158,-0.112969712873276,0.0901801017384736,0.825971561059596
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ZBTB17,Zinc finger and BTB domain-containing protein 17,15778,0.0106402246230488,0.0485087388995886,-0.0844369036201447,0.105717352866242,0.826382941295966
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD34,Hematopoietic progenitor cell antigen CD34,16176,0.00600068936954697,0.0273929967061648,-0.047689584174536,0.05969096291363,0.826606658171949
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CENPJ,Centromere protein J,13710,-0.017815212662502,0.0816232951527531,-0.177796871161898,0.142166445836894,0.827228718760814
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CDA,Cytidine deaminase,13946,-0.0116823191900192,0.0535449815844228,-0.116630483095488,0.0932658447154495,0.82729388013354
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,15724,-0.0167636071707233,0.0773181208936527,-0.168307124122283,0.134779909780836,0.828356558803707
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL6R,Interleukin-6 receptor subunit alpha,16031,0.00827902844985294,0.0382675926073611,-0.0667254530605747,0.0832835099602806,0.828721057596817
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MNDA,Myeloid cell nuclear differentiation antigen,16073,-0.0249578199685739,0.115448672698374,-0.251237218457388,0.20132157852024,0.828849338363681
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD3D,T-cell surface glycoprotein CD3 delta chain,13474,0.00846665919565158,0.0392285567978126,-0.068421312128061,0.0853546305193642,0.829124332337183
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SIRT2,NAD-dependent protein deacetylase sirtuin-2,16008,0.0215795293107278,0.100112249107918,-0.174640478940792,0.217799537562248,0.829338681364461
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ARID3A,AT-rich interactive domain-containing protein 3A,13474,0.00987780864339156,0.0459337286886343,-0.0801522995863316,0.0999079168731147,0.829735662710694
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DSG2,Desmoglein-2,16101,0.00647394498237481,0.0301821187417081,-0.0526830077513731,0.0656308977161227,0.830162972590616
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CPA4,Carboxypeptidase A4,13383,0.0105707833213449,0.0493476052067197,-0.0861505228838256,0.107292089526515,0.83038604666006
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GRSF1,G-rich sequence factor 1,13403,0.0200346785633314,0.0938250072038342,-0.163862335556184,0.203931692682846,0.830914974911665
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CREB3,Cyclic AMP-responsive element-binding protein 3,13480,0.0133095435699315,0.0624006209001444,-0.108995673394351,0.135614760534214,0.83110256274379
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NAMPT,Nicotinamide phosphoribosyltransferase,15724,0.0131045689746921,0.0614761957925255,-0.107388774778658,0.133597912728042,0.831201087355489
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PGF,Placenta growth factor,16272,0.00599857236425934,0.0281980488466333,-0.049269603375142,0.0612667481036606,0.83154019310356
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IDI2,Isopentenyl-diphosphate delta-isomerase 2,15688,0.0112723167885502,0.0530390096536568,-0.0926841421326172,0.115228775709718,0.831697279707948
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,15950,-0.0079014483374031,0.0371956443498537,-0.0808049112631163,0.0650020145883101,0.831774769765727
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,16008,0.0226396951325704,0.106656307530463,-0.186406667627137,0.231686057892277,0.831900853657308
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AXL,Tyrosine-protein kinase receptor UFO,16174,0.00661948962550848,0.0312328423162241,-0.0545968813142908,0.0678358605653077,0.832156491147388
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ANXA4,Annexin A4,16022,0.017589343794749,0.0831315665093616,-0.1453485265636,0.180527214153098,0.832433963303981
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HSPB6,Heat shock protein beta-6,16209,0.00914629905557586,0.0432362555422612,-0.0755967618072561,0.0938893599184078,0.832466752045783
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AGRP,Agouti-related protein,16272,0.0125126070563614,0.059326848667053,-0.103768016331063,0.128793230443785,0.832960388680489
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RGMA,Repulsive guidance molecule A,16230,-0.00741394333556607,0.03515487675791,-0.0763175017810696,0.0614896151099375,0.832972841269268
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PEAR1,Platelet endothelial aggregation receptor 1,16301,0.00544656674123933,0.025832307474826,-0.0451847559094196,0.0560778893918983,0.833012254037905
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TMPRSS11D,Transmembrane protease serine 11D,13893,-0.00929305834140589,0.0441066961915308,-0.0957421828768062,0.0771560661939945,0.833128405175512
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MRPL28,"39S ribosomal protein L28, mitochondrial",13946,-0.008677370817021,0.0411943150581292,-0.0894182283309542,0.0720634866969122,0.833167483296074
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ZP4,Zona pellucida sperm-binding protein 4,13480,0.00815912974079317,0.0387651397493736,-0.0678205441679791,0.0841388036495654,0.833299402380613
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GHRL,Appetite-regulating hormone,16102,0.0191970268531672,0.0916032894204269,-0.16034542041087,0.198739474117204,0.834008288856012
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CTSB,Cathepsin B,16106,-0.0124851041908253,0.0595935010556099,-0.129288366259821,0.10431815787817,0.834057107012302
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,13474,-0.0147560166128905,0.0705961634809041,-0.153124497035462,0.123612463809681,0.83443571661153
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,15778,0.00723242943261791,0.0346528123581589,-0.0606870827893735,0.0751519416546094,0.834676406863377
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CARHSP1,Calcium-regulated heat-stable protein 1,15688,-0.0122155773181462,0.0585969447111788,-0.127065588952057,0.102634434315764,0.834866415414581
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,13610,0.0060264599938933,0.0289616995099497,-0.0507384710456082,0.0627913910333948,0.835166666178725
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,13710,-0.0158650717123378,0.0764516779323792,-0.165710360459801,0.133980217035125,0.835608703749514
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NOTCH3,Neurogenic locus notch homolog protein 3,16301,-0.00788763389528765,0.0380314503476057,-0.0824292765765949,0.0666540087860195,0.835701901061119
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL3RA,Interleukin-3 receptor subunit alpha,15826,-0.00756585749498875,0.0365557573692215,-0.0792151419386629,0.0640834269486854,0.836037824441503
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DPP7,Dipeptidyl peptidase 2,15951,0.0140779708691839,0.0682501869156658,-0.119692395485521,0.147848337223889,0.836582590956147
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",15724,0.01200413855957,0.0581963217947244,-0.10206065215809,0.12606892927723,0.836582908756834
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CFHR5,Complement factor H-related protein 5,13796,0.00949220699318342,0.0462221219944604,-0.081103152115959,0.100087566102326,0.83729336132939
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,13913,0.00802215864148317,0.039290065426071,-0.0689863695936159,0.0850306868765823,0.83821755790342
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MPHOSPH8,M-phase phosphoprotein 8,15778,0.017635644738439,0.0864830165892001,-0.151871067776393,0.187142357253271,0.838418395045263
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ACRBP,Acrosin-binding protein,13894,-0.00916320882919726,0.0449468181695104,-0.0972589724414376,0.0789325547830431,0.838459799151756
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DUSP13,Dual specificity protein phosphatase 13 isoform A,13894,-0.00966527102387361,0.0474443816999028,-0.102656259155683,0.0833257171079358,0.83857691980341
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RAB6A,Ras-related protein Rab-6A,16073,-0.0107476431134738,0.0528081698773494,-0.114251656073079,0.092756369846131,0.838729353002207
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HMBS,Porphobilinogen deaminase,16209,0.0100043264869404,0.0492190310306716,-0.086464974333176,0.106473627307057,0.838933320058749
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LRP11,Low-density lipoprotein receptor-related protein 11,16102,-0.00821734161187562,0.0405414237194218,-0.0876785321019424,0.0712438488781911,0.839379894472755
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MED18,Mediator of RNA polymerase II transcription subunit 18,15724,0.0177088460531973,0.0874913355571888,-0.153774171638893,0.189191863745287,0.839601290946244
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DPP10,Inactive dipeptidyl peptidase 10,16073,-0.00788155038072536,0.0390366661144093,-0.0843934159649676,0.0686303152035169,0.839996508342702
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KIF1C,Kinesin-like protein KIF1C,13486,0.00800731685186187,0.0396944229825981,-0.0697937521940304,0.0858083858977541,0.840135563021204
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EFNA4,Ephrin-A4,15924,-0.0068001226905649,0.0337336542777315,-0.0729180850749187,0.0593178396937889,0.84024551147271
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CEP164,Centrosomal protein of 164 kDa,15826,-0.0142291020345522,0.0706652935556998,-0.152733077403724,0.124274873334619,0.840420360266561
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DDX39A,ATP-dependent RNA helicase DDX39A,13552,0.00512203311598452,0.0255123750528334,-0.0448822219875689,0.0551262882195379,0.840884086647361
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SMAD5,Mothers against decapentaplegic homolog 5,16008,-0.00461155679791109,0.0230018710279876,-0.0496952240127669,0.0404721104169447,0.841102930017478
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CNPY2,Protein canopy homolog 2,15778,-0.013690679974092,0.0683106754353898,-0.147579603827456,0.120198243879272,0.8411563712517
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ABCA2,ATP-binding cassette sub-family A member 2,13486,0.00833710559459191,0.0416126231926063,-0.0732236358629163,0.0898978470521002,0.841209574216176
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NINJ1,Ninjurin-1,15724,0.0126338231506747,0.0632235347294712,-0.111284304919089,0.136551951220438,0.841617804118647
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GDF15,Growth/differentiation factor 15,16301,0.00981658860563804,0.0491303712830209,-0.086478939109083,0.106112116320359,0.841634076529644
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,INSR,Insulin receptor,13552,0.00384017040074234,0.0192260275845051,-0.0338428436648876,0.0415231844663723,0.841688407219833
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CLEC5A,C-type lectin domain family 5 member A,16052,0.00666913376870912,0.0334107996148288,-0.0588160334763553,0.0721543010137735,0.841788041932601
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IFNL1,Interferon lambda-1,15688,0.00990008897365849,0.0498906735245266,-0.0878856311344136,0.107685809081731,0.842706789232671
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PAEP,Glycodelin,15950,-0.0294327479578318,0.148444304174072,-0.320383584139014,0.26151808822335,0.842832684460198
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RETN,Resistin,16076,-0.00964412663672035,0.048902858270104,-0.105493728846124,0.0862054755726835,0.843665797456696
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CYTL1,Cytokine-like protein 1,13972,0.00529541094524938,0.0268567657374152,-0.0473438499000844,0.0579346717905832,0.843695557762953
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ARG2,"Arginase-2, mitochondrial",13894,0.0101216059158058,0.051421915718218,-0.0906653488919014,0.110908560723513,0.843959951610909
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PCDH1,Protocadherin-1,16216,0.00464646455141202,0.0238195109387308,-0.0420397768885003,0.0513327059913243,0.845340838681303
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MLLT1,Protein ENL,13480,0.0151491102927291,0.0779545901522686,-0.137641886405717,0.167940106991176,0.845918471786391
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RILP,Rab-interacting lysosomal protein,16164,0.013105278444684,0.0676259257687662,-0.119441536062098,0.145652092951466,0.846342172330085
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GPNMB,Transmembrane glycoprotein NMB,15651,0.00632219408038645,0.0326524351447434,-0.0576765788033106,0.0703209669640835,0.846475242116888
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,16076,-0.00837323044366158,0.0432992354345544,-0.0932397318953882,0.0764932710080651,0.846663383287325
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,THY1,Thy-1 membrane glycoprotein,16230,0.00611201355453084,0.0316200627465753,-0.0558633094287567,0.0680873365378184,0.846730027795929
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SCN2B,Sodium channel subunit beta-2,13590,0.00637914237088989,0.0330935598978192,-0.0584842350288357,0.0712425197706155,0.847149157561944
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,F9,Coagulation factor IX,16155,0.00393576974936036,0.0204494449206651,-0.0361451422951433,0.044016681793864,0.847381653806237
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NGF,Beta-nerve growth factor,15950,-0.00263220729952851,0.0136960018850496,-0.0294763709942258,0.0242119563951687,0.847597389009043
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CDSN,Corneodesmosin,16227,-0.00932435833428637,0.0485460368371057,-0.104474590535013,0.0858258738664407,0.847687826389732
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DPT,Dermatopontin,16301,-0.00565152226845712,0.0296519921609735,-0.0637694269039652,0.052466382367051,0.848845261573911
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IFNL2,Interferon lambda-2,13474,-0.0135251245478994,0.0713425926391141,-0.153356606120563,0.126306357024764,0.849641165017681
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,16230,-0.00581723218648808,0.0307286664763948,-0.0660454184802219,0.0544109541072458,0.84985252493259
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LYZL2,Lysozyme-like protein 2,13480,0.00790014849985875,0.0417987504701651,-0.0740254024216649,0.0898256994213824,0.850092202613345
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,13896,0.0175846258483209,0.0930944856009307,-0.164880565929503,0.200049817626145,0.850181721365612
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DNAJA4,DnaJ homolog subfamily A member 4,13927,0.0154462842908282,0.0820339530493788,-0.145340263685954,0.176232832267611,0.850651006871859
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PSMD9,26S proteasome non-ATPase regulatory subunit 9,16008,0.012002125884729,0.0638158329056879,-0.113076906610419,0.137081158379877,0.85082069758314
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LXN,Latexin,15862,-0.0144912200728789,0.0773883822264455,-0.166172449236712,0.137190009090954,0.851464533659658
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL36A,Interleukin-36 alpha,13552,0.0122324556265158,0.0654248177836367,-0.116000187229412,0.140465098482444,0.851687226679805
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,THBS4,Thrombospondin-4,16123,-0.00968744781324884,0.0518343998712409,-0.111282871560881,0.0919079759343833,0.851747466369889
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MED21,Mediator of RNA polymerase II transcription subunit 21,13486,-0.0106146238273321,0.0569381625024913,-0.122213422332215,0.100984174677551,0.852115302807156
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FMR1,Synaptic functional regulator FMR1,15724,-0.00751117180792895,0.0403042087441036,-0.086507420946372,0.0714850773305141,0.852163318453794
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CLC,Galectin-10,16073,-0.0143829192415841,0.0772170406739446,-0.165728318962515,0.136962480479347,0.85223842065079
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ANGPTL7,Angiopoietin-related protein 7,16209,-0.00774417348755661,0.0416575050782573,-0.089392883440941,0.0739045364658278,0.852524695431068
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CRLF1,Cytokine receptor-like factor 1,16160,0.0053215399830712,0.028791400245114,-0.0511096044973523,0.0617526844634947,0.853364004039378
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DKK4,Dickkopf-related protein 4,15925,0.00969777556909108,0.0525973855480836,-0.0933931001051527,0.112788651243335,0.853719652745215
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CXCL12,Stromal cell-derived factor 1,15826,-0.00843242186459787,0.0457646408049153,-0.0981311178422318,0.0812662741130361,0.853814783394495
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PDGFA,Platelet-derived growth factor subunit A,16301,0.0150219820677131,0.081666226169914,-0.145043821225318,0.175087785360745,0.854059967102297
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NPTX1,Neuronal pentraxin-1,16101,-0.00834113454908176,0.0455148335254325,-0.0975502082589294,0.0808679391607659,0.85459484255747
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CNTF,Ciliary neurotrophic factor,13474,-0.00700706953641365,0.0383203813307195,-0.0821150169446239,0.0681008778717967,0.854914623911117
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SIGLEC5,Sialic acid-binding Ig-like lectin 5,16101,0.024166768221217,0.132576963477988,-0.235684080195639,0.284017616638073,0.855361506082394
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TNN,Tenascin-N,13972,-0.00899444912073444,0.0493776997424626,-0.105774740615961,0.0877858423744923,0.855462870375152
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,15778,-0.00566829363625427,0.0311474092534754,-0.0667172157730661,0.0553806285005575,0.855598541663886
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BEX3,Protein BEX3,13480,0.00956738645027674,0.0526923030531379,-0.0937095275338734,0.112844300434427,0.855922256772334
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,OSMR,Oncostatin-M-specific receptor subunit beta,16205,0.00415513376889172,0.0229962921178728,-0.0409175987821389,0.0492278663199223,0.856615431452713
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CCL7,C-C motif chemokine 7,16073,-0.0120756393400776,0.067097057116642,-0.143585871288696,0.119434592608541,0.857176261787912
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",13486,-0.00822228123609045,0.045708823869771,-0.0978115760208416,0.0813670135486607,0.857246424983284
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IZUMO1,Izumo sperm-egg fusion protein 1,13480,-0.00961472453222807,0.0534884473738949,-0.114452081385062,0.0952226323206059,0.857348957963848
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CALCA,Calcitonin,15925,0.0127454119949074,0.0714096585425482,-0.127217518748487,0.152708342738302,0.858345922242367
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,16272,0.00695001415327545,0.0391185376038545,-0.0697223195502793,0.0836223478568302,0.858987902339768
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CASP4,Caspase-4,13710,-0.0344692988457984,0.195313649019085,-0.417284050923206,0.348345453231609,0.859918077268547
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TNFSF14,Tumor necrosis factor ligand superfamily member 14,15950,0.0115280104621579,0.0653572920952521,-0.116572282044536,0.139628302968852,0.859994156264554
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,16230,0.0091215333647849,0.0518117350229887,-0.0924294672802729,0.110672534009843,0.860255686052611
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NEFL,Neurofilament light polypeptide,15645,0.00870994173160223,0.049508977078022,-0.088327653341321,0.105747536804525,0.860353954291272
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,15778,0.00696030037311255,0.0396390002270763,-0.0707321400719571,0.0846527408181822,0.860616563812246
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PCDH12,Protocadherin-12,13946,0.00497885279176017,0.0285153777076387,-0.0509112875152117,0.060868993098732,0.861394616052548
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PTP4A3,Protein tyrosine phosphatase type IVA 3,13552,-0.0102752379048867,0.0593654367186911,-0.126631493873521,0.106081018063748,0.862587582972557
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TYRO3,Tyrosine-protein kinase receptor TYRO3,16102,0.00556212723854416,0.0321589120987683,-0.0574693404750417,0.06859359495213,0.862686956217715
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,13894,-0.0195283572803023,0.112964005473132,-0.240937808007641,0.201881093447036,0.862754257404726
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LBR,Delta(14)-sterol reductase LBR,16230,0.0134001864225496,0.0777384114674169,-0.138967100053588,0.165767472898687,0.863144595677042
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SIRPB1,Signal-regulatory protein beta-1,16046,-0.00896696835713981,0.052136055616529,-0.111153637365537,0.0932197006512571,0.863446232307623
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,XG,Glycoprotein Xg,16225,-0.00611666778835864,0.0356555063801532,-0.0760014602934589,0.0637681247167417,0.863794217025156
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BCL2,Apoptosis regulator Bcl-2,13913,0.0105516545040468,0.061667594924148,-0.110316831547283,0.131420140555377,0.864143431566112
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FLT3,Receptor-type tyrosine-protein kinase FLT3,15724,-0.00586885454077241,0.0344012002646479,-0.0732952070594822,0.0615574979779374,0.864540271416566
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,16130,0.00995831174494695,0.0588122704577898,-0.105313738352321,0.125230361842215,0.865544153603158
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD200,OX-2 membrane glycoprotein,16073,-0.00497857099928844,0.029585481213839,-0.062966114178413,0.0530089721798361,0.866367088092646
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,B2M,Beta-2-microglobulin,13992,0.00608352696250515,0.0361541732248613,-0.0647786525582231,0.0769457064832334,0.866376262418896
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CRIP2,Cysteine-rich protein 2,15950,0.00693469183493642,0.0412923007002746,-0.0739982175376018,0.0878676012074747,0.866631415145633
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,M6PR,Cation-dependent mannose-6-phosphate receptor,13610,-0.00771102671255922,0.0460543803391158,-0.0979776121772261,0.0825555587521077,0.867031789216961
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GP6,Platelet glycoprotein VI,16074,0.0166954400315468,0.0997586301020979,-0.178831474968565,0.212222355031659,0.867090199581844
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MMP10,Stromelysin-2,16057,-0.0110169250719974,0.0659619429475373,-0.140302333249171,0.118268483105176,0.867356878135121
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PXN,Paxillin,15688,-0.00979177023880376,0.0590113986576814,-0.125454111607859,0.105870571130252,0.86821406013449
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ARTN,Artemin,15826,-0.00874896594844627,0.0528397021514482,-0.112314782165285,0.0948168502683922,0.868493059033541
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",13486,0.0121938078258312,0.0736851862798796,-0.132229157282733,0.156616772934395,0.868564580595594
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TRIAP1,TP53-regulated inhibitor of apoptosis 1,16209,0.0117630680294424,0.0710848751401483,-0.127563287245248,0.151089423304133,0.868568888292115
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,13913,0.00937791497359716,0.0571251262142564,-0.102587332406345,0.12134316235354,0.869604072606319
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GET3,ATPase GET3,13974,-0.0101319719740187,0.0621374807475096,-0.131921434239137,0.1116574902911,0.870475652610694
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SCARF1,Scavenger receptor class F member 1,16301,0.00782304764564247,0.0481574670749092,-0.0865655878211796,0.102211683112465,0.870955687391021
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HK2,Hexokinase-2,15778,-0.00508855462535028,0.0313906237381781,-0.0666141771521795,0.0564370679014789,0.871225809279326
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CCT5,T-complex protein 1 subunit epsilon,15724,0.00843814744442742,0.0521141080961274,-0.0937055044239823,0.110581799312837,0.871373488024295
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SOX2,Transcription factor SOX-2,13923,0.00424658677003662,0.0262903891080633,-0.0472825758817675,0.0557757494218408,0.871681320136
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ALDH1A1,Retinal dehydrogenase 1,16101,0.00987096180652568,0.0612254253099331,-0.110130871800943,0.129872795413995,0.871919597502323
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PODXL2,Podocalyxin-like protein 2,16118,-0.00508688041983075,0.0315900982639531,-0.0670034730171788,0.0568297121775173,0.872073614916502
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SSB,Lupus La protein,15688,-0.0102401091557397,0.0637842063616278,-0.13525715362453,0.114776935313051,0.872455404470704
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HRAS,GTPase Hras,13686,0.0180513790780616,0.11254380278461,-0.202534474379774,0.238637232535897,0.872572886764898
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RICTOR,Rapamycin-insensitive companion of mTOR,13552,0.0091520725323546,0.0570656325239194,-0.102696567214527,0.121000712279237,0.872585704398842
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,C1R,Complement C1r subcomponent,13992,0.00337648851411396,0.0210634165097946,-0.0379078078450834,0.0446607848733113,0.872646220816731
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ODAM,Odontogenic ameloblast-associated protein,15663,0.00953825621187707,0.0595807413575166,-0.107239996848856,0.12631650927261,0.872812570842015
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KRT19,"Keratin, type I cytoskeletal 19",16043,0.0120146110610506,0.075148344509603,-0.135276144177771,0.159305366299873,0.872978731925666
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GZMB,Granzyme B,16073,0.011889506736405,0.0745513328965079,-0.13423110574075,0.158010119213561,0.873292084178531
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GSN,Gelsolin,13928,-0.00325962784978082,0.0204571148282289,-0.0433555729131095,0.0368363172135479,0.873403660522589
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",15688,0.00883415719231443,0.0557297266521386,-0.100396107045877,0.118064421430506,0.874050787919221
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ACRV1,Acrosomal protein SP-10,13552,-0.0135605132569303,0.0856179300992454,-0.181371656251451,0.154250629737591,0.874156555393998
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CDKL5,Cyclin-dependent kinase-like 5,13474,0.00950523299156782,0.0602428899984437,-0.108570831405382,0.127581297388517,0.874631089372078
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",15985,0.0135885094069032,0.0867838313636127,-0.156507800065778,0.183684818879584,0.87557877951059
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PSMA1,Proteasome subunit alpha type-1,15724,0.00819261018501574,0.0523973432246643,-0.0945061825353262,0.110891402905358,0.875754859931566
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EDA2R,Tumor necrosis factor receptor superfamily member 27,16209,-0.00669359655174665,0.0428109593384307,-0.0906030768550707,0.0772158837515774,0.875757198044342
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AIDA,"Axin interactor, dorsalization-associated protein",13590,-0.0156334358140144,0.100489934959707,-0.21259370833504,0.181326836707011,0.876372587104365
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TNC,Tenascin,16174,0.00833155325507483,0.0539144914687354,-0.0973408500236465,0.114003956533796,0.877191640544474
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GSTP1,Glutathione S-transferase P,15586,-0.0117914545897607,0.0767629598033618,-0.16224685580435,0.138663946624828,0.877920307001452
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,16301,-0.00479677622686544,0.031343114812994,-0.0662292812603337,0.0566357288066028,0.878367974714438
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SLITRK1,SLIT and NTRK-like protein 1,13552,0.0056101923044005,0.0367598621527615,-0.066439137515012,0.077659522123813,0.87870232588948
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CEND1,Cell cycle exit and neuronal differentiation protein 1,13474,-0.0100271010808082,0.0668064054427373,-0.140967655748573,0.120913453586957,0.880694350440142
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TERF1,Telomeric repeat-binding factor 1,13552,0.00490991714498183,0.0330009660757827,-0.0597719763635523,0.069591810653516,0.881728649734355
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PON2,Serum paraoxonase/arylesterase 2,15778,0.00582235778065943,0.0393063630064582,-0.0712181137119987,0.0828628292733176,0.882243951301456
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ANXA3,Annexin A3,16198,0.0116520932836724,0.078946300426876,-0.143082655553005,0.166386842120349,0.882664099241563
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ALPP,"Alkaline phosphatase, placental type",16008,-0.017252403417958,0.117071139961398,-0.246711837742299,0.212207030906383,0.882844338690716
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL5RA,Interleukin-5 receptor subunit alpha,16073,0.00926610626062048,0.0629972028797,-0.114208411383591,0.132740623904832,0.883064737619632
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NUP50,Nuclear pore complex protein Nup50,13486,-0.00549999165383174,0.0375125163602768,-0.0790245237199743,0.0680245404123108,0.883436127743302
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SSNA1,Sjoegren syndrome nuclear autoantigen 1,13913,-0.00862279506581003,0.059058226519143,-0.12437691904333,0.10713132891171,0.883919575984313
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,JUN,Transcription factor AP-1,15826,0.00859818991261656,0.0591692858255259,-0.107373610305414,0.124569990130647,0.884463955731417
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD79B,B-cell antigen receptor complex-associated protein beta chain,16272,-0.00725321948979807,0.0501091958926725,-0.105467243439436,0.0909608044598401,0.884911419582215
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AMBN,Ameloblastin,15826,0.00449631772969843,0.0312175693297857,-0.0566901181566816,0.0656827536160784,0.885477319974863
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ANGPTL3,Angiopoietin-related protein 3,16123,-0.00584049368469955,0.0406596042060892,-0.0855333179286345,0.0738523305592354,0.885783672346957
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SIGLEC7,Sialic acid-binding Ig-like lectin 7,16102,0.00461207665847248,0.032150164960089,-0.0584022466633019,0.0676263999802468,0.885933265415154
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FUS,RNA-binding protein FUS,15696,0.00644078018609332,0.0449529216718469,-0.0816669462907266,0.0945485066629133,0.886072199020679
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PMM2,Phosphomannomutase 2,13486,-0.00978954959900637,0.0683554602679061,-0.143766251724102,0.12418715252609,0.886122267242974
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL12RB2,Interleukin-12 receptor subunit beta-2,13552,0.0065661526272383,0.045881014406616,-0.0833606356097291,0.0964929408642057,0.886203360410666
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GAD2,Glutamate decarboxylase 2,13552,-0.00728646884237861,0.0511303455806469,-0.107501946180447,0.0929290084956894,0.886681104634469
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,15826,0.00597110241967592,0.0422858821947254,-0.0769092266819858,0.0888514315213376,0.887707470619536
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ITGA11,Integrin alpha-11,16073,-0.00549773954843871,0.0390251690699115,-0.0819870709254653,0.0709915918285878,0.887969065335131
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TDP1,Tyrosyl-DNA phosphodiesterase 1,13894,0.0116493358080218,0.0828401680268326,-0.15071739352457,0.174016065140614,0.888168837056651
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CPA2,Carboxypeptidase A2,16170,-0.0104001464689446,0.0743530314573147,-0.156132088125281,0.135331795187392,0.888760325715078
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PLXNB3,Plexin-B3,16052,0.00760183906398079,0.0544078374908305,-0.0990375224180469,0.114241200546008,0.888883326543056
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CNTN5,Contactin-5,16122,-0.00585669003344198,0.041996065441732,-0.0881689782992366,0.0764555982323527,0.889089934661218
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,WFDC12,WAP four-disulfide core domain protein 12,16175,0.00997925937500769,0.071714950818614,-0.130582044229476,0.150540562979491,0.889331986158674
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KHDC3L,KH domain-containing protein 3,13480,0.0107779054624545,0.0775528062587318,-0.14122559480466,0.162781405729569,0.889471939705025
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SATB1,DNA-binding protein SATB1,13946,0.00470192362148351,0.0339399615143802,-0.0618204009467016,0.0712242481896686,0.889818423791602
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TAFA5,Chemokine-like protein TAFA-5,16008,0.00560776515084784,0.0406138746390744,-0.0739954291417379,0.0852109594434336,0.890182795989245
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RNASE1,Ribonuclease pancreatic,13982,-0.00385353111068989,0.027953240344418,-0.0586418821857491,0.0509348199643694,0.890355951911382
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NFIC,Nuclear factor 1 C-type,13946,0.00656186429656496,0.0476718059633475,-0.0868748753915961,0.099998603984726,0.890521675734285
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL12B,Interleukin-12 subunit beta,16272,0.00837501552470818,0.061127395708787,-0.111434680064514,0.128184711113931,0.891025220435345
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BRD1,Bromodomain-containing protein 1,13710,0.00483078881059649,0.0353762731874036,-0.0645067066367145,0.0741682842579075,0.891384961169527
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IKZF2,Zinc finger protein Helios,15724,-0.0142500340419324,0.10441009895864,-0.218893828000867,0.190393759917002,0.891442494881564
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SNAP23,Synaptosomal-associated protein 23,16102,0.0135230688604366,0.0991473783819585,-0.180805792768202,0.207851930489075,0.891511831556201
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CPB2,Carboxypeptidase B2,13968,-0.00347842230510769,0.0255129395941663,-0.0534837839096736,0.0465269392994582,0.891554838547465
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,15900,-0.00500892405676351,0.0372410465495339,-0.0780013752938499,0.0679835271803229,0.89300884500649
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ZP3,Zona pellucida sperm-binding protein 3,13610,-0.0401443709598584,0.299462360629738,-0.627090597794144,0.546801855874427,0.893361214673178
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",16008,0.0104661727879381,0.0786979888707802,-0.143781885398791,0.164714230974667,0.894201683421729
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CA4,Carbonic anhydrase 4,16301,-0.00356544615581021,0.0268744793516738,-0.0562394256850909,0.0491085333734704,0.894455744288947
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ANXA1,Annexin A1,13602,-0.00663125001469869,0.0507645873859154,-0.106129841291093,0.0928673412616955,0.896071938524993
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RASSF2,Ras association domain-containing protein 2,15724,-0.0085216283792786,0.0653055331264599,-0.13652047330714,0.119477216548583,0.896181534084696
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CCDC134,Coiled-coil domain-containing protein 134,13894,-0.00723788554133478,0.0555531090101877,-0.116121979201303,0.101646208118633,0.896340717088417
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PSME2,Proteasome activator complex subunit 2,15881,0.00535463265075615,0.0414537475978276,-0.0758947126409859,0.0866039779424982,0.897223777114649
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PLPBP,Pyridoxal phosphate homeostasis protein,16102,-0.0099253061927111,0.0772420170061413,-0.161319659524748,0.141469047139326,0.897757906028358
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DBI,Acyl-CoA-binding protein,16013,-0.0114049856830769,0.0890701785222,-0.185982535586589,0.163172564220435,0.898115017931415
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,16008,-0.00454600631402296,0.0355850176781978,-0.0742926409632906,0.0652006283352447,0.8983479744481
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TP53INP1,Tumor protein p53-inducible nuclear protein 1,15778,0.0043769325153807,0.0344121226794283,-0.0630708279362988,0.0718246929670602,0.898790385726578
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",13480,-0.00809891819839608,0.06378303926854,-0.133113675164735,0.116915838767942,0.898961252572703
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CSH1,Chorionic somatomammotropin hormone 1,13982,-0.00431905236702611,0.0342748341056729,-0.0714977272141451,0.0628596224800928,0.899723962815832
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NXPH3,Neurexophilin-3,13552,0.00426732731817353,0.0340144076997787,-0.0624009117733927,0.0709355664097398,0.900164052136617
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BMP6,Bone morphogenetic protein 6,15752,-0.00575496813253299,0.0462420312438766,-0.0963893493705311,0.0848794131054651,0.900958053440456
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BMPER,BMP-binding endothelial regulator protein,13684,0.00326945604848684,0.0263046787277326,-0.0482877142578691,0.0548266263548428,0.901086061645018
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CNTNAP4,Contactin-associated protein-like 4,13590,0.0151159373318414,0.121671826374056,-0.223360842361309,0.253592717024992,0.901130803026154
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GID8,Glucose-induced degradation protein 8 homolog,13946,-0.00464145428381407,0.0375319424485255,-0.0782040614829241,0.0689211529152959,0.901580903310781
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HEG1,Protein HEG homolog 1,13684,-0.00384110440836589,0.0310750390892051,-0.0647481810232078,0.0570659722064761,0.901627959983265
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,STX5,Syntaxin-5,13552,-0.00553862526297239,0.045261584615336,-0.0942513311090309,0.0831740805830861,0.902608422496579
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SEMA3F,Semaphorin-3F,16102,0.00362190177446178,0.0296147105794398,-0.0544229309612402,0.0616667345101637,0.90266235333396
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,APOC1,Apolipoprotein C-I,13968,-0.00518775670651179,0.0426018418901317,-0.0886873668111698,0.0783118533981462,0.903080502549841
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,13359,0.00445210437342887,0.0366680588309273,-0.0674172909351887,0.0763214996820464,0.903363041128912
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HDAC8,Histone deacetylase 8,13552,0.00839078257330708,0.069256994313647,-0.127352926281441,0.144134491428055,0.903570619821307
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MAGEA3,Melanoma-associated antigen 3,13710,0.0121740785451701,0.100569826801898,-0.184942781986551,0.209290939076891,0.903652412301998
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BPIFB2,BPI fold-containing family B member 2,13954,0.00890171697668306,0.0738995263174878,-0.135941354605593,0.153744788558959,0.904122857991479
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DCUN1D2,DCN1-like protein 2,13480,-0.011190011613837,0.093390661351314,-0.194235707862413,0.171855684634739,0.904628012978203
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD93,Complement component C1q receptor,15499,-0.00422240827867472,0.0353706598255908,-0.0735489015368326,0.0651040849794832,0.904979014351798
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HSPB1,Heat shock protein beta-1,15833,0.00942608447881974,0.0793881705989182,-0.14617472989506,0.165026898852699,0.905487512469575
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DLGAP5,Disks large-associated protein 5,13946,-0.00697635526407205,0.0591075858326571,-0.12282722349608,0.108874512967936,0.906047104965717
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,13552,0.00788267769233232,0.0673026170645315,-0.124030451754149,0.139795807138814,0.906764400408262
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FOLH1,Glutamate carboxypeptidase 2,13552,-0.0141360455286291,0.120798511373861,-0.250901127821397,0.222629036764139,0.906844604087773
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,VAMP5,Vesicle-associated membrane protein 5,15778,0.00706303893679789,0.0604100037452796,-0.11134056840395,0.125466646277546,0.906926233325364
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GPR37,Prosaposin receptor GPR37,15778,-0.00863863489182601,0.0741393834691582,-0.153951826491376,0.136674556707724,0.907242840640958
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SOD3,Extracellular superoxide dismutase,13982,0.00791214776254987,0.068322925134215,-0.126000785500512,0.141825081025611,0.9078086200386
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,13946,-0.015610015029095,0.135147816047393,-0.280499734481985,0.249279704423795,0.908047891355087
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HSP90B1,Endoplasmin,15616,0.00853658245280142,0.0742037197381129,-0.1369027082339,0.153975873139503,0.90841290501682
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CEP350,Centrosome-associated protein 350,13480,0.00489047133204062,0.0426044371931453,-0.0786142255665241,0.0883951682306053,0.908614998811618
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TUBB3,Tubulin beta-3 chain,13474,-0.00357379892412596,0.0312786776109696,-0.0648800070416264,0.0577324091933745,0.909035999055704
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ITGB1,Integrin beta-1,16100,0.00278452362980315,0.0245522792046557,-0.045337943611322,0.0509069908709283,0.90970532430108
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,OFD1,Oral-facial-digital syndrome 1 protein,13710,0.0083631133356629,0.0744040213517333,-0.137468768513734,0.15419499518506,0.910506822742944
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,15724,0.0163214548500019,0.146831449374407,-0.271468185923836,0.30411109562384,0.911492667495906
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,15724,0.00766876001931615,0.0692708879511327,-0.128102180364904,0.143439700403536,0.911850248442495
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CR2,Complement receptor type 2,16174,0.0058348222189577,0.0528484352525658,-0.0977481108760712,0.109417755313987,0.912088197566836
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,VIM,Vimentin,15778,0.0147022822915227,0.133504769833395,-0.246967066581932,0.276371631164978,0.912311230517372
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PRDX6,Peroxiredoxin-6,16209,0.00748849747947989,0.0680852448119032,-0.12595858235185,0.14093557731081,0.91242098175002
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD63,CD63 antigen,15924,0.00636342347805497,0.0579703761380561,-0.107258513752535,0.119985360708645,0.912592959038989
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RPS10,40S ribosomal protein S10,13486,0.00517987589121978,0.047218083423542,-0.0873675676189225,0.097727319401362,0.912648058597195
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IGLON5,IgLON family member 5,13480,-0.0113060416167951,0.103160528980968,-0.213500678419492,0.190888595185901,0.912730952724291
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PEPD,Xaa-Pro dipeptidase,13982,0.00318589020787817,0.0292479463882406,-0.0541400847130733,0.0605118651288296,0.91326197883581
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HYAL1,Hyaluronidase-1,16023,-0.00285731518621068,0.0262430286838163,-0.0542936514064906,0.0485790210340693,0.913299813676783
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FLI1,Friend leukemia integration 1 transcription factor,15724,-0.0136982343170482,0.12627653504042,-0.261200242996271,0.233803774362175,0.913617863910886
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,16107,-0.0032398022827865,0.0299432692068601,-0.0619286099282322,0.0554490053626592,0.913839968600561
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,S100A4,Protein S100-A4,16118,-0.0067096924719827,0.0641861102996851,-0.132514468659366,0.1190950837154,0.916746128007988
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SETMAR,Histone-lysine N-methyltransferase SETMAR,15900,-0.00352359895779892,0.0340215202477374,-0.0702057786433643,0.0631585807277665,0.917512134302285
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GBA,Lysosomal acid glucosylceramidase,13590,-0.00662666666147713,0.0640292306776961,-0.132123958789761,0.118870625466807,0.917572124340816
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,13610,0.00431690614370821,0.041816716784299,-0.0776438587535179,0.0862776710409343,0.917778793654067
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HBZ,Hemoglobin subunit zeta,13974,0.0123058077062961,0.119223834746329,-0.221372908396509,0.245984523809101,0.917793021656483
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CDH15,Cadherin-15,16205,0.00662111204203868,0.0645937093709959,-0.119982558325113,0.133224782409191,0.918357926406923
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PNLIP,Pancreatic triacylglycerol lipase,13982,-0.00723389268160686,0.0706155055492968,-0.145640283558229,0.131172498195015,0.918408452870129
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RNF31,E3 ubiquitin-protein ligase RNF31,13552,-0.00430088852600952,0.0420347078534296,-0.0866889159187315,0.0780871388667124,0.918506137065143
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ERVV_1,,13486,-0.00517315733078508,0.0509738910500574,-0.105081983788898,0.0947356691273275,0.919165853478031
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TAGLN3,Transgelin-3,13480,-0.00704118485547724,0.0694018153877135,-0.143068743015396,0.128986373304441,0.919190517697251
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,VASN,Vasorin,15858,0.00312328964485864,0.0308603198498073,-0.0573629372607637,0.063609516550481,0.919387182658609
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,16008,0.0052745857783796,0.0522085843445135,-0.0970542395368669,0.107603411093626,0.919528634020436
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SHBG,Sex hormone-binding globulin,13982,0.00572955976540416,0.0574933709534199,-0.106957447303299,0.118416566834107,0.920618858256699
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SART1,U4/U6.U5 tri-snRNP-associated protein 1,13486,0.00426795837590743,0.0428850528962851,-0.0797867453008114,0.0883226620526263,0.920726187923771
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KIF20B,Kinesin-like protein KIF20B,13474,-0.00871338967903073,0.0878031547663703,-0.180807573021117,0.163380793663055,0.920950960938259
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CXCL11,C-X-C motif chemokine 11,16230,0.00890610382006002,0.0901946423938355,-0.167875395271858,0.185687602911978,0.921343421695216
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD209,CD209 antigen,16132,0.00432939824899481,0.043859808137468,-0.0816358257004424,0.090294622198432,0.921369818067566
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,13710,-0.00726661632653545,0.0737587588204673,-0.151833783614651,0.137300550961581,0.921521873083844
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SCRG1,Scrapie-responsive protein 1,13974,0.00305098024024429,0.0310334709167167,-0.0577746227565205,0.0638765832370091,0.921685509676288
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RNASEH2A,Ribonuclease H2 subunit A,13946,0.0055091584779991,0.0566432624002763,-0.105511635826543,0.116529952782541,0.922520832219886
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SOD1,Superoxide dismutase [Cu-Zn],15774,-0.0054570175826594,0.0565864791451368,-0.116366516707127,0.105452481541809,0.923174911845939
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NID2,Nidogen-2,16101,-0.00792456983428985,0.0838202215180116,-0.172212204009593,0.156363064341013,0.924679433747451
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IFNGR2,Interferon gamma receptor 2,15950,-0.00552443293894668,0.0585052946674465,-0.120194810487142,0.109145944609248,0.924771787501833
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GAS2,Growth arrest-specific protein 2,13710,-0.00565508096833398,0.0601462871474157,-0.123541803777269,0.112231641840601,0.925092966774578
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",13474,0.00575599346425707,0.0619278119114523,-0.115622517882189,0.127134504810704,0.925947189498477
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,VCPKMT,Protein-lysine methyltransferase METTL21D,13480,-0.00927480469093816,0.100110977080827,-0.20549231976936,0.186942710387484,0.926186786549246
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KYAT1,Kynurenine--oxoglutarate transaminase 1,16075,0.00603017971645029,0.0652253253690676,-0.121811458006922,0.133871817439823,0.926340469912015
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,16101,-0.00379326548319479,0.0413053496992342,-0.0847517508936937,0.0771652199273041,0.926830496524021
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,POF1B,Protein POF1B,13552,0.00474957300992946,0.0517275772513272,-0.0966364784026719,0.106135624422531,0.926843228134969
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DAPK2,Death-associated protein kinase 2,13552,0.00580828652840453,0.0634545471161013,-0.118562625819154,0.130179198875963,0.92706916983918
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NFASC,Neurofascin,16272,0.00290123199845022,0.0318419314246306,-0.0595089535938257,0.0653114175907262,0.927403473909379
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MUC13,Mucin-13,15688,-0.00512521546342816,0.0567912410443728,-0.116436047910399,0.106185616983542,0.92809242037369
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CXCL5,C-X-C motif chemokine 5,16057,0.011790166906031,0.130707942552437,-0.244397400496745,0.267977734308807,0.928127522762964
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,13710,-0.00765005084022471,0.0848195680996193,-0.173896404315479,0.158596302635029,0.928135919572835
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KRT8,"Keratin, type II cytoskeletal 8",13474,0.00734511567225136,0.0815900774676436,-0.15257143616433,0.167261667508833,0.92826899027868
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PCSK9,Proprotein convertase subtilisin/kexin type 9,16301,0.00395806975766968,0.044613588943407,-0.083484564571408,0.0914007040867474,0.929306380782795
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PKLR,Pyruvate kinase PKLR,16102,-0.00669897865167832,0.0755809104069928,-0.154837563049384,0.141439605746027,0.929374517953411
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SUSD1,Sushi domain-containing protein 1,15778,-0.00483202459310717,0.054546278491436,-0.111742730436322,0.102078681250107,0.929412235341203
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CCNE1,G1/S-specific cyclin-E1,13552,-0.00926749634163074,0.105468617313396,-0.215985986275887,0.197450993592626,0.929981534605257
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KLK4,Kallikrein-4,16209,0.00620290556651581,0.0709450588399804,-0.132849409759846,0.145255220892877,0.930328798844517
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,13894,0.00849887792849117,0.0991332900970579,-0.185802370661742,0.202800126518725,0.93168083871672
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PPBP,Platelet basic protein,13890,-0.00812832671337993,0.0956779916161329,-0.195657190281,0.179400536854241,0.932298367342492
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ZBP1,Z-DNA-binding protein 1,13552,-0.00398682068957446,0.0469990624533462,-0.096104983098133,0.088131341718984,0.932399654241237
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TBCC,Tubulin-specific chaperone C,15950,0.00765899215970919,0.0911633931220363,-0.171021258359482,0.1863392426789,0.933046435820073
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,STAT5B,Signal transducer and activator of transcription 5B,16008,0.0130129467696221,0.1554001948171,-0.291571435071895,0.317597328611139,0.933265560038498
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RBM17,Splicing factor 45,13946,-0.00723451104801346,0.0864285588207953,-0.176634486336772,0.162165464240745,0.933292105797587
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CSF3,Granulocyte colony-stimulating factor,15826,-0.00459253073166199,0.0557261534955108,-0.113815791582863,0.104630730119539,0.934319752199904
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ACVRL1,Serine/threonine-protein kinase receptor R3,15924,-0.00226857827564185,0.027589730855648,-0.0563444507527119,0.0518072942014282,0.934468463215151
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SEMA4C,Semaphorin-4C,16008,-0.00255573729304274,0.0314799009355151,-0.0642563431266524,0.0591448685405669,0.935294794949099
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ITGA5,Integrin alpha-5,16101,0.00227052044006839,0.0284305741821623,-0.0534534049569696,0.0579944458371064,0.936348064304688
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SULT1A1,Sulfotransferase 1A1,16230,-0.0114662732835045,0.145313600732113,-0.296280930718446,0.273348384151437,0.937107497930805
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL12A_IL12B,Interleukin-12,16008,0.00690810858776025,0.0875583014614273,-0.164706162276637,0.178522379452158,0.937115343185582
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MORF4L2,Mortality factor 4-like protein 2,13480,-0.0033891242204373,0.0432567958161738,-0.0881724440201379,0.0813941955792633,0.937551650485066
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,16008,0.00351421492819438,0.0449326612967051,-0.0845538012133475,0.0915822310697363,0.937661428473144
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CCL11,Eotaxin,16272,-0.00327860124135313,0.0427202230063109,-0.0870102383337225,0.0804530358510163,0.938826647063431
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CDAN1,Codanin-1,13927,0.00206282567329045,0.0269801227027109,-0.050818214824023,0.0549438661706039,0.939056432520259
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD22,B-cell receptor CD22,16272,-0.00358667298040148,0.0470701956566523,-0.0958442564674399,0.0886709105066369,0.939262203603554
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,16130,0.00554914103181661,0.0732048613934061,-0.137932387299259,0.149030669362892,0.939576847151733
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD109,CD109 antigen,16101,-0.00285801129111913,0.0377689627121572,-0.0768851782069472,0.0711691556247089,0.939681871284641
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PXDNL,Peroxidasin-like protein,13894,-0.00489431903869741,0.0647218532243583,-0.13174915135844,0.121960513281045,0.939721868822801
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TGFBR1,TGF-beta receptor type-1,13552,-0.00200585518605901,0.0265287292468324,-0.0540021645098505,0.0499904541377325,0.939729958753986
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,15950,-0.00626153309112683,0.0832204811825791,-0.169373676208982,0.156850610026728,0.940024473283009
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,13590,-0.0043025556446951,0.0574610403872941,-0.116926194803791,0.108321083514401,0.940313052164038
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD7,T-cell antigen CD7,13524,-0.00358261515531487,0.0490725331046787,-0.0997647800404851,0.0925995497298553,0.941802005285875
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CRISP2,Cysteine-rich secretory protein 2,16209,-0.00476143019327989,0.0653645867666794,-0.132876020255972,0.123353159869412,0.941931007623828
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SHD,SH2 domain-containing adapter protein D,13457,-0.00694845536810498,0.0960109923788383,-0.195130000430628,0.181233089694418,0.942307376206867
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NPPC,C-type natriuretic peptide,16073,0.00381911076363139,0.0535795134010936,-0.101196735502512,0.108834957029775,0.943176348899632
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CA2,Carbonic anhydrase 2,16046,0.00567409194710091,0.0797531599674462,-0.150642101589094,0.161990285483295,0.943282708788222
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL2,Interleukin-2,15826,0.00251872733732799,0.0355046793322313,-0.0670704441538454,0.0721078988285014,0.943445836275242
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SUGT1,Protein SGT1 homolog,15724,0.0064649469125405,0.0917543920684278,-0.173373661541578,0.186303555366659,0.943829019568512
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SLURP1,Secreted Ly-6/uPAR-related protein 1,13870,-0.00301898352603577,0.0428829540638924,-0.0870695734912649,0.0810316064391933,0.943875869956638
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PRR5,Proline-rich protein 5,13552,0.00368463663755614,0.0523697746472306,-0.0989601216710159,0.106329394946128,0.943909697432761
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CXCL17,C-X-C motif chemokine 17,16272,-0.00329319315766786,0.0469856704143939,-0.0953851071698799,0.0887987208545441,0.94412343823606
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GBP6,Guanylate-binding protein 6,13486,-0.00352230472559724,0.0514881933324041,-0.104439163657109,0.0973945542059148,0.945460316777557
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MIF,Macrophage migration inhibitory factor,16077,0.00525140144359444,0.0769777946484487,-0.145625076067365,0.156127878954554,0.945611600632779
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CCL28,C-C motif chemokine 28,16012,0.00458317382956944,0.0672353378650654,-0.127198088385959,0.136364436045098,0.945654228061427
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SELPLG,P-selectin glycoprotein ligand 1,16073,0.00217659627836243,0.031975905778766,-0.060496179048019,0.0648493716047439,0.945730849249861
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CRYM,Ketimine reductase mu-crystallin,13474,-0.00583875236770655,0.0864121181906849,-0.175206504021449,0.163528999286036,0.946129995378203
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RBP1,Retinol-binding protein 1,13590,-0.00554073613408895,0.0828946856255606,-0.168014319960188,0.15693284769201,0.946709531920557
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CYB5A,Cytochrome b5,13480,-0.00558267616788221,0.0835478960676275,-0.169336552460432,0.158171200124668,0.946725938474063
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SERPINC1,Antithrombin-III,13968,0.00111186717155737,0.0166787609811565,-0.0315785043515094,0.0338022386946242,0.946850423904741
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EFCAB2,Dynein regulatory complex protein 8,13710,0.00268426252800665,0.0410527684856214,-0.0777791637038113,0.0831476887598246,0.947867892403728
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PDCD5,Programmed cell death protein 5,16230,0.00429430454013846,0.0661787465109324,-0.125416038621289,0.134004647701566,0.948262795445743
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CMIP,C-Maf-inducing protein,13894,-0.00610919842715599,0.0947931812779659,-0.191903833731969,0.179685436877657,0.948614712214447
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ID4,DNA-binding protein inhibitor ID-4,13710,-0.00325226619439615,0.0505831202385637,-0.102395181861981,0.0958906494731886,0.948735887651443
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MUCL3,Mucin-like protein 3,13480,0.00307572502717491,0.0481458391082925,-0.0912901196250783,0.0974415696794281,0.949063933550143
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TXNDC9,Thioredoxin domain-containing protein 9,13927,-0.00383629060143678,0.0604611789921301,-0.122340201426012,0.114667620223138,0.94940870547002
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PADI2,Protein-arginine deiminase type-2,15826,0.00406973452747961,0.0644909336145196,-0.122332495356979,0.130471964411938,0.949683268664445
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SERPINB1,Leukocyte elastase inhibitor,16049,0.00642470645529969,0.102049295344169,-0.193591912419272,0.206441325329872,0.949801616176468
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KLHL41,Kelch-like protein 41,13946,0.00351648593602739,0.0563079688486055,-0.106847133007239,0.113880104879294,0.950204620732394
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SFTPA1,Pulmonary surfactant-associated protein A1,15724,0.00397847293196529,0.0653705723641707,-0.124147848901809,0.13210479476574,0.951471237493315
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CEP152,Centrosomal protein of 152 kDa,13480,0.00293180944689691,0.0482619640768149,-0.0916616401436604,0.0975252590374542,0.95156094301005
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DDC,Aromatic-L-amino-acid decarboxylase,16085,0.00330902233522673,0.0552162529869042,-0.104914833519106,0.111532878189559,0.952213396532195
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MANSC4,MANSC domain-containing protein 4,13486,0.00450080389245408,0.0751345999431318,-0.142763011996084,0.151764619780992,0.952233609962563
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,BMP10,Bone morphogenetic protein 10,13684,0.00191165624553558,0.0321096300274552,-0.0610232186082765,0.0648465310993477,0.952526625490143
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,VSTM1,V-set and transmembrane domain-containing protein 1,15688,0.00330106228339,0.055538486421674,-0.105554371103091,0.112156495669871,0.95260449616709
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SNCG,Gamma-synuclein,15950,-0.0044018019505068,0.0743232048029702,-0.150075283364328,0.141271679463315,0.952773531350406
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CHRDL2,Chordin-like protein 2,16102,-0.00358517820622608,0.0617480898851516,-0.124611434381123,0.117441077968671,0.95370047211221
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FDX2,"Ferredoxin-2, mitochondrial",13486,0.0036766913107946,0.063461045622352,-0.120706958109015,0.128060340730605,0.953800313892895
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,15950,-0.00261556156084839,0.0458370818996371,-0.0924562420841372,0.0872251189624404,0.954496417927278
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FGR,Tyrosine-protein kinase Fgr,15688,0.00373540980836269,0.0664092966700598,-0.126426811664954,0.13389763128168,0.955144723958854
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PKN3,Serine/threonine-protein kinase N3,13710,0.0049010114231787,0.0874017017289297,-0.166406323965523,0.176208346811881,0.955283233138649
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,16142,-0.00306672430326179,0.0558500497487917,-0.112532821810893,0.10639937320437,0.956210872703674
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,13972,0.0015925574521509,0.0290112388081389,-0.0552694706118014,0.0584545855161032,0.956223299203901
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CST5,Cystatin-D,15777,-0.00333166174601799,0.0628827760453032,-0.126581902794812,0.119918579302776,0.957746838446736
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SCG2,Secretogranin-2,16140,0.00190575771575405,0.0360158377372259,-0.0686852842492087,0.0724967996807167,0.957800738239293
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CRIM1,Cysteine-rich motor neuron 1 protein,16160,0.00119393913247312,0.022586772043646,-0.0430761340730731,0.0454640123380194,0.957844025809018
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NUDT16,U8 snoRNA-decapping enzyme,13891,0.00525144396395596,0.100098448445338,-0.190941514988906,0.201444402916818,0.958160698235922
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SLAMF1,Signaling lymphocytic activation molecule,15826,0.00353543895506903,0.0680054491590416,-0.129755241396652,0.13682611930679,0.958539243814094
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,15950,0.00226390665814395,0.0450497427627242,-0.0860335891567955,0.0905614024730834,0.959921018785218
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,16073,-0.00216093149409219,0.0435115947605848,-0.0874436572248384,0.0831217942366541,0.960391281694226
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SAP18,Histone deacetylase complex subunit SAP18,13710,0.00415236068823537,0.0847501713391465,-0.161957975136492,0.170262696512963,0.960923750109948
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NGRN,Neugrin,13927,-0.00125959543738041,0.0257855890095354,-0.0517993498960697,0.0492801590213089,0.961040481933282
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FAM171B,Protein FAM171B,13894,-0.00154741268623159,0.0318349348088201,-0.0639438849115189,0.0608490595390558,0.961232890074841
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SSH3,Protein phosphatase Slingshot homolog 3,13480,-0.00160817500006852,0.0334066873728759,-0.0670852822509053,0.0638689322507683,0.961605928684071
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,13972,0.00760705271194234,0.158651358279497,-0.303349609515872,0.318563714939756,0.961758183087432
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,MRI1,Methylthioribose-1-phosphate isomerase,13590,0.0037318968336963,0.0783174935548378,-0.149770390533786,0.157234184201178,0.961995189247348
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,16101,-0.00157610635216468,0.0332462377475874,-0.0667387323374359,0.0635865196331066,0.962189391613369
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ANKRA2,Ankyrin repeat family A protein 2,13480,-0.00300318491058879,0.064584689585885,-0.129589176498923,0.123582806677746,0.962912462563171
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SERPINA1,Alpha-1-antitrypsin,13724,0.000412339860823195,0.00888013948377052,-0.016992733527367,0.0178174132490134,0.962965062055895
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LIF,Leukemia inhibitory factor,15688,-0.00262884726560266,0.0575101256643311,-0.115348693567692,0.110090999036486,0.963541152084946
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,S100A3,Protein S100-A3,13894,-0.00224672144275393,0.049291483708991,-0.0988580295123763,0.0943645866268684,0.963645413500186
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AIF1,Allograft inflammatory factor 1,15724,-0.00268909984344577,0.0595222128275084,-0.119352636985362,0.113974437298471,0.963965932870513
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CLEC12A,C-type lectin domain family 12 member A,13552,-0.0010103530819992,0.0225092764342618,-0.0451285348931524,0.043107828729154,0.964198777799252
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IL6ST,Interleukin-6 receptor subunit beta,16102,-0.000897221117043963,0.0199926295335935,-0.0400827750028872,0.0382883327687993,0.964205432993507
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HNF1A,Hepatocyte nuclear factor 1-alpha,13590,-0.00384539567474162,0.0863141316406387,-0.173021093690394,0.16533030234091,0.964465718773774
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SEMA4D,Semaphorin-4D,16230,-0.00150692747705686,0.033909837142874,-0.06797020827709,0.0649563533229763,0.964554828690295
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GH1,Somatotropin,16085,0.00888749237416405,0.202163512956939,-0.387352993021437,0.405127977769765,0.964935319133072
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SIGLEC1,Sialoadhesin,16160,-0.00207138378481696,0.0476726864286121,-0.0955098491848967,0.0913670816152627,0.965343265405809
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,KLK6,Kallikrein-6,16100,0.00149829478206179,0.0345254475844934,-0.0661715824835452,0.0691681720476688,0.965385747809753
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,FEN1,Flap endonuclease 1,15724,0.00320158691509804,0.0741220035527957,-0.142077540048382,0.148480713878578,0.965547855286751
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SERPINA5,Plasma serine protease inhibitor,13802,0.00151108519782983,0.035693972853911,-0.0684491015958357,0.0714712719914953,0.966232684845069
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GGT5,Glutathione hydrolase 5 proenzyme,15950,0.00109529050317113,0.0259841286407432,-0.0498336016326855,0.0520241826390278,0.966377824572777
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SORBS1,Sorbin and SH3 domain-containing protein 1,13946,0.00182670866871341,0.0433947429758117,-0.0832269875638775,0.0868804049013043,0.966423441370519
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ITGAX,Integrin alpha-X,13710,-0.00255040132886019,0.0606163470734107,-0.121358441592745,0.116257638935025,0.966439936868894
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,VTCN1,V-set domain-containing T-cell activation inhibitor 1,15724,-0.00155112767429857,0.0368717707153733,-0.0738197982764302,0.070717542927833,0.966444894251906
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD177,CD177 antigen,16073,-0.00604861313512636,0.144495744941739,-0.289260273220935,0.277163046950682,0.966610706960218
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,XRCC4,DNA repair protein XRCC4,15688,0.00172184709541251,0.0411629810078552,-0.0789575956799836,0.0824012898708086,0.966634759943869
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CREG1,Protein CREG1,15846,0.00181217722968407,0.0434980226712851,-0.0834439472060348,0.087068301665403,0.966769357865189
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,VEGFC,Vascular endothelial growth factor C,16118,0.00258227559388226,0.0637735177997283,-0.122413819293585,0.12757837048135,0.967701907989024
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,13480,0.00119291018777083,0.0302490369273553,-0.0580952021898456,0.0604810225653873,0.968543121364434
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SIGLEC10,Sialic acid-binding Ig-like lectin 10,16073,-0.00148170802132368,0.0375981307848336,-0.0751740443595975,0.0722106283169501,0.968564724741562
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LEP,Leptin,16102,-0.0029820158849844,0.0761997965292871,-0.152333617082387,0.146369585312418,0.96878390270841
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,13894,0.00322182005623841,0.0834134792172292,-0.160268599209531,0.166712239322008,0.969190170019862
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DAND5,DAN domain family member 5,13552,-0.0023137686422109,0.0622821211102182,-0.124386726018239,0.119759188733817,0.970366108662434
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,REG4,Regenerating islet-derived protein 4,16107,0.00199846158439317,0.0553747181711013,-0.106535986030965,0.110532909199752,0.971211216308488
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,15724,-0.00273078017107506,0.0772719417724884,-0.154183786045152,0.148722225703002,0.971809182624323
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PFDN6,Prefoldin subunit 6,13590,0.00255332742286686,0.0724605693597455,-0.139469388522234,0.144576043367968,0.971890898967663
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HDAC9,Histone deacetylase 9,13474,-0.00256797963065237,0.0736962367599723,-0.147012603680198,0.141876644418893,0.972203483588117
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DDR1,Epithelial discoidin domain-containing receptor 1,16230,0.000888496408594223,0.0258225292429286,-0.0497236609075458,0.0515006537247342,0.972552387553241
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CUZD1,CUB and zona pellucida-like domain-containing protein 1,13590,0.00151329886585307,0.0441483451331189,-0.08501745759506,0.0880440553267662,0.972656299025584
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,APOA1,Apolipoprotein A-I,13992,0.00102087805642558,0.0304728816487931,-0.0587059699752089,0.0607477260880601,0.973275388457614
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LAMP1,Lysosome-associated membrane glycoprotein 1,13578,0.00106520312216038,0.0319042165821058,-0.061467061378767,0.0635974676230878,0.973366041654971
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CLEC2L,C-type lectin domain family 2 member L,13590,0.00201324588335407,0.0605481510215214,-0.116661130118828,0.120687621885536,0.973475453130049
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,STK11,Serine/threonine-protein kinase STK11,15778,0.00246174109929531,0.0817892822238439,-0.157845252059439,0.162768734258029,0.975988815749535
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,USP28,Ubiquitin carboxyl-terminal hydrolase 28,13927,-0.00130236014998798,0.043631420425751,-0.0868199441844599,0.0842152238844839,0.9761878004331
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,AK1,Adenylate kinase isoenzyme 1,16102,0.00210712146528126,0.0728287803810452,-0.140637288081567,0.14485153101213,0.976918753678336
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CLGN,Calmegin,13590,0.00148313732066058,0.0515294507149969,-0.0995145860807333,0.102480860722054,0.977038621904584
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SPRING1,SREBP regulating gene protein,13480,-0.00201333703801546,0.0700729500704035,-0.139356319176006,0.135329645099975,0.977078748566963
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GAGE2A,G antigen 2A,13480,0.00212961310001564,0.0742363939785507,-0.143373719097944,0.147632945297975,0.977114717757261
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,REXO2,"Oligoribonuclease, mitochondrial",13486,-0.00163351657566664,0.0577721766505872,-0.114866982810818,0.111599949659484,0.977443124230582
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GAD1,Glutamate decarboxylase 1,13480,0.000834290271466104,0.029980312767587,-0.0579271227530044,0.0595957032959366,0.977799796012964
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SPINK6,Serine protease inhibitor Kazal-type 6,16209,0.00156246917536794,0.0604315203382301,-0.116883310687563,0.120008249038299,0.979373150142469
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,13913,0.00116443166373247,0.0457097466762077,-0.0884266718216347,0.0907555351490996,0.979676875949131
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RNF43,E3 ubiquitin-protein ligase RNF43,13710,0.00169033020627283,0.0676070596958975,-0.130819506797686,0.134200167210232,0.980053514325257
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ERCC1,DNA excision repair protein ERCC-1,13480,0.000907372268969377,0.0363819191747114,-0.070401189313465,0.0722159338514037,0.980103033353437
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,DHODH,Dihydroorotate dehydrogenase,13486,0.00133006499129271,0.0540867344717856,-0.104679934573407,0.107340064555992,0.980381295317575
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SEMA7A,Semaphorin-7A,16251,-0.000706833868731025,0.0307055643746777,-0.0608897400430993,0.0594760723056372,0.981634815975021
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,16008,-0.000927092010655822,0.0433190126756914,-0.085832356855011,0.0839781728336993,0.98292564102171
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,16008,-0.00105147273744954,0.0491804457549978,-0.0974451464172453,0.0953422009423462,0.982942878534973
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EPCAM,Epithelial cell adhesion molecule,16081,0.00229551482650046,0.10888328679836,-0.211115727298285,0.215706756951286,0.98318023160316
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,VSIG2,V-set and immunoglobulin domain-containing protein 2,13894,0.00139980646946571,0.0681592314701991,-0.132192287212125,0.134991900151056,0.983615053796901
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CD74,HLA class II histocompatibility antigen gamma chain,16230,0.000787277113142637,0.0387009402091243,-0.0750665656967409,0.0766411199230262,0.983770336255376
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TPPP2,Tubulin polymerization-promoting protein family member 2,13710,0.0018638100050691,0.0935304578318507,-0.181455887345358,0.185183507355497,0.984101653122821
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RPL14,60S ribosomal protein L14,13610,-0.000850712251141187,0.0458727849097399,-0.0907613706742313,0.0890599461719489,0.985204325740926
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,RBP2,Retinol-binding protein 2,16008,-0.00155699503490968,0.0864556329964682,-0.171010035707987,0.167896045638168,0.985631754857415
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ANXA10,Annexin A10,15688,-0.00164671374197366,0.0914574754196794,-0.180903365564545,0.177609938080598,0.985634902808506
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ROBO4,Roundabout homolog 4,13610,-0.000345728886468155,0.0202146341212263,-0.0399664117640718,0.0392749539911354,0.98635477553118
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CRISP3,Cysteine-rich secretory protein 3,13858,0.000519361154636407,0.0304639017080842,-0.0591898861932085,0.0602286085024813,0.986398239669361
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TEF,Thyrotroph embryonic factor,13486,0.000809294621896712,0.0478289654019725,-0.0929354775659694,0.0945540668097629,0.986500212098344
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NME1,Nucleoside diphosphate kinase A,13552,-0.000393508819949543,0.0243168922499135,-0.04805461762978,0.0472675999898809,0.987089011748916
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GAST,Gastrin,13927,0.00229303100622797,0.146826144356211,-0.285486211931946,0.290072273944402,0.987539911255733
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IDUA,Alpha-L-iduronidase,16209,0.000763019073474649,0.0526045848884783,-0.102341967307943,0.103868005454892,0.988427427117734
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,INSL3,Insulin-like 3,13927,0.00115099118239376,0.08529552189117,-0.166028231724299,0.168330214089087,0.989233740525719
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PRND,Prion-like protein doppel,13927,0.000774191372800455,0.0585908733141138,-0.114063920322862,0.115612303068463,0.989457636773185
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NXPE4,NXPE family member 4,13486,-0.000489811621002922,0.0385149716080985,-0.0759791559728761,0.0749995327308702,0.989853417343291
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HPGDS,Hematopoietic prostaglandin D synthase,15724,0.000545092323195148,0.0433536554507018,-0.0844280723601805,0.0855182570065708,0.989968495988526
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HMOX1,Heme oxygenase 1,15911,-0.000602589860149051,0.0543623884601299,-0.107152871242004,0.105947691521706,0.991156022532608
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,IGFBP6,Insulin-like growth factor-binding protein 6,16045,-0.000366252565669558,0.0333050879848707,-0.0656442250160161,0.064911719884677,0.991226060704099
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,16174,-0.000496830724895126,0.047704934580714,-0.0939985025030945,0.0930048410533043,0.991690581504218
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ANXA5,Annexin A5,15627,-0.000341349700477054,0.0338370607064923,-0.0666619886852021,0.0659792892842479,0.9919511721942
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,13590,0.00120024014175989,0.120521546081889,-0.235021990178742,0.237422470462262,0.992054369989389
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,TNPO1,Transportin-1,13710,-0.000380533829800391,0.0420256800693746,-0.0827508667657747,0.0819897991061739,0.992775551141386
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EVPL,Envoplakin,13710,0.000226721872753655,0.0376737028810282,-0.0736137357740615,0.0740671795195688,0.995198414966813
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,ACP1,Low molecular weight phosphotyrosine protein phosphatase,13552,0.00028749069036373,0.0507478018394079,-0.0991782009148758,0.0997531822956033,0.995480022542919
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,CPVL,Probable serine carboxypeptidase CPVL,16175,-0.000244165016308989,0.0455977842760902,-0.0896158221974458,0.0891274921648278,0.995727609242275
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,HIP1R,Huntingtin-interacting protein 1-related protein,13903,0.000243100613852131,0.0507598329025074,-0.0992461718750624,0.0997323731027667,0.996178829153666
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,EIF5A,Eukaryotic translation initiation factor 5A-1,15826,-0.000134836095643919,0.034828634051452,-0.0683989588364898,0.068129286645202,0.996911114312626
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PGR,Progesterone receptor,13552,0.000386206975950088,0.117250679417243,-0.229425124681846,0.230197538633746,0.997371935605901
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,F10,Coagulation factor X,13982,8.5996319682507e-05,0.0299655212744053,-0.0586464253781519,0.0588184180175169,0.997710241284465
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,NECAP2,Adaptin ear-binding coat-associated protein 2,13486,0.000156986093440917,0.0767559909125504,-0.150284756095158,0.15059872828204,0.998368148635343
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,GPA33,Cell surface A33 antigen,16008,-0.000277352739474369,0.15337509371851,-0.300892536427753,0.300337830948804,0.998557184978784
Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,PNLIPRP2,Pancreatic lipase-related protein 2,16076,9.38567464858103e-05,0.332535488703315,-0.651675701112012,0.651863414604984,0.999774803938477
